This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection  (1000 codes) of the whole set of codes is shown
| Code | Display | 
|  1-8 | Acyclovir [Susceptibility] | 
|  10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer | 
|  100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10000-8 | R wave duration in lead AVR | 
|  10001-6 | R wave duration in lead I | 
|  10002-4 | R wave duration in lead II | 
|  10003-2 | R wave duration in lead III | 
|  10004-0 | R wave duration in lead V1 | 
|  10005-7 | R wave duration in lead V2 | 
|  10006-5 | R wave duration in lead V3 | 
|  10007-3 | R wave duration in lead V4 | 
|  10008-1 | R wave duration in lead V5 | 
|  10009-9 | R wave duration in lead V6 | 
|  1001-7 | DBG Ab [Presence] in Serum or Plasma from donor | 
|  10010-7 | R' wave amplitude in lead AVF | 
|  10011-5 | R' wave amplitude in lead AVL | 
|  10012-3 | R' wave amplitude in lead AVR | 
|  10013-1 | R' wave amplitude in lead I | 
|  10014-9 | R' wave amplitude in lead II | 
|  10015-6 | R' wave amplitude in lead III | 
|  10016-4 | R' wave amplitude in lead V1 | 
|  10017-2 | R' wave amplitude in lead V2 | 
|  10018-0 | R' wave amplitude in lead V3 | 
|  10019-8 | R' wave amplitude in lead V4 | 
|  1002-5 | DBG Ab [Presence] in Serum or Plasma | 
|  10020-6 | R' wave amplitude in lead V5 | 
|  10021-4 | R' wave amplitude in lead V6 | 
|  10022-2 | R' wave duration in lead AVF | 
|  10023-0 | R' wave duration in lead AVL | 
|  10024-8 | R' wave duration in lead AVR | 
|  10025-5 | R' wave duration in lead I | 
|  10026-3 | R' wave duration in lead II | 
|  10027-1 | R' wave duration in lead III | 
|  10028-9 | R' wave duration in lead V1 | 
|  10029-7 | R' wave duration in lead V2 | 
|  1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | 
|  10030-5 | R' wave duration in lead V3 | 
|  10031-3 | R' wave duration in lead V4 | 
|  10032-1 | R' wave duration in lead V5 | 
|  10033-9 | R' wave duration in lead V6 | 
|  10034-7 | S wave amplitude in lead AVF | 
|  10035-4 | S wave amplitude in lead AVL | 
|  10036-2 | S wave amplitude in lead AVR | 
|  10037-0 | S wave amplitude in lead I | 
|  10038-8 | S wave amplitude in lead II | 
|  10039-6 | S wave amplitude in lead III | 
|  1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | 
|  10040-4 | S wave amplitude in lead V1 | 
|  10041-2 | S wave amplitude in lead V2 | 
|  10042-0 | S wave amplitude in lead V3 | 
|  10043-8 | S wave amplitude in lead V4 | 
|  10044-6 | S wave amplitude in lead V5 | 
|  10045-3 | S wave amplitude in lead V6 | 
|  10046-1 | S wave duration in lead AVF | 
|  10047-9 | S wave duration in lead AVL | 
|  10048-7 | S wave duration in lead AVR | 
|  10049-5 | S wave duration in lead I | 
|  1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | 
|  10050-3 | S wave duration in lead II | 
|  10051-1 | S wave duration in lead III | 
|  10052-9 | S wave duration in lead V1 | 
|  10053-7 | S wave duration in lead V2 | 
|  10054-5 | S wave duration in lead V3 | 
|  10055-2 | S wave duration in lead V4 | 
|  10056-0 | S wave duration in lead V5 | 
|  10057-8 | S wave duration in lead V6 | 
|  10058-6 | S' wave amplitude in lead AVF | 
|  10059-4 | S' wave amplitude in lead AVL | 
|  1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells | 
|  10060-2 | S' wave amplitude in lead AVR | 
|  10061-0 | S' wave amplitude in lead I | 
|  10062-8 | S' wave amplitude in lead II | 
|  10063-6 | S' wave amplitude in lead III | 
|  10064-4 | S' wave amplitude in lead V1 | 
|  10065-1 | S' wave amplitude in lead V2 | 
|  10066-9 | S' wave amplitude in lead V3 | 
|  10067-7 | S' wave amplitude in lead V4 | 
|  10068-5 | S' wave amplitude in lead V5 | 
|  10069-3 | S' wave amplitude in lead V6 | 
|  1007-4 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | 
|  10070-1 | S' wave duration in lead AVF | 
|  10071-9 | S' wave duration in lead AVL | 
|  10072-7 | S' wave duration in lead AVR | 
|  10073-5 | S' wave duration in lead I | 
|  10074-3 | S' wave duration in lead II | 
|  10075-0 | S' wave duration in lead III | 
|  10076-8 | S' wave duration in lead V1 | 
|  10077-6 | S' wave duration in lead V2 | 
|  10078-4 | S' wave duration in lead V3 | 
|  10079-2 | S' wave duration in lead V4 | 
|  1008-2 | Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma | 
|  10080-0 | S' wave duration in lead V5 | 
|  10081-8 | S' wave duration in lead V6 | 
|  10082-6 | ST initial amplitude 6 ms in lead AVF | 
|  10083-4 | ST initial amplitude 6 ms in lead AVL | 
|  10084-2 | ST initial amplitude 6 ms in lead AVR | 
|  10085-9 | ST initial amplitude 6 ms in lead I | 
|  10086-7 | ST initial amplitude 6 ms in lead II | 
|  10087-5 | ST initial amplitude 6 ms in lead III | 
|  10088-3 | ST initial amplitude 6 ms in lead V1 | 
|  10089-1 | ST initial amplitude 6 ms in lead V2 | 
|  1009-0 | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | 
|  10090-9 | ST initial amplitude 6 ms in lead V3 | 
|  10091-7 | ST initial amplitude 6 ms in lead V4 | 
|  10092-5 | ST initial amplitude 6 ms in lead V5 | 
|  10093-3 | ST initial amplitude 6 ms in lead V6 | 
|  10094-1 | ST slope in lead AVF | 
|  10095-8 | ST slope in lead AVL | 
|  10096-6 | ST slope in lead AVR | 
|  10097-4 | ST slope in lead I | 
|  10098-2 | ST slope in lead II | 
|  10099-0 | ST slope in lead III | 
|  101-6 | Cefoperazone [Susceptibility] by Disk diffusion (KB) | 
|  1010-8 | Ew Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10100-6 | ST slope in lead V1 | 
|  10101-4 | ST slope in lead V2 | 
|  10102-2 | ST slope in lead V3 | 
|  10103-0 | ST slope in lead V4 | 
|  10104-8 | ST slope in lead V5 | 
|  10105-5 | ST slope in lead V6 | 
|  10106-3 | ST wave end displacement in lead AVF | 
|  10107-1 | ST wave end displacement in lead AVL | 
|  10108-9 | ST wave end displacement in lead AVR | 
|  10109-7 | ST wave end displacement in lead I | 
|  1011-6 | Ew Ab [Presence] in Serum or Plasma from donor | 
|  10110-5 | ST wave end displacement in lead II | 
|  10111-3 | ST wave end displacement in lead III | 
|  10112-1 | ST wave end displacement in lead V1 | 
|  10113-9 | ST wave end displacement in lead V2 | 
|  10114-7 | ST wave end displacement in lead V3 | 
|  10115-4 | ST wave end displacement in lead V4 | 
|  10116-2 | ST wave end displacement in lead V5 | 
|  10117-0 | ST wave end displacement in lead V6 | 
|  10118-8 | ST wave mid displacement in lead AVF | 
|  10119-6 | ST wave mid displacement in lead AVL | 
|  1012-4 | Ew Ab [Presence] in Serum or Plasma | 
|  10120-4 | ST wave mid displacement in lead AVR | 
|  10121-2 | ST wave mid displacement in lead I | 
|  10122-0 | ST wave mid displacement in lead II | 
|  10123-8 | ST wave mid displacement in lead III | 
|  10124-6 | ST wave mid displacement in lead V1 | 
|  10125-3 | ST wave mid displacement in lead V2 | 
|  10126-1 | ST wave mid displacement in lead V3 | 
|  10127-9 | ST wave mid displacement in lead V4 | 
|  10128-7 | ST wave mid displacement in lead V5 | 
|  10129-5 | ST wave mid displacement in lead V6 | 
|  1013-2 | Ew Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10130-3 | T' wave amplitude in lead AVF | 
|  10131-1 | T' wave amplitude in lead AVL | 
|  10132-9 | T' wave amplitude in lead AVR | 
|  10133-7 | T' wave amplitude in lead I | 
|  10134-5 | T' wave amplitude in lead II | 
|  10135-2 | T' wave amplitude in lead III | 
|  10136-0 | T' wave amplitude in lead V1 | 
|  10137-8 | T' wave amplitude in lead V2 | 
|  10138-6 | T' wave amplitude in lead V3 | 
|  10139-4 | T' wave amplitude in lead V4 | 
|  1014-0 | Ew Ag [Presence] on Red Blood Cells from donor | 
|  10140-2 | T' wave amplitude in lead V5 | 
|  10141-0 | T' wave amplitude in lead V6 | 
|  10142-8 | T wave amplitude in lead AVF | 
|  10143-6 | T wave amplitude in lead AVL | 
|  10144-4 | T wave amplitude in lead AVR | 
|  10145-1 | T wave amplitude in lead I | 
|  10146-9 | T wave amplitude in lead II | 
|  10147-7 | T wave amplitude in lead III | 
|  10148-5 | T wave amplitude in lead V1 | 
|  10149-3 | T wave amplitude in lead V2 | 
|  1015-7 | Ew Ag [Presence] on Red Blood Cells | 
|  10150-1 | T wave amplitude in lead V3 | 
|  10151-9 | T wave amplitude in lead V4 | 
|  10152-7 | T wave amplitude in lead V5 | 
|  10153-5 | T wave amplitude in lead V6 | 
|  10154-3 | Chief complaint Narrative - Reported | 
|  10155-0 | History of allergies, reported | 
|  10156-8 | History of Childhood diseases Narrative | 
|  10157-6 | History of family member diseases Narrative | 
|  10158-4 | History of Functional status Narrative | 
|  10159-2 | History of Industrial exposure Narrative | 
|  1016-5 | E Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10160-0 | History of Medication use Narrative | 
|  10161-8 | History of Occupational exposure Narrative | 
|  10162-6 | History of pregnancies Narrative | 
|  10163-4 | History of pregnancies | 
|  10164-2 | History of Present illness Narrative | 
|  10165-9 | Deprecated History of psychiatric symptoms and diseases Narrative | 
|  10166-7 | History of Social function Narrative | 
|  10167-5 | History of Surgical procedures Narrative | 
|  10168-3 | History of Cardiovascular system disorders Narrative | 
|  10169-1 | History of Ear disorders Narrative | 
|  1017-3 | E Ab [Presence] in Serum or Plasma from donor | 
|  10170-9 | History of Endocrine system disorders Narrative | 
|  10171-7 | History of Eyes disorders Narrative | 
|  10172-5 | History of Hematologic system disorders Narrative | 
|  10173-3 | History of Musculoskeletal system disorders Narrative | 
|  10174-1 | History of Nose disorders Narrative | 
|  10175-8 | History of Oral cavity disorders Narrative | 
|  10176-6 | History of Reproductive system disorders Narrative | 
|  10177-4 | History of Respiratory system disorders Narrative | 
|  10178-2 | History of Skin disorders Narrative | 
|  10179-0 | History of Throat and Neck disorders Narrative | 
|  1018-1 | E Ab [Presence] in Serum or Plasma | 
|  10180-8 | History of Throat and Neck disorders | 
|  10181-6 | History of Urinary tract disorders Narrative | 
|  10182-4 | History of Travel Narrative | 
|  10183-2 | Hospital discharge medications Narrative | 
|  10184-0 | Hospital discharge physical findings Narrative | 
|  10185-7 | Hospital discharge procedures Narrative | 
|  10186-5 | Identifying information Narrative Observed | 
|  10187-3 | Review of systems Narrative - Reported | 
|  10188-1 | Review of systems overview Narrative - Reported | 
|  10189-9 | Review of systems overview - Reported | 
|  1019-9 | E Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10190-7 | Mental status Narrative | 
|  10191-5 | Physical findings of Abdomen Narrative | 
|  10192-3 | Physical findings of Back Narrative | 
|  10193-1 | Physical findings of Breasts Narrative | 
|  10194-9 | Physical findings of Neurologic deep tendon reflexes Narrative | 
|  10195-6 | Physical findings of Ear Narrative | 
|  10196-4 | Physical findings of Extremities Narrative | 
|  10197-2 | Physical findings of Eye Narrative | 
|  10198-0 | Physical findings of Genitourinary tract Narrative | 
|  10199-8 | Physical findings of Head Narrative | 
|  102-4 | Cefoperazone [Susceptibility] by Serum bactericidal titer | 
|  1020-7 | E Ag [Presence] on Red Blood Cells from donor | 
|  10200-4 | Physical findings of Heart Narrative | 
|  10201-2 | Physical findings of Mouth and Throat and Teeth Narrative | 
|  10202-0 | Physical findings of Nervous system Narrative | 
|  10203-8 | Physical findings of Nose Narrative | 
|  10204-6 | Physical findings of Pelvis Narrative | 
|  10205-3 | Physical findings of Rectum Narrative | 
|  10206-1 | Physical findings of Skin Narrative | 
|  10207-9 | Physical findings of Thorax and Lungs Narrative | 
|  10208-7 | Physical findings of Vessels Narrative | 
|  10209-5 | Physical findings of Neurologic balance and Coordination Narrative | 
|  1021-5 | E Ag [Presence] on Red Blood Cells | 
|  10210-3 | Physical findings of General status Narrative | 
|  10211-1 | Physical findings of Sense of touch Narrative | 
|  10212-9 | Physical findings of Strength Narrative | 
|  10213-7 | Surgical operation note anesthesia Narrative | 
|  10214-5 | Surgical operation note anesthesia duration | 
|  10215-2 | Surgical operation note findings Narrative | 
|  10216-0 | Surgical operation note fluids Narrative | 
|  10217-8 | Surgical operation note indications [Interpretation] Narrative | 
|  10218-6 | Surgical operation note postoperative diagnosis Narrative | 
|  10219-4 | Surgical operation note preoperative diagnosis Narrative | 
|  1022-3 | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10220-2 | Surgical operation note prep time duration | 
|  10221-0 | Surgical operation note specimens taken Narrative | 
|  10222-8 | Surgical operation note surgical complications [Interpretation] Narrative | 
|  10223-6 | Surgical operation note surgical procedure Narrative | 
|  10224-4 | Hemodynamic method special circumstances | 
|  10225-1 | Cardiac measurement device Institution inventory number | 
|  10226-9 | Oxygen content in Intravascular space | 
|  10227-7 | Cardiac measurement device Vendor model number | 
|  10228-5 | Cardiac measurement device Vendor serial number | 
|  10229-3 | Hemodynamic method Type of | 
|  1023-1 | Fy sup(a) Ab [Presence] in Serum or Plasma from donor | 
|  10230-1 | Left ventricular Ejection fraction | 
|  10231-9 | Right ventricular Ejection fraction | 
|  10232-7 | Oxygen content in Aorta root | 
|  10233-5 | Oxygen content in Left atrium | 
|  10234-3 | Oxygen content in Right atrium | 
|  10235-0 | Oxygen content in High right atrium | 
|  10236-8 | Oxygen content in Low right atrium | 
|  10237-6 | Oxygen content in Mid right atrium | 
|  10238-4 | Oxygen content in Left ventricle | 
|  10239-2 | Oxygen content in Right ventricular outflow tract | 
|  1024-9 | Fy sup(a) Ab [Presence] in Serum or Plasma | 
|  10240-0 | Oxygen content in Right ventricle | 
|  10241-8 | Oxygen content in Coronary sinus | 
|  10242-6 | Oxygen content in Ductus arteriosus | 
|  10243-4 | Oxygen content in Inferior vena cava | 
|  10244-2 | Oxygen content in Left pulmonary artery | 
|  10245-9 | Oxygen content in Main pulmonary artery | 
|  10246-7 | Oxygen content in Right pulmonary artery | 
|  10247-5 | Oxygen content in Pulmonary wedge | 
|  10248-3 | Oxygen content in Superior vena cava | 
|  10249-1 | Heart rate device Institution inventory number | 
|  1025-6 | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10250-9 | Heart rate device Vendor model number | 
|  10251-7 | Heart rate device Vendor serial number | 
|  10252-5 | Biliary drain site | 
|  10253-3 | Type of Biliary drain | 
|  10254-1 | Type of Peritoneal drain | 
|  10255-8 | Type of Subarachnoid drain | 
|  10256-6 | Biliary drain Institution inventory number | 
|  10257-4 | Chest tube Institution inventory number | 
|  10258-2 | Enteral tube Institution inventory number | 
|  10259-0 | Gastrostomy tube Institution inventory number | 
|  1026-4 | Fy sup(a) Ag [Presence] on Red Blood Cells from donor | 
|  10260-8 | GI tube Institution inventory number | 
|  10261-6 | Intravascular tube Institution inventory number | 
|  10262-4 | IO tube Institution inventory number | 
|  10263-2 | Nasogastric tube Institution inventory number | 
|  10264-0 | Oral tube Institution inventory number | 
|  10265-7 | Peritoneal drain Institution inventory number | 
|  10266-5 | Peritoneal tube Institution inventory number | 
|  10267-3 | Rate control device Institution inventory number | 
|  10268-1 | Stool collection device Institution inventory number | 
|  10269-9 | Subarachnoid drain Institution inventory number | 
|  1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells | 
|  10270-7 | Synovial drain Institution inventory number | 
|  10271-5 | Tube or drain Institution inventory number | 
|  10272-3 | Upper GI tube Institution inventory number | 
|  10273-1 | Bladder irrigation tube Institution inventory number | 
|  10274-9 | Urine tube Institution inventory number | 
|  10275-6 | Wound drain device Institution inventory number | 
|  10276-4 | Peritoneal drain site | 
|  10277-2 | Stool collection site | 
|  10278-0 | Subarachnoid drain site | 
|  10279-8 | Biliary drain Vendor model number | 
|  1028-0 | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10280-6 | Chest tube Vendor model number | 
|  10281-4 | Enteral tube Vendor model number | 
|  10282-2 | Gastrostomy tube Vendor model number | 
|  10283-0 | GI tube Vendor model number | 
|  10284-8 | Intravascular tube Vendor model number | 
|  10285-5 | IO tube Vendor model number | 
|  10286-3 | Nasogastric tube Vendor model number | 
|  10287-1 | Oral tube Vendor model number | 
|  10288-9 | Peritoneal drain Vendor model number | 
|  10289-7 | Peritoneal tube Vendor model number | 
|  1029-8 | Fy sup(b) Ab [Presence] in Serum or Plasma from donor | 
|  10290-5 | Rate control device Vendor model number | 
|  10291-3 | Stool collection device Vendor model number | 
|  10292-1 | Subarachnoid drain Vendor model number | 
|  10293-9 | Synovial drain Vendor model number | 
|  10294-7 | Tube or drain Vendor model number | 
|  10295-4 | Upper GI tube Vendor model number | 
|  10296-2 | Bladder irrigation tube Vendor model number | 
|  10297-0 | Urine tube Vendor model number | 
|  10298-8 | Wound drain device Vendor model number | 
|  10299-6 | Biliary drain Vendor serial number | 
|  103-2 | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1030-6 | Fy sup(b) Ab [Presence] in Serum or Plasma | 
|  10300-2 | Chest tube Vendor serial number | 
|  10301-0 | Enteral tube Vendor serial number | 
|  10302-8 | Gastrostomy tube Vendor serial number | 
|  10303-6 | GI tube Vendor serial number | 
|  10304-4 | Intravascular tube Vendor serial number | 
|  10305-1 | IO tube Vendor serial number | 
|  10306-9 | Nasogastric tube Vendor serial number | 
|  10307-7 | Oral tube Vendor serial number | 
|  10308-5 | Peritoneal drain Vendor serial number | 
|  10309-3 | Peritoneal tube Vendor serial number | 
|  1031-4 | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10310-1 | Rate control device Vendor serial number | 
|  10311-9 | Stool collection device Vendor serial number | 
|  10312-7 | Subarachnoid drain Vendor serial number | 
|  10313-5 | Synovial drain Vendor serial number | 
|  10314-3 | Tube or drain Vendor serial number | 
|  10315-0 | Upper GI tube Vendor serial number | 
|  10316-8 | Bladder irrigation tube Vendor serial number | 
|  10317-6 | Urine tube Vendor serial number | 
|  10318-4 | Wound drain device Vendor serial number | 
|  10319-2 | Enema device Institution inventory number | 
|  1032-2 | Fy sup(b) Ag [Presence] on Red Blood Cells from donor | 
|  10320-0 | Enema device Vendor model number | 
|  10321-8 | Enema device Vendor serial number | 
|  10322-6 | Potassium intake 24 hour | 
|  10323-4 | Wound drain fluid [Appearance] Lower GI tract | 
|  10324-2 | Breath rate device Institution inventory number | 
|  10325-9 | Breath rate device Vendor model number | 
|  10326-7 | Breath rate device Vendor serial number | 
|  10327-5 | Eosinophils/100 leukocytes in Sputum by Manual count | 
|  10328-3 | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  10329-1 | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells | 
|  10330-9 | Monocytes/100 leukocytes in Body fluid by Manual count | 
|  10331-7 | Rh [Type] in Blood | 
|  10332-5 | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM | 
|  10333-3 | Appearance of Cerebral spinal fluid | 
|  10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma | 
|  10335-8 | Color of Cerebral spinal fluid | 
|  10336-6 | Gonadotropin peptide [Mass/volume] in Urine | 
|  10337-4 | Procollagen type I [Mass/volume] in Serum | 
|  10338-2 | Barbiturates [Mass/volume] in Serum or Plasma | 
|  10339-0 | Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | 
|  1034-8 | Fetal cell screen [Interpretation] in Blood | 
|  10340-8 | Molindone [Mass/volume] in Serum or Plasma | 
|  10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma | 
|  10342-4 | Sulfamethoxazole [Mass/volume] in Serum or Plasma | 
|  10343-2 | Temazepam [Mass/volume] in Serum or Plasma | 
|  10344-0 | Tranylcypromine [Mass/volume] in Serum or Plasma | 
|  10345-7 | Trihexyphenidyl [Mass/volume] in Urine | 
|  10346-5 | Hemoglobin A [Units/volume] in Blood by Electrophoresis | 
|  10347-3 | Babesia microti identified in Blood by Light microscopy | 
|  10348-1 | Bordetella parapertussis Ab [Presence] in Serum | 
|  10349-9 | Brucella sp Ab [Units/volume] in Serum | 
|  1035-5 | Fresh frozen plasma given [Volume] | 
|  10350-7 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay | 
|  10351-5 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | 
|  10352-3 | Bacteria identified in Genital specimen by Aerobe culture | 
|  10353-1 | Bacteria identified in Nose by Aerobe culture | 
|  10354-9 | Bacteria identified in Urethra by Culture | 
|  10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain | 
|  10356-4 | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain | 
|  10357-2 | Microscopic observation [Identifier] in Wound by Gram stain | 
|  10358-0 | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) | 
|  10359-8 | Asialoganglioside GM1 IgM Ab [Titer] in Serum | 
|  1036-3 | G Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10360-6 | DNA single strand IgG Ab [Units/volume] in Serum | 
|  10361-4 | DNA single strand IgM Ab [Units/volume] in Serum | 
|  10362-2 | Endomysium IgA Ab [Presence] in Serum | 
|  10363-0 | Barbiturates [Presence] in Unspecified specimen | 
|  10364-8 | Cotinine [Mass/mass] in Hair | 
|  10365-5 | Cotinine [Mass/volume] in Serum or Plasma | 
|  10366-3 | Cotinine [Mass/volume] in Urine | 
|  10367-1 | Ethanol [Mass/volume] in Gastric fluid | 
|  10368-9 | Lead [Mass/volume] in Capillary blood | 
|  10369-7 | Opiates [Mass/mass] in Hair | 
|  1037-1 | G Ab [Presence] in Serum or Plasma from donor | 
|  10370-5 | Phencyclidine [Mass/mass] in Hair | 
|  10371-3 | Bite cells [Presence] in Blood by Light microscopy | 
|  10372-1 | Blister cells [Presence] in Blood by Light microscopy | 
|  10373-9 | Fragments [Presence] in Blood by Light microscopy | 
|  10374-7 | Helmet cells [Presence] in Blood by Light microscopy | 
|  10375-4 | Irregularly contracted cells [Presence] in Blood by Light microscopy | 
|  10376-2 | Oval macrocytes [Presence] in Blood by Light microscopy | 
|  10377-0 | Pencil cells [Presence] in Blood by Light microscopy | 
|  10378-8 | Polychromasia [Presence] in Blood by Light microscopy | 
|  10379-6 | Erythrocytes.dual population [Presence] in Blood by Light microscopy | 
|  1038-9 | G Ab [Presence] in Serum or Plasma | 
|  10380-4 | Stomatocytes [Presence] in Blood by Light microscopy | 
|  10381-2 | Target cells [Presence] in Blood by Light microscopy | 
|  10382-0 | A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10383-8 | A,B variant NOS Ag [Presence] on Red Blood Cells from donor | 
|  10384-6 | A,B variant NOS Ag [Presence] on Red Blood Cells | 
|  10385-3 | Albumin concentration given | 
|  10386-1 | Albumin given [Volume] | 
|  10387-9 | Autologous erythrocytes given [Volume] | 
|  10388-7 | Autologous whole blood given [Volume] | 
|  10389-5 | Blood product.other [Type] | 
|  1039-7 | G Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10390-3 | Blood product special preparation [Type] | 
|  10391-1 | Cytomegalovirus immune globulin given [Volume] | 
|  10392-9 | Cryoprecipitate given [Volume] | 
|  10393-7 | Factor IX given [Type] | 
|  10394-5 | Factor IX given [Volume] | 
|  10395-2 | Factor VIII given [Type] | 
|  10396-0 | Factor VIII given [Volume] | 
|  10397-8 | Hepatitis B immune globulin given [Volume] | 
|  10398-6 | I Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10399-4 | I Ag [Presence] on Red Blood Cells from donor | 
|  104-0 | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1040-5 | G Ag [Presence] on Red Blood Cells from donor | 
|  10400-0 | I Ag [Presence] on Red Blood Cells | 
|  10401-8 | Immune serum globulin given [Type] | 
|  10402-6 | Immune serum globulin given [Volume] | 
|  10403-4 | Inject immune serum globulin [Volume] | 
|  10404-2 | Inject Rh immune globulin [Volume] | 
|  10405-9 | Inject varicella zoster virus immune globulin [Volume] | 
|  10406-7 | little i Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10407-5 | little i Ag [Presence] on Red Blood Cells from donor | 
|  10408-3 | little i Ag [Presence] on Red Blood Cells | 
|  10409-1 | Pentaspan given [Volume] | 
|  1041-3 | G Ag [Presence] on Red Blood Cells | 
|  10410-9 | Plasma given [Type] | 
|  10411-7 | Plasma given [Volume] | 
|  10412-5 | Platelets given [Type] | 
|  10413-3 | Rh immune globulin given [Volume] | 
|  10414-1 | Transfuse albumin [Volume] | 
|  10415-8 | Transfuse blood exchange transfusion [Volume] | 
|  10416-6 | Transfuse blood product other [Volume] | 
|  10417-4 | Transfuse cryoprecipitate [Volume] | 
|  10418-2 | Transfuse factor IX [Volume] | 
|  10419-0 | Transfuse factor VIII [Volume] | 
|  1042-1 | H Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10420-8 | Transfuse immune serum globulin [Volume] | 
|  10421-6 | Transfuse Pentaspan [Volume] | 
|  10422-4 | Transfuse plasma [Volume] | 
|  10423-2 | Transfuse platelets [Volume] | 
|  10424-0 | Transfuse erythrocytes [Volume] | 
|  10425-7 | Transfuse Rh immune globulin [Volume] | 
|  10426-5 | Transfuse whole blood [Volume] | 
|  10427-3 | Transfuse whole blood autologous [Volume] | 
|  10428-1 | Varicella zoster virus immune globulin given [Volume] | 
|  10429-9 | AE 1 Ag [Presence] in Tissue by Immune stain | 
|  1043-9 | H Ab [Presence] in Serum or Plasma from donor | 
|  10430-7 | AE 3 Ag [Presence] in Tissue by Immune stain | 
|  10431-5 | B-cell Ag [Presence] in Tissue by Immune stain | 
|  10432-3 | CD30 Ag [Presence] in Tissue by Immune stain | 
|  10433-1 | BR-2 Ag [Presence] in Tissue by Immune stain | 
|  10434-9 | Complement C3 Ag [Presence] in Tissue by Immune stain | 
|  10435-6 | C5B-9 Ag [Presence] in Tissue by Immune stain | 
|  10436-4 | CD15 Ag [Presence] in Tissue by Immune stain | 
|  10437-2 | CD16 Ag [Presence] in Tissue by Immune stain | 
|  10438-0 | CD20 Ag [Presence] in Tissue by Immune stain | 
|  10439-8 | CD3 Ag [Presence] in Tissue by Immune stain | 
|  1044-7 | H Ab [Presence] in Serum | 
|  10440-6 | Deprecated CD30 Ag [Presence] in Tissue by Immune stain | 
|  10441-4 | CD34 Ag [Presence] in Tissue by Immune stain | 
|  10442-2 | CD56 Ag [Presence] in Tissue by Immune stain | 
|  10443-0 | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain | 
|  10444-8 | CD57 Ag [Presence] in Tissue by Immune stain | 
|  10445-5 | CD11c Ag [Presence] in Tissue by Immune stain | 
|  10446-3 | Leukocyte common Ag [Presence] in Tissue by Immune stain | 
|  10447-1 | M-5 Ag [Presence] in Tissue by Immune stain | 
|  10448-9 | T-cell Ag [Presence] in Tissue by Immune stain | 
|  10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal | 
|  1045-4 | H NOS Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10450-5 | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting | 
|  10451-3 | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting | 
|  10452-1 | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO | 
|  10453-9 | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO | 
|  10454-7 | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO | 
|  10455-4 | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO | 
|  10456-2 | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting | 
|  10457-0 | Actin Ag [Presence] in Tissue by Immune stain | 
|  10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain | 
|  10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain | 
|  1046-2 | H NOS Ab [Presence] in Serum or Plasma from donor | 
|  10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain | 
|  10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain | 
|  10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain | 
|  10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain | 
|  10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain | 
|  10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain | 
|  10466-1 | Anion gap 3 in Serum or Plasma | 
|  10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain | 
|  10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain | 
|  10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain | 
|  1047-0 | H NOS Ab [Presence] in Serum or Plasma | 
|  10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain | 
|  10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain | 
|  10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain | 
|  10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain | 
|  10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain | 
|  10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain | 
|  10476-0 | Desmin Ag [Presence] in Tissue by Immune stain | 
|  10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain | 
|  10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain | 
|  10479-4 | CD227 Ag [Presence] in Tissue by Immune stain | 
|  1048-8 | H NOS Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain | 
|  10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain | 
|  10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain | 
|  10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain | 
|  10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain | 
|  10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain | 
|  10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain | 
|  10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain | 
|  10488-5 | IgA Ag [Presence] in Tissue by Immune stain | 
|  10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain | 
|  1049-6 | H NOS Ag [Presence] on Red Blood Cells from donor | 
|  10490-1 | IgE Ag [Presence] in Tissue by Immune stain | 
|  10491-9 | IgG Ag [Presence] in Tissue by Immune stain | 
|  10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain | 
|  10493-5 | IgM Ag [Presence] in Tissue by Immune stain | 
|  10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain | 
|  10495-0 | Insulin Ag [Presence] in Tissue by Immune stain | 
|  10496-8 | Immunoglobulin light chains.kappa Ag [Presence] in Tissue by Immune stain | 
|  10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain | 
|  10498-4 | Keratin Ag [Presence] in Tissue by Immune stain | 
|  10499-2 | Immunoglobulin light chains.lambda Ag [Presence] in Tissue by Immune stain | 
|  105-7 | Ceforanide [Susceptibility] by Disk diffusion (KB) | 
|  1050-4 | H NOS Ag [Presence] on Red Blood Cells | 
|  10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain | 
|  10501-5 | Lutropin [Units/volume] in Serum or Plasma | 
|  10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain | 
|  10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain | 
|  10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain | 
|  10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain | 
|  10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain | 
|  10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain | 
|  10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain | 
|  10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain | 
|  1051-2 | Hemolytic disease of newborn screen [Interpretation] in Blood | 
|  10510-6 | S-100 Ag Ag [Presence] in Tissue by Immune stain | 
|  10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain | 
|  10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain | 
|  10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain | 
|  10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain | 
|  10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain | 
|  10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain | 
|  10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain | 
|  10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain | 
|  10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain | 
|  1052-0 | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit | 
|  10520-5 | Coagulation factor VI Ag [Presence] in Tissue by Immune stain | 
|  10521-3 | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain | 
|  10522-1 | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain | 
|  10523-9 | Fibrinogen Ag [Presence] in Tissue by Immune stain | 
|  10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain | 
|  10525-4 | Microscopic observation [Identifier] in Unspecified specimen by Cyto stain | 
|  10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain | 
|  10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain | 
|  10528-8 | Acetophenazine [Mass/volume] in Serum or Plasma | 
|  10529-6 | Amoxapine metabolite [Mass/volume] in Serum or Plasma | 
|  1053-8 | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor | 
|  10530-4 | Aprobarbital [Mass/volume] in Serum or Plasma | 
|  10531-2 | Bretylium [Mass/volume] in Serum or Plasma | 
|  10532-0 | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma | 
|  10533-8 | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma | 
|  10534-6 | Diazoxide [Mass/volume] in Serum or Plasma | 
|  10535-3 | Digoxin [Mass/volume] in Serum or Plasma | 
|  10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma | 
|  10537-9 | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma | 
|  10538-7 | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | 
|  10539-5 | Glipizide [Mass/volume] in Serum or Plasma | 
|  1054-6 | Deprecated I (intermediate) subtype [Presence] in srum | 
|  10540-3 | Glyburide [Mass/volume] in Serum or Plasma | 
|  10541-1 | Mepivacaine [Mass/volume] in Serum or Plasma | 
|  10542-9 | Metharbital [Mass/volume] in Serum or Plasma | 
|  10543-7 | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma | 
|  10544-5 | Normeperidine [Presence] in Serum or Plasma | 
|  10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma | 
|  10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma | 
|  10547-8 | Primidone+Phenobarbital [Mass/volume] in Serum or Plasma | 
|  10548-6 | Phenytoin Free/Phenytoin.total in Serum or Plasma | 
|  10549-4 | Pirmenol [Mass/volume] in Serum or Plasma | 
|  1055-3 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit | 
|  10550-2 | Deprecated Temazepam [Mass/volume] in Serum or Plasma | 
|  10551-0 | Triamterene [Mass/volume] in Serum or Plasma | 
|  10552-8 | Tricyclic antidepressants [Mass/volume] in Serum or Plasma | 
|  10553-6 | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid | 
|  10554-4 | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma | 
|  10555-1 | Acrosin [Entitic Catalytic Activity] in Spermatozoa | 
|  10556-9 | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma | 
|  10557-7 | Adenosine triphosphate [Moles/volume] in Semen | 
|  10558-5 | Albumin [Moles/volume] in Semen | 
|  10559-3 | Deprecated Calcium [Molecules/volume] in Semen | 
|  1056-1 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor | 
|  10560-1 | Carcinoembryonic Ag [Units/volume] in Semen | 
|  10561-9 | Carnitine [Moles/volume] in Semen | 
|  10562-7 | Cells [#/volume] in Cervical mucus | 
|  10563-5 | Cells other than spermatozoa [#/volume] in Semen | 
|  10564-3 | Cervical mucus [Volume] | 
|  10565-0 | Choriogonadotropin [Units/volume] in Semen | 
|  10566-8 | Deprecated Choriogonadotropin [Molecules/volume] in Semen | 
|  10567-6 | Citrate [Moles/volume] in Semen | 
|  10568-4 | Clarity of Semen | 
|  10569-2 | Color of Semen | 
|  1057-9 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells | 
|  10570-0 | Consistency of Cervical mucus | 
|  10571-8 | Deprecated Consistency of Semen | 
|  10572-6 | Deprecated Duration^post ejaculation | 
|  10573-4 | Ferning [Type] in Cervical mucus | 
|  10574-2 | Fructose [Moles/volume] in Semen | 
|  10575-9 | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen | 
|  10576-7 | Germ cells.immature [#/volume] in Semen | 
|  10577-5 | Glucosidase [Enzymatic activity/volume] in Seminal plasma | 
|  10578-3 | Glycerophosphocholine [Moles/volume] in Seminal plasma | 
|  10579-1 | Leukocytes [#/volume] in Semen | 
|  1058-7 | I Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10580-9 | Liquefaction [Time] in Semen | 
|  10581-7 | Deprecated Number of entities [#] in Spermatozoa | 
|  10582-5 | pH of Cervical mucus | 
|  10583-3 | Prostaglandin F1 alpha [Moles/volume] in Semen | 
|  10584-1 | Deprecated Protein [Mass/volume] in Semen | 
|  10585-8 | Round cells [#/volume] in Semen | 
|  10586-6 | Deprecated Volume of Semen | 
|  10587-4 | Sexual abstinence duration | 
|  10588-2 | Spermatogonia [#/volume] in Semen | 
|  10589-0 | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) | 
|  1059-5 | I Ab [Presence] in Serum or Plasma from donor | 
|  10590-8 | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) | 
|  10591-6 | Primary Spermatocytes [#/volume] in Semen | 
|  10592-4 | Secondary Spermatocytes [#/volume] in Semen | 
|  10593-2 | Spermatozoa Pyriform Head/100 spermatozoa in Semen | 
|  10594-0 | Spermatozoa Tapering Head/100 spermatozoa in Semen | 
|  10595-7 | Deprecated Spermatozoa [#/volume] in Semen | 
|  10596-5 | Deprecated Spermatozoa Ab in cervical mucosa | 
|  10597-3 | Deprecated Spermatozoa Ab in semen | 
|  10598-1 | Deprecated Spermatozoa Ab in serum | 
|  10599-9 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test | 
|  106-5 | Ceforanide [Susceptibility] by Serum bactericidal titer | 
|  1060-3 | I Ab [Presence] in Serum or Plasma | 
|  10600-5 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa | 
|  10601-3 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus | 
|  10602-1 | Spermatozoa Abnormal Head/100 spermatozoa in Semen | 
|  10603-9 | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen | 
|  10604-7 | Spermatozoa Abnormal Tail/100 spermatozoa in Semen | 
|  10605-4 | Spermatozoa Agglutinated/100 spermatozoa in Semen | 
|  10606-2 | Spermatozoa Amorphous Head/100 spermatozoa in Semen | 
|  10607-0 | Spermatozoa Coiled Tail/100 spermatozoa in Semen | 
|  10608-8 | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen | 
|  10609-6 | Spermatozoa Duplicate Head/100 spermatozoa in Semen | 
|  1061-1 | I NOS Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10610-4 | Spermatozoa Duplicate Tail/100 spermatozoa in Semen | 
|  10611-2 | Spermatozoa Immotile/100 spermatozoa in Semen | 
|  10612-0 | Spermatozoa Large Oval Head/100 spermatozoa in Semen | 
|  10613-8 | Spermatozoa Viable/100 spermatozoa in Semen | 
|  10614-6 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead | 
|  10615-3 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction | 
|  10616-1 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead | 
|  10617-9 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction | 
|  10618-7 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead | 
|  10619-5 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction | 
|  1062-9 | I NOS Ab [Presence] in Serum or Plasma from donor | 
|  10620-3 | Spermatozoa Nonprogressive/100 spermatozoa in Semen | 
|  10621-1 | Spermatozoa Normal Head/100 spermatozoa in Semen | 
|  10622-9 | Spermatozoa Normal/100 spermatozoa in Semen | 
|  10623-7 | Spermatozoa Pin Head/100 spermatozoa in Semen | 
|  10624-5 | Spermatozoa Rapid/100 spermatozoa in Semen | 
|  10625-2 | Spermatozoa Round Head/100 spermatozoa in Semen | 
|  10626-0 | Spermatozoa Slow/100 spermatozoa in Semen | 
|  10627-8 | Spermatozoa Small Oval Head/100 spermatozoa in Semen | 
|  10628-6 | Spermatozoa Tail Swelling/100 spermatozoa in Semen | 
|  10629-4 | Spermatozoa Vacuolated Head/100 spermatozoa in Semen | 
|  1063-7 | I NOS Ab [Presence] in Serum or Plasma | 
|  10630-2 | Spinnbarkeit [Length] in Cervical mucus | 
|  10631-0 | Testosterone [Moles/volume] in Semen | 
|  10632-8 | Time until next menstrual period | 
|  10633-6 | Zinc [Moles/volume] in Semen | 
|  10634-4 | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma | 
|  10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture | 
|  10636-9 | Acanthamoeba sp identified in Eye by Wet preparation | 
|  10637-7 | Microscopic observation [Identifier] in Tissue by Night blue stain | 
|  10638-5 | Thermophilic Actinomycetes colony count [#/volume] in Unspecified specimen by Organism specific culture | 
|  10639-3 | Thermophilic Actinomycetes identified in Unspecified specimen by Organism specific culture | 
|  1064-5 | I NOS Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10640-1 | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy | 
|  10641-9 | Amoeba identified in Aspirate by Immune stain | 
|  10642-7 | Amoeba identified in Aspirate by Wet preparation | 
|  10643-5 | Amoeba identified in Stool by Organism specific culture | 
|  10644-3 | Arthropod identified in Unspecified specimen | 
|  10645-0 | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence | 
|  10646-8 | Astrovirus [Identifier] in Stool by Electron microscopy | 
|  10647-6 | Babesia sp identified in Blood by Thick film | 
|  10648-4 | Babesia sp identified in Blood by Thin film | 
|  10649-2 | Calicivirus [Identifier] in Stool by Electron microscopy | 
|  1065-2 | I NOS Ag [Presence] on Red Blood Cells from donor | 
|  10650-0 | Candida sp DNA [Presence] in Blood by Probe with amplification | 
|  10651-8 | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial | 
|  10652-6 | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification | 
|  10653-4 | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  10654-2 | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) | 
|  10655-9 | Coccidia identified in Duodenal fluid by Acid fast stain | 
|  10656-7 | Coccidia identified in Stool by Acid fast stain | 
|  10657-5 | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence | 
|  10658-3 | Cyanobacterium identified in Water by Light microscopy | 
|  10659-1 | Cyclospora sp identified in Stool by Acid fast stain | 
|  1066-0 | I NOS Ag [Presence] on Red Blood Cells | 
|  10660-9 | Cytomegalovirus Ag [Presence] in Tissue by Immune stain | 
|  10661-7 | Dinoflagellate identified in Water by Light microscopy | 
|  10662-5 | Filaria identified in Blood by Concentration | 
|  10663-3 | Filaria identified in Blood by Thick film | 
|  10664-1 | Filaria identified in Blood by Thin film | 
|  10665-8 | Fungus colony count [#/volume] in Unspecified specimen by Environmental culture | 
|  10666-6 | Fungus identified in Tissue by Fontana-Masson stain | 
|  10667-4 | Fungus identified in Unspecified specimen by Animal inoculation | 
|  10668-2 | Fungus identified in Unspecified specimen by Environmental culture | 
|  10669-0 | Fungus identified in Unspecified specimen by Sticky tape for environmental fungus | 
|  1067-8 | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10670-8 | Giardia lamblia [Presence] in Stool by Organism specific culture | 
|  10671-6 | Helminth identified in Unspecified specimen | 
|  10672-4 | Helminth+Arthropod identified in Unspecified specimen | 
|  10673-2 | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain | 
|  10674-0 | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain | 
|  10675-7 | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain | 
|  10676-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | 
|  10677-3 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain | 
|  10678-1 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain | 
|  10679-9 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain | 
|  1068-6 | Jk sup(a) Ab [Presence] in Serum or Plasma from donor | 
|  10680-7 | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy | 
|  10681-5 | Herpes simplex virus identified in Tissue by Electron microscopy | 
|  10682-3 | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification | 
|  10683-1 | Hydatid cyst identified in Aspirate by Immune stain | 
|  10684-9 | Hydatid cyst identified in Liver by Wet preparation | 
|  10685-6 | Hydatid cyst identified in Lung tissue by Wet preparation | 
|  10686-4 | Leishmania sp identified in Tissue by Giemsa stain | 
|  10687-2 | Leishmania sp identified in Tissue by Organism specific culture | 
|  10688-0 | Microscopic observation [Identifier] in Hair by KOH preparation | 
|  10689-8 | Microscopic observation [Identifier] in Nail by KOH preparation | 
|  1069-4 | Jk sup(a) Ab [Presence] in Serum or Plasma | 
|  10690-6 | Microsporidia identified in Duodenal fluid by Trichrome stain modified | 
|  10691-4 | Mushroom.toxic identified by Inspection | 
|  10692-2 | Mushroom.toxic identified in Food by Light microscopy | 
|  10693-0 | Mushroom.toxic identified in Vomitus by Light microscopy | 
|  10694-8 | Naegleria sp identified in Tissue by Organism specific culture | 
|  10695-5 | Naegleria sp identified in Tissue by Wet preparation | 
|  10696-3 | Norovirus [Identifier] in Stool by Electron microscopy | 
|  10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  10699-7 | Onchocerca sp identified in Tissue by Wet preparation | 
|  107-3 | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1070-2 | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10700-3 | Orthopoxvirus [Identifier] in Skin by Electron microscopy | 
|  10701-1 | Ova and parasites identified in Stool by Concentration | 
|  10702-9 | Ova and parasites identified in Stool by Immune stain | 
|  10703-7 | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain | 
|  10704-5 | Ova and parasites identified in Stool by Light microscopy | 
|  10705-2 | Human papilloma virus Ag [Presence] in Tissue by Immune stain | 
|  10706-0 | Picornavirus [Identifier] in Stool by Electron microscopy | 
|  10707-8 | Toxic Plant identified in plant specimen by Inspection | 
|  10708-6 | Toxic Plant identified in Vomitus by Light microscopy | 
|  10709-4 | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence | 
|  1071-0 | Jk sup(a) Ag [Presence] on Red Blood Cells from donor | 
|  10710-2 | Plasmodium sp identified in Blood by Thin film | 
|  10711-0 | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence | 
|  10712-8 | Pneumocystis sp identified in Lung tissue | 
|  10713-6 | Prototheca identified in Unspecified specimen by Culture | 
|  10714-4 | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy | 
|  10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy | 
|  10716-9 | Schistosoma sp identified in Unspecified specimen by Organism specific culture | 
|  10717-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination | 
|  10718-5 | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay | 
|  10719-3 | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot (IB) | 
|  1072-8 | Jk sup(a) Ag [Presence] on Red Blood Cells | 
|  10720-1 | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  10721-9 | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) | 
|  10722-7 | Torovirus [Identifier] in Stool by Electron microscopy | 
|  10723-5 | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay | 
|  10724-3 | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay | 
|  10725-0 | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification | 
|  10726-8 | Toxoplasma gondii [Presence] in Tissue by Giemsa stain | 
|  10727-6 | Toxoplasma gondii identified in Tissue | 
|  10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture | 
|  10729-2 | Trypanosoma sp identified in Blood by Light microscopy | 
|  1073-6 | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10730-0 | Trypanosoma sp identified in Blood by Organism specific culture | 
|  10731-8 | Trypanosoma sp identified in Blood by Thick film | 
|  10732-6 | Trypanosoma sp identified in Blood by Thin film | 
|  10733-4 | Trypanosoma sp identified in Blood by Wet preparation | 
|  10734-2 | Varicella zoster virus identified in Skin by Electron microscopy | 
|  10735-9 | Viral sequencing [Identifier] in Serum by Sequencing | 
|  10736-7 | Virus identified in Cerebral spinal fluid by Electron microscopy | 
|  10737-5 | Virus identified in Stool by Electron microscopy | 
|  10738-3 | Virus identified in Tissue by Electron microscopy | 
|  10739-1 | Virus identified in Unspecified specimen by Electron microscopy | 
|  1074-4 | Jk sup(b) Ab [Presence] in Serum or Plasma from donor | 
|  10740-9 | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain | 
|  10741-7 | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain | 
|  10742-5 | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified | 
|  10743-3 | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain | 
|  10744-1 | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain | 
|  10745-8 | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain | 
|  10746-6 | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain | 
|  10747-4 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain | 
|  10748-2 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain | 
|  10749-0 | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain | 
|  1075-1 | Jk sup(b) Ab [Presence] in Serum or Plasma | 
|  10750-8 | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson | 
|  10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain | 
|  10752-4 | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain | 
|  10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain | 
|  10754-0 | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain | 
|  10755-7 | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott | 
|  10756-5 | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain | 
|  10757-3 | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald | 
|  10758-1 | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain | 
|  10759-9 | Iron.microscopic observation [Identifier] in Sputum by Gomori stain | 
|  1076-9 | Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10760-7 | Iron.microscopic observation [Identifier] in Tissue by Gomori stain | 
|  10761-5 | Iron.microscopic observation [Identifier] in Tissue by Other stain | 
|  10762-3 | Microscopic observation [Identifier] in Blood by Hemosiderin stain | 
|  10763-1 | Microscopic observation [Identifier] in Body fluid by Sudan black stain | 
|  10764-9 | Microscopic observation [Identifier] in Sputum by Silver stain | 
|  10765-6 | Microscopic observation [Identifier] in Tissue by Acetate esterase stain | 
|  10766-4 | Microscopic observation [Identifier] in Tissue by Alcian blue stain | 
|  10767-2 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated | 
|  10768-0 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff | 
|  10769-8 | Microscopic observation [Identifier] in Tissue by Alizarin red S stain | 
|  1077-7 | Jk sup(b) Ag [Presence] on Red Blood Cells from donor | 
|  10770-6 | Microscopic observation [Identifier] in Tissue by Argentaffin stain | 
|  10771-4 | Deprecated Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain | 
|  10772-2 | Microscopic observation [Identifier] in Tissue by Azure-eosin stain | 
|  10773-0 | Microscopic observation [Identifier] in Tissue by Basic fuchsin stain | 
|  10774-8 | Microscopic observation [Identifier] in Tissue by Bielschowsky stain | 
|  10775-5 | Microscopic observation [Identifier] in Tissue by Bleach stain | 
|  10776-3 | Microscopic observation [Identifier] in Tissue by Bodian stain | 
|  10777-1 | Microscopic observation [Identifier] in Tissue by Brown and Brenn stain | 
|  10778-9 | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain | 
|  10779-7 | Microscopic observation [Identifier] in Tissue by Carmine stain.Best | 
|  1078-5 | Jk sup(b) Ag [Presence] on Red Blood Cells | 
|  10780-5 | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain | 
|  10781-3 | Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain | 
|  10782-1 | Microscopic observation [Identifier] in Tissue by Congo red stain | 
|  10783-9 | Microscopic observation [Identifier] in Tissue by Crystal violet stain | 
|  10784-7 | Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific | 
|  10785-4 | Microscopic observation [Identifier] in Tissue by Fite-Faraco stain | 
|  10786-2 | Microscopic observation [Identifier] in Tissue by Giemsa stain.3 micron | 
|  10787-0 | Microscopic observation [Identifier] in Tissue by Gridley stain | 
|  10788-8 | Microscopic observation [Identifier] in Tissue by Hansel stain | 
|  10789-6 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain | 
|  1079-3 | Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10790-4 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain | 
|  10791-2 | Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain | 
|  10792-0 | Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones | 
|  10793-8 | Microscopic observation [Identifier] in Tissue by Methyl green stain | 
|  10794-6 | Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain | 
|  10795-3 | Microscopic observation [Identifier] in Tissue by Methyl violet stain | 
|  10796-1 | Microscopic observation [Identifier] in Tissue by Mucicarmine stain | 
|  10797-9 | Microscopic observation [Identifier] in Tissue by Neutral red stain | 
|  10798-7 | Microscopic observation [Identifier] in Tissue by Oil red O stain | 
|  10799-5 | Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat | 
|  108-1 | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1080-1 | Js sup(a) Ab [Presence] in Serum or Plasma from donor | 
|  10800-1 | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion | 
|  10801-9 | Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain | 
|  10802-7 | Microscopic observation [Identifier] in Tissue by Prussian blue stain | 
|  10803-5 | Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain | 
|  10804-3 | Microscopic observation [Identifier] in Tissue by Reticulin stain | 
|  10805-0 | Microscopic observation [Identifier] in Tissue by Safranin stain | 
|  10806-8 | Microscopic observation [Identifier] in Tissue by Schmorl stain | 
|  10807-6 | Microscopic observation [Identifier] in Tissue by Sevier-Munger stain | 
|  10808-4 | Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle | 
|  10809-2 | Microscopic observation [Identifier] in Tissue by Silver nitrate stain | 
|  1081-9 | Js sup(a) Ab [Presence] in Serum or Plasma | 
|  10810-0 | Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson | 
|  10811-8 | Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius | 
|  10812-6 | Microscopic observation [Identifier] in Tissue by Steiner stain | 
|  10813-4 | Microscopic observation [Identifier] in Tissue by Sudan black stain | 
|  10814-2 | Microscopic observation [Identifier] in Tissue by Supravital stain | 
|  10815-9 | Microscopic observation [Identifier] in Tissue by Tetrachrome stain | 
|  10816-7 | Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain | 
|  10817-5 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley | 
|  10818-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified | 
|  10819-1 | Microscopic observation [Identifier] in Tissue by Wade stain | 
|  1082-7 | Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10820-9 | Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain | 
|  10821-7 | Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain | 
|  10822-5 | Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer | 
|  10823-3 | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale | 
|  10824-1 | Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain | 
|  10825-8 | Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain | 
|  10826-6 | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain | 
|  10827-4 | Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain | 
|  10828-2 | Urate crystals.microscopic observation [type] in Tissue by De Galantha stain | 
|  10829-0 | Silicon [Mass/volume] in Serum or Plasma | 
|  1083-5 | Js sup(a) Ag [Presence] on Red Blood Cells from donor | 
|  10830-8 | Deprecated Surgical operation note complications | 
|  10831-6 | Surgical operation note complications [Interpretation] | 
|  10832-4 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post 50 g lactose PO | 
|  10833-2 | Insulin [Mass/volume] in Serum or Plasma --7 hours post 75 g glucose PO | 
|  10834-0 | Globulin [Mass/volume] in Serum by calculation | 
|  10835-7 | Lipoprotein a [Mass/volume] in Serum or Plasma | 
|  10836-5 | Niacin [Mass/volume] in Blood | 
|  10837-3 | Organic acids [Presence] in Serum or Plasma | 
|  10838-1 | Phosphoserine [Mass/volume] in Serum or Plasma | 
|  10839-9 | Troponin I.cardiac [Mass/volume] in Serum or Plasma | 
|  1084-3 | Js sup(a) Ag [Presence] on Red Blood Cells | 
|  10840-7 | Atropine [Mass/volume] in Urine | 
|  10841-5 | Methazolamide [Mass/volume] in Serum or Plasma | 
|  10842-3 | Deprecated HLA-DQ1 [Presence] | 
|  10843-1 | Deprecated HLA-DQ2 [Presence] | 
|  10844-9 | Deprecated HLA-DQ3 [Presence] | 
|  10845-6 | Deprecated HLA-DQ4 [Presence] | 
|  10846-4 | Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification | 
|  10847-2 | Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification | 
|  10848-0 | Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence | 
|  10849-8 | Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence | 
|  1085-0 | Js sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10850-6 | Cyclospora cayetanensis [Presence] in Unspecified specimen | 
|  10851-4 | Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture | 
|  10852-2 | Deprecated Fungus identified in Blood by Culture | 
|  10853-0 | Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified | 
|  10854-8 | Deprecated Midrofilaria identified in Blood by Concentration | 
|  10855-5 | Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy | 
|  10856-3 | Microscopic observation [Identifier] in Genital mucus by Gram stain | 
|  10857-1 | Microsporidia identified in Unspecified specimen by Light microscopy | 
|  10858-9 | Teichoate Ab [Presence] in Serum | 
|  10859-7 | Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain | 
|  1086-8 | Js sup(b) Ab [Presence] in Serum or Plasma from donor | 
|  10860-5 | Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture | 
|  10861-3 | Progesterone receptor [Mass/mass] in Tissue | 
|  10862-1 | Basement membrane Ab [Titer] in Serum | 
|  10863-9 | Endomysium IgA Ab [Titer] in Serum | 
|  10864-7 | Immune complex [Units/volume] in Serum or Plasma by Raji cell assay | 
|  10865-4 | Intercellular substance Ab [Presence] in Serum | 
|  10866-2 | Sulfatide IgG Ab [Titer] in Serum | 
|  10867-0 | Sulfatide IgM Ab [Titer] in Serum | 
|  10868-8 | Bacitracin [Susceptibility] by Disk diffusion (KB) | 
|  10869-6 | Xylose [Mass/volume] in Blood --3 hours post 25 g xylose PO | 
|  1087-6 | Js sup(b) Ab [Presence] in Serum or Plasma | 
|  10870-4 | Xylose [Mass/volume] in Blood --4 hours post 25 g xylose PO | 
|  10871-2 | Xylose [Mass/volume] in Blood --5 hours post 25 g xylose PO | 
|  10872-0 | Xylose [Mass/volume] in Blood --baseline | 
|  10873-8 | Beta-2-Microglobulin [Mass/time] in 24 hour Urine | 
|  10874-6 | Bombesin [Mass/volume] in Plasma | 
|  10875-3 | Carnitine esters [Mass/volume] in Urine | 
|  10876-1 | Carnitine esters [Mass/volume] in Serum or Plasma | 
|  10877-9 | Carnitine free (C0) [Mass/volume] in Urine | 
|  10878-7 | Iodine.protein bound [Mass/volume] in Serum or Plasma | 
|  10879-5 | Isovalerylglycine [Mass/volume] in Urine | 
|  1088-4 | Js sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10880-3 | Magnesium [Mass/mass] in Stool | 
|  10881-1 | Pentacarboxylporphyrins [Mass/volume] in Red Blood Cells | 
|  10882-9 | Pentacarboxylporphyrins [Mass/volume] in Serum or Plasma | 
|  10883-7 | Phenolphthalein [Mass/mass] in Stool | 
|  10884-5 | Phosphate [Mass/mass] in Stool | 
|  10885-2 | Porphyrins [Mass/time] in 24 hour Urine | 
|  10886-0 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma | 
|  10887-8 | Pyridinoline [Mass/time] in 24 hour Urine | 
|  10888-6 | Lipase [Enzymatic activity/volume] in Urine | 
|  10889-4 | Bisacodyl [Mass/mass] in Stool | 
|  1089-2 | Js sup(b) Ag [Presence] on Red Blood Cells from donor | 
|  10890-2 | Deprecated Normethsuximide [Mass/volume] in Serum or Plasma | 
|  10891-0 | Oxyphenisatin [Mass/mass] in Stool | 
|  10892-8 | Pentoxifylline [Mass/volume] in Serum or Plasma | 
|  10893-6 | Trenbolone [Mass/volume] in Urine | 
|  10894-4 | Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID) | 
|  10895-1 | Clostridium difficile toxin B [Presence] in Stool | 
|  10896-9 | Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence | 
|  10897-7 | Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  10898-5 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence | 
|  10899-3 | Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  109-9 | Cefotaxime [Susceptibility] by Disk diffusion (KB) | 
|  1090-0 | Js sup(b) Ag [Presence] on Red Blood Cells | 
|  10900-9 | Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay | 
|  10901-7 | HIV 2 gp125 Ab [Presence] in Serum by Immunoblot (IB) | 
|  10902-5 | HIV 2 gp36 Ab [Presence] in Serum by Immunoblot (IB) | 
|  10903-3 | Hyaluronidase Ab [Titer] in Serum | 
|  10904-1 | La Crosse virus IgG Ab [Titer] in Serum by Immunofluorescence | 
|  10905-8 | La Crosse virus IgM Ab [Titer] in Serum by Immunofluorescence | 
|  10906-6 | Saint Louis encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence | 
|  10907-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence | 
|  10908-2 | Streptococcus pneumoniae 7 IgG Ab [Units/volume] in Serum by Immunoassay | 
|  10909-0 | Benzidine [Mass/volume] in Urine | 
|  1091-8 | K Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10910-8 | Borate [Mass/volume] in Urine | 
|  10911-6 | Dichlorobenzidine [Mass/volume] in Urine | 
|  10912-4 | Lead [Mass/volume] in Serum or Plasma | 
|  10913-2 | 4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Urine | 
|  10914-0 | Methylenediamine [Mass/volume] in Urine | 
|  10915-7 | Phencyclidine [Mass/volume] in Unspecified specimen | 
|  10916-5 | Platinum [Mass/volume] in Blood | 
|  10917-3 | Zinc [Mass/mass] in Stool | 
|  10918-1 | Zinc [Mass/volume] in Unspecified specimen | 
|  10919-9 | Anisakis IgE Ab [Units/volume] in Serum | 
|  1092-6 | K Ab [Presence] in Serum or Plasma from donor | 
|  10920-7 | Bamboo shoot IgE Ab [Units/volume] in Serum | 
|  10921-5 | Blomia tropicalis IgE Ab [Units/volume] in Serum | 
|  10922-3 | Bovine serum albumin (BSA) IgE Ab [Units/volume] in Serum | 
|  10923-1 | Bromelin IgE Ab [Units/volume] in Serum | 
|  10924-9 | Starfruit IgE Ab [Units/volume] in Serum | 
|  10925-6 | Chub Mackerel IgE Ab [Units/volume] in Serum | 
|  10926-4 | Deer epithelium IgE Ab [Units/volume] in Serum | 
|  10927-2 | Elk or Moose Meat IgE Ab [Units/volume] in Serum | 
|  10928-0 | Fennel Fresh IgE Ab [Units/volume] in Serum | 
|  10929-8 | Fennel Seed IgE Ab [Units/volume] in Serum | 
|  1093-4 | K Ab [Presence] in Serum or Plasma | 
|  10930-6 | Fish Feed IgE Ab [Units/volume] in Serum | 
|  10931-4 | Daphnia (fish feed) IgE Ab [Units/volume] in Serum | 
|  10932-2 | Tetramin IgE Ab [Units/volume] in Serum | 
|  10933-0 | Guar gum IgE Ab [Units/volume] in Serum | 
|  10934-8 | Guava IgE Ab [Units/volume] in Serum | 
|  10935-5 | Horse serum proteins IgE Ab [Units/volume] in Serum | 
|  10936-3 | Mare milk IgE Ab [Units/volume] in Serum | 
|  10937-1 | Marjoram IgE Ab [Units/volume] in Serum | 
|  10938-9 | Mediterranean flour moth IgE Ab [Units/volume] in Serum | 
|  10939-7 | Whiff IgE Ab [Units/volume] in Serum | 
|  1094-2 | K Ag [Presence] on Red Blood Cells from Blood product unit | 
|  10940-5 | Cow milk boiled IgE Ab [Units/volume] in Serum | 
|  10941-3 | Milk powder IgE Ab [Units/volume] in Serum | 
|  10942-1 | Cockspur IgE Ab [Units/volume] in Serum | 
|  10943-9 | Mink epithelium IgE Ab [Units/volume] in Serum | 
|  10944-7 | Octopus IgE Ab [Units/volume] in Serum | 
|  10945-4 | Papain IgE Ab [Units/volume] in Serum | 
|  10946-2 | Passion fruit IgE Ab [Units/volume] in Serum | 
|  10947-0 | Persimmon IgE Ab [Units/volume] in Serum | 
|  10948-8 | Pigeon feather IgE Ab [Units/volume] in Serum | 
|  10949-6 | Malassezia furfur IgE Ab [Units/volume] in Serum | 
|  1095-9 | K Ag [Presence] on Red Blood Cells from donor | 
|  10950-4 | Reindeer epithelium IgE Ab [Units/volume] in Serum | 
|  10951-2 | Sericin IgE Ab [Units/volume] in Serum | 
|  10952-0 | Swine urine proteins IgE Ab [Units/volume] in Serum | 
|  10953-8 | Timothy IgG Ab [Units/volume] in Serum | 
|  10954-6 | Pine Nut IgE Ab [Units/volume] in Serum | 
|  10955-3 | Long Leaf Pine IgE Ab [Units/volume] in Serum | 
|  10956-1 | Short Leaf Pine IgE Ab [Units/volume] in Serum | 
|  10957-9 | Slash Pine IgE Ab [Units/volume] in Serum | 
|  10958-7 | Virginia Scrub Pine IgE Ab [Units/volume] in Serum | 
|  10959-5 | Plaice IgE Ab [Units/volume] in Serum | 
|  1096-7 | K Ag [Presence] on Red Blood Cells | 
|  10960-3 | Rabbit serum proteins IgE Ab [Units/volume] in Serum | 
|  10961-1 | Rabbit urine proteins IgE Ab [Units/volume] in Serum | 
|  10962-9 | Deprecated Sagebrush tridenda IgE Ab [Units/volume] in Serum | 
|  10963-7 | Spondylocladium citrovirens IgE Ab [Units/volume] in Serum | 
|  10964-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM | 
|  10965-2 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM | 
|  10966-0 | Glucose [Presence] in Urine by Test strip --2.5 hours post 75 g glucose PO | 
|  10967-8 | Glucose [Presence] in Urine by Test strip --3.5 hours post 75 g glucose PO | 
|  10968-6 | Glucose [Presence] in Urine by Test strip --4.5 hours post 75 g glucose PO | 
|  10969-4 | Cystine+Homocysteine [Presence] in Urine | 
|  1097-5 | Kp sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  10970-2 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Blood | 
|  10971-0 | Lysozyme [Mass/volume] in Urine | 
|  10972-8 | Organic acids [Mass/volume] in Urine | 
|  10973-6 | 3 methoxy O desmethylencainide [Mass/volume] in Serum or Plasma | 
|  10974-4 | 5-Fluorocytosine [Mass/volume] in Urine | 
|  10975-1 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine | 
|  10976-9 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine | 
|  10977-7 | Alprazolam [Mass/volume] in Blood | 
|  10978-5 | Amitriptyline+Nortriptyline [Mass/volume] in Urine | 
|  10979-3 | Carisoprodol [Mass/volume] in Urine | 
|  1098-3 | Kp sup(a) Ab [Presence] in Serum or Plasma from donor | 
|  10980-1 | Cephapirin [Mass/volume] in Serum or Plasma | 
|  10981-9 | Clonidine [Mass/volume] in Urine | 
|  10982-7 | Demeclocycline [Mass/volume] in Serum or Plasma | 
|  10983-5 | Norparamethadione [Mass/volume] in Serum or Plasma | 
|  10984-3 | Dicloxacillin [Mass/volume] in Serum or Plasma | 
|  10985-0 | Doxapram [Mass/volume] in Serum or Plasma | 
|  10986-8 | Doxycycline [Mass/volume] in Serum or Plasma | 
|  10987-6 | Fluconazole [Mass/volume] in Serum or Plasma | 
|  10988-4 | Fluvoxamine [Mass/volume] in Serum or Plasma | 
|  10989-2 | Itraconazole [Mass/volume] in Serum or Plasma | 
|  1099-1 | Kp sup(a) Ab [Presence] in Serum or Plasma | 
|  10990-0 | Ketoconazole [Mass/volume] in Serum or Plasma | 
|  10991-8 | Metronidazole [Mass/volume] in Serum or Plasma | 
|  10992-6 | Norclozapine [Mass/volume] in Serum or Plasma | 
|  10993-4 | Nafcillin [Mass/volume] in Serum or Plasma | 
|  10994-2 | Naltrexone [Mass/volume] in Serum or Plasma | 
|  10995-9 | Neomycin [Mass/volume] in Serum or Plasma | 
|  10996-7 | Normeperidine [Mass/volume] in Serum or Plasma | 
|  10997-5 | O-desmethylencainide [Mass/volume] in Serum or Plasma | 
|  10998-3 | Oxycodone [Presence] in Urine | 
|  10999-1 | Paramethadione [Mass/volume] in Serum or Plasma | 
|  11-7 | Amikacin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  110-7 | Cefotaxime [Susceptibility] by Serum bactericidal titer | 
|  1100-7 | Kp sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11000-7 | Promethazine [Presence] in Urine | 
|  11001-5 | Pyrazinamide [Mass/volume] in Serum or Plasma | 
|  11002-3 | Scopolamine [Presence] in Urine | 
|  11003-1 | Ticlopidine [Mass/volume] in Serum or Plasma | 
|  11004-9 | Tricyclic antidepressants [Presence] in Urine | 
|  11005-6 | Trimethoprim [Mass/volume] in Serum or Plasma | 
|  11006-4 | Borrelia burgdorferi Ab [Presence] in Serum | 
|  11007-2 | Borrelia burgdorferi Ag [Units/volume] in Urine | 
|  11008-0 | Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  11009-8 | Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  1101-5 | Kp sup(a) Ag [Presence] on Red Blood Cells from donor | 
|  11010-6 | Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  11011-4 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method | 
|  11012-2 | Reovirus Ab [Titer] in Serum by Complement fixation | 
|  11013-0 | DNA double strand Ab [Titer] in Serum | 
|  11014-8 | Somatotropin Ab [Titer] in Serum or Plasma | 
|  11015-5 | Somatotropin binding protein [Moles/volume] in Serum or Plasma | 
|  11016-3 | Microscopic observation [Identifier] in Blood or Marrow by Esterase stain.non-specific | 
|  11017-1 | Microscopic observation [Identifier] in Blood or Marrow by Chloracetate esterase stain | 
|  11018-9 | Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain | 
|  11019-7 | Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain | 
|  1102-3 | Kp sup(a) Ag [Presence] on Red Blood Cells | 
|  11020-5 | Microscopic observation [Identifier] in Blood or Marrow by Tartrate-resistant acid phosphatase stain | 
|  11021-3 | Microscopic observation [Identifier] in Blood or Marrow by Terminal deoxynucleotidyl transferase stain | 
|  11022-1 | Barbiturates [Mass/volume] in Meconium | 
|  11023-9 | Benzodiazepines [Mass/volume] in Meconium | 
|  11024-7 | Benzodiazepines [Mass/volume] in Serum or Plasma | 
|  11025-4 | Methadone [Mass/volume] in Meconium | 
|  11026-2 | Methaqualone [Mass/volume] in Meconium | 
|  11027-0 | Propoxyphene [Mass/volume] in Meconium | 
|  11028-8 | Zinc [Mass/volume] in Body fluid | 
|  11029-6 | Consistency of Stool | 
|  1103-1 | Kp sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11030-4 | Aspergillus fumigatus+Aspergillus niger IgE Ab [Units/volume] in Serum | 
|  11031-2 | Lymphocytes/100 leukocytes in Body fluid | 
|  11032-0 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post 50 g lactose PO | 
|  11033-8 | Thyrotropin [Mass/volume] in Serum or Plasma --45 minutes post dose TRH IV | 
|  11034-6 | Acetylcholine receptor binding Ab [Moles/volume] in Serum | 
|  11035-3 | Adenylate kinase [Enzymatic activity/volume] in Red Blood Cells | 
|  11036-1 | Deprecated Aldolase [Enzymatic activity/volume] in Red Blood Cells | 
|  11037-9 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in Serum or Plasma | 
|  11038-7 | Beta+gamma tocopherol [Mass/volume] in Serum or Plasma | 
|  11039-5 | C reactive protein [Presence] in Serum or Plasma | 
|  1104-9 | Kp sup(b) Ab [Presence] in Serum or Plasma from donor | 
|  11040-3 | Cortisol Free [Mass/volume] in Urine | 
|  11041-1 | Creatinine [Mass/volume] in Serum or Plasma --post dialysis | 
|  11042-9 | Creatinine [Mass/volume] in Serum or Plasma --pre dialysis | 
|  11043-7 | Cryofibrinogen [Presence] in Plasma | 
|  11044-5 | Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells | 
|  11045-2 | Enolase [Enzymatic activity/volume] in Red Blood Cells | 
|  11046-0 | Epinephrine [Mass/volume] in Urine | 
|  11047-8 | Glucose phosphate isomerase [Enzymatic activity/volume] in Red Blood Cells | 
|  11048-6 | Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells | 
|  11049-4 | Deprecated Hydroxyproline [Mass/volume] in Urine | 
|  1105-6 | Kp sup(b) Ab [Presence] in Serum or Plasma | 
|  11050-2 | Immunoglobulin light chains.kappa [Mass/volume] in Serum or Plasma | 
|  11051-0 | Immunoglobulin light chains.lambda [Mass/volume] in Serum or Plasma | 
|  11052-8 | Ketamine [Mass/volume] in Urine | 
|  11053-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells | 
|  11054-4 | Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma | 
|  11055-1 | Melatonin [Mass/volume] in Serum or Plasma | 
|  11056-9 | Melatonin [Flow] in 24 hour Urine | 
|  11057-7 | Monophosphoglyceromutase [Enzymatic activity/volume] in Red Blood Cells | 
|  11058-5 | Phosphofructokinase [Enzymatic activity/volume] in Red Blood Cells | 
|  11059-3 | Phosphoglycerate kinase [Enzymatic activity/volume] in Red Blood Cells | 
|  1106-4 | Kp sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11060-1 | Reducing substances [Presence] in Stool | 
|  11061-9 | Thromboxane beta 2 [Mass/time] in 24 hour Urine | 
|  11062-7 | Thyroxine (T4).albumin bound [Mass/volume] in Serum or Plasma | 
|  11063-5 | Triosephosphate isomerase [Enzymatic activity/volume] in Red Blood Cells | 
|  11064-3 | Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis | 
|  11065-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis | 
|  11066-8 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Red Blood Cells | 
|  11067-6 | Bleeding time | 
|  11068-4 | Microscopic observation [Identifier] in Body fluid by Cyto stain | 
|  11069-2 | Microscopic observation [Identifier] in Gastric fluid by Cyto stain | 
|  1107-2 | Kp sup(b) Ag [Presence] on Red Blood Cells from donor | 
|  11070-0 | Microscopic observation [Identifier] in Urine by Cyto stain | 
|  11071-8 | Butalbital [Mass/volume] in Urine | 
|  11072-6 | Despropionylfentanyl [Mass/volume] in Serum or Plasma | 
|  11073-4 | Despropionylfentanyl [Mass/volume] in Urine | 
|  11074-2 | Norfentanyl [Mass/volume] in Serum or Plasma | 
|  11075-9 | Norfentanyl [Mass/volume] in Urine | 
|  11076-7 | Hepatitis C virus 5-1-1 Ab [Presence] in Serum by Immunoblot (IB) | 
|  11077-5 | Hepatitis C virus superoxide dismutase Ab [Presence] in Serum by Immunoblot (IB) | 
|  11078-3 | HIV 2 gp80 Ab [Presence] in Serum by Immunoblot (IB) | 
|  11079-1 | HIV 2 p26 Ab [Presence] in Serum by Immunoblot (IB) | 
|  1108-0 | Kp sup(b) Ag [Presence] on Red Blood Cells | 
|  11080-9 | HIV 2 p53 Ab [Presence] in Serum by Immunoblot (IB) | 
|  11081-7 | HIV 2 p56 Ab [Presence] in Serum by Immunoblot (IB) | 
|  11082-5 | HIV 2 p68 Ab [Presence] in Serum by Immunoblot (IB) | 
|  11083-3 | Human papilloma virus identified in Cervix | 
|  11084-1 | Reagin Ab [Titer] in Serum | 
|  11085-8 | Schistosoma sp identified in Stool by Concentration | 
|  11086-6 | Streptococcus pneumoniae Ag [Presence] in Serum | 
|  11087-4 | Insulin Ab [Titer] in Serum | 
|  11088-2 | Neuronal nuclear Ab [Presence] in Serum | 
|  11089-0 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid | 
|  1109-8 | Deprecated L little b | 
|  11090-8 | Smith extractable nuclear Ab [Units/volume] in Serum | 
|  11091-6 | Alpha chlordane [Mass/volume] in Serum or Plasma | 
|  11092-4 | Barbiturates [Mass/mass] in Hair | 
|  11093-2 | Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma | 
|  11094-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma | 
|  11095-7 | Dieldrin [Mass/volume] in Serum or Plasma | 
|  11096-5 | Gamma chlordane [Mass/volume] in Serum or Plasma | 
|  11097-3 | Lindane [Mass/volume] in Serum or Plasma | 
|  11098-1 | Malaoxon [Mass/volume] in Serum or Plasma | 
|  11099-9 | Methoxychlor [Mass/volume] in Serum or Plasma | 
|  111-5 | Cefotetan [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1110-6 | Le sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11100-5 | Tetrachloroethylene [Mass/volume] in Blood | 
|  11101-3 | Bacteria [#/area] in Synovial fluid by Microscopy high power field | 
|  11102-1 | Charcot-leyden crystals [type] in Unspecified specimen by Trichrome stain | 
|  11103-9 | Band form neutrophils/100 cells in Bone marrow by Manual count | 
|  11104-7 | Normoblasts Basophilic/100 cells in Bone marrow by Manual count | 
|  11105-4 | Basophils/100 cells in Bone marrow by Manual count | 
|  11106-2 | Eosinophils/100 cells in Bone marrow by Manual count | 
|  11107-0 | Variant lymphocytes/100 cells in Bone marrow by Manual count | 
|  11108-8 | Lymphocytes/100 cells in Bone marrow by Manual count | 
|  11109-6 | Mast cells/100 cells in Bone marrow by Manual count | 
|  1111-4 | Le sup(a) Ab [Presence] in Serum or Plasma from donor | 
|  11110-4 | Megakaryocytes/100 cells in Bone marrow by Manual count | 
|  11111-2 | Metamyelocytes/100 cells in Bone marrow by Manual count | 
|  11112-0 | Monocytes/100 cells in Bone marrow by Manual count | 
|  11113-8 | Myeloblasts/100 cells in Bone marrow by Manual count | 
|  11114-6 | Myelocytes/100 cells in Bone marrow by Manual count | 
|  11115-3 | Neutrophils/100 cells in Bone marrow by Manual count | 
|  11116-1 | Normoblasts Orthochromic/100 cells in Bone marrow by Manual count | 
|  11117-9 | Plasma cells immature/100 cells in Bone marrow by Manual count | 
|  11118-7 | Plasma cells/100 cells in Bone marrow by Manual count | 
|  11119-5 | Normoblasts Polychromatophilic/100 cells in Bone marrow by Manual count | 
|  1112-2 | Le sup(a) Ab [Presence] in Serum or Plasma | 
|  11120-3 | Promyelocytes/100 cells in Bone marrow by Manual count | 
|  11121-1 | Prolymphocytes/100 cells in Bone marrow by Manual count | 
|  11122-9 | Promonocytes/100 cells in Bone marrow by Manual count | 
|  11123-7 | Deprecated Promyelocytes/100 cells in Bone marrow by Microscopy | 
|  11124-5 | Pronormoblasts/100 cells in Bone marrow by Manual count | 
|  11125-2 | Platelet morphology finding [Identifier] in Blood | 
|  11126-0 | Platelets [Morphology] in Bone marrow | 
|  11127-8 | Erythrocytes [Morphology] in Bone marrow | 
|  11128-6 | Segmented neutrophils/100 cells in Bone marrow | 
|  11129-4 | Pronormoblasts [#/volume] in Blood | 
|  1113-0 | Le sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11130-2 | B lymphocytes [#/volume] in Blood | 
|  11131-0 | Deprecated Normoblasts Basophilic/100 cells in Bone marrow by Microscopy | 
|  11132-8 | Deprecated Bilirubin [Mass/volume] in Body fluid | 
|  11133-6 | Catecholamines Free [Mass/volume] in Urine | 
|  11134-4 | Appearance of Spun Body fluid | 
|  11135-1 | Appearance of Spun Cerebral spinal fluid | 
|  11136-9 | Deprecated Normoblasts Orthochromic/100 cells in Bone marrow by Microscopy | 
|  11137-7 | Deprecated Normoblasts Polychromatophilic/100 cells in Bone marrow by Microscopy | 
|  11138-5 | Myeloid cells/Erythroid cells [# Ratio] in Bone marrow | 
|  11139-3 | Metanephrine [Mass/volume] in Urine | 
|  1114-8 | Le sup(a) Ag [Presence] on Red Blood Cells from donor | 
|  11140-1 | Metanephrine [Moles/time] in 24 hour Urine | 
|  11141-9 | Phosphate/Creatinine [Mass Ratio] in Urine | 
|  11142-7 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post 100 g glucose PO | 
|  11143-5 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post 100 g glucose PO | 
|  11144-3 | Homovanillate [Mass/volume] in Urine | 
|  11145-0 | 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine | 
|  11146-8 | Homovanillate/Creatinine [Mass Ratio] in Urine | 
|  11147-6 | Myoglobin/Creatinine [Mass Ratio] in Urine | 
|  11148-4 | Potassium/Creatinine [Mass Ratio] in Urine | 
|  11149-2 | Sodium/Creatinine [Mass Ratio] in Urine | 
|  1115-5 | Le sup(a) Ag [Presence] on Red Blood Cells | 
|  11150-0 | Blasts/100 cells in Bone marrow | 
|  11151-8 | Hematocrit [Volume Fraction] of Cord blood | 
|  11152-6 | Eosinophils/100 cells in Bone marrow | 
|  11153-4 | Hematocrit [Volume Fraction] of Body fluid | 
|  11154-2 | Cholinesterase [Enzymatic activity/volume] in Blood | 
|  11155-9 | Cortisol/Creatinine [Mass Ratio] in Urine | 
|  11156-7 | Leukocyte morphology finding [Identifier] in Blood | 
|  11157-5 | Leukocytes [Morphology] in Bone marrow | 
|  11158-3 | Appearance of Serum | 
|  11159-1 | Alkalase IgE Ab [Units/volume] in Serum | 
|  1116-3 | Le sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11160-9 | Beta lactoglobulin IgG Ab [Units/volume] in Serum | 
|  11161-7 | Wheat Bran IgE Ab [Units/volume] in Serum | 
|  11162-5 | Deprecated Cocoa IgE Ab [Units/volume] in Serum | 
|  11163-3 | Carageenan IgE Ab [Units/volume] in Serum | 
|  11164-1 | Cream Cheese IgE Ab [Units/volume] in Serum | 
|  11165-8 | Chinchilla IgE Ab [Units/volume] in Serum | 
|  11166-6 | Chortoglyphus arcuatus IgE Ab [Units/volume] in Serum | 
|  11167-4 | Cockatiel feather IgE Ab [Units/volume] in Serum | 
|  11168-2 | Arizona Cypress IgE Ab [Units/volume] in Serum | 
|  11169-0 | Deer hair IgE Ab [Units/volume] in Serum | 
|  1117-1 | Le sup(b) Ab [Presence] in Serum or Plasma from donor | 
|  11170-8 | Dematiaceae IgE Ab [Units/volume] in Serum | 
|  11171-6 | Erythromycin IgE Ab [Units/volume] in Serum | 
|  11172-4 | Ferret epithelium IgE Ab [Units/volume] in Serum | 
|  11173-2 | Fig IgE Ab [Units/volume] in Serum | 
|  11174-0 | Grain weevel IgE Ab [Units/volume] in Serum | 
|  11175-7 | Helminthosporium sativum IgE Ab [Units/volume] in Serum | 
|  11176-5 | Lactalbumin alpha IgG Ab [Units/volume] in Serum | 
|  11177-3 | Lactalbumin beta IgE Ab [Units/volume] in Serum | 
|  11178-1 | Beta galactosidase IgE Ab [Units/volume] in Serum | 
|  11179-9 | Linden IgE Ab [Units/volume] in Serum | 
|  1118-9 | Le sup(b) Ab [Presence] in Serum or Plasma | 
|  11180-7 | Lupin IgE Ab [Units/volume] in Serum | 
|  11181-5 | Lycopodium spp IgE Ab [Units/volume] in Serum | 
|  11182-3 | Lysozyme IgE Ab [Units/volume] in Serum | 
|  11183-1 | Macadamia IgE Ab [Units/volume] in Serum | 
|  11184-9 | Scad IgE Ab [Units/volume] in Serum | 
|  11185-6 | Maxatase IgE Ab [Units/volume] in Serum | 
|  11186-4 | Foxtail Millet IgE Ab [Units/volume] in Serum | 
|  11187-2 | Penicillium frequentans IgE Ab [Units/volume] in Serum | 
|  11188-0 | Cayenne IgE Ab [Units/volume] in Serum | 
|  11189-8 | Jalepeno Pepper IgE Ab [Units/volume] in Serum | 
|  1119-7 | Le sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11190-6 | Mint IgE Ab [Units/volume] in Serum | 
|  11191-4 | Pollock IgE Ab [Units/volume] in Serum | 
|  11192-2 | Protamine IgE Ab [Units/volume] in Serum | 
|  11193-0 | Pumpkin Seed IgE Ab [Units/volume] in Serum | 
|  11194-8 | Rape Pollen IgE Ab [Units/volume] in Serum | 
|  11195-5 | Rapeseed IgE Ab [Units/volume] in Serum | 
|  11196-3 | Orange roughy IgE Ab [Units/volume] in Serum | 
|  11197-1 | Sardine (pilchard) IgE Ab [Units/volume] in Serum | 
|  11198-9 | Shark IgE Ab [Units/volume] in Serum | 
|  11199-7 | Silver IgE Ab [Units/volume] in Serum | 
|  112-3 | Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1120-5 | Le sup(b) Ag [Presence] on Red Blood Cells from donor | 
|  11200-3 | Escargot IgE Ab [Units/volume] in Serum | 
|  11201-1 | Succinylcholine IgE Ab [Units/volume] in Serum | 
|  11202-9 | Tarragon IgE Ab [Units/volume] in Serum | 
|  11203-7 | Trichosporon pullulans IgE Ab [Units/volume] in Serum | 
|  11204-5 | Ulocladium chartarum IgE Ab [Units/volume] in Serum | 
|  11205-2 | Deprecated Paper Wasp IgE Ab [Units/volume] in Serum | 
|  11206-0 | 18-Hydroxydeoxycorticosterone [Mass/volume] in Serum or Plasma | 
|  11207-8 | Alpha-1-Fetoprotein [Mass/volume] in Body fluid | 
|  11208-6 | Atrial natriuretic factor [Mass/volume] in Plasma | 
|  11209-4 | Beta glucuronidase [Enzymatic activity/volume] in Cerebral spinal fluid | 
|  1121-3 | Le sup(b) Ag [Presence] on Red Blood Cells | 
|  11210-2 | Cancer Ag 125 [Units/volume] in Body fluid | 
|  11211-0 | Carbon dioxide, total [Moles/volume] in Body fluid | 
|  11212-8 | Coproporphyrin [Mass/volume] in Urine | 
|  11213-6 | Corticotropin releasing hormone [Mass/volume] in Serum or Plasma | 
|  11214-4 | Deprecated Creatinine | 
|  11215-1 | Delta aminolevulinate [Mass/volume] in Urine | 
|  11216-9 | Deoxypyridinoline [Mass/volume] in Urine | 
|  11217-7 | Deprecated Hexaporphyrin [Mass/time] in 24 hour Urine | 
|  11218-5 | Microalbumin [Mass/volume] in Urine by Test strip | 
|  11219-3 | Immunoglobulin light chains [Presence] in Serum | 
|  1122-1 | Le sup(x) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11220-1 | Iodine Free [Mass/time] in 24 hour Urine | 
|  11221-9 | Pentacarboxylporphyrins [Mass/volume] in Urine | 
|  11222-7 | Pentacarboxylporphyrins [Presence] in Urine | 
|  11223-5 | Deprecated Phenolphthalein | 
|  11224-3 | Phosphoethanolamine [Mass/volume] in Cerebral spinal fluid | 
|  11225-0 | Porphyrins [Mass/volume] in Urine | 
|  11226-8 | Prorenin [Units/volume] in Plasma | 
|  11227-6 | Pyruvate kinase [Presence] in Blood | 
|  11228-4 | Uroporphyrin [Mass/volume] in Urine | 
|  11229-2 | 3-O-Methyldopa [Mass/volume] in Serum or Plasma | 
|  1123-9 | Le sup(x) Ab [Presence] in Serum or Plasma from donor | 
|  11230-0 | Amobarbital [Mass/volume] in Urine | 
|  11231-8 | Astemizole [Mass/volume] in Serum or Plasma | 
|  11232-6 | Bromocriptine [Mass/volume] in Serum or Plasma | 
|  11233-4 | Brompheniramine [Mass/volume] in Serum or Plasma | 
|  11234-2 | Propoxyphene [Mass/mass] in Hair | 
|  11235-9 | Fentanyl [Presence] in Urine | 
|  11236-7 | Gemfibrozil [Mass/volume] in Serum or Plasma | 
|  11237-5 | Hydralazine [Mass/volume] in Serum or Plasma | 
|  11238-3 | Hydroxyalprazolam [Mass/volume] in Urine | 
|  11239-1 | Deprecated Hydroxyzine | 
|  1124-7 | Le sup(x) Ab [Presence] in Serum or Plasma | 
|  11240-9 | Hydroxyzine [Mass/volume] in Urine | 
|  11241-7 | Hyoscyamine [Mass/volume] in Serum or Plasma | 
|  11242-5 | Mercaptopurine [Mass/volume] in Serum or Plasma | 
|  11243-3 | Methadone [Mass/mass] in Hair | 
|  11244-1 | Morphine Free [Mass/volume] in Serum or Plasma | 
|  11245-8 | Deprecated Orphenadrine | 
|  11246-6 | Oxycodone [Mass/volume] in Urine | 
|  11247-4 | Oxymorphone [Presence] in Urine | 
|  11248-2 | Pergolide [Mass/volume] in Serum or Plasma | 
|  11249-0 | Phenacemide [Mass/volume] in Serum or Plasma | 
|  1125-4 | Le Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11250-8 | Phenylethylmalonate [Mass/volume] in Serum or Plasma | 
|  11251-6 | Piroxicam [Mass/volume] in Serum or Plasma | 
|  11252-4 | Scopolamine [Mass/volume] in Serum or Plasma | 
|  11253-2 | Tacrolimus [Mass/volume] in Blood | 
|  11254-0 | Chlamydophila pneumoniae Ab [Titer] in Serum | 
|  11255-7 | Haemophilus ducreyi [Presence] in Unspecified specimen by Organism specific culture | 
|  11256-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum | 
|  11257-3 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay | 
|  11258-1 | Hepatitis B virus DNA [Units/volume] in Serum | 
|  11259-9 | Hepatitis C virus RNA [Presence] in Serum or Plasma by Probe and target amplification method | 
|  1126-2 | Le Ab [Presence] in Serum or Plasma from donor | 
|  11260-7 | HTLV I Ab [Presence] in Serum by Immunoassay | 
|  11261-5 | Bacteria identified in Vaginal fluid by Aerobe culture | 
|  11262-3 | Parainfluenza virus 3 IgG Ab [Titer] in Serum | 
|  11263-1 | Parainfluenza virus 3 IgM Ab [Titer] in Serum | 
|  11264-9 | Salmonella paratyphi A Ab [Presence] in Serum by Agglutination | 
|  11265-6 | Salmonella paratyphi B Ab [Presence] in Serum by Agglutination | 
|  11266-4 | Streptococcus agalactiae Ag [Presence] in Unspecified specimen | 
|  11267-2 | Streptococcus.beta-hemolytic [Presence] in Genital specimen by Organism specific culture | 
|  11268-0 | Streptococcus pyogenes [Presence] in Throat by Organism specific culture | 
|  11269-8 | Streptococcus pyogenes Ag [Presence] in Serum by Agglutination | 
|  1127-0 | Le NOS Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11270-6 | Viral inclusion bodies [Identifier] in Unspecified specimen by Cyto stain | 
|  11271-4 | Hematocrit [Volume Fraction] of Cord blood by Automated count | 
|  11272-2 | Erythrocyte mean corpuscular volume [Entitic volume] in Cord blood by Automated count | 
|  11273-0 | Erythrocytes [Morphology] in Blood by Automated count | 
|  11274-8 | Elliptocytes [Presence] in Blood by Light microscopy | 
|  11275-5 | Large granular lymphocytes/100 leukocytes in Blood by Manual count | 
|  11276-3 | Tubular cells [Presence] in Urine sediment by Light microscopy | 
|  11277-1 | Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field | 
|  11278-9 | Bladder cells [#/area] in Urine sediment by Microscopy high power field | 
|  11279-7 | Urine sediment comments by Light microscopy Narrative | 
|  1128-8 | Le NOS Ab [Presence] in Serum or Plasma from donor | 
|  11280-5 | Cabot rings [Presence] in Blood by Light microscopy | 
|  11281-3 | Auer rods [Presence] in Blood by Light microscopy | 
|  11282-1 | Cells Counted Total [#] in Blood | 
|  11283-9 | Acuity assessment [Function] at First encounter | 
|  11284-7 | Acuity assessment practitioner identification | 
|  11285-4 | Acuity assessment practitioner profession | 
|  11286-2 | Alcohol binge episodes per month - Reported | 
|  11287-0 | Alcoholic drinks per drinking day - Reported | 
|  11288-8 | Arrival time documented | 
|  11289-6 | Body temperature at First encounter | 
|  1129-6 | Le NOS Ab [Presence] in Serum or Plasma | 
|  11290-4 | Body temperature measurement site at First encounter | 
|  11291-2 | Respiratory rate at First encounter | 
|  11292-0 | Deprecated Chief complaint: Prid: Pt: ^Patient: Nom: Reported | 
|  11293-8 | Type of Referral source | 
|  11294-6 | Current employment Narrative - Reported | 
|  11295-3 | Current employment - Reported | 
|  11296-1 | ED clinical finding practitioner identifier | 
|  11297-9 | ED clinical finding practitioner profession | 
|  11298-7 | ED consultant practitioner identifier | 
|  11299-5 | ED consultant practitioner profession | 
|  113-1 | Cefotetan [Susceptibility] by Disk diffusion (KB) | 
|  1130-4 | Le NOS Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11300-1 | ED diagnosis | 
|  11301-9 | ED diagnosis type | 
|  11302-7 | ED discharge disposition | 
|  11303-5 | ED disposition consult/referral | 
|  11304-3 | ED disposition diagnosis practitioner identification | 
|  11305-0 | ED disposition diagnosis practitioner profession | 
|  11306-8 | ED medication practitioner identification | 
|  11307-6 | ED medication practitioner profession | 
|  11308-4 | ED outcome observation practitioner identification | 
|  11309-2 | ED outcome observation practitioner profession | 
|  1131-2 | Le NOS Ag [Presence] on Red Blood Cells from donor | 
|  11310-0 | ED patient satisfaction report type | 
|  11311-8 | ED procedure practitioner profession | 
|  11312-6 | ED procedure practitioner identifier | 
|  11313-4 | ED procedure result observation [Interpretation] | 
|  11314-2 | ED procedure result type | 
|  11315-9 | ED service level | 
|  11316-7 | ED service level practitioner profession | 
|  11317-5 | ED service level practitioner identification | 
|  11318-3 | Ambulance transport agency EMS system | 
|  11319-1 | Ambulance transport unit [Identifier] EMS system | 
|  1132-0 | Le NOS Ag [Presence] on Red Blood Cells | 
|  11320-9 | Feeding and dietary status Narrative - Reported | 
|  11321-7 | Feeding and dietary status - Reported | 
|  11322-5 | History of General health Narrative | 
|  11323-3 | General health - Reported | 
|  11324-1 | Glasgow coma score eye opening at First encounter | 
|  11325-8 | Glasgow coma score motor at First encounter | 
|  11326-6 | Glasgow coma score verbal at First encounter | 
|  11327-4 | Heart rate method at First encounter | 
|  11328-2 | Heart rate at First encounter | 
|  11329-0 | History general Narrative - Reported | 
|  1133-8 | Lu sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11330-8 | History of Alcohol use Narrative | 
|  11331-6 | History of Alcohol use | 
|  11332-4 | History of Cognitive function Narrative | 
|  11333-2 | History of Cognitive function | 
|  11334-0 | History of Growth+Development Narrative | 
|  11335-7 | History of Growth+Development | 
|  11336-5 | History of Hospitalization Narrative | 
|  11337-3 | History of Hospitalization | 
|  11338-1 | History of Major illnesses and injuries Narrative | 
|  11339-9 | History of Major illnesses and injuries | 
|  1134-6 | Lu sup(a) Ab [Presence] in Serum or Plasma from donor | 
|  11340-7 | History of Occupation Narrative | 
|  11341-5 | History of Occupation | 
|  11342-3 | History of Other nonmedical drug use Narrative | 
|  11343-1 | History of Other nonmedical drug use | 
|  11344-9 | History of Other social factors Narrative | 
|  11345-6 | History of Other social factors | 
|  11346-4 | History of Outpatient visits Narrative | 
|  11347-2 | History of Outpatient visits | 
|  11348-0 | History of Past illness Narrative | 
|  11349-8 | History of Past illness | 
|  1135-3 | Lu sup(a) Ab [Presence] in Serum or Plasma | 
|  11350-6 | History of Sexual behavior Narrative | 
|  11351-4 | History of Sexual behavior | 
|  11352-2 | History of Allergenic and Immunologic disorders Narrative | 
|  11353-0 | History of Breasts disorders Narrative | 
|  11354-8 | History of Ears and Nose and Sinuses and Mouth and Throat disorders Narrative | 
|  11355-5 | History of Gastrointestinal system disorders Narrative | 
|  11356-3 | History of Genitourinary systems disorders Narrative | 
|  11357-1 | History of Integumentary system disorders Narrative | 
|  11358-9 | History of Psychiatric disorders Narrative | 
|  11359-7 | History of Allergenic and Immunologic disorders | 
|  1136-1 | Lu sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11360-5 | History of Breasts disorders | 
|  11361-3 | History of Ears and Nose and Sinuses and Mouth and Throat disorders | 
|  11362-1 | History of Gastrointestinal system disorders | 
|  11363-9 | History of Genitourinary systems disorders | 
|  11364-7 | History of Integumentary system disorders | 
|  11365-4 | History of Psychiatric disorders | 
|  11366-2 | History of Tobacco use Narrative | 
|  11367-0 | History of Tobacco use | 
|  11368-8 | Illness or injury onset date and time | 
|  11369-6 | History of Immunization Narrative | 
|  1137-9 | Lu sup(a) Ag [Presence] on Red Blood Cells from donor | 
|  11370-4 | Immunization status - Reported | 
|  11371-2 | Initial visit for chief complaint | 
|  11372-0 | Injury associated activity | 
|  11373-8 | Injury cause | 
|  11374-6 | Injury incident description Narrative | 
|  11375-3 | Injury intent | 
|  11376-1 | Injury location | 
|  11377-9 | Diastolic blood pressure at First encounter | 
|  11378-7 | Systolic blood pressure at First encounter | 
|  11379-5 | Highest level of education [Time] - Reported | 
|  1138-7 | Lu sup(a) Ag [Presence] on Red Blood Cells | 
|  11380-3 | Marital status and living arrangements Narrative - Reported | 
|  11381-1 | Marital status and living arrangements - Reported | 
|  11382-9 | Medication allergy - Reported | 
|  11383-7 | Patient problem outcome Narrative | 
|  11384-5 | Physical examination by organ systems | 
|  11385-2 | Physical findings of Ankle Narrative | 
|  11386-0 | Physical findings of Upper arm Narrative | 
|  11387-8 | Physical findings of Axilla Narrative | 
|  11388-6 | Physical findings of Buttocks Narrative | 
|  11389-4 | Physical findings of Calf Narrative | 
|  1139-5 | Lu sup(ab) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11390-2 | Physical findings of Cardiovascular system Narrative | 
|  11391-0 | Physical findings of Chest Narrative | 
|  11392-8 | Physical findings of Chest wall Narrative | 
|  11393-6 | Physical findings of Ears and Nose and Mouth and Throat Narrative | 
|  11394-4 | Physical findings of Elbow Narrative | 
|  11395-1 | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed | 
|  11396-9 | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed. | 
|  11397-7 | Physical findings of Foot Narrative | 
|  11398-5 | Physical findings of Forearm Narrative | 
|  11399-3 | Physical findings of Gastrointestinal system Narrative | 
|  114-9 | Cefotetan [Susceptibility] by Serum bactericidal titer | 
|  1140-3 | Lu sup(ab) Ab [Presence] in Serum or Plasma from donor | 
|  11400-9 | Physical findings of Genitalia Narrative | 
|  11401-7 | Physical findings of Female genitalia Narrative | 
|  11402-5 | Physical findings of Male genitalia Narrative | 
|  11403-3 | Physical findings of Groin Narrative | 
|  11404-1 | Physical findings of Hand Narrative | 
|  11405-8 | Deprecated Physical findings: Find: Pt: Heart: Nar: Observed | 
|  11406-6 | Physical findings of Hip Narrative | 
|  11407-4 | Physical findings of Knee Narrative | 
|  11408-2 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed | 
|  11409-0 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed. | 
|  1141-1 | Lu sup(ab) Ab [Presence] in Serum or Plasma | 
|  11410-8 | Physical findings of Musculoskeletal system Narrative | 
|  11411-6 | Physical findings of Neck Narrative | 
|  11412-4 | Physical findings of Respiratory system Narrative | 
|  11413-2 | Physical findings of Shoulder Narrative | 
|  11414-0 | Physical findings of Thigh Narrative | 
|  11415-7 | Physical findings of Wrist Narrative | 
|  11416-5 | Physical findings of Ankle | 
|  11417-3 | Physical findings of Upper arm | 
|  11418-1 | Physical findings of Axilla | 
|  11419-9 | Physical findings of Buttocks | 
|  1142-9 | Lu sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11420-7 | Physical findings of Calf | 
|  11421-5 | Physical findings of Cardiovascular system | 
|  11422-3 | Physical findings of Chest | 
|  11423-1 | Physical findings of Chest wall | 
|  11424-9 | Physical findings of Ears and Nose and Mouth and Throat | 
|  11425-6 | Physical findings of Elbow | 
|  11426-4 | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed | 
|  11427-2 | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed. | 
|  11428-0 | Physical findings of Foot | 
|  11429-8 | Physical findings of Forearm | 
|  1143-7 | Lu sup(b) Ab [Presence] in Serum or Plasma from donor | 
|  11430-6 | Physical findings of Gastrointestinal system | 
|  11431-4 | Physical findings of Genitalia | 
|  11432-2 | Physical findings of Female genitalia | 
|  11433-0 | Physical findings of Male genitalia | 
|  11434-8 | Physical findings of Groin | 
|  11435-5 | Physical findings of Hand | 
|  11436-3 | Deprecated Physical findings: Find: Pt: Heart: Nom: Observed | 
|  11437-1 | Physical findings of Hip | 
|  11438-9 | Physical findings of Knee | 
|  11439-7 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed. | 
|  1144-5 | Lu sup(b) Ab [Presence] in Serum or Plasma | 
|  11440-5 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed | 
|  11441-3 | Physical findings of Musculoskeletal system | 
|  11442-1 | Physical findings of Neck | 
|  11443-9 | Physical findings of Respiratory system | 
|  11444-7 | Physical findings of Shoulder | 
|  11445-4 | Physical findings of Thigh | 
|  11446-2 | Physical findings of Wrist | 
|  11447-0 | Physical findings of Hematologic and Lymphatic and Immunologic System Narrative | 
|  11448-8 | Physical findings of Hematologic and Lymphatic and Immunologic System | 
|  11449-6 | Pregnancy status [Interpretation] - Reported | 
|  1145-2 | Lu sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11450-4 | Problem list - Reported | 
|  11451-2 | Psychiatric findings Narrative | 
|  11452-0 | Psychiatric findings | 
|  11453-8 | Receiving facility EMS system | 
|  11454-6 | Responsiveness assessment at First encounter | 
|  11455-3 | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nar: Reported | 
|  11456-1 | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nom: Reported | 
|  11457-9 | Safety equipment used | 
|  11458-7 | Clostridium tetani immunization status | 
|  11459-5 | Transport mode EMS system | 
|  1146-0 | Lu sup(b) Ag [Presence] on Red Blood Cells from donor | 
|  11467-8 | Bacillus anthracis Ab [Units/volume] in Serum by Immunoblot (IB) | 
|  11468-6 | Bacillus anthracis Ab [Units/volume] in Unspecified specimen by Immunofluorescence | 
|  11469-4 | Bacillus anthracis [Presence] in Unspecified specimen by Organism specific culture | 
|  1147-8 | Lu sup(b) Ag [Presence] on Red Blood Cells | 
|  11470-2 | Clostridium botulinum toxin [Units/volume] in Stool | 
|  11471-0 | Deprecated Cryptococcus neoformans Ag [Titer] in Unspecified specimen | 
|  11472-8 | Deprecated Cryptococcus neoformans Ag [Presence] in Unspecified specimen | 
|  11473-6 | Cryptococcus sp Ag [Titer] in Unspecified specimen | 
|  11474-4 | Hydatid cyst identified in Unspecified specimen by Wet preparation | 
|  11475-1 | Microorganism identified in Unspecified specimen by Culture | 
|  11476-9 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain | 
|  11477-7 | Microscopic observation [Identifier] in Sputum by Acid fast stain | 
|  11478-5 | Microscopic observation [Identifier] in Stool by Acid fast stain | 
|  11479-3 | Microscopic observation [Identifier] in Tissue by Acid fast stain | 
|  1148-6 | Lu NOS Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11480-1 | Microscopic observation [Identifier] in Urine by Acid fast stain | 
|  11481-9 | Human papilloma virus identified in Unspecified specimen | 
|  11482-7 | Rickettsia rickettsii RNA [Presence] in Tissue by Probe and target amplification method | 
|  11483-5 | Varicella zoster virus DNA [Presence] in Unspecified specimen by Probe and target amplification method | 
|  11484-3 | Virus identified in Amniotic fluid by Culture | 
|  11485-0 | Anesthesia records | 
|  11486-8 | Chemotherapy records | 
|  11487-6 | Consultation request (narrative) | 
|  11488-4 | Consult note | 
|  11489-2 | Dictating practitioner identifier | 
|  1149-4 | Lu NOS Ab [Presence] in Serum or Plasma from donor | 
|  11490-0 | Physician Discharge summary | 
|  11491-6 | Deprecated Provider-unspecified ED visit note | 
|  11492-6 | Provider-unspecifed, History and physical note | 
|  11493-4 | Hospital discharge studies summary Narrative | 
|  11494-2 | Deprecated Physician Initial assessment note at First encounter | 
|  11495-9 | Deprecated Physical therapy Initial assessment note at First encounter | 
|  11496-7 | Deprecated Podiatry Initial assessment note at First encounter | 
|  11497-5 | Deprecated Psychology Initial assessment note at First encounter | 
|  11498-3 | Deprecated Social work Initial assessment note at First encounter | 
|  11499-1 | Deprecated Speech therapy Initial assessment note at First encounter | 
|  115-6 | Cefoxitin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1150-2 | Lu NOS Ab [Presence] in Serum or Plasma | 
|  11500-6 | Deprecated Occupational therapy Initial assessment note at First encounter | 
|  11501-6 | Deprecated Labor and delivery records | 
|  11502-2 | Laboratory report | 
|  11503-0 | Medical records | 
|  11504-8 | Provider-unspecified Operation note | 
|  11505-5 | Physician Procedure note | 
|  11506-3 | Provider-unspecified Progress note | 
|  11507-1 | Occupational therapy Progress note | 
|  11508-9 | Physical therapy Progress note | 
|  11509-7 | Podiatry Progress note | 
|  1151-0 | Lu NOS Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11510-5 | Psychology Progress note | 
|  11511-3 | Deprecated Provider-unspecified progress note | 
|  11512-1 | Speech-language pathology Progress note | 
|  11513-9 | Provider.signing [Identifier] Report | 
|  11514-7 | Chiropractic Records total Encounter | 
|  11515-4 | Physical therapy Records total Encounter | 
|  11516-2 | Physician Records total Encounter | 
|  11517-0 | Podiatry Records total Encounter | 
|  11518-8 | Psychology Records total Encounter | 
|  11519-6 | Social service Records total Encounter | 
|  1152-8 | Lu NOS Ag [Presence] on Red Blood Cells from donor | 
|  11520-4 | Speech therapy Records total Encounter | 
|  11521-2 | Occupational therapy Records total Encounter | 
|  11522-0 | Deprecated Cardiac echo study | 
|  11523-8 | EEG study | 
|  11524-6 | EKG Study | 
|  11525-3 | US Pelvis Fetus for pregnancy | 
|  11526-1 | Pathology study | 
|  11527-9 | Psychiatry study | 
|  11528-7 | Deprecated Radiology Unspecified site and modality Study | 
|  11529-5 | Surgical pathology study | 
|  1153-6 | Lu NOS Ag [Presence] on Red Blood Cells | 
|  11530-3 | Surgeon.assisting [Identifier] | 
|  11531-1 | Surgeon.resident [Identifier] | 
|  11532-9 | Surgeon.staff [Identifier] | 
|  11533-7 | Surgical drains | 
|  11534-5 | Temperature charts | 
|  11535-2 | Hospital discharge Dx Narrative | 
|  11536-0 | Nurse Notes | 
|  11537-8 | Surgical drains Narrative | 
|  11538-6 | Deprecated CT Chest study | 
|  11539-4 | Deprecated CT Head study | 
|  1154-4 | little c Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11540-2 | Deprecated CT Abdomen study | 
|  11541-0 | Deprecated MRI Brain study | 
|  11542-8 | Deprecated Provider-unspecified visit note | 
|  11543-6 | Nursery records | 
|  11544-4 | Hospital discharge follow-up Narrative | 
|  11545-1 | Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain | 
|  11546-9 | Microscopic observation [Identifier] in Unspecified specimen by Other stain | 
|  1155-1 | little c Ab [Presence] in Serum or Plasma from donor | 
|  11550-1 | Borrelia burgdorferi [Presence] in Unspecified specimen by Organism specific culture | 
|  11551-9 | Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by Probe with amplification | 
|  11552-7 | Microscopic exam [Interpretation] of Tissue fine needle aspirate by Cytology | 
|  11553-5 | Microscopic exam [Interpretation] of Sputum by Cytology | 
|  11554-3 | Deprecated Magnesium [Molecules/volume] in Serum or Plasma | 
|  11555-0 | Base excess in Blood by calculation | 
|  11556-8 | Oxygen [Partial pressure] in Blood | 
|  11557-6 | Carbon dioxide [Partial pressure] in Blood | 
|  11558-4 | pH of Blood | 
|  11559-2 | Fractional oxyhemoglobin in Blood | 
|  1156-9 | little c Ab [Presence] in Serum or Plasma | 
|  11560-0 | Acetylcholine receptor binding Ab [Units/volume] in Serum | 
|  11561-8 | Acetylcholine receptor blocking Ab [Units/volume] in Serum | 
|  11562-6 | Acetylcholine receptor modulation Ab [Units/volume] in Serum | 
|  11563-4 | Deprecated DNA double strand Ab [Units/volume] in Serum | 
|  11564-2 | Intrinsic factor Ab [Units/volume] in Serum | 
|  11565-9 | Jo-1 extractable nuclear Ab [Units/volume] in Serum | 
|  11566-7 | Liver kidney microsomal Ab [Units/volume] in Serum | 
|  11567-5 | Deprecated Neutrophil cytoplasmic Ab [Units/volume] in Serum | 
|  11568-3 | Phosphatidylserine IgG Ab [Presence] in Serum | 
|  11569-1 | Phosphatidylserine IgM Ab [Presence] in Serum | 
|  1157-7 | little c Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11570-9 | Platelet IgG Ab [Units/volume] in Serum | 
|  11571-7 | Rheumatoid arthritis nuclear Ab [Units/volume] in Serum | 
|  11572-5 | Rheumatoid factor [Units/volume] in Serum or Plasma | 
|  11573-3 | Rheumatoid factor IgM [Units/volume] in Serum | 
|  11574-1 | Deprecated Thyroperoxidase Ab [Units/volume] in Serum | 
|  11575-8 | Cefmetazole [Susceptibility] by Gradient strip | 
|  11576-6 | Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip | 
|  11577-4 | Sulfamethoxazole [Susceptibility] by Gradient strip | 
|  11578-2 | Sulfisoxazole [Susceptibility] by Gradient strip | 
|  11579-0 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L | 
|  1158-5 | little c Ag [Presence] on Red Blood Cells from donor | 
|  11580-8 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L | 
|  11581-6 | Ebola virus Ab [Units/volume] in Serum | 
|  11582-4 | Wuchereria bancrofti Ab [Units/volume] in Serum | 
|  11583-2 | Aspergillus fumigatus 1 Ab [Presence] in Serum | 
|  11584-0 | Aureobasidium pullulans Ab [Presence] in Serum | 
|  11585-7 | Bordetella pertussis Ab [Units/volume] in Serum | 
|  11586-5 | Brucella abortus Ab [Units/volume] in Serum | 
|  11587-3 | Brucella canis Ab [Units/volume] in Serum | 
|  11588-1 | Brucella melitensis Ab [Units/volume] in Serum | 
|  11589-9 | Brucella suis Ab [Units/volume] in Serum | 
|  1159-3 | little c Ag [Presence] on Red Blood Cells | 
|  11590-7 | Coxsackievirus A10 Ab [Units/volume] in Serum | 
|  11591-5 | Coxsackievirus A2 Ab [Units/volume] in Serum | 
|  11592-3 | Aspergillus fumigatus 6 Ab [Presence] in Serum | 
|  11593-1 | Coxsackievirus A4 Ab [Units/volume] in Serum | 
|  11594-9 | Echovirus 16 Ab [Units/volume] in Serum | 
|  11595-6 | Echovirus 18 Ab [Units/volume] in Serum | 
|  11596-4 | Shigella dysenteriae Ab [Units/volume] in Serum | 
|  11597-2 | Treponema pallidum Ab [Units/volume] in Serum | 
|  11598-0 | Toxoplasma gondii Ab [Units/volume] in Serum | 
|  11599-8 | Coxsackievirus A21 Ab [Units/volume] in Serum | 
|  116-4 | Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1160-1 | little e Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11600-4 | Shigella flexneri Ab [Units/volume] in Serum | 
|  11601-2 | Echovirus 7 Ab [Units/volume] in Serum | 
|  11602-0 | Shigella boydii Ab [Units/volume] in Serum | 
|  11603-8 | Salmonella sp Ab [Units/volume] in Serum | 
|  11604-6 | Burkholderia pseudomallei Ab [Units/volume] in Serum | 
|  11605-3 | Lymphocytic choriomeningitis virus Ab [Units/volume] in Serum | 
|  11606-1 | Leptospira interrogans Ab [Units/volume] in Serum | 
|  11607-9 | Junin virus Ab [Units/volume] in Serum | 
|  11608-7 | Japanese encephalitis virus Ab [Units/volume] in Serum | 
|  11609-5 | HTLV I Ab [Units/volume] in Serum | 
|  1161-9 | little e Ab [Presence] in Serum or Plasma from donor | 
|  11610-3 | Heterophile Ab [Units/volume] in Serum | 
|  11611-1 | Shigella sonnei Ab [Units/volume] in Serum | 
|  11612-9 | [#] Abortions | 
|  11613-7 | [#] Abortions.induced | 
|  11614-5 | [#] Abortions.spontaneous | 
|  11615-2 | Fetal Heart Activity US | 
|  11616-0 | Fetal Heart Narrative Activity US | 
|  11617-8 | Fetal Limbs Activity US | 
|  11618-6 | Fetal Limbs Narrative Activity US | 
|  11619-4 | Fetal Respiratory Activity US | 
|  1162-7 | little e Ab [Presence] in Serum or Plasma | 
|  11620-2 | Fetal Respiratory Narrative Activity US | 
|  11621-0 | Fetal Trunk Activity US | 
|  11622-8 | Fetal Trunk Narrative Activity US | 
|  11623-6 | Fetal Quadrant four Amniotic fluid index derived by US | 
|  11624-4 | Fetal Quadrant four one Amniotic fluid index derived by US | 
|  11625-1 | Fetal Quadrant three Amniotic fluid index derived by US | 
|  11626-9 | Fetal Quadrant two Amniotic fluid index derived by US | 
|  11627-7 | Fetal Amniotic fluid index.sum derived by US | 
|  11628-5 | Fetal Head Binocular distance estimated from Biparietal diameter on US | 
|  11629-3 | Fetal Head Binocular distance US | 
|  1163-5 | little e Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11630-1 | Fetal Biophysical profile.amniotic fluid volume US | 
|  11631-9 | Fetal Biophysical profile.body movement US | 
|  11632-7 | Fetal Biophysical profile.breathing movement US | 
|  11633-5 | Fetal Biophysical profile.heart rate reactivity US | 
|  11634-3 | Fetal Biophysical profile.sum Derived | 
|  11635-0 | Fetal Biophysical profile.tone US | 
|  11636-8 | [#] Births.live | 
|  11637-6 | [#] Births.preterm | 
|  11638-4 | [#] Births.still living | 
|  11639-2 | [#] Births.term | 
|  1164-3 | little e Ag [Presence] on Red Blood Cells from donor | 
|  11640-0 | [#] Births total | 
|  11641-8 | Fetal Mitral valve Peak A wave US.doppler | 
|  11642-6 | Deprecated Mitral valve Blood flow.diastolic.atrial wave.max by US.doppler | 
|  11643-4 | Fetal Tricuspid valve Peak A wave US.doppler | 
|  11644-2 | Deprecated Tricuspid valve Peak A velocity US.doppler | 
|  11645-9 | Fetal Mitral valve Peak E wave US.doppler | 
|  11646-7 | Deprecated Mitral valve Peak E velocity US.doppler | 
|  11647-5 | Fetal Tricuspid valve Peak E wave US.doppler | 
|  11648-3 | Deprecated Tricuspid valve Peak E velocity US.doppler | 
|  11649-1 | Fetal Mitral valve E-wave/A-wave US.doppler | 
|  1165-0 | little e Ag [Presence] on Red Blood Cells | 
|  11650-9 | Deprecated Mitral valve Blood flow.diastolic.early wave/Atrial wave Doppler.measured | 
|  11651-7 | Fetal Tricuspid valve E-wave/A-wave US.doppler | 
|  11652-5 | Deprecated Tricuspid valve Blood flow.diastolic.early wave/Atrial wave Doppler.measured | 
|  11653-3 | Circulatory system End diastolic blood flow US.doppler | 
|  11654-1 | Fetal Cerebral artery anterior Minimal flow velocity US.doppler | 
|  11655-8 | Cerebral artery anterior Minimal flow velocity US.doppler | 
|  11656-6 | Fetal Cerebral artery middle Minimal flow velocity US.doppler | 
|  11657-4 | Cerebral artery middle Minimal flow velocity US.doppler | 
|  11658-2 | Ovarian artery - left Minimal flow velocity US.doppler | 
|  11659-0 | Ovarian artery - right Minimal flow velocity US.doppler | 
|  1166-8 | little f Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11660-8 | Fetal Umbilical artery at fetus Minimal flow velocity US.doppler | 
|  11661-6 | Fetal Umbilical artery at placenta Minimal flow velocity US.doppler | 
|  11662-4 | Fetal Umbilical artery between fetus and placenta Minimal flow velocity US.doppler | 
|  11663-2 | Uterine artery - left Minimal flow velocity US.doppler | 
|  11664-0 | Uterine artery - right Minimal flow velocity US.doppler | 
|  11665-7 | Circulatory system Minimal flow velocity US.doppler | 
|  11666-5 | Fetal Aorta ascending Mean blood flow US.doppler | 
|  11667-3 | Aorta ascending Mean blood flow US.doppler | 
|  11668-1 | Fetal Aorta descending Mean blood flow US.doppler | 
|  11669-9 | Aorta descending Mean blood flow US.doppler | 
|  1167-6 | little f Ab [Presence] in Serum or Plasma from donor | 
|  11670-7 | Fetal Aortic arch Mean blood flow US.doppler | 
|  11671-5 | Aortic arch Mean blood flow US.doppler | 
|  11672-3 | Fetal Cerebral artery anterior Mean blood flow US.doppler | 
|  11673-1 | Cerebral artery anterior Mean blood flow US.doppler | 
|  11674-9 | Cerebral artery middle Mean blood flow US.doppler | 
|  11675-6 | Fetal Ductus arteriosus Mean blood flow US.doppler | 
|  11676-4 | Ductus arteriosus Mean blood flow US.doppler | 
|  11677-2 | Fetal Pulmonary valve Mean blood flow US.doppler | 
|  11678-0 | Pulmonary valve Mean blood flow by US.doppler | 
|  11679-8 | Fetal Left ventricular outflow tract Mean blood flow US.doppler | 
|  1168-4 | little f Ab [Presence] in Serum or Plasma | 
|  11680-6 | Deprecated Left ventricular outflow tract Mean blood flow Doppler.measured | 
|  11681-4 | Fetal Right ventricular outflow tract Mean blood flow US.doppler | 
|  11682-2 | Deprecated Right ventricular outflow tract Mean blood flow Doppler.measured | 
|  11683-0 | Ovarian artery - left Mean blood flow US.doppler | 
|  11684-8 | Ovarian artery - right Mean blood flow US.doppler | 
|  11685-5 | Fetal Main pulmonary artery Mean blood flow US.doppler | 
|  11686-3 | Main pulmonary artery Mean blood flow US.doppler | 
|  11687-1 | Fetal Umbilical artery at fetus Mean blood flow US.doppler | 
|  11688-9 | Fetal Umbilical artery at placenta Mean blood flow US.doppler | 
|  11689-7 | Fetal Umbilical artery between fetus and placenta Mean blood flow US.doppler | 
|  1169-2 | little f Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11690-5 | Uterine artery - left Mean blood flow US.doppler | 
|  11691-3 | Uterine artery - right Mean blood flow US.doppler | 
|  11692-1 | Circulatory system Maximum blood flow mean US.doppler | 
|  11693-9 | Fetal Aorta ascending Peak systolic flow US.doppler | 
|  11694-7 | Aorta ascending Peak systolic flow US.doppler | 
|  11695-4 | Fetal Aorta descending Peak systolic flow US.doppler | 
|  11696-2 | Aorta descending Peak systolic flow US.doppler | 
|  11697-0 | Fetal Aortic arch Peak systolic flow US.doppler | 
|  11698-8 | Aortic arch Peak systolic flow US.doppler | 
|  11699-6 | Fetal Cerebral artery anterior Peak systolic flow US.doppler | 
|  117-2 | Cefoxitin [Susceptibility] by Disk diffusion (KB) | 
|  1170-0 | little f Ag [Presence] on Red Blood Cells from donor | 
|  11700-2 | Cerebral artery anterior Peak systolic flow US.doppler | 
|  11701-0 | Fetal Cerebral artery middle Peak systolic flow US.doppler | 
|  11702-8 | Cerebral artery middle Peak systolic flow US.doppler | 
|  11703-6 | Fetal Ductus arteriosus Peak systolic flow US.doppler | 
|  11704-4 | Ductus arteriosus Peak systolic flow US.doppler | 
|  11705-1 | Fetal Aortic valve Peak systolic flow US.doppler | 
|  11706-9 | Aortic valve Peak systolic flow by US.doppler | 
|  11707-7 | Fetal Mitral valve Peak systolic flow US.doppler | 
|  11708-5 | Mitral valve Peak systolic flow by US.doppler | 
|  11709-3 | Fetal Pulmonary valve Peak systolic flow US.doppler | 
|  1171-8 | little f Ag [Presence] on Red Blood Cells | 
|  11710-1 | Pulmonary valve Peak systolic flow by US.doppler | 
|  11711-9 | Fetal Tricuspid valve Peak systolic flow US.doppler | 
|  11712-7 | Tricuspid valve Peak systolic flow by US.doppler | 
|  11713-5 | Fetal Left ventricular outflow tract Peak systolic flow US.doppler | 
|  11714-3 | Deprecated Left ventricular outflow tract Peak systolic flow Doppler.measured | 
|  11715-0 | Fetal Right ventricular outflow tract Peak systolic flow US.doppler | 
|  11716-8 | Deprecated Right ventricular outflow tract Peak systolic flow Doppler.measured | 
|  11717-6 | Ovarian artery - left Peak systolic flow US.doppler | 
|  11718-4 | Ovarian artery - right Peak systolic flow US.doppler | 
|  11719-2 | Fetal Main pulmonary artery Peak systolic flow US.doppler | 
|  1172-6 | Deprecated little i-1 subtype [Presence] in Serum or Plasma from Blood product unit | 
|  11720-0 | Main pulmonary artery Peak systolic flow US.doppler | 
|  11721-8 | Fetal Umbilical artery at fetus Peak systolic flow US.doppler | 
|  11722-6 | Fetal Umbilical artery at placenta Peak systolic flow US.doppler | 
|  11723-4 | Fetal Umbilical artery between fetus and placenta Peak systolic flow US.doppler | 
|  11724-2 | Uterine artery - left Peak systolic flow US.doppler | 
|  11725-9 | Uterine artery - right Peak systolic flow US.doppler | 
|  11726-7 | Circulatory system Peak systolic flow US.doppler | 
|  11727-5 | Fetal Body weight estimated by US | 
|  11728-3 | Fetal Body weight estimated from Abdominal circumference on US | 
|  11729-1 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US | 
|  1173-4 | Deprecated little i-1 subtype [Presence] in serum or plasma from donor | 
|  11730-9 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US | 
|  11731-7 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US | 
|  11732-5 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Hadlock 1985 method | 
|  11733-3 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Roberts 1985 method | 
|  11734-1 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Hadlock 1984 method | 
|  11735-8 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Hadlock 1985 method | 
|  11736-6 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Woo 1985 method | 
|  11737-4 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Eik-Nes 1982 method | 
|  11738-2 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Hadlock 1984 method | 
|  11739-0 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Shepard 1982 method | 
|  1174-2 | Deprecated little i-1 subtype [Presence] in serum | 
|  11740-8 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Thurnau 1983 method | 
|  11741-6 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Warsof 1977 method | 
|  11742-4 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Weinberger 1984 method | 
|  11743-2 | Fetal Body weight estimated from Abdominal circumference and Femur length on US | 
|  11744-0 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US | 
|  11745-7 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Hadlock 1984 method | 
|  11746-5 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Hadlock 1985 method | 
|  11747-3 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Ott 1986 method | 
|  11748-1 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Vintzileos 1987 method | 
|  11749-9 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Weiner 1985 method | 
|  1175-9 | Deprecated little i-1 subtype [Presence] on Red Blood Cells from Blood product unit | 
|  11750-7 | Fetal Body weight estimated from Abdominal circumference and Femur length on US by Hadlock 1984 method | 
|  11751-5 | Fetal Body weight estimated from Abdominal circumference and Femur length on US by Hadlock 1985 method | 
|  11752-3 | Fetal Body weight estimated from Abdominal circumference and Femur length on US by Woo 1985 method | 
|  11753-1 | Fetal Body weight estimated from Abdominal circumference and Head circumference on US | 
|  11754-9 | Fetal Body weight estimated from Abdominal circumference and Head circumference on US by Hadlock 1984 method | 
|  11755-6 | Fetal Body weight estimated from Abdominal circumference and Head circumference on US by Jordaan 1983 method | 
|  11756-4 | Fetal Body weight estimated from Abdominal circumference on US by Campbell 1975 method | 
|  11757-2 | Fetal Body weight estimated from Abdominal circumference on US by Vintzileos 1987 method | 
|  11758-0 | Fetal Body weight estimated from Abdominal circumference on US by Warsof 1977 method | 
|  11759-8 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US | 
|  1176-7 | Deprecated little i-1 subtype [Presence] on Red Blood Cells from donor | 
|  11760-6 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter and Femur length on US | 
|  11761-4 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter and Femur length on US by Rose 1987 method | 
|  11762-2 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US by Rose 1987 method | 
|  11763-0 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US by Vintzileos 1987 method | 
|  11764-8 | Fetal Body weight estimated from Abdominal diameter and Femur length on US | 
|  11765-5 | Fetal Body weight estimated from Abdominal diameter and Femur length on US by Rose 1987 method | 
|  11766-3 | Fetal Body weight percentile Comparison of estimated fetal weight with standard population distribution at same estimated gestational age | 
|  11767-1 | Body weight percentile Comparison of estimated fetal weight with standard population distribution at same estimated gestational age | 
|  11768-9 | Fetal Body weight percentile range Categorization by comparison with standards | 
|  11769-7 | Body weight percentile range Categorization by comparison with standards | 
|  1177-5 | Deprecated little i-1 subtype [Presence] on Red Blood Cells | 
|  11770-5 | [Percentile] Body weight.10th Estimated.pop birth wgt gestational age corr.ref | 
|  11771-3 | [Percentile] Body weight.25th Estimated.pop birth wgt gestational age corr.ref | 
|  11772-1 | [Percentile] Body weight.50th Estimated.pop birth wgt gestational age corr.ref | 
|  11773-9 | [Percentile] Body weight.75th Estimated.pop birth wgt gestational age corr.ref | 
|  11774-7 | [Percentile] Body weight.90th Estimated.pop birth wgt gestational age corr.ref | 
|  11775-4 | Fetal body weight estimation formula Narrative [Bibliographic Citation] Citation | 
|  11776-2 | Gestational age estimation formula Narrative [Bibliographic Citation] Citation | 
|  11777-0 | Fetal Abdomen [Area] Cross section derived by US | 
|  11778-8 | Delivery date Estimated | 
|  11779-6 | Delivery date Estimated from last menstrual period | 
|  1178-3 | Deprecated little i-2 subtype [Presence] in Serum or Plasma from Blood product unit | 
|  11780-4 | Delivery date Estimated from ovulation date | 
|  11781-2 | Delivery date US composite estimate | 
|  11782-0 | Fetal Bowel Diameter US | 
|  11783-8 | Bowel Diameter US | 
|  11784-6 | Cervical canal external os Diameter palpation | 
|  11785-3 | Cervical canal external os Diameter US | 
|  11786-1 | Cervical canal internal os Diameter palpation | 
|  11787-9 | Cervical canal internal os Diameter US | 
|  11788-7 | Cervical canal Diameter Probe insertion.Hagar | 
|  11789-5 | Cervical canal Diameter Probe insertion.Pratt | 
|  1179-1 | Deprecated little i-2 subtype [Presence] in serum or plasmafrom donor | 
|  11790-3 | Fetal Colon lumen Diameter US | 
|  11791-1 | Colon lumen Diameter US | 
|  11792-9 | Fetal Eye Diameter US | 
|  11793-7 | Follicle Diameter US | 
|  11794-5 | Fetal Aortic valve Diameter US | 
|  11795-2 | Aortic valve Diameter by US | 
|  11796-0 | Fetal Mitral valve Diameter US | 
|  11797-8 | Deprecated Mitral valve Diameter by US | 
|  11798-6 | Fetal Pulmonary valve Diameter US | 
|  11799-4 | Pulmonary valve Diameter by US | 
|  118-0 | Cefoxitin [Susceptibility] by Serum bactericidal titer | 
|  1180-9 | Deprecated little i-2 subtype [Presence] in serum | 
|  11800-0 | Fetal Tricuspid valve Diameter US | 
|  11801-8 | Tricuspid valve Diameter by US | 
|  11802-6 | Fetal Left ventricular outflow tract Diameter US.doppler | 
|  11803-4 | Left ventricular outflow tract Diameter US.doppler | 
|  11804-2 | Fetal Right ventricular outflow tract Diameter US | 
|  11805-9 | Right ventricular outflow tract Diameter US | 
|  11806-7 | Fetal Pulmonary artery Diameter US | 
|  11807-5 | Pulmonary artery Diameter US | 
|  11808-3 | Fetal Renal pelvis - left Diameter US | 
|  11809-1 | Renal pelvis - left Diameter US | 
|  1181-7 | Deprecated little i-2 subtype [Presence] on Red Blood Cells from Blood product unit | 
|  11810-9 | Fetal Renal pelvis - right Diameter US | 
|  11811-7 | Renal pelvis - right Diameter US | 
|  11812-5 | Fetal Small bowel Diameter US | 
|  11813-3 | Small bowel Diameter US | 
|  11814-1 | Fetal Umbilical vein Diameter US | 
|  11815-8 | Fetal Urinary bladder Diameter US | 
|  11816-6 | Fetal Yolk sac Diameter US | 
|  11817-4 | Fetal Amniotic fluid space Diameter largest pocket US | 
|  11818-2 | Fetal Abdomen Diameter.anterior-posterior US | 
|  11819-0 | Fetal Thorax Diameter.anterior-posterior US | 
|  1182-5 | Deprecated little i-2 subtype [Presence] on Red Blood Cells from donor | 
|  11820-8 | Fetal Head Diameter.biparietal US | 
|  11821-6 | Fetal Head Mean biparietal diameter Estimated from gestational age | 
|  11822-4 | Fetal Head Mean biparietal diameter estimated from Cerebellar diameter (US) | 
|  11823-2 | Fetal Head Diameter.biparietal/Diameter.occipital derived by US | 
|  11824-0 | Fetal Head Diameter.BPD.area-corrected derived by US | 
|  11825-7 | Fetal Kidney - left Hilum-cortex diameter US | 
|  11826-5 | Kidney - left Hilum-cortex diameter US | 
|  11827-3 | Fetal Kidney - right Hilum-cortex diameter US | 
|  11828-1 | Kidney - right Hilum-cortex diameter US | 
|  11829-9 | Ovary - left Hilum-cortex diameter US | 
|  1183-3 | Deprecated little i-2 subtype [Presence] on Red Blood Cells | 
|  11830-7 | Ovary - right Hilum-cortex diameter US | 
|  11831-5 | Fetal Kidney Mean width Estimated from gestational age | 
|  11832-3 | Fetal Amniotic fluid space Maximum diameter largest pocket US | 
|  11833-1 | Fetal Amniotic fluid space Mean diameter largest pocket US | 
|  11834-9 | Fetal Kidney - left Longitudinal diameter US | 
|  11835-6 | Kidney - left Longitudinal diameter US | 
|  11836-4 | Fetal Kidney - right Longitudinal diameter US | 
|  11837-2 | Kidney - right Longitudinal diameter US | 
|  11838-0 | Fetal Liver Longitudinal diameter US | 
|  11839-8 | Liver Longitudinal diameter US | 
|  1184-1 | little i Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11840-6 | Ovary - left Longitudinal diameter US | 
|  11841-4 | Ovary - right Longitudinal diameter US | 
|  11842-2 | Uterus Longitudinal diameter US | 
|  11843-0 | Fetal Kidney Mean longitudinal diameter Estimated from gestational age | 
|  11844-8 | Fetal Liver Mean longitudinal diameter Estimated from abdominal circumference | 
|  11845-5 | Fetal Liver Mean longitudinal diameter Estimated from gestational age | 
|  11846-3 | Ovary largest follicle Maximum diameter US | 
|  11847-1 | Ovary - left largest follicle Maximum diameter US | 
|  11848-9 | Ovary - right largest follicle Maximum diameter US | 
|  11849-7 | Fetal Abdomen Mean diameter Estimated from gestational age | 
|  1185-8 | little i Ab [Presence] in Serum or Plasma from donor | 
|  11850-5 | Gestational sac Mean diameter US | 
|  11851-3 | Fetal Head Diameter.occipito-frontal US | 
|  11852-1 | Fetal Head Diameter.outer to outer US | 
|  11853-9 | Fetal Kidney - left Thickeness US | 
|  11854-7 | Kidney - left Thickeness US | 
|  11855-4 | Fetal Kidney - right Thickeness US | 
|  11856-2 | Kidney - right Thickeness US | 
|  11857-0 | Ovary - left Thickeness US | 
|  11858-8 | Ovary - right Thickeness US | 
|  11859-6 | Uterus Thickeness US | 
|  1186-6 | little i Ab [Presence] in Serum or Plasma | 
|  11860-4 | Fetal Cisterna magna Diameter.sagittal US | 
|  11861-2 | Fetal Cisterna magna Mean sagittal diameter Estimated from gestational age | 
|  11862-0 | Fetal Abdomen Diameter transverse US | 
|  11863-8 | Fetal Cerebellum Diameter transverse US | 
|  11864-6 | Fetal Thorax Diameter transverse US | 
|  11865-3 | Uterus Diameter transverse US | 
|  11866-1 | Fetal Cerebellum Mean transverse diameter Estimated from gestational age | 
|  11867-9 | Effacement Cervix | 
|  11868-7 | Fetal body weight estimation formula Narrative [Equation] Equation | 
|  11869-5 | Gestational age estimation formula Narrative [Equation] Equation | 
|  1187-4 | little i NOS Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11870-3 | Examination level ultrasound | 
|  11871-1 | Fetal Femur length/Abdominal circumference derived by US | 
|  11872-9 | Fetal Femur length/Biparietal diameter derived by US | 
|  11873-7 | Fetal Femur length/Head circumference derived by US | 
|  11874-5 | Fetal position palpation | 
|  11875-2 | Fetal position US | 
|  11876-0 | Fetal presentation palpation | 
|  11877-8 | Fetal presentation US | 
|  11878-6 | Number of fetuses by US | 
|  11879-4 | Ovary - left [#] Follicles US | 
|  1188-2 | little i NOS Ag [Presence] on Red Blood Cells from donor | 
|  11880-2 | Ovary - right [#] Follicles US | 
|  11881-0 | Uterus Fundal height Tape measure | 
|  11882-8 | Fetal Sex US | 
|  11883-6 | Fetal Narrative Sex US | 
|  11884-4 | Gestational age Estimated | 
|  11885-1 | Gestational age Estimated from last menstrual period | 
|  11886-9 | Gestational age Estimated from ovulation date | 
|  11887-7 | Gestational age Estimated from selected delivery date | 
|  11888-5 | Gestational age US composite estimate | 
|  11889-3 | Gestational age estimated from Abdominal circumference on US | 
|  1189-0 | little i NOS Ag [Presence] on Red Blood Cells | 
|  11890-1 | Gestational age estimated from Abdominal circumference on US by Campbell 1975 method | 
|  11891-9 | Gestational age estimated from Abdominal circumference on US by Hadlock 1982 method | 
|  11892-7 | Gestational age estimated from Abdominal circumference on US by Hadlock 1984 method | 
|  11893-5 | Gestational age estimated from Abdominal circumference on US by Jeanty 1984 method | 
|  11894-3 | Gestational age estimated from area corrected Biparietal circumference (US) | 
|  11895-0 | Gestational age estimated from Binocular distance on US | 
|  11896-8 | Gestational age estimated from Binocular distance on US by Jeanty 1984 method | 
|  11897-6 | Gestational age estimated from Biparietal circumference (US) | 
|  11898-4 | Gestational age estimated from Biparietal diameter on US | 
|  11899-2 | Gestational age estimated from Biparietal diameter on US by Campbell 1975 method | 
|  119-8 | Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1190-8 | little k Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11900-8 | Gestational age estimated from Biparietal diameter on US by Doubilet 1993 method | 
|  11901-6 | Gestational age estimated from Biparietal diameter on US by Hadlock 1982 method | 
|  11902-4 | Gestational age estimated from Biparietal diameter on US by Hadlock 1984 method | 
|  11903-2 | Gestational age estimated from Biparietal diameter on US by Hansmann 1985 method | 
|  11904-0 | Gestational age estimated from Biparietal diameter on US by Hobbins 1983 method | 
|  11905-7 | Gestational age estimated from Biparietal diameter on US by Jeanty 1984 method | 
|  11906-5 | Gestational age estimated from Biparietal diameter on US by Kurtz 1980 method | 
|  11907-3 | Gestational age estimated from Biparietal diameter on US by Sabbagha 1978 method | 
|  11908-1 | Gestational age estimated from Cerebellar diameter by method of Goldstein 1987 (US) | 
|  11909-9 | Gestational age estimated from Crown rump length on US | 
|  1191-6 | little k Ab [Presence] in Serum or Plasma from donor | 
|  11910-7 | Gestational age estimated from Crown rump length on US by Hadlock 1992 method | 
|  11911-5 | Gestational age estimated from Crown rump length on US by Hansmann 1985 method | 
|  11912-3 | Gestational age estimated from Crown rump length on US by Jeanty 1984 method | 
|  11913-1 | Gestational age estimated from Crown rump length on US by Nelson 1981 method | 
|  11914-9 | Gestational age estimated from Crown rump length on US by Robinson 1975 method | 
|  11915-6 | Gestational age estimated from Crown rump length on US by Yeh 1988 method | 
|  11916-4 | Gestational age estimated from Fibula length (US) | 
|  11917-2 | Gestational age estimated from Fibula length by method of Jeanty 1984 (US) | 
|  11918-0 | Gestational age estimated from Fibula length by method of Merz 1987 (US) | 
|  11919-8 | Gestational age estimated from Femur length on US | 
|  1192-4 | little k Ab [Presence] in Serum or Plasma | 
|  11920-6 | Gestational age estimated from Femur length on US by Hadlock 1984 method | 
|  11921-4 | Gestational age estimated from Femur length on US by Hansmann 1985 method | 
|  11922-2 | Gestational age estimated from Femur length on US by Hohler 1982 method | 
|  11923-0 | Gestational age estimated from Femur length on US by Jeanty 1984 method | 
|  11924-8 | Gestational age estimated from Femur length on US by Merz 1987 method | 
|  11925-5 | Gestational age estimated from Femur length on US by Obrien 1982 method | 
|  11926-3 | Gestational age estimated from Foot length on US by Mercer 1987 method | 
|  11927-1 | Gestational age estimated from Gestational sac diameter on US | 
|  11928-9 | Gestational age estimated from Gestational sac diameter on US by Hellman 1969 method | 
|  11929-7 | Gestational age estimated from Gestational sac diameter on US by Rempen 1991 method | 
|  1193-2 | little k Ag [Presence] on Red Blood Cells from Blood product unit | 
|  11930-5 | Gestational age estimated from Head circumference on US | 
|  11931-3 | Gestational age estimated from Head circumference on US by Hadlock 1982 method | 
|  11932-1 | Gestational age estimated from Head circumference on US by Hadlock 1984 method | 
|  11933-9 | Gestational age estimated from Head circumference on US by Hoffbauer 1979 method | 
|  11934-7 | Gestational age estimated from Head circumference on US by Jeanty 1984 method | 
|  11935-4 | Gestational age estimated from Humerus length on US | 
|  11936-2 | Gestational age estimated from Humerus length on US by Jeanty 1984 method | 
|  11937-0 | Gestational age estimated from Humerus length on US by Merz 1987 method | 
|  11938-8 | Gestational age estimated from Radius length (US) | 
|  11939-6 | Gestational age estimated from Radius length by method of Merz 1987 (US) | 
|  1194-0 | little k Ag [Presence] on Red Blood Cells from donor | 
|  11940-4 | Gestational age estimated from Tibia length on US | 
|  11941-2 | Gestational age estimated from Tibia length on US by Jeanty 1984 method | 
|  11942-0 | Gestational age estimated from Tibia length on US by Merz 1987 method | 
|  11943-8 | Gestational age estimated from Ulna length (US) | 
|  11944-6 | Gestational age estimated from Ulna length by method of Jeanty 1984 (US) | 
|  11945-3 | Gestational age estimated from Ulna length by method of Merz 1987 (US) | 
|  11946-1 | Fetal Placenta Grade US | 
|  11947-9 | Head circumference/Abdominal circumference derived by US | 
|  11948-7 | Fetal Heart rate US | 
|  11949-5 | Fetal Identification criteria US | 
|  1195-7 | little k Ag [Presence] on Red Blood Cells | 
|  11950-3 | Fetal Narrative Identification criteria US | 
|  11951-1 | Fetal [Identifier] Identifier | 
|  11952-9 | Fetal Umbilical cord.placenta Narrative Insertion site US | 
|  11953-7 | OB ultrasound imaging device Institution inventory number | 
|  11954-5 | Fetal Kidney length/Abdominal circumference derived by US | 
|  11955-2 | Deprecated Last menstrual period | 
|  11956-0 | Fetal Head Lateral ventricular body width/Hemispheric width derived by US | 
|  11957-8 | Fetal Crown Rump length US | 
|  11958-6 | Cervical canal [Length] palpation | 
|  11959-4 | Cervical canal [Length] US | 
|  1196-5 | Little NOS Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11960-2 | Cervix externally palpable surface [Length] palpation | 
|  11961-0 | Cervix [Length] US | 
|  11962-8 | Fetal Clavicle diaphysis [Length] US | 
|  11963-6 | Fetal Femur diaphysis [Length] US | 
|  11964-4 | Fetal Fibula diaphysis [Length] US | 
|  11965-1 | Fetal Foot [Length] US | 
|  11966-9 | Fetal Humerus diaphysis [Length] US | 
|  11967-7 | Fetal Radius diaphysis [Length] US | 
|  11968-5 | Fetal Tibia diaphysis [Length] US | 
|  11969-3 | Fetal Ulna diaphysis [Length] US | 
|  1197-3 | Little NOS Ab [Presence] in Serum or Plasma from donor | 
|  11970-1 | Fetal Femur diaphysis [Length] mean Estimated from gestational age.Merz. 1987 | 
|  11971-9 | Fetal Fibula diaphysis [Length] mean Estimated from gestational age.Merz. 1987 | 
|  11972-7 | Fetal Humerus diaphysis [Length] mean Estimated from gestational age.Merz. 1987 | 
|  11973-5 | Fetal Radius diaphysis [Length] mean Estimated from gestational age.Merz. 1987 | 
|  11974-3 | Fetal Tibia diaphysis [Length] mean Estimated from gestational age.Merz. 1987 | 
|  11975-0 | Fetal Ulna diaphysis [Length] mean Estimated from gestational age.Merz. 1987 | 
|  11976-8 | Ovulation date | 
|  11977-6 | [#] Parity | 
|  11978-4 | Fetal Abdomen Circumference derived by US | 
|  11979-2 | Fetal Abdomen Circumference US | 
|  1198-1 | Little NOS Ab [Presence] in Serum or Plasma | 
|  11980-0 | Fetal Abdomen Circumference measured by ellipse overlay (US) | 
|  11981-8 | Fetal Abdomen Circumference US.traced | 
|  11982-6 | Fetal Head Circumference derived from occipital-frontal diameter and outer-outer transaxial diameter (US) | 
|  11983-4 | Fetal Head Circumference derived from occipital-frontal diameter and outer-inner biparietal diameter (US) | 
|  11984-2 | Fetal Head Circumference US | 
|  11985-9 | Fetal Head Circumference measured by ellipse overlay (US) | 
|  11986-7 | Fetal Head Circumference US.traced | 
|  11987-5 | Fetal Thorax Circumference derived by US | 
|  11988-3 | Fetal Thorax Circumference US | 
|  11989-1 | Fetal Thorax Circumference measured by ellipse overlay (US) | 
|  1199-9 | pk Ab [Presence] in Serum or Plasma from Blood product unit | 
|  11990-9 | Fetal Thorax Circumference US.traced | 
|  11991-7 | Fetal Abdomen Mean perimeter Estimated from gestational age | 
|  11992-5 | Fetal Heart position US | 
|  11993-3 | Fetal Narrative Heart position US | 
|  11994-1 | Placenta position US | 
|  11995-8 | Narrative Placenta position US | 
|  11996-6 | [#] Pregnancies | 
|  11997-4 | Fetal Cerebral artery anterior Pulsatility index US.doppler | 
|  11998-2 | Cerebral artery anterior Pulsatility index US.doppler | 
|  11999-0 | Fetal Cerebral artery middle Pulsatility index US.doppler | 
|  12-5 | Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  120-6 | Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1200-5 | pk Ab [Presence] in Serum or Plasma from donor | 
|  12000-6 | Cerebral artery middle Pulsatility index US.doppler | 
|  12001-4 | Ovarian artery - left Pulsatility index US.doppler | 
|  12002-2 | Ovarian artery - right Pulsatility index US.doppler | 
|  12003-0 | Fetal Umbilical artery at fetus Pulsatility index US.doppler | 
|  12004-8 | Fetal Umbilical artery at placenta Pulsatility index US.doppler | 
|  12005-5 | Fetal Umbilical artery between fetus and placenta Pulsatility index US.doppler | 
|  12006-3 | Uterine artery - left Pulsatility index US.doppler | 
|  12007-1 | Uterine artery - right Pulsatility index US.doppler | 
|  12008-9 | Pulsatility index US.doppler | 
|  12009-7 | Fetal Heart R-R duration US | 
|  1201-3 | pk Ab [Presence] in Serum or Plasma | 
|  12010-5 | R-R duration US | 
|  12011-3 | Replicate summarization | 
|  12012-1 | Fetal Cerebral artery anterior Resistivity index US.doppler | 
|  12013-9 | Deprecated Fetal Cerebral artery anterior Resistivity index Doppler.calculated | 
|  12014-7 | Cerebral artery middle Resistivity index US.doppler | 
|  12015-4 | Deprecated Resistivity index of Cerebral artery middle Doppler.calculated | 
|  12016-2 | Ovarian artery - left Resistivity index US.doppler | 
|  12017-0 | Ovarian artery - right Resistivity index US.doppler | 
|  12018-8 | Fetal Umbilical artery at fetus Resistivity index US.doppler | 
|  12019-6 | Fetal Umbilical artery at placenta Resistivity index US.doppler | 
|  1202-1 | pk Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12020-4 | Fetal Umbilical artery between fetus and placenta Resistivity index US.doppler | 
|  12021-2 | Uterine artery - left Resistivity index US.doppler | 
|  12022-0 | Uterine artery - right Resistivity index US.doppler | 
|  12023-8 | Resistivity index US.doppler | 
|  12024-6 | Left ventricle [Length] Short axis during diastole US.M-mode+Measured | 
|  12025-3 | Left ventricle [Length] Short axis during diastole Measured by real time two dimension US | 
|  12026-1 | Left ventricle [Length] Short axis during systole US.M-mode+Measured | 
|  12027-9 | Left ventricle [Length] Short axis during systole Measured by real time two dimension US | 
|  12028-7 | Fetal Abdomen Study observation US | 
|  12029-5 | Fetal Abdomen Narrative Study observation US | 
|  1203-9 | pk Ag [Presence] on Red Blood Cells from donor | 
|  12030-3 | Fetal Abdominal wall Study observation US | 
|  12031-1 | Fetal Abdominal wall Narrative Study observation US | 
|  12032-9 | Fetal Aorta ascending Study observation US | 
|  12033-7 | Fetal Aorta ascending Narrative Study observation US | 
|  12034-5 | Fetal Aorta descending Study observation US | 
|  12035-2 | Fetal Aorta descending Narrative Study observation US | 
|  12036-0 | Fetal Aorta Study observation US | 
|  12037-8 | Fetal Aorta Narrative Study observation US | 
|  12038-6 | Fetal Aortic arch Study observation US | 
|  12039-4 | Fetal Aortic arch Narrative Study observation US | 
|  1204-7 | pk Ag [Presence] on Red Blood Cells | 
|  12040-2 | Fetal Cerebellum Study observation US | 
|  12041-0 | Fetal Cerebellum Narrative Study observation US | 
|  12042-8 | Fetal Cerebrum Study observation US | 
|  12043-6 | Fetal Cerebrum Narrative Study observation US | 
|  12044-4 | Inspection Cervix Study observation | 
|  12045-1 | palpation Cervix Study observation | 
|  12046-9 | US Cervix Study observation | 
|  12047-7 | Fetal Colon Study observation US | 
|  12048-5 | Fetal Colon Narrative Study observation US | 
|  12049-3 | Fetal Cranium Study observation US | 
|  1205-4 | little p Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12050-1 | Fetal Cranium Narrative Study observation US | 
|  12051-9 | Fetal Diaphragm Study observation US | 
|  12052-7 | Fetal Diaphragm Narrative Study observation US | 
|  12053-5 | Fetal ductal arch Study observation US | 
|  12054-3 | Fetal ductal arch Narrative Study observation US | 
|  12055-0 | Fetal Face Study observation US | 
|  12056-8 | Fetal Face Narrative Study observation US | 
|  12057-6 | Fetal Choroid plexus Study observation US | 
|  12058-4 | Fetal Choroid plexus Narrative Study observation US | 
|  12059-2 | Fetal Fourth ventricle Study observation US | 
|  1206-2 | little p Ag [Presence] on Red Blood Cells from donor | 
|  12060-0 | Fetal Fourth ventricle Narrative Study observation US | 
|  12061-8 | Fetal Intracranial anatomy Study observation US | 
|  12062-6 | Fetal Intracranial anatomy Narrative Study observation US | 
|  12063-4 | Fetal Lateral cerebral ventricles Study observation US | 
|  12064-2 | Fetal Lateral cerebral ventricles Narrative Study observation US | 
|  12065-9 | Fetal Posterior fossa Study observation US | 
|  12066-7 | Fetal Posterior fossa Narrative Study observation US | 
|  12067-5 | Fetal Head Third Ventricle Study observation US | 
|  12068-3 | Fetal Head Third Ventricle Narrative Study observation US | 
|  12069-1 | Fetal Head Study observation US | 
|  1207-0 | little p Ag [Presence] on Red Blood Cells | 
|  12070-9 | Fetal Head Narrative Study observation US | 
|  12071-7 | Fetal Aortic valve Study observation US | 
|  12072-5 | Fetal Aortic valve Narrative Study observation US | 
|  12073-3 | Fetal Atrium Study observation US | 
|  12074-1 | Fetal Atrium Narrative Study observation US | 
|  12075-8 | Fetal Heart chambers Study observation US | 
|  12076-6 | Fetal Heart chambers Narrative Study observation US | 
|  12077-4 | Fetal Heart great vessels Study observation US | 
|  12078-2 | Fetal Heart great vessels Narrative Study observation US | 
|  12079-0 | Fetal Interventricular septum Study observation US | 
|  1208-8 | little s Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12080-8 | Fetal Interventricular septum Narrative Study observation US | 
|  12081-6 | Fetal Mitral valve Study observation US | 
|  12082-4 | Fetal Mitral valve Narrative Study observation US | 
|  12083-2 | Fetal Pulmonary valve Study observation US | 
|  12084-0 | Fetal Tricuspid valve Study observation US | 
|  12085-7 | Fetal Tricuspid valve Narrative Study observation US | 
|  12086-5 | Fetal Heart valves Study observation US | 
|  12087-3 | Fetal Heart valves Narrative Study observation US | 
|  12088-1 | Fetal Left ventricular outflow tract Study observation US | 
|  12089-9 | Fetal Left ventricular outflow tract Narrative Study observation US | 
|  1209-6 | little s Ab [Presence] in Serum or Plasma from donor | 
|  12090-7 | Fetal Right ventricular outflow tract Study observation US | 
|  12091-5 | Fetal Right ventricular outflow tract Narrative Study observation US | 
|  12092-3 | Fetal Intestine Study observation US | 
|  12093-1 | Fetal Intestine Narrative Study observation US | 
|  12094-9 | Fetal Kidney - left Study observation US | 
|  12095-6 | Fetal Kidney - left Narrative Study observation US | 
|  12096-4 | Fetal Kidney - right Study observation US | 
|  12097-2 | Fetal Kidney - right Narrative Study observation US | 
|  12098-0 | Fetal Kidney Study observation US | 
|  12099-8 | Fetal Kidney Narrative Study observation US | 
|  121-4 | Cefpodoxime [Susceptibility] by Disk diffusion (KB) | 
|  1210-4 | little s Ab [Presence] in Serum or Plasma | 
|  12100-4 | Fetal Limbs Study observation US | 
|  12101-2 | Fetal Limbs Narrative Study observation US | 
|  12102-0 | Fetal Nuchal fold Study observation US | 
|  12103-8 | Fetal Nuchal fold Narrative Study observation US | 
|  12104-6 | Fetal Pulmonary artery Study observation US | 
|  12105-3 | Fetal Pulmonary artery Narrative Study observation US | 
|  12106-1 | Fetal Pulmonary vein Study observation US | 
|  12107-9 | Fetal Pulmonary vein Narrative Study observation US | 
|  12108-7 | Fetal Small bowel Study observation US | 
|  12109-5 | Fetal Small bowel Narrative Study observation US | 
|  1211-2 | little s Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12110-3 | Fetal Spine Study observation US | 
|  12111-1 | Fetal Spine Narrative Study observation US | 
|  12112-9 | Fetal Stomach Study observation US | 
|  12113-7 | Fetal Stomach Narrative Study observation US | 
|  12114-5 | Fetal Thorax Study observation US | 
|  12115-2 | Fetal Thorax Narrative Study observation US | 
|  12116-0 | Fetal Umbilical cord Study observation US | 
|  12117-8 | Fetal Umbilical cord Narrative Study observation US | 
|  12118-6 | Fetal Urinary bladder Study observation US | 
|  12119-4 | Fetal Urinary bladder Narrative Study observation US | 
|  1212-0 | little s Ag [Presence] on Red Blood Cells from donor | 
|  12120-2 | Fetal Inferior vena cava Study observation US | 
|  12121-0 | Fetal Inferior vena cava Narrative Study observation US | 
|  12122-8 | Fetal Superior vena cava Study observation US | 
|  12123-6 | Fetal Superior vena cava Narrative Study observation US | 
|  12124-4 | Fetal Vena cava Study observation US | 
|  12125-1 | Fetal Vena cava Narrative Study observation US | 
|  12126-9 | US Unspecified body region Study observation Narrative | 
|  12127-7 | Deprecated Fetal Yolk sac Quantitative Study observation US | 
|  12128-5 | Fetal Yolk sac Narrative Study observation US | 
|  12129-3 | Fetal [Interpretation] Study observation general US | 
|  1213-8 | little s Ag [Presence] on Red Blood Cells | 
|  12130-1 | Fetal Narrative [Interpretation] Study observation general US | 
|  12131-9 | US Study observation general [Interpretation] | 
|  12132-7 | US Study observation general [Interpretation] Narrative | 
|  12133-5 | Fetal Cerebral artery anterior Systolic flow/Diastolic flow US.doppler | 
|  12134-3 | Cerebral artery anterior Systolic flow/Diastolic flow US.doppler | 
|  12135-0 | Fetal Cerebral artery middle Systolic flow/Diastolic flow US.doppler | 
|  12136-8 | Cerebral artery middle Systolic flow/Diastolic flow US.doppler | 
|  12137-6 | Ovarian artery - left Systolic flow/Diastolic flow US.doppler | 
|  12138-4 | Ovarian artery - right Systolic flow/Diastolic flow US.doppler | 
|  12139-2 | Fetal Umbilical artery at fetus Systolic flow/Diastolic flow US.doppler | 
|  1214-6 | LW Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12140-0 | Fetal Umbilical artery at placenta Systolic flow/Diastolic flow US.doppler | 
|  12141-8 | Fetal Umbilical artery between fetus and placenta Systolic flow/Diastolic flow US.doppler | 
|  12142-6 | Uterine artery - left Systolic flow/Diastolic flow US.doppler | 
|  12143-4 | Uterine artery - right Systolic flow/Diastolic flow US.doppler | 
|  12144-2 | Systolic flow/Diastolic flow US.doppler | 
|  12145-9 | Endometrium Thickness US | 
|  12146-7 | Fetal Nuchal fold Thickness US | 
|  12147-5 | Fetal Placenta Thickness US | 
|  12148-3 | Fetal Interventricular septum Thickness diastolic US.M-mode+Measured | 
|  12149-1 | Fetal Interventricular septum Thickness diastolic Measured by real time two dimension US | 
|  1215-3 | LW Ab [Presence] in Serum or Plasma from donor | 
|  12150-9 | Fetal Left ventricular posterior wall Thickness diastolic US.M-mode+Measured | 
|  12151-7 | Fetal Left ventricular posterior wall Thickness diastolic Measured by real time two dimension US | 
|  12152-5 | Fetal Interventricular septum Thickness.systolic US.M-mode+Measured | 
|  12153-3 | Fetal Interventricular septum Thickness.systolic Measured by real time two dimension US | 
|  12154-1 | Fetal Left ventricular posterior wall Thickness.systolic US.M-mode+Measured | 
|  12155-8 | Fetal Left ventricular posterior wall Thickness.systolic Measured by real time two dimension US | 
|  12156-6 | Transducer site | 
|  12157-4 | Ultrasonographer gravidity number | 
|  12158-2 | OB ultrasound imaging device Class | 
|  12159-0 | Ultrasound scan quality | 
|  1216-1 | LW Ab [Presence] in Serum or Plasma | 
|  12160-8 | OB ultrasound imaging device Vendor model number | 
|  12161-6 | OB ultrasound imaging device Vendor serial number | 
|  12162-4 | Fetal Kidney - left Volume derived by US | 
|  12163-2 | Fetal Kidney - right Volume derived by US | 
|  12164-0 | Ovary - left Volume derived by US | 
|  12165-7 | Ovary - right Volume derived by US | 
|  12166-5 | Fetal Yolk sac Volume US | 
|  12167-3 | Fetal Amniotic fluid space [Interpretation] Volume.amniotic fluid US | 
|  12168-1 | Fetal Urinary bladder Volume post void US | 
|  12169-9 | Fetal Urinary bladder Volume.pre void US | 
|  1217-9 | LW Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12170-7 | Fetal Head Hemisphere width US | 
|  12171-5 | Fetal Lateral cerebral ventricles Transverse width US | 
|  12172-3 | 5-Hydroxyindoleacetate [Presence] in 24 hour Urine | 
|  12173-1 | Non prostatic acid phosphatase [Enzymatic activity/volume] in Serum or Plasma | 
|  12174-9 | Albumin/Globulin [Mass Ratio] in Body fluid | 
|  12175-6 | Deprecated Albumin/Globulin [Mass ratio] in Serum | 
|  12176-4 | Amino acids [Moles/volume] in Serum or Plasma | 
|  12177-2 | Amino acids/Creatinine [Ratio] in Urine | 
|  12178-0 | Bacteria [Presence] in Genital specimen by Wet preparation | 
|  12179-8 | Basophils/100 leukocytes in Body fluid by Manual count | 
|  1218-7 | LW Ag [Presence] on Red Blood Cells from donor | 
|  12180-6 | Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) | 
|  12181-4 | Calcium [Moles/volume] in Body fluid | 
|  12182-2 | Cells [#/volume] in Body fluid by Manual count | 
|  12183-0 | Cholesterol [Mass/volume] in Body fluid | 
|  12184-8 | Choriogonadotropin [Presence] in Body fluid | 
|  12185-5 | aPTT in control Blood by Coagulation assay | 
|  12186-3 | Colloid oncotic pressure [Partial pressure] in Plasma | 
|  12187-1 | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis | 
|  12188-9 | Deprecated Creatine kinase.MB/Creatine kinase.total | 
|  12189-7 | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by calculation | 
|  1219-5 | LW Ag [Presence] on Red Blood Cells | 
|  12190-5 | Creatinine [Mass/volume] in Body fluid | 
|  12191-3 | Creatinine [Mass/volume] in Peritoneal fluid | 
|  12192-1 | Creatinine [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis | 
|  12193-9 | Creatinine [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis | 
|  12194-7 | Creatinine [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis | 
|  12195-4 | Creatinine renal clearance/1.73 sq M in 24 hour | 
|  12196-2 | Cryofibrinogen [Presence] in Plasma by 4 hour cold incubation | 
|  12197-0 | Cryofibrinogen [Presence] in Plasma by 1 day cold incubation | 
|  12198-8 | Cryofibrinogen [Presence] in Plasma by 2 day cold incubation | 
|  12199-6 | Cryofibrinogen [Presence] in Plasma by 3 day cold incubation | 
|  122-2 | Cefpodoxime [Susceptibility] by Serum bactericidal titer | 
|  1220-3 | Mg Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12200-2 | Cryoglobulin [Presence] in Serum by 4 hour cold incubation | 
|  12201-0 | Cryoglobulin [Presence] in Serum by 1 day cold incubation | 
|  12202-8 | Cryoglobulin [Presence] in Serum by 2 day cold incubation | 
|  12203-6 | Cryoglobulin [Presence] in Serum by 3 day cold incubation | 
|  12204-4 | Cryoglobulin [Presence] in Serum by 4 day cold incubation | 
|  12205-1 | Cryoglobulin [Presence] in Serum by 5 day cold incubation | 
|  12206-9 | Cryoglobulin [Presence] in Serum by 6 day cold incubation | 
|  12207-7 | Cryoglobulin [Presence] in Serum by 1 week cold incubation | 
|  12208-5 | Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  12209-3 | Eosinophils/100 leukocytes in Body fluid by Manual count | 
|  1221-1 | Mg Ab [Presence] in Serum or Plasma from donor | 
|  12210-1 | Eosinophils/100 leukocytes in Urine sediment by Manual count | 
|  12211-9 | Epithelial cells [Presence] in Vaginal fluid by Wet preparation | 
|  12212-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Serum by Immunofluorescence | 
|  12213-5 | Deprecated Estradiol [Mass/volume] in Serum or Plasma by RIA | 
|  12214-3 | Deprecated Estradiol [Mass/volume] in Serum or Plasma by MEIA | 
|  12215-0 | Fatty acids.very long chain [Moles/volume] in Serum or Plasma | 
|  12216-8 | Deprecated Gastrin [Mass/volume] in Serum or Plasma | 
|  12217-6 | Globulin [Mass/volume] in Body fluid | 
|  12218-4 | Glucose [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis | 
|  12219-2 | Glucose [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis | 
|  1222-9 | Mg Ab [Presence] in Serum or Plasma | 
|  12220-0 | Glucose [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis | 
|  12221-8 | Heterophile Ab [Presence] in Serum by Sheep Cell Agglutination | 
|  12222-6 | Human papilloma virus Ag [Presence] in Genital specimen | 
|  12223-4 | Human papilloma virus 16+18 Ag [Presence] in Genital specimen | 
|  12224-2 | Leukocytes [#/area] in Nose by Microscopy high power field | 
|  12225-9 | Leukocytes [#/area] in Sputum by Microscopy high power field | 
|  12226-7 | Leukocytes [Presence] in Vaginal fluid by Wet preparation | 
|  12227-5 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood | 
|  12228-3 | Triglyceride [Mass/volume] in Body fluid | 
|  12229-1 | Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  1223-7 | Mg Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12230-9 | Macrophages/100 leukocytes in Body fluid by Manual count | 
|  12231-7 | Prolactin [Mass/volume] in Serum or Plasma --baseline | 
|  12232-5 | Measles virus Ag [Presence] in Unspecified specimen by Immunofluorescence | 
|  12233-3 | Mesothelial cells/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  12234-1 | Mesothelial cells/100 leukocytes in Body fluid by Manual count | 
|  12235-8 | Microscopic observation [Identifier] in Urine sediment by Light microscopy | 
|  12236-6 | Mononuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  12237-4 | Mumps virus Ag [Presence] in Unspecified specimen by Immunofluorescence | 
|  12238-2 | Neutrophils/100 leukocytes in Body fluid by Manual count | 
|  12239-0 | Oligosaccharides [Presence] in Urine | 
|  1224-5 | Mg Ag [Presence] on Red Blood Cells from donor | 
|  12240-8 | Orotidine [Moles/volume] in Urine | 
|  12241-6 | Osmotic fragility of Red Blood Cells by Diluted RBC | 
|  12242-4 | Phosphate [Mass/volume] in Body fluid | 
|  12243-2 | Deprecated Platelets [Morphology] in Blood | 
|  12244-0 | Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  12245-7 | Porphobilinogen [Presence] in 24 hour Urine | 
|  12246-5 | Porphyrins [Presence] in 24 hour Urine | 
|  12247-3 | Pyruvate [Mass/volume] in Serum or Plasma | 
|  12248-1 | Epithelial cells.renal [Presence] in Urine sediment by Light microscopy | 
|  12249-9 | Deprecated Renin [Enzymatic activity/volume] in Plasma | 
|  1225-2 | Mg Ag [Presence] on Red Blood Cells | 
|  12250-7 | Reticulocytes/1000 erythrocytes hematocrit adjusted in Blood | 
|  12251-5 | Rubella virus Ag [Presence] in Unspecified specimen by Immunofluorescence | 
|  12252-3 | Deprecated Insulin-Like growth factor-I [Mass/volume] in Serum or Plasma | 
|  12253-1 | Somatotropin [Mass/volume] in Serum or Plasma --baseline | 
|  12254-9 | Volume of Body fluid | 
|  12255-6 | Volume of 5 hour Urine | 
|  12256-4 | Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy | 
|  12257-2 | Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post vasectomy | 
|  12258-0 | Epithelial cells.squamous [Presence] in Urine sediment by Light microscopy | 
|  12259-8 | Streptococcus pyogenes enzyme Ab [Presence] in Serum by Sheep Cell Agglutination | 
|  1226-0 | M Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12260-6 | Sucrose hemolysis [Presence] of Red Blood Cells | 
|  12261-4 | Toxoplasma gondii IgG Ab [Titer] in Serum by Immunoassay | 
|  12262-2 | Toxoplasma gondii IgM Ab [Titer] in Serum by Immunoassay | 
|  12263-0 | Deprecated EBV [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  12264-8 | Deprecated Epstein Barr virus early restricted Ab [Mass/volume] in Body fluid | 
|  12265-5 | Urea nitrogen [Mass/volume] in Peritoneal fluid | 
|  12266-3 | Urea nitrogen [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis | 
|  12267-1 | Urea nitrogen [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis | 
|  12268-9 | Urea nitrogen [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis | 
|  12269-7 | Urobilinogen [Presence] in 24 hour Urine | 
|  1227-8 | M Ab [Presence] in Serum or Plasma from donor | 
|  12270-5 | Uroporphyrin [Presence] in 24 hour Urine | 
|  12271-3 | Varicella zoster virus Ab [Presence] in Serum by Latex agglutination | 
|  12272-1 | Virus identified in Unspecified specimen by Immunofluorescence | 
|  12273-9 | Xanthochromia [Presence] of Body fluid Qualitative | 
|  12274-7 | Xylose [Mass/time] in 5 hour Urine | 
|  12275-4 | Yeast [Presence] in Genital specimen by Wet preparation | 
|  12276-2 | Deprecated Escherichia coli O157:H7 identified in Stool by Organism specific culture | 
|  12277-0 | DNA double strand Ab [Presence] in Serum by Farr method | 
|  12278-8 | Band form neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  12279-6 | Deprecated Spermatozoa Ab [Units/volume] in Semen | 
|  1228-6 | M Ab [Presence] in Serum or Plasma | 
|  12280-4 | Alanine [Mass/volume] in Amniotic fluid | 
|  12281-2 | Bacteria identified in Cervix by Anaerobe culture | 
|  12282-0 | Warfarin [Presence] in Urine | 
|  12283-8 | Corticotropin releasing hormone [Units/volume] in Serum or Plasma | 
|  12284-6 | Growth hormone-releasing hormone [Units/volume] in Serum or Plasma | 
|  12285-3 | HLA-DP [Type] | 
|  12286-1 | Drugs identified in Urine by Screen method | 
|  12287-9 | Drugs identified in Gastric fluid by Screen method | 
|  12288-7 | Diuretics [Identifier] in Urine | 
|  12289-5 | Drugs identified in Vitreous fluid by Screen method | 
|  1229-4 | M Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12290-3 | Procyclidine [Presence] in Urine | 
|  12291-1 | Mephentermine [Presence] in Urine | 
|  12292-9 | Dimethyltryptamine [Presence] in Urine | 
|  12293-7 | Cotinine [Presence] in Urine | 
|  12294-5 | Nicotine [Presence] in Urine | 
|  12295-2 | Hallucinogens [Identifier] in Urine | 
|  12296-0 | Mescaline [Presence] in Urine | 
|  12297-8 | Chlorate [Presence] in Blood | 
|  12298-6 | Erythromycin [Presence] in Urine | 
|  12299-4 | Ethinamate [Presence] in Urine | 
|  123-0 | Cefprozil [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1230-2 | M Ag [Presence] on Red Blood Cells from donor | 
|  12300-0 | Polythiazide [Presence] in Urine | 
|  12301-8 | Procaine [Presence] in Urine | 
|  12302-6 | Theobromine [Presence] in Serum or Plasma | 
|  12303-4 | Theobromine [Presence] in Urine | 
|  12304-2 | Benzyl alcohol [Presence] in Serum or Plasma | 
|  12305-9 | Chlordecone [Presence] in Blood | 
|  12306-7 | Cyclohexane [Mass/volume] in Blood | 
|  12307-5 | Dichloroethane [Mass/volume] in Blood | 
|  12308-3 | Hydrocodone [Presence] in Urine | 
|  12309-1 | Naltrexone [Presence] in Urine | 
|  1231-0 | M Ag [Presence] on Red Blood Cells | 
|  12310-9 | Phenytoin [Presence] in Urine | 
|  12311-7 | Prazepam [Mass/volume] in Urine | 
|  12312-5 | Cyclopropane [Mass/volume] in Blood | 
|  12313-3 | Aprobarbital [Presence] in Urine | 
|  12314-1 | Clorazepate [Presence] in Urine | 
|  12315-8 | Mephobarbital [Presence] in Urine | 
|  12316-6 | Deprecated Methapyrilene [Presence] in Urine | 
|  12317-4 | Phenolphthalein [Presence] in Urine | 
|  12318-2 | Spironolactone [Presence] in Urine | 
|  12319-0 | Thioridazine [Presence] in Urine | 
|  1232-8 | Mi sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12320-8 | Thiothixene [Presence] in Urine | 
|  12321-6 | Trifluoperazine [Presence] in Urine | 
|  12322-4 | Triflupromazine [Presence] in Urine | 
|  12323-2 | Trimeprazine [Presence] in Urine | 
|  12324-0 | Hydroxyzine [Presence] in Urine | 
|  12325-7 | Tetrahydrocortisone [Presence] in Urine | 
|  12326-5 | Diamorphine [Presence] in Unknown substance | 
|  12327-3 | Ketamine [Presence] in Urine | 
|  12328-1 | Beta blockers [Identifier] in Urine | 
|  12329-9 | Chlorpropamide [Presence] in Urine | 
|  1233-6 | Mi sup(a) Ag [Presence] on Red Blood Cells from donor | 
|  12330-7 | Hypoglycemics.oral [Identifier] in Urine | 
|  12331-5 | Phenethylamine [Presence] in Urine | 
|  12332-3 | Antihistamines [Identifier] in Urine | 
|  12333-1 | Butorphanol [Presence] in Urine | 
|  12334-9 | Para aminophenol [Mass/volume] in Urine | 
|  12335-6 | Halothane [Presence] in Blood | 
|  12336-4 | Hydralazine [Presence] in Serum or Plasma | 
|  12337-2 | Dimethylsulfoxide [Presence] in Serum or Plasma | 
|  12338-0 | Pentachlorophenol [Presence] in Serum or Plasma | 
|  12339-8 | Diquat [Presence] in Urine | 
|  1234-4 | Mi sup(a) Ag [Presence] on Red Blood Cells | 
|  12340-6 | Ethylene [Presence] in Blood | 
|  12341-4 | Mazindol [Presence] in Serum or Plasma | 
|  12342-2 | Oxymorphone [Presence] in Serum or Plasma | 
|  12343-0 | Thiazides [Identifier] in Urine | 
|  12344-8 | Antipsychotics [Identifier] in Serum or Plasma | 
|  12345-5 | Cyclothiazide [Presence] in Urine | 
|  12346-3 | Methyclothiazide [Presence] in Urine | 
|  12347-1 | Metolazone [Presence] in Urine | 
|  12348-9 | Quinethazone [Presence] in Urine | 
|  12349-7 | Trichlormethiazide [Presence] in Urine | 
|  1235-1 | Mi sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12350-5 | Amphetamines [Presence] in Stool | 
|  12351-3 | Tetrahydrocannabinol [Presence] in Stool | 
|  12352-1 | Benzoylecgonine [Presence] in Stool | 
|  12353-9 | Methaqualone [Presence] in Stool | 
|  12354-7 | Opiates [Presence] in Stool | 
|  12355-4 | Phencyclidine [Presence] in Stool | 
|  12356-2 | Methadone [Presence] in Stool | 
|  12357-0 | Propoxyphene [Presence] in Stool | 
|  12358-8 | Barbiturates [Presence] in Stool | 
|  12359-6 | Benzodiazepines [Presence] in Stool | 
|  1236-9 | Mi sup(a) Ab [Presence] in Serum or Plasma from donor | 
|  12360-4 | Barbital [Presence] in Urine | 
|  12361-2 | Oxazepam [Presence] in Urine | 
|  12362-0 | Oxazepam [Presence] in Serum or Plasma | 
|  12363-8 | Carbamazepine [Presence] in Urine | 
|  12364-6 | Benzodiazepines [Presence] in Gastric fluid | 
|  12365-3 | Dimenhydrinate [Presence] in Urine | 
|  12366-1 | Disopyramide [Presence] in Urine | 
|  12367-9 | Mesoridazine [Presence] in Urine | 
|  12368-7 | Phenacetin [Presence] in Urine | 
|  12369-5 | Sympathomimetics [Identifier] in Urine | 
|  1237-7 | Mi sup(a) Ab [Presence] in Serum or Plasma | 
|  12370-3 | Thiopental [Mass/volume] in Urine | 
|  12371-1 | Isopropyl ether [Mass/volume] in Blood | 
|  12372-9 | Dimethylacetamide [Mass/volume] in Urine | 
|  12373-7 | Deprecated Norchlordiazepoxide [Mass/volume] in Serum or Plasma | 
|  12374-5 | Clobazam [Mass/volume] in Urine | 
|  12375-2 | Clozapine+Norclozapine [Mass/volume] in Serum or Plasma | 
|  12376-0 | Deprecated Norclozapine [Mass/volume] in Serum or Plasma | 
|  12377-8 | Demoxepam [Mass/volume] in Serum or Plasma | 
|  12378-6 | Diazepam [Presence] in Stool | 
|  12379-4 | Halazepam [Mass/volume] in Serum or Plasma | 
|  1238-5 | M NOS Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12380-2 | Lorazepam [Presence] in Stool | 
|  12381-0 | Oxazepam [Presence] in Stool | 
|  12382-8 | Temazepam [Mass/volume] in Urine | 
|  12383-6 | Hydroxytriazolam [Presence] in Stool | 
|  12384-4 | Triazolam [Presence] in Stool | 
|  12385-1 | Deprecated Nordoxepin [Mass/volume] in Serum or Plasma | 
|  12386-9 | Nordoxepin [Mass/volume] in Urine | 
|  12387-7 | Primidone [Mass/volume] in Urine | 
|  12388-5 | Phenylethylmalonamide [Mass/volume] in Serum or Plasma | 
|  12389-3 | Olanzapine [Mass/volume] in Serum or Plasma | 
|  1239-3 | M NOS Ab [Presence] in Serum or Plasma from donor | 
|  12390-1 | Sulfasalazine [Mass/volume] in Serum or Plasma | 
|  12391-9 | Dimenhydrinate [Mass/volume] in Serum or Plasma | 
|  12392-7 | Deprecated Itraconazole [Mass/volume] in Serum or Plasma | 
|  12393-5 | Deprecated Ketoconazole [Mass/volume] in Serum or Plasma | 
|  12394-3 | Butorphanol [Mass/volume] in Serum or Plasma | 
|  12395-0 | Butorphanol [Mass/volume] in Urine | 
|  12396-8 | Chlorpropamide [Mass/volume] in Urine | 
|  12397-6 | Colchicine [Mass/volume] in Serum or Plasma | 
|  12398-4 | Diphenoxylate [Mass/volume] in Serum or Plasma | 
|  12399-2 | Emetine [Mass/volume] in Serum or Plasma | 
|  124-8 | Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1240-1 | M NOS Ab [Presence] in Serum or Plasma | 
|  12400-8 | Emetine [Mass/volume] in Urine | 
|  12401-6 | Ethinamate [Mass/volume] in Serum or Plasma | 
|  12402-4 | Griseofulvin [Mass/volume] in Serum or Plasma | 
|  12403-2 | Mephentermine [Mass/volume] in Blood | 
|  12404-0 | Nitroglycerin [Mass/volume] in Serum or Plasma | 
|  12405-7 | Nabumetone [Mass/volume] in Serum or Plasma | 
|  12406-5 | Nadolol [Mass/volume] in Serum or Plasma | 
|  12407-3 | 6-Beta naltrexone [Mass/volume] in Serum or Plasma | 
|  12408-1 | Oxybutynin [Mass/volume] in Serum or Plasma | 
|  12409-9 | Deprecated Pentoxyfylline [Mass/volume] in Serum or Plasma | 
|  1241-9 | M NOS Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12410-7 | Pimozide [Mass/volume] in Serum or Plasma | 
|  12411-5 | Promazine [Mass/volume] in Serum or Plasma | 
|  12412-3 | Pyridine [Mass/volume] in Serum or Plasma | 
|  12413-1 | Resperine [Mass/volume] in Serum or Plasma | 
|  12414-9 | Resperine [Mass/volume] in Urine | 
|  12415-6 | Selegiline [Mass/volume] in Serum or Plasma | 
|  12416-4 | Sotalol [Mass/volume] in Serum or Plasma | 
|  12417-2 | Sulindac [Mass/volume] in Serum or Plasma | 
|  12418-0 | Terfenadine [Mass/volume] in Serum or Plasma | 
|  12419-8 | Terfenadine [Mass/volume] in Urine | 
|  1242-7 | M NOS Ag [Presence] on Red Blood Cells from donor | 
|  12420-6 | Thiosulfate [Mass/volume] in Urine | 
|  12421-4 | Thiosulfate/Creatinine [Mass Ratio] in Urine | 
|  12422-2 | Triflupromazine [Mass/volume] in Serum or Plasma | 
|  12423-0 | Trimeprazine [Mass/volume] in Serum or Plasma | 
|  12424-8 | Triprolidine [Mass/volume] in Serum or Plasma | 
|  12425-5 | Chlorzoxazone [Mass/volume] in Serum or Plasma | 
|  12426-3 | Brodifacoum [Mass/volume] in Serum or Plasma | 
|  12427-1 | Chlormezanone [Mass/volume] in Serum or Plasma | 
|  12428-9 | Flurbiprofen [Mass/volume] in Serum or Plasma | 
|  12429-7 | Succinylcholine [Mass/volume] in Urine | 
|  1243-5 | M NOS Ag [Presence] on Red Blood Cells | 
|  12430-5 | Cumene [Mass/volume] in Serum or Plasma | 
|  12431-3 | Norfenfluramine [Mass/volume] in Serum or Plasma | 
|  12432-1 | Hydroxytriazolam [Mass/volume] in Urine | 
|  12433-9 | Bufotenine [Mass/volume] in Serum or Plasma | 
|  12434-7 | Prednisone [Mass/volume] in Serum or Plasma | 
|  12435-4 | Naphthalene [Mass/volume] in Serum or Plasma | 
|  12436-2 | Naphthol [Mass/volume] in Serum or Plasma | 
|  12437-0 | Tramadol [Mass/volume] in Serum or Plasma | 
|  12438-8 | Nortramadol [Mass/volume] in Serum or Plasma | 
|  12439-6 | Fluoxetine [Mass/volume] in Urine | 
|  1244-3 | M1 Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12440-4 | Midazolam [Presence] in Stool | 
|  12441-2 | Tolmetin [Mass/volume] in Serum or Plasma | 
|  12442-0 | Acetaminophen [Mass/volume] in Unspecified specimen | 
|  12443-8 | Trimipramine [Mass/volume] in Urine | 
|  12444-6 | Nortrimipramine [Mass/volume] in Urine | 
|  12445-3 | Norfluoxetine [Mass/volume] in Urine | 
|  12446-1 | Halogenated organic molecules [Identifier] in Urine | 
|  12447-9 | Deprecated Phenylethylmalonamide | 
|  12448-7 | Ketones [Mass/volume] in Urine by Test strip --fasting | 
|  12449-5 | Ketones [Mass/volume] in Urine by Test strip --1 hour post XXX challenge | 
|  1245-0 | M1 Ab [Presence] in Serum or Plasma from donor | 
|  12450-3 | Ketones [Mass/volume] in Urine by Test strip --2 hours post XXX challenge | 
|  12451-1 | Ketones [Mass/volume] in Urine by Test strip --3 hours post XXX challenge | 
|  12452-9 | Epithelial cells [Presence] in Semen by Light microscopy | 
|  12453-7 | Phosphate crystals amorphous [Presence] in Urine sediment by Light microscopy | 
|  12454-5 | Urate crystals amorphous [Presence] in Urine sediment by Light microscopy | 
|  12455-2 | Histoplasma capsulatum yeast phase Ab [Presence] in Cerebral spinal fluid | 
|  12456-0 | Histoplasma capsulatum mycelial phase Ab [Presence] in Cerebral spinal fluid | 
|  12457-8 | Volume of Dialysis fluid | 
|  12458-6 | Corticotropin [Mass/volume] in Plasma --2nd specimen post XXX challenge | 
|  12459-4 | Corticotropin [Mass/volume] in Plasma --3rd specimen post XXX challenge | 
|  1246-8 | M1 Ab [Presence] in Serum or Plasma | 
|  12460-2 | Corticotropin [Mass/volume] in Plasma --4th specimen post XXX challenge | 
|  12461-0 | Corticotropin [Mass/volume] in Plasma --5th specimen post XXX challenge | 
|  12462-8 | Corticotropin [Mass/volume] in Plasma --6th specimen post XXX challenge | 
|  12463-6 | Corticotropin [Mass/volume] in Plasma --7th specimen post XXX challenge | 
|  12464-4 | Corticotropin [Mass/volume] in Plasma --8th specimen post XXX challenge | 
|  12465-1 | Ethanol [Mass/volume] in Vitreous fluid | 
|  12466-9 | Alpha 1 antitrypsin [Mass/volume] in Amniotic fluid by Nephelometry | 
|  12467-7 | Amino acids [Identifier] in Urine | 
|  12468-5 | Amino acids [Identifier] in Serum or Plasma | 
|  12469-3 | Cystine crystals [type] in Stone by Light microscopy | 
|  1247-6 | M1 Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12470-1 | Homocysteine [Mass/volume] in Urine | 
|  12471-9 | Amino beta guanidinopropionate [Mass/volume] in Urine | 
|  12472-7 | Amino beta guanidinopropionate [Mass/volume] in 24 hour Urine | 
|  12473-5 | Phosphoethanolamine [Mass/time] in Urine | 
|  12474-3 | Carnosine [Mass/volume] in 24 hour Urine | 
|  12475-0 | Delta aminolevulinate [Mass/time] in Urine | 
|  12476-8 | Bilirubin.total [Mass/volume] in Amniotic fluid by Spectrophotometry direct | 
|  12477-6 | Dextromethamphetamine [Mass/volume] in Urine | 
|  12478-4 | Levomethamphetamine [Mass/volume] in Urine | 
|  12479-2 | Androsterone [Mass/time] in Urine | 
|  1248-4 | M1 Ag [Presence] on Red Blood Cells from donor | 
|  12480-0 | Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid | 
|  12481-8 | Arsenic.inorganic [Mass/volume] in Urine | 
|  12482-6 | Ascorbate [Mass/volume] in Leukocytes | 
|  12483-4 | Tungsten [Presence] in Serum or Plasma | 
|  12484-2 | Phenobarbital [Presence] in Gastric fluid | 
|  12485-9 | Amobarbital [Presence] in Gastric fluid | 
|  12486-7 | Butabarbital [Presence] in Gastric fluid | 
|  12487-5 | Butalbital [Presence] in Gastric fluid | 
|  12488-3 | Pentobarbital [Presence] in Gastric fluid | 
|  12489-1 | Secobarbital [Presence] in Gastric fluid | 
|  1249-2 | M1 Ag [Presence] on Red Blood Cells | 
|  12490-9 | Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma | 
|  12491-7 | Methohexital [Presence] in Serum or Plasma | 
|  12492-5 | Thiamylal [Presence] in Serum or Plasma | 
|  12493-3 | Hexobarbital [Mass/volume] in Serum or Plasma | 
|  12494-1 | Amobarbital [Presence] in Stool | 
|  12495-8 | Barbital [Presence] in Stool | 
|  12496-6 | Butabarbital [Presence] in Stool | 
|  12497-4 | Butalbital [Presence] in Stool | 
|  12498-2 | Metharbital [Presence] in Stool | 
|  12499-0 | Pentobarbital [Presence] in Stool | 
|  125-5 | Cefprozil [Susceptibility] by Disk diffusion (KB) | 
|  1250-0 | Major crossmatch [Interpretation] | 
|  12500-5 | Secobarbital [Presence] in Stool | 
|  12501-3 | Phenobarbital [Presence] in Stool | 
|  12502-1 | Allobarbital [Presence] in Stool | 
|  12503-9 | Hemoglobin.gastrointestinal [Presence] in Stool --4th specimen | 
|  12504-7 | Hemoglobin.gastrointestinal [Presence] in Stool --5th specimen | 
|  12505-4 | Cadmium [Mass/volume] in Red Blood Cells | 
|  12506-2 | Calcitonin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12507-0 | Calcitonin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12508-8 | Calcitonin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12509-6 | Calcitonin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  1251-8 | Major crossmatch [Interpretation] by Immediate spin | 
|  12510-4 | Calcitonin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12511-2 | Calcium [Mass/volume] in 4 hour Urine | 
|  12512-0 | Calcium hydrogen phosphate dihydrate crystals [Presence] in Urine sediment by Light microscopy | 
|  12513-8 | Bicarbonate [Moles/volume] in Water | 
|  12514-6 | Bicarbonate [Moles/volume] in Dialysis fluid | 
|  12515-3 | Carcinoembryonic Ag [Mass/volume] in Body fluid | 
|  12516-1 | Catecholamines [Mass/volume] in Urine --2nd specimen post XXX challenge | 
|  12517-9 | Catecholamines [Mass/volume] in Urine --3rd specimen post XXX challenge | 
|  12518-7 | Catecholamines [Mass/volume] in Urine --4th specimen post XXX challenge | 
|  12519-5 | Catecholamines [Mass/volume] in Urine --5th specimen post XXX challenge | 
|  1252-6 | Major crossmatch [Interpretation] --post immediate spin | 
|  12520-3 | Catecholamines [Mass/volume] in Urine --6th specimen post XXX challenge | 
|  12521-1 | Catecholamines [Mass/volume] in Urine --7th specimen post XXX challenge | 
|  12522-9 | Catecholamines [Mass/volume] in Plasma --2nd specimen post XXX challenge | 
|  12523-7 | Catecholamines [Mass/volume] in Plasma --3rd specimen post XXX challenge | 
|  12524-5 | Catecholamines [Mass/volume] in Plasma --4th specimen post XXX challenge | 
|  12525-2 | Norepinephrine [Mass/volume] in Plasma --1 hour post XXX challenge | 
|  12526-0 | Norepinephrine [Mass/volume] in Plasma --2 hours post XXX challenge | 
|  12527-8 | Norepinephrine [Mass/volume] in Plasma --3 hours post XXX challenge | 
|  12528-6 | Norepinephrine [Mass/volume] in Plasma --4 hours post XXX challenge | 
|  12529-4 | Epinephrine [Mass/volume] in Plasma --2 hours post XXX challenge | 
|  1253-4 | Major crossmatch [Interpretation] by Prewarmed | 
|  12530-2 | Chloride [Moles/volume] in Water | 
|  12531-0 | Deprecated Cholesterol [Mass/volume] in Body fluid | 
|  12532-8 | Meclizine [Presence] in Serum or Plasma | 
|  12533-6 | Thiazolidine-2-Thione-4-Carboxylic acid [Mass/volume] in Urine | 
|  12534-4 | Thiazolidine-2-Thione-4-Carboxylic acid/Creatinine [Mass Ratio] in Urine | 
|  12535-1 | Amyl nitrite [Presence] in Blood | 
|  12536-9 | Butyl nitrate [Presence] in Blood | 
|  12537-7 | Phenylglyoxylate [Mass/volume] in Urine | 
|  12538-5 | Nitrate [Mass/volume] in Blood | 
|  12539-3 | 2-Methylcitrate [Mass/volume] in Urine | 
|  1254-2 | Major crossmatch.re-crossmatch [Interpretation] | 
|  12540-1 | 2-Methylcitrate [Mass/volume] in Serum or Plasma | 
|  12541-9 | Meta methylhippurate+Para methylhippurate [Mass/volume] in Urine | 
|  12542-7 | N-methylacetamide [Mass/volume] in Urine | 
|  12543-5 | Methyl formamide [Mass/volume] in Urine | 
|  12544-3 | Nefazodone [Mass/volume] in Serum or Plasma | 
|  12545-0 | Zomepirac [Mass/volume] in Serum or Plasma | 
|  12546-8 | Quinethazone [Presence] in Serum or Plasma | 
|  12547-6 | Phorate [Mass/volume] in Serum or Plasma | 
|  12548-4 | Tybamate [Mass/volume] in Serum or Plasma | 
|  12549-2 | Turpentine [Mass/volume] in Serum or Plasma | 
|  1255-9 | Minor crossmatch [Interpretation] | 
|  12550-0 | Papaverine [Mass/volume] in Serum or Plasma | 
|  12551-8 | Isocarboxazid [Mass/volume] in Serum or Plasma | 
|  12552-6 | Propylene glycol [Mass/volume] in Serum or Plasma | 
|  12553-4 | Stimulants [Identifier] in Urine | 
|  12554-2 | Narcotics and opioids [Identifier] in Urine | 
|  12555-9 | Turpentine [Mass/volume] in Urine | 
|  12556-7 | Copper [Mass/volume] in Blood | 
|  12557-5 | Cortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12558-3 | Cortisol [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12559-1 | Cortisol [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  1256-7 | N Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12560-9 | Cortisol [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12561-7 | Cortisol [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12562-5 | Cortisol [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  12563-3 | Cortisol [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  12564-1 | Cortisol [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  12565-8 | Cortisol [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge | 
|  12566-6 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | 
|  12567-4 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  12568-2 | Cortisol [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge | 
|  12569-0 | Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge | 
|  1257-5 | N Ab [Presence] in Serum or Plasma from donor | 
|  12570-8 | Cortisol [Mass/volume] in Serum or Plasma --post XXX challenge | 
|  12571-6 | Deprecated Creatinine [Mass/volume] in Body fluid | 
|  12572-4 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen | 
|  12573-2 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen | 
|  12574-0 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen | 
|  12575-7 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --baseline | 
|  12576-5 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --1st specimen | 
|  12577-3 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --2nd specimen | 
|  12578-1 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --3rd specimen | 
|  12579-9 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --4th specimen | 
|  1258-3 | N Ab [Presence] in Serum or Plasma | 
|  12580-7 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --5th specimen | 
|  12581-5 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --6th specimen | 
|  12582-3 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --7th specimen | 
|  12583-1 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --8th specimen | 
|  12584-9 | Creatinine [Mass/volume] in Vitreous fluid | 
|  12585-6 | Creatinine [Mass/time] in 2 hour Urine | 
|  12586-4 | Creatinine [Mass/time] in 4 hour Urine | 
|  12587-2 | Creatinine [Mass/time] in 6 hour Urine | 
|  12588-0 | Creatinine [Mass/time] in 8 hour Urine | 
|  12589-8 | Creatinine [Mass/time] in 12 hour Urine | 
|  1259-1 | N Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12590-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12591-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12592-2 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12593-0 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12594-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12595-5 | Estradiol (E2) [Mass/volume] in Urine | 
|  12596-3 | Estradiol (E2) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | 
|  12597-1 | Estrogen [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12598-9 | Fat.neutral [Presence] in Stool | 
|  12599-7 | Pristanate (C15:0(CH3)4) [Mass/volume] in Serum or Plasma | 
|  126-3 | Cefprozil [Susceptibility] by Serum bactericidal titer | 
|  1260-9 | N Ag [Presence] on Red Blood Cells from donor | 
|  12600-3 | Pristanate (C15:0(CH3)4)/Phytanate (C16:0(CH3)4) [Mass Ratio] in Serum or Plasma | 
|  12601-1 | Fluoride [Mass/volume] in Dialysis fluid | 
|  12602-9 | Hydroxyethylflurazepam [Mass/volume] in Urine | 
|  12603-7 | N-desalkylflurazepam [Presence] in Stool | 
|  12604-5 | Hydroxyethylflurazepam [Presence] in Stool | 
|  12605-2 | Flurazepam [Presence] in Stool | 
|  12606-0 | Dolichol [Mass/volume] in Serum or Plasma | 
|  12607-8 | Glucose [Mass/volume] in Peritoneal dialysis fluid --pre dialysis | 
|  12608-6 | Glucose [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen | 
|  12609-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen | 
|  1261-7 | N Ag [Presence] on Red Blood Cells | 
|  12610-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | 
|  12611-0 | Glucose [Mass/volume] in Serum or Plasma --4 hour specimen | 
|  12612-8 | Glucose [Mass/volume] in Dialysis fluid --2 hour specimen | 
|  12613-6 | Glucose [Mass/volume] in Dialysis fluid --4 hour specimen | 
|  12614-4 | Glucose [Mass/volume] in Serum or Plasma --7 hours post meal | 
|  12615-1 | Glucose [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge | 
|  12616-9 | Glucose [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12617-7 | Glucose [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12618-5 | Glucose [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12619-3 | Glucose [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  1262-5 | N NOS Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12620-1 | Glucose [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12621-9 | Glucose [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  12622-7 | Glucose [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge | 
|  12623-5 | Glucose [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge | 
|  12624-3 | Glucose [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge | 
|  12625-0 | Glucose [Mass/volume] in Serum or Plasma --13th specimen post XXX challenge | 
|  12626-8 | Glucose [Mass/volume] in Serum or Plasma --14th specimen post XXX challenge | 
|  12627-6 | Glucose [Mass/volume] in Serum or Plasma --15th specimen post XXX challenge | 
|  12628-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid | 
|  12629-2 | Glucose [Mass/volume] in 24 hour Peritoneal dialysis fluid | 
|  1263-3 | N NOS Ab [Presence] in Serum or Plasma from donor | 
|  12630-0 | Glucose [Mass/volume] in Peritoneal dialysis fluid --1st specimen | 
|  12631-8 | Glucose [Mass/volume] in Peritoneal dialysis fluid --2nd specimen | 
|  12632-6 | Glucose [Mass/volume] in Peritoneal dialysis fluid --3rd specimen | 
|  12633-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid --4th specimen | 
|  12634-2 | Glucose [Mass/volume] in Peritoneal dialysis fluid --5th specimen | 
|  12635-9 | Glucose [Mass/volume] in Peritoneal dialysis fluid --6th specimen | 
|  12636-7 | Glucose [Mass/volume] in Peritoneal dialysis fluid --7th specimen | 
|  12637-5 | Glucose [Mass/volume] in Peritoneal dialysis fluid --8th specimen post XXX challenge | 
|  12638-3 | Glucose [Mass/volume] in Serum or Plasma --pre dose lactose PO | 
|  12639-1 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge | 
|  1264-1 | N NOS Ab [Presence] in Serum or Plasma | 
|  12640-9 | Glucose [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge | 
|  12641-7 | Glucose [Mass/volume] in Serum or Plasma --7 hours post XXX challenge | 
|  12642-5 | Glucose [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge | 
|  12643-3 | Glucose [Mass/volume] in Serum or Plasma --8 hours post XXX challenge | 
|  12644-1 | Glucose [Mass/volume] in Serum or Plasma --9 hours post XXX challenge | 
|  12645-8 | Glucose [Mass/volume] in Serum or Plasma --10 hours post XXX challenge | 
|  12646-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  12647-4 | Glucose [Mass/volume] in Serum or Plasma --12 hours post XXX challenge | 
|  12648-2 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose lactose PO | 
|  12649-0 | Glucose [Mass/volume] in Serum or Plasma --6th specimen post dose lactose | 
|  1265-8 | N NOS Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12650-8 | Glucose [Mass/volume] in Serum or Plasma --3.5 hours post dose lactose PO | 
|  12651-6 | Glucose [Mass/volume] in Serum or Plasma --10 minutes pre XXX challenge | 
|  12652-4 | Glucose [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge | 
|  12653-2 | Glucose [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge | 
|  12654-0 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  12655-7 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge | 
|  12656-5 | Glucose [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge | 
|  12657-3 | Glucose [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge | 
|  12658-1 | Glucose [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge | 
|  12659-9 | Glucose [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge | 
|  1266-6 | N NOS Ag [Presence] on Red Blood Cells from donor | 
|  12660-7 | Follitropin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge | 
|  12661-5 | Follitropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  12662-3 | Follitropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge | 
|  12663-1 | Follitropin [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge | 
|  12664-9 | Follitropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12665-6 | Follitropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12666-4 | Follitropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12667-2 | Follitropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12668-0 | Follitropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12669-8 | Follitropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  1267-4 | N NOS Ag [Presence] on Red Blood Cells | 
|  12670-6 | Follitropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  12671-4 | Follitropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  12672-2 | Lutropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  12673-0 | Lutropin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge | 
|  12674-8 | Lutropin [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge | 
|  12675-5 | Lutropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge | 
|  12676-3 | Lutropin [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge | 
|  12677-1 | Lutropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12678-9 | Lutropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12679-7 | Lutropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  1268-2 | Not otherwise specified Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12680-5 | Lutropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12681-3 | Lutropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12682-1 | Lutropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  12683-9 | Lutropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  12684-7 | Lutropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  12685-4 | Somatotropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12686-2 | Somatotropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12687-0 | Somatotropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12688-8 | Somatotropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12689-6 | Somatotropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  1269-0 | Not otherwise specified Ab [Presence] in Serum or Plasma from donor | 
|  12690-4 | Somatotropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  12691-2 | Somatotropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  12692-0 | Somatotropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  12693-8 | Somatotropin [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge | 
|  12694-6 | Somatotropin [Moles/volume] in Serum or Plasma --post XXX challenge | 
|  12695-3 | Somatotropin [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge | 
|  12696-1 | Somatotropin [Moles/volume] in Serum or Plasma --pre XXX challenge | 
|  12697-9 | Somatotropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  12698-7 | Somatotropin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge | 
|  12699-5 | Somatotropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge | 
|  127-1 | Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1270-8 | Unidentified Ab [Presence] in Serum or Plasma | 
|  12700-1 | Somatotropin [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge | 
|  12701-9 | Somatotropin [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge | 
|  12702-7 | Antimony [Presence] in Serum or Plasma | 
|  12703-5 | Gallium [Mass/volume] in Serum or Plasma | 
|  12704-3 | Length of Hair | 
|  12705-0 | Strontium [Mass/volume] in Urine | 
|  12706-8 | Tellurium [Mass/volume] in Serum or Plasma | 
|  12707-6 | Thorium [Mass/volume] in Serum or Plasma | 
|  12708-4 | Tin [Mass/volume] in Urine | 
|  12709-2 | Norastemizole [Mass/volume] in Serum or Plasma | 
|  1271-6 | Deprecated O group [Presence] [Presence] in Serum or Plasma from Blood product unit | 
|  12710-0 | Hemoglobin pattern [Interpretation] in Blood | 
|  12711-8 | Hemoglobin A region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) | 
|  12712-6 | Hemoglobin S+D+G region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) | 
|  12713-4 | Hemoglobin C+E+O+A2 region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) | 
|  12714-2 | N-methylhistamine [Mass/volume] in Urine | 
|  12715-9 | Homovanillate [Mass/time] in Urine | 
|  12716-7 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12717-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12718-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12719-1 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  1272-4 | Deprecated O group [Presence] in serum or plasma from donor | 
|  12720-9 | Hydroxyproline [Mass/volume] in 2 hour Urine | 
|  12721-7 | Melatonin [Units/volume] in Serum or Plasma | 
|  12722-5 | Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma | 
|  12723-3 | Insulin-like growth factor binding protein 2 [Mass/volume] in Serum or Plasma | 
|  12724-1 | Voltage-gated calcium channel IgG Ab [Units/volume] in Serum | 
|  12725-8 | IgA.secretory [Units/volume] in Serum or Plasma | 
|  12726-6 | Leucine-enkephalin [Units/volume] in Serum or Plasma | 
|  12727-4 | Prednisolone [Mass/volume] in Serum or Plasma | 
|  12728-2 | Alpha subunit [Units/volume] in Serum or Plasma | 
|  12729-0 | Interferon gamma [Units/volume] in Serum or Plasma | 
|  1273-2 | Deprecated O group [Presence] in serum | 
|  12730-8 | Interferon beta [Units/volume] in Serum or Plasma | 
|  12731-6 | Interferon alpha [Units/volume] in Serum or Plasma | 
|  12732-4 | Interleukin 12 [Units/volume] in Serum or Plasma | 
|  12733-2 | Tryptase [Enzymatic activity/volume] in Serum or Plasma | 
|  12734-0 | Cytokeratin Ab [Units/volume] in Serum | 
|  12735-7 | Collagen Ab [Units/volume] in Urine | 
|  12736-5 | Hyaluronate [Mass/volume] in Serum or Plasma | 
|  12737-3 | Endothelin [Units/volume] in Serum or Plasma | 
|  12738-1 | Insulin [Mass/volume] in Serum or Plasma --pre XXX challenge | 
|  12739-9 | Insulin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  1274-0 | Deprecated O group [Presence] on Red Blood Cells from Blood product unit | 
|  12740-7 | Insulin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12741-5 | Insulin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12742-3 | Insulin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12743-1 | Insulin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12744-9 | Insulin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  12745-6 | Insulin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  12746-4 | Insulin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  12747-2 | Insulin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge | 
|  12748-0 | Insulin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge | 
|  12749-8 | Insulin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge | 
|  1275-7 | Deprecated O group [Presence] on Red Blood Cells from donor | 
|  12750-6 | Insulin [Mass/volume] in Serum or Plasma --7 hours post XXX challenge | 
|  12751-4 | Insulin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge | 
|  12752-2 | Insulin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge | 
|  12753-0 | Insulin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge | 
|  12754-8 | Insulin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge | 
|  12755-5 | Insulin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge | 
|  12756-3 | Insulin [Mass/volume] in Serum or Plasma --12 hours post XXX challenge | 
|  12757-1 | Insulin [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge | 
|  12758-9 | Insulin [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge | 
|  12759-7 | Insulin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge | 
|  1276-5 | Deprecated O group [Presence] on Red Blood Cells | 
|  12760-5 | Insulin [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge | 
|  12761-3 | Insulin [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge | 
|  12762-1 | Insulin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge | 
|  12763-9 | Insulin [Mass/volume] in Serum or Plasma --19 minutes post XXX challenge | 
|  12764-7 | Insulin [Mass/volume] in Serum or Plasma --22 minutes post XXX challenge | 
|  12765-4 | Insulin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge | 
|  12766-2 | Insulin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge | 
|  12767-0 | Insulin [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge | 
|  12768-8 | Insulin [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge | 
|  12769-6 | 17-Ketosteroids.total neutral [Mass/time] in 24 hour Urine | 
|  1277-3 | P Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12770-4 | Lead [Mass/mass] in Tissue | 
|  12771-2 | Cholesterol in HDL [Presence] in Serum or Plasma by Electrophoresis | 
|  12772-0 | Cholesterol in HDL [Units/volume] in Serum or Plasma by Electrophoresis | 
|  12773-8 | Cholesterol in LDL [Units/volume] in Serum or Plasma by Electrophoresis | 
|  12774-6 | Mercury [Mass/volume] in Red Blood Cells | 
|  12775-3 | Mercury [Mass/volume] in Dentin | 
|  12776-1 | Mucin-like carcinoma associated Ag [Units/volume] in Serum or Plasma | 
|  12777-9 | Immunoglobulin light chains.kappa.free [Units/volume] in Urine | 
|  12778-7 | Immunoglobulin light chains.lambda.free [Units/volume] in Urine | 
|  12779-5 | Nickel [Mass/time] in Urine | 
|  1278-1 | P Ab [Presence] in Serum or Plasma from donor | 
|  12780-3 | Nickel [Mass/volume] in Red Blood Cells | 
|  12781-1 | Borrelia burgdorferi Ab band pattern [Interpretation] in Serum by Immunoblot (IB) | 
|  12782-9 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Electrophoresis | 
|  12783-7 | Oligoclonal bands [Interpretation] in Serum or Plasma | 
|  12784-5 | Codeine Free [Mass/volume] in Serum or Plasma | 
|  12785-2 | Dihydrocodeine Free [Mass/volume] in Serum or Plasma | 
|  12786-0 | Hydrocodone Free [Mass/volume] in Serum or Plasma | 
|  12787-8 | Hydromorphone Free [Mass/volume] in Serum or Plasma | 
|  12788-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma | 
|  12789-4 | Oxycodone Free [Mass/volume] in Serum or Plasma | 
|  1279-9 | P Ab [Presence] in Serum or Plasma | 
|  12790-2 | Oxalate [Mass/volume] in Urine --2nd specimen post XXX challenge | 
|  12791-0 | Oxalate [Mass/volume] in Urine --3rd specimen post XXX challenge | 
|  12792-8 | Oxalate [Mass/volume] in Urine --4th specimen post XXX challenge | 
|  12793-6 | Oxalate [Mass/volume] in Urine --5th specimen post XXX challenge | 
|  12794-4 | Oxalate [Mass/volume] in Urine --6th specimen post XXX challenge | 
|  12795-1 | Oxalate [Mass/volume] in Urine --7th specimen post XXX challenge | 
|  12796-9 | Oxalate [Mass/volume] in Urine --8th specimen post XXX challenge | 
|  12797-7 | Oxalate [Mass/volume] in Urine --9th specimen post XXX challenge | 
|  12798-5 | Oxalate [Mass/volume] in Urine --10th specimen post XXX challenge | 
|  12799-3 | Parathyrin Ab [Units/volume] in Serum | 
|  128-9 | Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1280-7 | P NOS Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12800-9 | Deprecated Trimeprazine | 
|  12801-7 | Methdilazine [Mass/volume] in Serum or Plasma | 
|  12802-5 | Propiomazine [Mass/volume] in Serum or Plasma | 
|  12803-3 | Phenylalanine [Presence] in Blood by Guthrie test | 
|  12804-1 | Acid phosphatase [Enzymatic activity/volume] in Body fluid | 
|  12805-8 | Alkaline phosphatase isoenzyme [Units/volume] in Serum or Plasma | 
|  12806-6 | Alkaline phosphatase.lung [Enzymatic activity/volume] in Serum or Plasma | 
|  12807-4 | Phosphoserine [Mass/volume] in Cerebral spinal fluid | 
|  12808-2 | Uroporphyrin [Mass/time] in Urine | 
|  12809-0 | Coproporphyrin [Mass/time] in Urine | 
|  1281-5 | P NOS Ab [Presence] in Serum or Plasma from donor | 
|  12810-8 | Porphobilinogen deaminase [Enzymatic activity/volume] in Blood | 
|  12811-6 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Blood | 
|  12812-4 | Potassium [Moles/volume] in Serum or Plasma --2nd specimen | 
|  12813-2 | Potassium [Moles/volume] in Serum or Plasma --3rd specimen | 
|  12814-0 | Potassium [Moles/volume] in Vitreous fluid | 
|  12815-7 | Progesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12816-5 | Progesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12817-3 | Progesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12818-1 | Progesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12819-9 | Progesterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  1282-3 | P NOS Ab [Presence] in Serum or Plasma | 
|  12820-7 | Progesterone [Mass/volume] in 24 hour Urine | 
|  12821-5 | Progesterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | 
|  12822-3 | Progesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  12823-1 | Prolactin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12824-9 | Prolactin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12825-6 | Prolactin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12826-4 | Prolactin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12827-2 | Prolactin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12828-0 | Prolactin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  12829-8 | Prolactin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  1283-1 | P NOS Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12830-6 | Prolactin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  12831-4 | Prolactin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge | 
|  12832-2 | Prolactin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  12833-0 | Prolactin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge | 
|  12834-8 | Prolactin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge | 
|  12835-5 | Prolactin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge | 
|  12836-3 | Prostaglandin E2 [Mass/volume] in 24 hour Urine | 
|  12837-1 | Prostaglandin E1 [Mass/volume] in 24 hour Urine | 
|  12838-9 | Prostaglandin D2 [Mass/volume] in Urine | 
|  12839-7 | Prostaglandin D2 [Mass/volume] in Serum or Plasma | 
|  1284-9 | P NOS Ag [Presence] on Red Blood Cells from donor | 
|  12840-5 | Prostaglandin F2 alpha [Moles/volume] in Urine | 
|  12841-3 | Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma | 
|  12842-1 | Protein [Mass/volume] in 12 hour Urine | 
|  12843-9 | Protein [Mass/volume] in Peritoneal dialysis fluid | 
|  12844-7 | Protein [Mass/volume] in Peritoneal dialysis fluid --2nd specimen | 
|  12845-4 | Protein [Mass/volume] in Peritoneal dialysis fluid --3rd specimen | 
|  12846-2 | Protein [Mass/volume] in Peritoneal dialysis fluid --4th specimen | 
|  12847-0 | Protein [Mass/volume] in Peritoneal dialysis fluid --5th specimen | 
|  12848-8 | Protein [Mass/volume] in Peritoneal dialysis fluid --6th specimen | 
|  12849-6 | Protein [Mass/volume] in Peritoneal dialysis fluid --7th specimen | 
|  1285-6 | P NOS Ag [Presence] on Red Blood Cells | 
|  12850-4 | Protein [Mass/volume] in Peritoneal dialysis fluid --8th specimen | 
|  12851-2 | Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis | 
|  12852-0 | Bovine inner ear Ag [Presence] in Serum or Plasma by Immunoblot (IB) | 
|  12853-8 | Purkinje cells Ab [Presence] in Serum by Immunoblot (IB) | 
|  12854-6 | Neuronal nuclear type 1 Ab [Units/volume] in Serum | 
|  12855-3 | HIV 1 p23 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12856-1 | HIV 1 p65 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12857-9 | HIV 1 p28 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12858-7 | HIV 1 p32 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12859-5 | HIV 1 p18 Ab [Presence] in Serum by Immunoblot (IB) | 
|  1286-4 | P1 Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12860-3 | Borrelia burgdorferi 39kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  12861-1 | Borrelia burgdorferi 88kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  12862-9 | Borrelia burgdorferi 66kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  12863-7 | Borrelia burgdorferi 41kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  12864-5 | Borrelia burgdorferi 25kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  12865-2 | Borrelia burgdorferi 29kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  12866-0 | Borrelia burgdorferi 18kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  12867-8 | Borrelia burgdorferi 58kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  12868-6 | Borrelia burgdorferi 47kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  12869-4 | Borrelia burgdorferi 30kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  1287-2 | P1 Ab [Presence] in Serum or Plasma from donor | 
|  12870-2 | HIV 1 gp34 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12871-0 | HIV 1 p26 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12872-8 | HIV 1 p15 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12873-6 | Borrelia burgdorferi 88kD Ab [Presence] in Serum by Immunoblot (IB) | 
|  12874-4 | Borrelia burgdorferi 93kD Ab [Presence] in Serum by Immunoblot (IB) | 
|  12875-1 | HIV 1 p64 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12876-9 | HIV 1 p53 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12877-7 | Borrelia burgdorferi 47kD Ab [Presence] in Serum by Immunoblot (IB) | 
|  12878-5 | Borrelia burgdorferi 29kD Ab [Presence] in Serum by Immunoblot (IB) | 
|  12879-3 | Borrelia burgdorferi 25kD Ab [Presence] in Serum by Immunoblot (IB) | 
|  1288-0 | P1 Ab [Presence] in Serum or Plasma | 
|  12880-1 | Borrelia burgdorferi 58kD Ab [Presence] in Body fluid by Immunoblot (IB) | 
|  12881-9 | Borrelia burgdorferi 47kD Ab [Presence] in Body fluid by Immunoblot (IB) | 
|  12882-7 | Borrelia burgdorferi 29kD Ab [Presence] in Body fluid by Immunoblot (IB) | 
|  12883-5 | Borrelia burgdorferi 18kD Ab [Presence] in Body fluid by Immunoblot (IB) | 
|  12884-3 | Borrelia burgdorferi 39kD Ab [Presence] in Body fluid by Immunoblot (IB) | 
|  12885-0 | Borrelia burgdorferi 88kD Ab [Presence] in Body fluid by Immunoblot (IB) | 
|  12886-8 | Borrelia burgdorferi 66kD Ab [Presence] in Body fluid by Immunoblot (IB) | 
|  12887-6 | Borrelia burgdorferi 41kD Ab [Presence] in Body fluid by Immunoblot (IB) | 
|  12888-4 | Borrelia burgdorferi 25kD Ab [Presence] in Body fluid by Immunoblot (IB) | 
|  12889-2 | Borrelia burgdorferi 30kD Ab [Presence] in Body fluid by Immunoblot (IB) | 
|  1289-8 | P1 Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12890-0 | Borrelia burgdorferi 45kD Ab [Presence] in Serum by Immunoblot (IB) | 
|  12891-8 | Borrelia burgdorferi 41kD Ab [Presence] in Serum by Immunoblot (IB) | 
|  12892-6 | Borrelia burgdorferi 30kD Ab [Presence] in Serum by Immunoblot (IB) | 
|  12893-4 | HIV 1 gp105 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12894-2 | HIV 1 p68 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12895-9 | HIV 1 p58 Ab [Presence] in Serum by Immunoblot (IB) | 
|  12896-7 | Borrelia burgdorferi 58kD Ab [Presence] in Serum by Immunoblot (IB) | 
|  12897-5 | Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  12898-3 | Chloride [Moles/volume] in Vitreous fluid | 
|  12899-1 | Acetylene [Mass/volume] in Serum or Plasma | 
|  129-7 | Cefsulodin [Susceptibility] by Disk diffusion (KB) | 
|  1290-6 | P1 Ag [Presence] on Red Blood Cells from donor | 
|  12900-7 | Renin [Enzymatic activity/volume] in Plasma --2nd specimen post XXX challenge | 
|  12901-5 | Renin [Enzymatic activity/volume] in Plasma --3rd specimen post XXX challenge | 
|  12902-3 | Renin [Enzymatic activity/volume] in Plasma --4th specimen post XXX challenge | 
|  12903-1 | Renin [Enzymatic activity/volume] in Plasma --5th specimen post XXX challenge | 
|  12904-9 | Renin [Enzymatic activity/volume] in Plasma --6th specimen post XXX challenge | 
|  12905-6 | Renin [Enzymatic activity/volume] in Plasma --7th specimen post XXX challenge | 
|  12906-4 | Renin [Enzymatic activity/volume] in Plasma --8th specimen post XXX challenge | 
|  12907-2 | Sodium [Moles/volume] in Red Blood Cells | 
|  12908-0 | Sodium [Moles/volume] in Vitreous fluid | 
|  12909-8 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | 
|  1291-4 | P1 Ag [Presence] on Red Blood Cells | 
|  12910-6 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  12911-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge | 
|  12912-2 | Lipids [Mass/volume] in Body fluid | 
|  12913-0 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Leukocytes | 
|  12914-8 | Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Serum | 
|  12915-5 | Beta galactosidase [Enzymatic activity/volume] in Leukocytes | 
|  12916-3 | Porphobilinogen synthase [Enzymatic activity/volume] in Blood | 
|  12917-1 | Porphobilinogen synthase [Enzymatic activity/volume] in Serum or Plasma | 
|  12918-9 | Monoamine oxidase [Enzymatic activity/volume] in Platelet rich plasma | 
|  12919-7 | Monoamine oxidase [Enzymatic activity/volume] in Blood | 
|  1292-2 | Deprecated P2 Ab [Presence] in Serum or Plasma from Blood product unit | 
|  12920-5 | Sulfate [Mass/volume] in 24 hour Urine | 
|  12921-3 | Testosterone [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | 
|  12922-1 | Testosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  12923-9 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12924-7 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12925-4 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12926-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12927-0 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12928-8 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  12929-6 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  1293-0 | Deprecated P2 Ab [Presence] on Red Blood Cells from donor | 
|  12930-4 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  12931-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  12932-0 | Thyrotropin [Units/volume] in Serum or Plasma --post XXX challenge | 
|  12933-8 | Thyrotropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  12934-6 | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge | 
|  12935-3 | Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge | 
|  12936-1 | Thyrotropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge | 
|  12937-9 | Thyrotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge | 
|  12938-7 | Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge | 
|  12939-5 | Thyrotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge | 
|  1294-8 | Deprecated P2 Ab | 
|  12940-3 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes pre XXX challenge | 
|  12941-1 | Thyrotropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12942-9 | Thyrotropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12943-7 | Thyrotropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12944-5 | Thyrotropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12945-2 | Thyrotropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12946-0 | Thyrotropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  12947-8 | Thyrotropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  12948-6 | Thyrotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  12949-4 | Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma | 
|  1295-5 | P2 Ag [Presence] on Red Blood Cells from Blood product unit | 
|  12950-2 | Deprecated Triglyceride [Mass/volume] in Body fluid | 
|  12951-0 | Triglyceride [Mass/volume] in Serum or Plasma by calculation | 
|  12952-8 | Deprecated Thyroxine (T4) uptake [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  12953-6 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  12954-4 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  12955-1 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  12956-9 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  12957-7 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  12958-5 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  12959-3 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  1296-3 | P2 Ag [Presence] on Red Blood Cells from donor | 
|  12960-1 | Alpha 1 antitrypsin fecal clearance | 
|  12961-9 | Urea nitrogen [Mass/volume] in Arterial blood | 
|  12962-7 | Urea nitrogen [Mass/volume] in Venous blood | 
|  12963-5 | Urea nitrogen [Mass/volume] in Peripheral blood | 
|  12964-3 | Urea nitrogen [Mass/volume] in Blood --baseline | 
|  12965-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --70 minute specimen | 
|  12966-8 | Urea nitrogen [Mass/volume] in Serum or Plasma --2 hour specimen | 
|  12967-6 | Urea nitrogen [Mass/volume] in 24 hour Urine | 
|  12968-4 | Urea nitrogen [Mass/volume] in Dialysis fluid --4 hour specimen | 
|  12969-2 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --baseline | 
|  1297-1 | P2 Ag [Presence] on Red Blood Cells | 
|  12970-0 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen | 
|  12971-8 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen | 
|  12972-6 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --1st specimen | 
|  12973-4 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4th specimen | 
|  12974-2 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --3rd specimen | 
|  12975-9 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --5th specimen | 
|  12976-7 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --6th specimen | 
|  12977-5 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --8th specimen | 
|  12978-3 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --7th specimen | 
|  12979-1 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen | 
|  1298-9 | Packed erythrocytes given [Volume] | 
|  12980-9 | Deprecated Urate [Mass/volume] in Body fluid | 
|  12981-7 | Urea nitrogen [Mass Ratio] in Peritoneal dialysis fluid --post dialysis/pre dialysis | 
|  12982-5 | Vasopressin [Mass/volume] in Plasma --2nd specimen post XXX challenge | 
|  12983-3 | Volatiles and gases [Identifier] in Urine | 
|  12984-1 | 2,4 toluenediamine [Mass/volume] in Blood | 
|  12985-8 | 2,6 toluenediamine [Mass/volume] in Blood | 
|  12986-6 | 2,5-Hexanedione [Mass/volume] in Blood | 
|  12987-4 | Acetonitrile [Mass/volume] in Urine | 
|  12988-2 | Acrylamide [Mass/volume] in Blood | 
|  12989-0 | Allyl alcohol [Mass/volume] in Serum or Plasma | 
|  1299-7 | Platelets given [Volume] | 
|  12990-8 | Polychlorinated biphenyl.Aroclor 1260 [Mass/volume] in Serum or Plasma | 
|  12991-6 | Polychlorinated biphenyl.Aroclor 1254 [Mass/volume] in Serum or Plasma | 
|  12992-4 | Isobutane [Mass/volume] in Blood | 
|  12993-2 | Hydrocarbons.chlorinated [Identifier] in Blood | 
|  12994-0 | Oxychlordane [Mass/volume] in Blood | 
|  12995-7 | Cyclohexanone [Mass/volume] in Blood | 
|  12996-5 | Dichlorodifluoroethane [Mass/volume] in Blood | 
|  12997-3 | 1,4-Dioxane [Mass/volume] in Serum or Plasma | 
|  12998-1 | Methylene chloride [Mass/volume] in Blood | 
|  12999-9 | Epichlorohydrin [Mass/volume] in Serum or Plasma | 
|  13-3 | Amikacin [Susceptibility] by Disk diffusion (KB) | 
|  130-5 | Cefsulodin [Susceptibility] by Serum bactericidal titer | 
|  1300-3 | Deprecated PP1 Ab [Presence] in Serum or Plasma from Blood product unit | 
|  13000-5 | Mandelate [Mass/volume] in Urine | 
|  13001-3 | Mandelate/Creatinine [Mass Ratio] in Urine | 
|  13002-1 | Mesityl oxide [Mass/volume] in Blood | 
|  13003-9 | Halogenated organic molecules [Identifier] in Blood | 
|  13004-7 | Hydrocarbons.halogenated.volatile [Identifier] in Blood | 
|  13005-4 | 2,4,5-Trichlorophenoxyacetate [Type] in Serum or Plasma | 
|  13006-2 | 1,4-Dichlorobenzene [Mass/volume] in Serum or Plasma | 
|  13007-0 | Ethane [Mass/volume] in Blood | 
|  13008-8 | Methyl propyl ketone [Mass/volume] in Blood | 
|  13009-6 | Methyl ethyl ketone [Mass/volume] in Urine | 
|  1301-1 | Deprecated PP1 Ab [Presence] serum or plasma from donor | 
|  13010-4 | Methyl amyl ketone [Mass/volume] in Blood | 
|  13011-2 | Methyl ethyl ketone [Mass/volume] in Blood | 
|  13012-0 | Methyl isoamyl ketone [Mass/volume] in Blood | 
|  13013-8 | Methyl isobutyl ketone [Mass/volume] in Blood | 
|  13014-6 | Methyl butyl ketone [Mass/volume] in Blood | 
|  13015-3 | Diisobutylketone [Mass/volume] in Blood | 
|  13016-1 | Nitrophenol [Units/volume] in Blood | 
|  13017-9 | Deprecated Tetrachloroethylene [Mass/volume] in Blood | 
|  13018-7 | Pesticides [Identifier] in Urine | 
|  13019-5 | Pesticides [Identifier] in Serum or Plasma | 
|  1302-9 | Deprecated PP1 Ab | 
|  13020-3 | Pesticides [Identifier] in Blood | 
|  13021-1 | Pesticides [Identifier] in Gastric fluid | 
|  13022-9 | Propane [Mass/volume] in Blood | 
|  13023-7 | Trichlorofluoromethane [Mass/volume] in Blood | 
|  13024-5 | Trichlorofluoroethane [Mass/volume] in Blood | 
|  13025-2 | Trichlorotrifluoroethane [Mass/volume] in Blood | 
|  13026-0 | Orthocresol [Mass/volume] in Urine | 
|  13027-8 | Ethyl acetate [Mass/volume] in Serum or Plasma | 
|  13028-6 | Xylose [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge | 
|  13029-4 | Xylose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | 
|  1303-7 | Reverse ABO group [Type] | 
|  13030-2 | Xylose [Mass/volume] in Serum or Plasma --4 hours post XXX challenge | 
|  13031-0 | Xylose [Mass/volume] in Serum or Plasma --5 hours post XXX challenge | 
|  13032-8 | C peptide [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  13033-6 | C peptide [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  13034-4 | C peptide [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  13035-1 | C peptide [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  13036-9 | C peptide [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  13037-7 | C peptide [Mass/volume] in Serum or Plasma --fasting | 
|  13038-5 | C peptide [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | 
|  13039-3 | C peptide [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  1304-5 | D Ab [Titer] in Serum or Plasma | 
|  13040-1 | C peptide [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge | 
|  13041-9 | C peptide [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | 
|  13042-7 | C peptide [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge | 
|  13043-5 | C peptide [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | 
|  13044-3 | C peptide [Mass/volume] in Serum or Plasma --5 hours post XXX challenge | 
|  13045-0 | C peptide [Mass/volume] in Serum or Plasma --6 hours post XXX challenge | 
|  13046-8 | Variant lymphocytes/100 leukocytes in Blood | 
|  13047-6 | Plasma cells/100 leukocytes in Blood | 
|  13048-4 | Sezary cells [Presence] in Blood by Light microscopy | 
|  13049-2 | Deprecated von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunologic method | 
|  1305-2 | D Ag [Presence] in Blood | 
|  13050-0 | Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasma | 
|  13051-8 | Deprecated Protein S [Units/volume] in Platelet poor plasma | 
|  13052-6 | Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assay | 
|  13053-4 | Kaolin activated time [Units/volume] in Platelet poor plasma | 
|  13054-2 | Fibrin+Fibrinogen fragments [Units/volume] in Urine | 
|  13055-9 | Heparin [Units/volume] in Platelet poor plasma | 
|  13056-7 | Platelets [#/volume] in Plasma by Automated count | 
|  13057-5 | Platelets [Units/volume] in Dialysis fluid | 
|  13058-3 | aPTT in Platelet poor plasma by Coagulation assay --2nd specimen | 
|  13059-1 | aPTT in Platelet poor plasma by Coagulation assay --3rd specimen | 
|  1306-0 | D NOS Ab [Presence] in Serum or Plasma | 
|  13060-9 | aPTT in Platelet poor plasma by Coagulation assay --4th specimen | 
|  13061-7 | Platelet IgM Ab [Units/volume] in Serum | 
|  13062-5 | Platelet IgA Ab [Units/volume] in Serum | 
|  13063-3 | Drug induced platelet Ab [Units/volume] in Serum | 
|  13064-1 | Platelet associated IgA Ab [Units/volume] in Blood | 
|  13065-8 | Deprecated Platelet Ab [Units/volume] in Serum | 
|  13066-6 | Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence | 
|  13067-4 | Nuclear Ab pattern [Interpretation] in Body fluid by Immunofluorescence | 
|  13068-2 | Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence | 
|  13069-0 | Phosphatidylserine IgA Ab [Units/volume] in Serum | 
|  1307-8 | D NOS Ab [Presence] in Serum or Plasma from Blood product unit | 
|  13070-8 | Phosphatidate IgG Ab [Units/volume] in Serum | 
|  13071-6 | Phosphatidate IgM Ab [Units/volume] in Serum | 
|  13072-4 | Phosphatidate IgA Ab [Units/volume] in Serum | 
|  13073-2 | Phosphatidylcholine IgG Ab [Units/volume] in Serum | 
|  13074-0 | Phosphatidylcholine IgM Ab [Units/volume] in Serum | 
|  13075-7 | Phosphatidylcholine IgA Ab [Units/volume] in Serum | 
|  13076-5 | Phosphatidylethanolamine IgG Ab [Units/volume] in Serum | 
|  13077-3 | Phosphatidylethanolamine IgM Ab [Units/volume] in Serum | 
|  13078-1 | Phosphatidylethanolamine IgA Ab [Units/volume] in Serum | 
|  13079-9 | Phosphatidylglycerol IgG Ab [Units/volume] in Serum | 
|  1308-6 | D NOS Ab [Presence] in Serum or Plasma from donor | 
|  13080-7 | Phosphatidylglycerol IgM Ab [Units/volume] in Serum | 
|  13081-5 | Phosphatidylglycerol IgA Ab [Units/volume] in Serum | 
|  13082-3 | Phosphatidylinositol IgG Ab [Units/volume] in Serum | 
|  13083-1 | Phosphatidylinositol IgM Ab [Units/volume] in Serum | 
|  13084-9 | Phosphatidylinositol IgA Ab [Units/volume] in Serum | 
|  13085-6 | Complement C4 Nephritic [Mass/volume] in Serum or Plasma | 
|  13086-4 | Complement C3 Nephritic [Mass/volume] in Serum or Plasma | 
|  13087-2 | Complement alternate pathway AH50 [Units/volume] in Serum or Plasma | 
|  13088-0 | Complement total hemolytic CH100 [Units/volume] in Serum or Plasma | 
|  13089-8 | Deprecated Asialoganglioside GM1 Ab | 
|  1309-4 | Deprecated D NOS Ab [Presence] in Serum or Plasma | 
|  13090-6 | Deprecated Asialoganglioside GM1 Ab.IgG | 
|  13091-4 | Deoxyribonucleoprotein Ab [Units/volume] in Serum | 
|  13092-2 | Endomysium Ab [Units/volume] in Serum | 
|  13093-0 | Deprecated Monosialoganglioside GM1 Ab.IgM | 
|  13094-8 | Deprecated Monosialoganglioside GM1 Ab.IgA in serum | 
|  13095-5 | Deprecated Monosialoganglioside GM1 Ab.IgA in serum or plasma | 
|  13096-3 | Deprecated Myelin associated glycoprotein Ab.IgM in serum | 
|  13097-1 | Deprecated PM-SCL extractable nuclear Ab | 
|  13098-9 | Deprecated Sulfatide Ab.IgG | 
|  13099-7 | Deprecated Sulfatide Ab.IgM in serum | 
|  131-3 | Cefsulodin [Mass/volume] in Serum or Plasma | 
|  1310-2 | D NOS Ag [Presence] on Red Blood Cells from Blood product unit | 
|  13100-3 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab.IgM in serum | 
|  13101-1 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab.IgM in CSF | 
|  13102-9 | Deprecated Disialylganglioside GD1b Ab in serum | 
|  13103-7 | Deprecated Disialylganglioside GD1b Ab.IgG | 
|  13104-5 | Deprecated Disialylganglioside GD1b Ab.IgM | 
|  13105-2 | Deprecated Tetrasialylganglioside GQ1b Ab.IgG | 
|  13106-0 | Deprecated Tetrasialylganglioside GQ1b Ab in serum | 
|  13107-8 | Deprecated Disialylganglioside GD1a Ab | 
|  13108-6 | Deprecated Tetrasialylganglioside GQ1b Ab in serum or plasma | 
|  13109-4 | Deprecated Disialylganglioside GD1b Ab in serum or plasma | 
|  1311-0 | D NOS Ag [Presence] on Red Blood Cells from donor | 
|  13110-2 | Deprecated Beta tubulin Ab.IgM | 
|  13111-0 | Deprecated Nuclear Ab by Immunofluorescence | 
|  13112-8 | Deprecated Nuclear Ab Immunofluorescence (rat kidney substrate) | 
|  13113-6 | Deprecated Myelin associated glycoprotein Ab.IgM in serum or plasma | 
|  13114-4 | Deprecated Neuronal nuclear type 2 Ab | 
|  13115-1 | Deprecated Neuronal nuclear type 1 Ab | 
|  13116-9 | Deprecated Reticulin Ab.IgG | 
|  13117-7 | Complement Sc5b-9 Ab [Units/volume] in Serum or Plasma | 
|  13118-5 | Deprecated Myelin associated glycoprotein Ab | 
|  13119-3 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunoblot (IB) | 
|  1312-8 | D NOS Ag [Presence] on Red Blood Cells | 
|  13120-1 | Ovary Ab [Units/volume] in Serum | 
|  13121-9 | Deprecated Ribosomal P protein Ab | 
|  13122-7 | Deprecated Sulfatide Ab.IgM in serum or plasma | 
|  13123-5 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab in serum | 
|  13124-3 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab in serum or plasma | 
|  13125-0 | Deprecated Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot (IB) | 
|  13126-8 | Deprecated Hepatitis B virus DNA [Presence] in Blood by Immunoblot (IB) | 
|  13127-6 | Cancer Ag DM/70K [Units/volume] in Serum or Plasma | 
|  13128-4 | Protein.immunoacidic [Units/volume] in Serum or Plasma | 
|  13129-2 | Pancreatic oncofetal Ag [Units/volume] in Serum or Plasma | 
|  1313-6 | Rh immune globulin dosage.vials recommended [#] | 
|  13130-0 | Motilin [Units/volume] in Serum or Plasma | 
|  13131-8 | Streptococcus pneumoniae 1 Ab [Units/volume] in Serum | 
|  13132-6 | Streptococcus pneumoniae 4 Ab [Units/volume] in Serum | 
|  13133-4 | Streptococcus pneumoniae 26 Ab [Units/volume] in Serum | 
|  13134-2 | Streptococcus pneumoniae 8 Ab [Units/volume] in Serum | 
|  13135-9 | Streptococcus pneumoniae 12 Ab [Units/volume] in Serum | 
|  13136-7 | Streptococcus pneumoniae 56 Ab [Units/volume] in Serum | 
|  13137-5 | Streptococcus pneumoniae 19 Ab [Units/volume] in Serum | 
|  13138-3 | Streptococcus pneumoniae 23 Ab [Units/volume] in Serum | 
|  13139-1 | Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --1st specimen | 
|  1314-4 | Rh immune globulin screen [interpretation] | 
|  13140-9 | Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --2nd specimen | 
|  13141-7 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --1st specimen | 
|  13142-5 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --2nd specimen | 
|  13143-3 | Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --1st specimen | 
|  13144-1 | Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --2nd specimen | 
|  13145-8 | Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --1st specimen | 
|  13146-6 | Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --2nd specimen | 
|  13147-4 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum --1st specimen | 
|  13148-2 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum --2nd specimen | 
|  13149-0 | Streptococcus pneumoniae 8 Ab [Units/volume] in Serum --1st specimen | 
|  1315-1 | S Ab [Presence] in Serum or Plasma from Blood product unit | 
|  13150-8 | Streptococcus pneumoniae 8 Ab [Units/volume] in Serum --2nd specimen | 
|  13151-6 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum --1st specimen | 
|  13152-4 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum --2nd specimen | 
|  13153-2 | Streptococcus pneumoniae 12 Ab [Units/volume] in Serum --1st specimen | 
|  13154-0 | Streptococcus pneumoniae 12 Ab [Ratio] in Serum --2nd specimen/1st specimen | 
|  13155-7 | Streptococcus pneumoniae 14 Ab [Units/volume] in Serum --1st specimen | 
|  13156-5 | Streptococcus pneumoniae 14 Ab [Ratio] in Serum --2nd specimen/1st specimen | 
|  13157-3 | Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --1st specimen | 
|  13158-1 | Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --2nd specimen | 
|  13159-9 | Streptococcus pneumoniae 19 Ab [Units/volume] in Serum --1st specimen | 
|  1316-9 | S Ab [Presence] in Serum or Plasma from donor | 
|  13160-7 | Streptococcus pneumoniae 19 Ab [Units/volume] in Serum --2nd specimen | 
|  13161-5 | Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --1st specimen | 
|  13162-3 | Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --2nd specimen | 
|  13163-1 | Deprecated Streptococcus pneumoniae 12 Ab [Units/volume] in Serum | 
|  13164-9 | Human antimouse Ab [Units/volume] in Serum | 
|  13165-6 | Deprecated Streptococcus pneumoniae 19 Ab [Units/volume] in Serum | 
|  13166-4 | Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum | 
|  13167-2 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum | 
|  13168-0 | Streptococcus pneumoniae 6+26 Ab [Units/volume] in Serum | 
|  13169-8 | Immunoelectrophoresis for Serum or Plasma | 
|  1317-7 | S Ab [Presence] in Serum or Plasma | 
|  13170-6 | Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay | 
|  13171-4 | Immune complex [Units/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay | 
|  13172-2 | Complement C1q Ag [Units/volume] in Serum or Plasma by Raji cell assay | 
|  13173-0 | Fibronectin aggregate IgA Ab [Units/volume] in Serum | 
|  13174-8 | Immunofixation for Cerebral spinal fluid | 
|  13175-5 | Liver cytosol Ab [Presence] in Serum | 
|  13176-3 | Wasp venom IgE Ab [Units/volume] in Serum | 
|  13177-1 | Russian olive IgE Ab [Units/volume] in Serum | 
|  13178-9 | Wasp venom IgG Ab [Units/volume] in Serum | 
|  13179-7 | English Walnut IgG Ab [Units/volume] in Serum | 
|  1318-5 | S Ag [Presence] on Red Blood Cells from Blood product unit | 
|  13180-5 | Formaldehyde IgG Ab [Units/volume] in Serum | 
|  13181-3 | Bahia grass IgG Ab [Units/volume] in Serum | 
|  13182-1 | Mesquite IgG Ab [Units/volume] in Serum | 
|  13183-9 | White Elm IgG Ab [Units/volume] in Serum | 
|  13184-7 | Cottonwood IgG Ab [Units/volume] in Serum | 
|  13185-4 | Nettle IgG Ab [Units/volume] in Serum | 
|  13186-2 | Yellow Dock IgG Ab [Units/volume] in Serum | 
|  13187-0 | False ragweed IgG Ab [Units/volume] in Serum | 
|  13188-8 | Mugwort IgG Ab [Units/volume] in Serum | 
|  13189-6 | English plantain IgG Ab [Units/volume] in Serum | 
|  1319-3 | S Ag [Presence] on Red Blood Cells from donor | 
|  13190-4 | Formaldehyde IgM Ab [Units/volume] in Serum or Plasma | 
|  13191-2 | Deprecated Rheumatoid factor [Units/volume] in Serum | 
|  13192-0 | Adenovirus Ab [Units/volume] in Cerebral spinal fluid | 
|  13193-8 | Aspergillus flavus Ab [Units/volume] in Cerebral spinal fluid | 
|  13194-6 | Aspergillus glaucus Ab [Units/volume] in Serum | 
|  13195-3 | Ehrlichia chaffeensis Ab [Units/volume] in Serum | 
|  13196-1 | Ehrlichia sp IgG Ab [Presence] in Serum | 
|  13197-9 | Ehrlichia sp IgM Ab [Presence] in Serum | 
|  13198-7 | Thermoactinomyces Ab [Units/volume] in Serum | 
|  13199-5 | Rickettsia conorii IgG Ab [Units/volume] in Serum | 
|  132-1 | Ceftazidime [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1320-1 | S Ag [Presence] on Red Blood Cells | 
|  13200-1 | Rickettsia conorii IgM Ab [Units/volume] in Serum | 
|  13201-9 | Blastomyces dermatitidis Ab [Units/volume] in Cerebral spinal fluid | 
|  13202-7 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  13203-5 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  13204-3 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | 
|  13205-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | 
|  13206-8 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoblot (IB) | 
|  13207-6 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoblot (IB) | 
|  13208-4 | Borrelia hermsii IgG Ab [Units/volume] in Serum | 
|  13209-2 | Borrelia hermsii IgM Ab [Units/volume] in Serum | 
|  1321-9 | Transfusion duration | 
|  13210-0 | Brucella sp IgG Ab [Units/volume] in Serum | 
|  13211-8 | Brucella sp IgA Ab [Units/volume] in Serum | 
|  13212-6 | Brucella abortus IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  13213-4 | Brucella abortus IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  13214-2 | Brucella canis IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  13215-9 | Brucella canis IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  13216-7 | Candida albicans immune complex [Units/volume] in Serum or Plasma | 
|  13217-5 | Chlamydia trachomatis B Ab [Units/volume] in Serum | 
|  13218-3 | Chlamydia trachomatis C Ab [Units/volume] in Serum | 
|  13219-1 | Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum | 
|  1322-7 | Transfusion volume | 
|  13220-9 | Chlamydia trachomatis C IgM Ab [Units/volume] in Serum | 
|  13221-7 | Chlamydia trachomatis G+F+K IgM Ab [Units/volume] in Serum | 
|  13222-5 | Deprecated Chlamydia trachomatis C Ab [Units/volume] in Serum | 
|  13223-3 | Deprecated Chlamydia trachomatis B Ab [Units/volume] in Serum | 
|  13224-1 | Deprecated Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum | 
|  13225-8 | Cytomegalovirus IgG Ab [Units/volume] in Serum --1st specimen | 
|  13226-6 | Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  13227-4 | Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum | 
|  13228-2 | Eastern equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  13229-0 | Eastern equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  1323-5 | U Ab [Presence] in Serum or Plasma from Blood product unit | 
|  13230-8 | Saint Louis encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  13231-6 | Saint Louis encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  13232-4 | Coxsackievirus A Ab [Units/volume] in Cerebral spinal fluid | 
|  13233-2 | Coxsackievirus A2 Ab [Units/volume] in Cerebral spinal fluid | 
|  13234-0 | Coxsackievirus A4 Ab [Units/volume] in Cerebral spinal fluid | 
|  13235-7 | Coxsackievirus A16 Ab [Units/volume] in Cerebral spinal fluid | 
|  13236-5 | Epstein Barr virus early diffuse Ab [Presence] in Serum by Immunofluorescence | 
|  13237-3 | Epstein Barr virus early restricted Ab [Presence] in Serum by Immunofluorescence | 
|  13238-1 | Epstein Barr virus Ab [Units/volume] in Serum | 
|  13239-9 | Deprecated Epstein Barr virus nuclear IgG Ab [Presence] in Serum | 
|  1324-3 | U Ab [Presence] in Serum or Plasma from donor | 
|  13240-7 | Phoma herbarum IgE Ab [Units/volume] in Serum | 
|  13241-5 | Sporothrix schenckii IgG Ab [Units/volume] in Serum | 
|  13242-3 | Sporothrix schenckii IgM Ab [Units/volume] in Serum | 
|  13243-1 | Sporothrix schenckii IgA Ab [Units/volume] in Serum | 
|  13244-9 | Filaria IgG Ab [Units/volume] in Serum | 
|  13245-6 | Filaria IgM Ab [Units/volume] in Serum | 
|  13246-4 | Haemophilus influenzae B Ab [Units/volume] in Serum | 
|  13247-2 | HTLV I+II Ab [Units/volume] in Cerebral spinal fluid | 
|  13248-0 | Hepatitis D virus Ab [Presence] in Serum | 
|  13249-8 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  1325-0 | U Ab [Presence] in Serum or Plasma | 
|  13250-6 | Herpes virus 6 IgG+IgM Ab [Units/volume] in Serum | 
|  13251-4 | Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  13252-2 | Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  13253-0 | Legionella non-pneumophila Ab [Presence] in Serum | 
|  13254-8 | Legionella pneumophila atypical Ab [Presence] in Serum | 
|  13255-5 | Legionella longbeachae 1+2 Ab [Presence] in Serum | 
|  13256-3 | Leishmania donovani IgG Ab [Units/volume] in Serum | 
|  13257-1 | Leishmania donovani IgM Ab [Units/volume] in Serum | 
|  13258-9 | Leishmania brasilensis IgG Ab [Units/volume] in Serum | 
|  13259-7 | Leishmania brasilensis IgM Ab [Units/volume] in Serum | 
|  1326-8 | U Ag [Presence] on Red Blood Cells from Blood product unit | 
|  13260-5 | Leishmania mexicana IgG Ab [Units/volume] in Serum | 
|  13261-3 | Leishmania mexicana IgM Ab [Units/volume] in Serum | 
|  13262-1 | Leishmania tropica IgG Ab [Units/volume] in Serum | 
|  13263-9 | Leishmania tropica IgM Ab [Units/volume] in Serum | 
|  13264-7 | Leptospira sp IgG Ab [Titer] in Serum | 
|  13265-4 | Leptospira sp IgM Ab [Titer] in Serum | 
|  13266-2 | Mumps virus IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  13267-0 | Mumps virus IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  13268-8 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --1st specimen | 
|  13269-6 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --2nd specimen | 
|  1327-6 | U Ag [Presence] on Red Blood Cells from donor | 
|  13270-4 | Mycoplasma pneumoniae IgA Ab [Units/volume] in Serum | 
|  13271-2 | Neisseria meningitidis A Ab [Units/volume] in Serum | 
|  13272-0 | Neisseria meningitidis C Ab [Units/volume] in Serum | 
|  13273-8 | Sporothrix schenckii Ab [Presence] in Serum | 
|  13274-6 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid | 
|  13275-3 | Toxocara canis IgM Ab [Units/volume] in Serum | 
|  13276-1 | Toxocara canis IgA Ab [Units/volume] in Serum | 
|  13277-9 | Schistosoma sp IgG Ab [Units/volume] in Serum | 
|  13278-7 | Schistosoma sp IgM Ab [Units/volume] in Serum | 
|  13279-5 | Rubella virus IgG Ab [Units/volume] in Serum --1st specimen | 
|  1328-4 | U Ag [Presence] on Red Blood Cells | 
|  13280-3 | Rubella virus IgG Ab [Units/volume] in Serum --2nd specimen | 
|  13281-1 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  13282-9 | Rubella virus IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  13283-7 | Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  13284-5 | Salmonella typhi H D Ab [Presence] in Serum | 
|  13285-2 | Salmonella typhi O D Ab [Presence] in Serum | 
|  13286-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum --2nd specimen | 
|  13287-8 | Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid | 
|  13288-6 | Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence | 
|  13289-4 | Hantavirus hantaan Ab [Units/volume] in Serum | 
|  1329-2 | V Ab [Presence] in Serum or Plasma from Blood product unit | 
|  13290-2 | Trypanosoma cruzi IgM Ab [Units/volume] in Serum | 
|  13291-0 | Trypanosoma cruzi IgG Ab [Units/volume] in Serum | 
|  13292-8 | Colorado tick fever virus IgG Ab [Units/volume] in Serum | 
|  13293-6 | Colorado tick fever virus IgM Ab [Units/volume] in Serum | 
|  13294-4 | Hepatitis E virus Ab [Presence] in Serum | 
|  13295-1 | Coxsackievirus A10 Ab [Units/volume] in Cerebral spinal fluid | 
|  13296-9 | Deprecated Coxsackievirus A10 Ab [Units/volume] in Serum | 
|  13297-7 | Coxsackievirus A1 Ab [Units/volume] in Serum | 
|  13298-5 | HLA-A [Type] | 
|  13299-3 | HLA-B [Type] | 
|  133-9 | Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1330-0 | V Ab [Presence] in Serum or Plasma from donor | 
|  13300-9 | HLA-A+B [Type] | 
|  13301-7 | HLA-A+B+Bw [Type] | 
|  13302-5 | HLA-C [Type] | 
|  13303-3 | HLA-A+B+C (class I) [Type] | 
|  13304-1 | HLA-DR [Type] | 
|  13305-8 | HLA-DQ [Type] | 
|  13306-6 | HLA-DR beta [Type] | 
|  13307-4 | HLA-DQ alpha [Type] | 
|  13308-2 | Deprecated DNA | 
|  13309-0 | Duffy group Ag [Type] on Red Blood Cells | 
|  1331-8 | V Ab [Presence] in Serum or Plasma | 
|  13310-8 | Kell group Ag [Type] on Red Blood Cells | 
|  13311-6 | MNS group Ag [Type] on Red Blood Cells | 
|  13312-4 | IgA IgG Ab [Units/volume] in Serum or Plasma | 
|  13313-2 | IgM IgM Ab [Units/volume] in Serum or Plasma | 
|  13314-0 | Bacteria identified in Semen | 
|  13315-7 | Bacteria identified in 24 hour Urine by Culture | 
|  13316-5 | Vancomycin resistant enterococcus [Presence] in Unspecified specimen by Organism specific culture | 
|  13317-3 | Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture | 
|  13318-1 | Escherichia coli enteroinvasive identified in Stool by Organism specific culture | 
|  13319-9 | Ova and parasites identified in Stool by Light microscopy--2nd specimen | 
|  1332-6 | V Ag [Presence] on Red Blood Cells from Blood product unit | 
|  13320-7 | Ova and parasites identified in Stool by Light microscopy--3rd specimen | 
|  13321-5 | Human papilloma virus IgG Ab [Presence] in Serum | 
|  13322-3 | Human papilloma virus IgM Ab [Presence] in Serum | 
|  13323-1 | Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunofluorescence | 
|  13324-9 | Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunofluorescence | 
|  13325-6 | Bartonella sp identified in Blood by Light microscopy | 
|  13326-4 | Pneumocystis sp identified in Unspecified specimen by Light microscopy | 
|  13327-2 | Parainfluenza virus Ag [Presence] in Unspecified specimen by Immunofluorescence | 
|  13328-0 | Measles virus Ag [Presence] in Serum or Plasma by Immunofluorescence | 
|  13329-8 | Escherichia coli labile toxin [Presence] in Unspecified specimen | 
|  1333-4 | V Ag [Presence] on Red Blood Cells from donor | 
|  13330-6 | Barr bodies [Presence] in Cervix by Light microscopy | 
|  13331-4 | CD2+CD26+ cells/100 cells in Blood | 
|  13332-2 | CD4+CD25+ cells/100 cells in Blood | 
|  13333-0 | CD3+CD25+ cells/100 cells in Blood | 
|  13334-8 | CD8+CD25+ cells/100 cells in Blood | 
|  13335-5 | CD4+CD29+ cells/100 cells in Blood | 
|  13336-3 | CD4+CD45RA+ cells/100 cells in Blood | 
|  13337-1 | CD8+HLA-DR+ cells/100 cells in Blood | 
|  13338-9 | CD8+CD57+ cells/100 cells in Blood | 
|  13339-7 | CD8+CD56+ cells/100 cells in Blood | 
|  1334-2 | V Ag [Presence] on Red Blood Cells | 
|  13340-5 | CD3+CD38+ cells/100 cells in Blood | 
|  13341-3 | CD3+CD25+ cells/100 cells in Tissue | 
|  13342-1 | CD3+CD26+ cells/100 cells in Blood | 
|  13343-9 | CD4+HLA-DR+ cells/100 cells in Blood | 
|  13344-7 | CD8+CD38+ cells/100 cells in Blood | 
|  13345-4 | CD8+CD11b+ cells/100 cells in Blood | 
|  13346-2 | CD35 cells/100 cells in Blood | 
|  13347-0 | RNA polymerase I+II+III Ab [Presence] in Serum | 
|  13348-8 | Monoclonal band observed [Identifier] in Serum or Plasma | 
|  13349-6 | Leukocytes [#/volume] in Stool by Manual count | 
|  1335-9 | Whole blood given [Volume] | 
|  13350-4 | Deprecated Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  13351-2 | Leukocytes other [#/volume] in Cerebral spinal fluid by Manual count | 
|  13352-0 | Deprecated Neutrophils/100 leukocytes in Body fluid by Manual count | 
|  13353-8 | Deprecated Eosinophils/100 leukocytes in Body fluid by Manual count | 
|  13354-6 | Band form neutrophils/100 leukocytes in Body fluid by Manual count | 
|  13355-3 | Unspecified cells/100 leukocytes in Body fluid by Manual count | 
|  13356-1 | Fat [Presence] in Body fluid | 
|  13357-9 | Synovial cells [Units/volume] in Body fluid | 
|  13358-7 | Collection time of Semen | 
|  13359-5 | Character of Semen | 
|  1336-7 | Xg sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  13360-3 | Deprecated Color of Semen - impression | 
|  13361-1 | Semen analysis panel | 
|  13362-9 | Collection duration of Urine | 
|  13363-7 | Collection duration of Stool | 
|  13364-5 | Amino beta guanidinopropionate [Mass/volume] in Plasma | 
|  13365-2 | Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid | 
|  13366-0 | Alpha aminoadipate [Mass/volume] in Cerebral spinal fluid | 
|  13367-8 | Beta aminoisobutyrate [Mass/volume] in Cerebral spinal fluid | 
|  13368-6 | Beta alanine [Mass/volume] in Cerebral spinal fluid | 
|  13369-4 | Carnosine [Mass/volume] in Cerebral spinal fluid | 
|  1337-5 | Xg sup(a) Ab [Presence] in Serum or Plasma from donor | 
|  13370-2 | Cystathionine [Mass/volume] in Cerebral spinal fluid | 
|  13371-0 | Cystine [Mass/volume] in Cerebral spinal fluid | 
|  13372-8 | Homocystine [Mass/volume] in Cerebral spinal fluid | 
|  13373-6 | Hydroxylysine [Mass/volume] in Cerebral spinal fluid | 
|  13374-4 | Hydroxyproline [Mass/volume] in Cerebral spinal fluid | 
|  13375-1 | Lysine [Mass/volume] in Cerebral spinal fluid | 
|  13376-9 | Methionine [Mass/volume] in Cerebral spinal fluid | 
|  13377-7 | 1-Methylhistidine [Mass/volume] in Cerebral spinal fluid | 
|  13378-5 | 3-Methylhistidine [Mass/volume] in Cerebral spinal fluid | 
|  13379-3 | Ornithine [Mass/volume] in Cerebral spinal fluid | 
|  1338-3 | Xg sup(a) Ab [Presence] in Serum or Plasma | 
|  13380-1 | Sarcosine [Mass/volume] in Cerebral spinal fluid | 
|  13381-9 | Tyrosine [Mass/volume] in Cerebral spinal fluid | 
|  13382-7 | Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid | 
|  13383-5 | Alpha aminobutyrate [Mass/volume] in Amniotic fluid | 
|  13384-3 | Alpha aminoadipate [Mass/volume] in Amniotic fluid | 
|  13385-0 | Beta aminoisobutyrate [Mass/volume] in Amniotic fluid | 
|  13386-8 | Anserine [Mass/volume] in Amniotic fluid | 
|  13387-6 | Arginine [Mass/volume] in Amniotic fluid | 
|  13388-4 | Asparagine [Mass/volume] in Amniotic fluid | 
|  13389-2 | Aspartate [Mass/volume] in Amniotic fluid | 
|  1339-1 | Xg sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  13390-0 | Beta alanine [Mass/volume] in Amniotic fluid | 
|  13391-8 | Carnosine [Mass/volume] in Amniotic fluid | 
|  13392-6 | Citrulline [Mass/volume] in Amniotic fluid | 
|  13393-4 | Cystathionine [Mass/volume] in Amniotic fluid | 
|  13394-2 | Cystine [Mass/volume] in Amniotic fluid | 
|  13395-9 | Glutamate [Mass/volume] in Amniotic fluid | 
|  13396-7 | Glutamine [Mass/volume] in Amniotic fluid | 
|  13397-5 | Glycine [Mass/volume] in Amniotic fluid | 
|  13398-3 | Histidine [Mass/volume] in Amniotic fluid | 
|  13399-1 | Homocystine [Mass/volume] in Amniotic fluid | 
|  134-7 | Ceftazidime [Susceptibility] by Disk diffusion (KB) | 
|  1340-9 | Xg sup(a) Ag [Presence] on Red Blood Cells from donor | 
|  13400-7 | Hydroxylysine [Mass/volume] in Amniotic fluid | 
|  13401-5 | Hydroxyproline [Mass/volume] in Amniotic fluid | 
|  13402-3 | Isoleucine [Mass/volume] in Amniotic fluid | 
|  13403-1 | Leucine [Mass/volume] in Amniotic fluid | 
|  13404-9 | Lysine [Mass/volume] in Amniotic fluid | 
|  13405-6 | Methionine [Mass/volume] in Amniotic fluid | 
|  13406-4 | 1-Methylhistidine [Mass/volume] in Amniotic fluid | 
|  13407-2 | 3-Methylhistidine [Mass/volume] in Amniotic fluid | 
|  13408-0 | Ornithine [Mass/volume] in Amniotic fluid | 
|  13409-8 | Phenylalanine [Mass/volume] in Amniotic fluid | 
|  1341-7 | Xg sup(a) Ag [Presence] on Red Blood Cells | 
|  13410-6 | Phosphoethanolamine [Mass/volume] in Amniotic fluid | 
|  13411-4 | Phosphoserine [Mass/volume] in Amniotic fluid | 
|  13412-2 | Proline [Mass/volume] in Amniotic fluid | 
|  13413-0 | Sarcosine [Mass/volume] in Amniotic fluid | 
|  13414-8 | Serine [Mass/volume] in Amniotic fluid | 
|  13415-5 | Taurine [Mass/volume] in Amniotic fluid | 
|  13416-3 | Threonine [Mass/volume] in Amniotic fluid | 
|  13417-1 | Tyrosine [Mass/volume] in Amniotic fluid | 
|  13418-9 | Tryptophan [Mass/volume] in Amniotic fluid | 
|  13419-7 | Valine [Mass/volume] in Amniotic fluid | 
|  1342-5 | Yt sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  13420-5 | Epinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge | 
|  13421-3 | Epinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge | 
|  13422-1 | Epinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge | 
|  13423-9 | Epinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge | 
|  13424-7 | Epinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge | 
|  13425-4 | Epinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge | 
|  13426-2 | Norepinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge | 
|  13427-0 | Norepinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge | 
|  13428-8 | Norepinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge | 
|  13429-6 | Norepinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge | 
|  1343-3 | Yt sup(a) Ab [Presence] in Serum or Plasma from donor | 
|  13430-4 | Norepinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge | 
|  13431-2 | Norepinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge | 
|  13432-0 | Dopamine [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  13433-8 | Dopamine [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  13434-6 | Dopamine [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  13435-3 | Dopamine [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  13436-1 | Dopamine [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  13437-9 | Dopamine [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  13438-7 | Protein Fractions [Interpretation] in Urine by Electrophoresis | 
|  13439-5 | Protein Fractions [Interpretation] in Cerebral spinal fluid by Electrophoresis | 
|  1344-1 | Yt sup(a) Ab [Presence] in Serum or Plasma | 
|  13440-3 | Immunofixation for Urine | 
|  13441-1 | Creatinine renal clearance in 4 hour | 
|  13442-9 | Creatinine renal clearance in 6 hour | 
|  13443-7 | Creatinine renal clearance in 8 hour | 
|  13444-5 | Calcium/Albumin [Mass Ratio] in Serum or Plasma | 
|  13445-2 | Deprecated Creatinine renal clearance/1.73 sq M in 24 hour | 
|  13446-0 | Creatinine renal clearance/1.73 sq M in 4 hour | 
|  13447-8 | Creatinine renal clearance/1.73 sq M in 6 hour | 
|  13448-6 | Calcium/Osmolality [Mass Ratio] in Serum or Plasma | 
|  13449-4 | Creatinine renal clearance/1.73 sq M in 8 hour | 
|  1345-8 | Yt sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  13450-2 | Creatinine renal clearance/1.73 sq M in 12 hour | 
|  13451-0 | Creatinine dialysis fluid clearance | 
|  13452-8 | Iron/Transferrin [Mass Ratio] in Serum or Plasma | 
|  13453-6 | Deprecated Glucose mean value | 
|  13454-4 | Calcium-phosphorus product [(Moles/volume)*2] in Serum or Plasma | 
|  13455-1 | Lithium.plasma/Lithium.RBC [Mass Ratio] in Blood | 
|  13456-9 | IgG synthesis rate [Units/volume] in Serum and CSF | 
|  13457-7 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 
|  13458-5 | Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation | 
|  13459-3 | Cholesterol in LDL/Cholesterol.total [Mass Ratio] in Serum or Plasma | 
|  1346-6 | Yt sup(a) Ag [Presence] on Red Blood Cells from donor | 
|  13460-1 | Deprecated Cholesterol.in LDL/Cholesterol.in HDL [Mass ratio] in Serum or Plasma | 
|  13461-9 | Monoacetyldapsone/Dapsone [Mass Ratio] in Serum or Plasma | 
|  13462-7 | Apolipoprotein A-I/Apolipoprotein B [Mass Ratio] in Serum or Plasma | 
|  13463-5 | Arsenic/Creatinine [Mass Ratio] in Urine | 
|  13464-3 | Chromium/Creatinine [Mass Ratio] in Urine | 
|  13465-0 | Mercury/Creatinine [Mass Ratio] in Urine | 
|  13466-8 | Lead/Creatinine [Mass Ratio] in Urine | 
|  13467-6 | Selenium/Creatinine [Mass Ratio] in Urine | 
|  13468-4 | Cobalt/Creatinine [Mass Ratio] in Urine | 
|  13469-2 | Thallium/Creatinine [Mass Ratio] in Urine | 
|  1347-4 | Yt sup(a) Ag [Presence] on Red Blood Cells | 
|  13470-0 | Aluminum/Creatinine [Mass Ratio] in Urine | 
|  13471-8 | Cadmium/Creatinine [Mass Ratio] in Urine | 
|  13472-6 | Nickel/Creatinine [Mass Ratio] in Urine | 
|  13473-4 | Zinc/Creatinine [Mass Ratio] in Urine | 
|  13474-2 | Magnesium/Creatinine [Mass Ratio] in Urine | 
|  13475-9 | Fluoride/Creatinine [Mass Ratio] in Urine | 
|  13476-7 | Silver/Creatinine [Mass Ratio] in Urine | 
|  13477-5 | Orthocresol/Creatinine [Mass Ratio] in Urine | 
|  13478-3 | Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine | 
|  13479-1 | Benzoylecgonine/Creatinine [Mass Ratio] in Urine | 
|  1348-2 | Yt sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | 
|  13480-9 | 18-Hydroxydeoxycortisol/Creatinine [Mass Ratio] in Urine | 
|  13481-7 | Gonadotropin peptide/Creatinine [Mass Ratio] in Urine | 
|  13482-5 | Aldosterone/Creatinine [Mass Ratio] in Urine | 
|  13483-3 | Oxalate/Creatinine [Mass Ratio] in Urine | 
|  13484-1 | Creatine/Creatinine [Mass Ratio] in Urine | 
|  13485-8 | Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine | 
|  13486-6 | Testosterone/Creatinine [Mass Ratio] in Urine | 
|  13487-4 | Phenol/Creatinine [Mass Ratio] in Urine | 
|  13488-2 | aPTT in control Platelet poor plasma by Coagulation assay | 
|  13489-0 | Follitropin/Creatinine [Mass Ratio] in Urine | 
|  1349-0 | Yt sup(b) Ab [Presence] in Serum or Plasma from donor | 
|  13490-8 | Lutropin/Creatinine [Mass Ratio] in Urine | 
|  13491-6 | Deprecated CD4+CD25+ cells/100 cells in Blood | 
|  13492-4 | Deprecated CD4+HLA-DR+ cells/100 cells in Blood | 
|  13493-2 | Deprecated CD8+CD25+ cells/100 cells in Blood | 
|  13494-0 | Volume of 4 hour Dialysis fluid | 
|  13495-7 | Volume of 24 hour Dialysis fluid | 
|  13496-5 | Triple phosphate crystals [type] in Stone by Light microscopy | 
|  13497-3 | Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine | 
|  13498-1 | Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine | 
|  13499-9 | HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot (IB) | 
|  135-4 | Ceftazidime [Susceptibility] by Serum bactericidal titer | 
|  1350-8 | Yt sup(b) Ab [Presence] in Serum or Plasma | 
|  13500-4 | Amino acid pattern [Interpretation] in Serum or Plasma | 
|  13501-2 | Herpes simplex virus 2 Ab pattern [Interpretation] in Serum | 
|  13502-0 | Borrelia burgdorferi Ab.IgG band pattern [Interpretation] in Serum by Immunoblot (IB) | 
|  13503-8 | Borrelia burgdorferi Ab.IgM band pattern [Interpretation] in Serum by Immunoblot (IB) | 
|  13504-6 | Deprecated Borrelia burgdorferi Ab [interpretation] in Serum | 
|  13505-3 | Herpes simplex virus 1+2 Ab pattern [Interpretation] in Serum | 
|  13506-1 | Urea nitrogen renal clearance | 
|  13507-9 | Lupus erythematosus cells [Presence] in Blood | 
|  13508-7 | Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation | 
|  13509-5 | Microscopic observation [Identifier] in Blood by Crystal violet stain | 
|  1351-6 | Yt sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | 
|  13510-3 | Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain | 
|  13511-1 | Cyanide ascorbate screen [Presence] in Blood | 
|  13512-9 | Microscopic observation [Identifier] in Bone marrow by Butyrate esterase stain | 
|  13513-7 | Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain | 
|  13514-5 | Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Narrative | 
|  13515-2 | Hemoglobin pattern [Interpretation] in Blood by Electrophesis citrate agar Narrative | 
|  13516-0 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  13517-8 | Variant lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  13518-6 | Variant lymphocytes/100 leukocytes in Body fluid by Manual count | 
|  13519-4 | Basophils/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  1352-4 | Yt sup(b) Ag [Presence] on Red Blood Cells from donor | 
|  13520-2 | Deprecated Basophils/100 leukocytes in Body fluid by Manual count | 
|  13521-0 | Blasts/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  13522-8 | Blasts/100 leukocytes in Body fluid by Manual count | 
|  13523-6 | Leukocytes other/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  13524-4 | Leukocytes other/100 leukocytes in Body fluid by Manual count | 
|  13525-1 | Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  13526-9 | Nonhematic cells/100 leukocytes in Body fluid by Manual count | 
|  13527-7 | Unidentified cells/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  13528-5 | Unidentified cells/100 leukocytes in Body fluid by Manual count | 
|  13529-3 | Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Manual count | 
|  1353-2 | Yt sup(b) Ag [Presence] on Red Blood Cells | 
|  13530-1 | Nucleated erythrocytes [#/volume] in Body fluid by Manual count | 
|  13531-9 | Fat.microscopic observation [Presence] in Sputum by Sudan III stain | 
|  13532-7 | Xanthochromia [Presence] of Cerebral spinal fluid Qualitative | 
|  13533-5 | Acid hemolysis [Presence] of Blood | 
|  13534-3 | Sucrose hemolysis [Presence] of Blood | 
|  13535-0 | Sucrose hemolysis of Red Blood Cells | 
|  13536-8 | Globulin [Mass/volume] in Plasma | 
|  13537-6 | Deprecated Protein [Mass/volume] in Plasma. | 
|  13538-4 | Carbon dioxide, total [Moles/volume] in Urine | 
|  13539-2 | Phosphate [Moles/volume] in Urine | 
|  1354-0 | 11-Deoxycorticosteroids [Mass/volume] in Plasma --9 hours post 3 g metyrapone PO overnight | 
|  13540-0 | Carbon dioxide, total [Moles/volume] in Cerebral spinal fluid | 
|  13541-8 | Deprecated Carbon dioxide [Molecules/volume] in Body fluid | 
|  13542-6 | Phosphate [Mass/volume] in Cerebral spinal fluid | 
|  13543-4 | Deprecated Phosphate [Mass/volume] in Body fluid | 
|  13544-2 | 4-Hydroxyglutethimide [Presence] in Serum or Plasma | 
|  13545-9 | Alprazolam [Presence] in Serum or Plasma | 
|  13546-7 | Amikacin [Mass/volume] in Body fluid | 
|  13547-5 | Butriptyline [Presence] in Serum or Plasma | 
|  13548-3 | Chlorpromazine [Presence] in Serum or Plasma | 
|  13549-1 | Clomipramine [Presence] in Serum or Plasma | 
|  1355-7 | 11-Deoxycorticosteroids [Mass/volume] in Plasma --pre 3 g metyrapone PO overnight | 
|  13550-9 | Clonazepam [Presence] in Serum or Plasma | 
|  13551-7 | Clorazepate [Presence] in Serum or Plasma | 
|  13552-5 | Clozapine [Presence] in Serum or Plasma | 
|  13553-3 | Cocaethylene [Presence] in Serum or Plasma | 
|  13554-1 | Cyclobenzaprine [Presence] in Serum or Plasma | 
|  13555-8 | D-pseudoephedrine [Presence] in Serum or Plasma | 
|  13556-6 | Demoxepam [Presence] in Serum or Plasma | 
|  13557-4 | Norsertraline [Presence] in Serum or Plasma | 
|  13558-2 | Disopyramide [Presence] in Serum or Plasma | 
|  13559-0 | Flecainide [Presence] in Serum or Plasma | 
|  1356-5 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyrapone PO | 
|  13560-8 | Fluvoxamine [Presence] in Serum or Plasma | 
|  13561-6 | Gentamicin [Mass/volume] in Cerebral spinal fluid | 
|  13562-4 | Gentamicin [Mass/volume] in Body fluid | 
|  13563-2 | Glutethimide [Presence] in Serum or Plasma | 
|  13564-0 | Ibuprofen [Presence] in Serum or Plasma | 
|  13565-7 | Lorazepam [Presence] in Serum or Plasma | 
|  13566-5 | Mesoridazine [Presence] in Serum or Plasma | 
|  13567-3 | Mexiletine [Presence] in Serum or Plasma | 
|  13568-1 | N-desalkylflurazepam [Presence] in Serum or Plasma | 
|  13569-9 | Norchlordiazepoxide [Presence] in Serum or Plasma | 
|  1357-3 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --post 750 mg metyrapone q4h X 6 | 
|  13570-7 | Norclomipramine [Presence] in Serum or Plasma | 
|  13571-5 | Norclozapine [Presence] in Serum or Plasma | 
|  13572-3 | Nordiazepam [Presence] in Serum or Plasma | 
|  13573-1 | Nordoxepin [Presence] in Serum or Plasma | 
|  13574-9 | Norfluoxetine [Presence] in Serum or Plasma | 
|  13575-6 | Normaprotiline [Presence] in Serum or Plasma | 
|  13576-4 | Oxycodone [Presence] in Serum or Plasma | 
|  13577-2 | Paroxetine [Presence] in Serum or Plasma | 
|  13578-0 | Promazine [Presence] in Serum or Plasma | 
|  13579-8 | Sertraline [Presence] in Serum or Plasma | 
|  1358-1 | Corticotropin [Mass/volume] in Plasma --1.5 hours post dose insulin IV | 
|  13580-6 | Temazepam [Presence] in Serum or Plasma | 
|  13581-4 | Theophylline [Mass/volume] in Cerebral spinal fluid | 
|  13582-2 | Theophylline [Mass/volume] in Body fluid | 
|  13583-0 | Thioridazine [Presence] in Serum or Plasma | 
|  13584-8 | Tobramycin [Mass/volume] in Body fluid | 
|  13585-5 | Trifluoperazine [Presence] in Serum or Plasma | 
|  13586-3 | Vancomycin [Mass/volume] in Cerebral spinal fluid | 
|  13587-1 | Vancomycin [Mass/volume] in Body fluid | 
|  13588-9 | Venlafaxine [Presence] in Serum or Plasma | 
|  13589-7 | Activated protein C resistance [Presence] in Blood by Probe and target amplification method | 
|  1359-9 | Corticotropin [Mass/volume] in Plasma --1 hour post 1 ug/kg CRH IV | 
|  13590-5 | Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay | 
|  13591-3 | Factor inhibitor XXX [Units/volume] in Platelet poor plasma by Coagulation assay | 
|  13592-1 | Platelet aggregation XXX induced in Platelet rich plasma | 
|  13593-9 | Platelet aggregation prostaglandin induced in Platelet rich plasma | 
|  13594-7 | Prekallikrein (Fletcher Factor) [Presence] in Platelet poor plasma | 
|  13595-4 | Basophils/100 leukocytes in Nose | 
|  13596-2 | Histiocytes [Presence] in Nose by Light microscopy | 
|  13597-0 | Neutrophils/100 leukocytes in Nose | 
|  13598-8 | Deprecated Promyelocytes/100 leukocytes in Blood by Manual count | 
|  13599-6 | Promonocytes/100 leukocytes in Blood by Manual count | 
|  136-2 | Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1360-7 | Corticotropin [Mass/volume] in Plasma --1 hour post dose insulin IV | 
|  13600-2 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin | 
|  13601-0 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin | 
|  13602-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin | 
|  13603-6 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin | 
|  13604-4 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin | 
|  13605-1 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin | 
|  13606-9 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 50 g lactose PO | 
|  13607-7 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 50 g lactose PO | 
|  13608-5 | Insulin [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO | 
|  13609-3 | Insulin [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO | 
|  1361-5 | Corticotropin [Mass/volume] in Plasma --1 minute post 1 ug/kg CRH IV | 
|  13610-1 | 3-Beta-Androstanediol [Mass/volume] in Serum or Plasma | 
|  13611-9 | 6-Beta-Hydroxycortisol [Mass/time] in 24 hour Urine | 
|  13612-7 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine | 
|  13613-5 | Ethanolamine [Mass/volume] in Cerebral spinal fluid | 
|  13614-3 | Etiocholanolone [Mass/volume] in Serum or Plasma | 
|  13615-0 | Gamma aminobutyrate [Mass/volume] in Cerebral spinal fluid | 
|  13616-8 | Nitrite [Mass/volume] in Water | 
|  13617-6 | Deprecated Prostaglandin D2 [Mass/volume] in Serum or Plasma | 
|  13618-4 | Tetrahydroaldosterone [Mass/time] in 24 hour Urine | 
|  13619-2 | Volume of 2 hour Urine | 
|  1362-3 | Corticotropin [Mass/volume] in Plasma --30 minutes post 1 ug/kg CRH IV | 
|  13620-0 | Volume of 12 hour Urine | 
|  13621-8 | Deprecated Thrombin time in Platelet poor plasma from control by Coagulation assay | 
|  13622-6 | Acetaminophen [Mass/volume] in Urine | 
|  13623-4 | Dextromethorphan [Mass/volume] in Serum or Plasma | 
|  13624-2 | Doxorubicin [Mass/volume] in Serum or Plasma | 
|  13625-9 | Methoxsalen [Mass/volume] in Serum or Plasma | 
|  13626-7 | Mitotane [Mass/volume] in Serum or Plasma | 
|  13627-5 | Erythrocytes [Presence] in Semen by Light microscopy | 
|  13628-3 | Deprecated Spermatozoa Motile/100 spermatozoa in Semen | 
|  13629-1 | Interleukin 1 beta [Mass/volume] in Serum or Plasma | 
|  1363-1 | Corticotropin [Mass/volume] in Plasma --30 minutes post dose insulin IV | 
|  13630-9 | Deprecated Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay | 
|  13631-7 | Immune complex [Mass/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay | 
|  13632-5 | Insulin receptor Ab [Titer] in Serum | 
|  13633-3 | Insulin receptor Ab [Presence] in Serum | 
|  13634-1 | Rheumatoid factor [Units/volume] in Synovial fluid | 
|  13635-8 | Ribosomal Ab [Titer] in Serum | 
|  13636-6 | Ribosomal P Ab [Units/volume] in Serum | 
|  13637-4 | Trichloroethane [Mass/volume] in Serum or Plasma | 
|  13638-2 | Chlordecone [Mass/volume] in Blood | 
|  13639-0 | Chlordecone [Mass/volume] in Serum or Plasma | 
|  1364-9 | Corticotropin [Mass/volume] in Plasma --45 minutes post 1 ug/kg CRH IV | 
|  13640-8 | Vinyl chloride [Mass/volume] in Urine | 
|  13641-6 | Codeine [Presence] in Urine by SAMHSA confirm method | 
|  13642-4 | Deprecated Ethylene glycol | 
|  13643-2 | Lindane [Mass/volume] in Urine | 
|  13644-0 | 1,3-Dimethylbenzene [Mass/volume] in Blood | 
|  13645-7 | Manganese [Mass/volume] in Water | 
|  13646-5 | Methaqualone [Mass/mass] in Hair | 
|  13647-3 | Deprecated Methylene chloride [Mass/volume] in Blood | 
|  13648-1 | Morphine [Presence] in Urine by SAMHSA confirm method | 
|  13649-9 | Nickel [Mass/volume] in Water | 
|  1365-6 | Corticotropin [Mass/volume] in Plasma --45 minutes post dose insulin IV | 
|  13650-7 | 1,2-Dimethylbenzene [Mass/volume] in Blood | 
|  13651-5 | 1,4-Dimethylbenzene [Mass/volume] in Blood | 
|  13652-3 | Zinc [Mass/mass] in Hair | 
|  13653-1 | Epithelial cells.renal [#/volume] in Urine sediment | 
|  13654-9 | Epithelial cells.squamous [#/volume] in Urine sediment | 
|  13655-6 | Leukocytes [Presence] in Stool by Light microscopy | 
|  13656-4 | Phosphate crystals amorphous [#/volume] in Urine sediment | 
|  13657-2 | Urate crystals amorphous [#/volume] in Urine sediment | 
|  13658-0 | Urobilinogen [Presence] in Urine | 
|  13659-8 | Epidermal growth factor receptor [Mass/mass] in Tissue | 
|  1366-4 | Corticotropin [Mass/volume] in Plasma --5 minutes post 1 ug/kg CRH IV | 
|  13660-6 | Gonadotropin releasing hormone [Mass/volume] in Serum or Plasma | 
|  13661-4 | Ganglioside GD1b IgM Ab [Titer] in Serum | 
|  13662-2 | Ganglioside GD1b IgG Ab [Titer] in Serum | 
|  13663-0 | Asialoganglioside GM1 IgG Ab [Titer] in Serum | 
|  13664-8 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum | 
|  13665-5 | 1-Methylhistidine/Creatinine [Mass Ratio] in Urine | 
|  13666-3 | Alpha aminoadipate/Creatinine [Mass Ratio] in Urine | 
|  13667-1 | Alpha aminobutyrate/Creatinine [Mass Ratio] in Urine | 
|  13668-9 | 2-Ethyl-3-Hydroxypropionate/Creatinine [Mass Ratio] in Urine | 
|  13669-7 | 2-Hydroxy-3-Methylvalerate/Creatinine [Mass Ratio] in Urine | 
|  1367-2 | Corticotropin [Mass/volume] in Plasma --pre 1 ug/kg CRH IV | 
|  13670-5 | 2-Hydroxyadipate/Creatinine [Mass Ratio] in Urine | 
|  13671-3 | Alpha hydroxybutyrate/Creatinine [Mass Ratio] in Urine | 
|  13672-1 | 2-Hydroxyglutarate/Creatinine [Mass Ratio] in Urine | 
|  13673-9 | 2-Hydroxyisocaproate/Creatinine [Mass Ratio] in Urine | 
|  13674-7 | 2-Hydroxyisovalerate/Creatinine [Mass Ratio] in Urine | 
|  13675-4 | 2-methyl-3-hydroxybutyrate (C5-OH)/Creatinine [Mass Ratio] in Urine | 
|  13676-2 | 2-Oxo,3-Methylvalerate/Creatinine [Mass Ratio] in Urine | 
|  13677-0 | 2-Oxoadipate/Creatinine [Mass Ratio] in Urine | 
|  13678-8 | Alpha ketoglutarate/Creatinine [Mass Ratio] in Urine | 
|  13679-6 | 2-Oxoisocaproate/Creatinine [Mass Ratio] in Urine | 
|  1368-0 | Corticotropin [Mass/volume] in Plasma --pre dose insulin IV | 
|  13680-4 | 2-Oxoisovalerate/Creatinine [Mass Ratio] in Urine | 
|  13681-2 | Beta aminoisobutyrate/Creatinine [Mass Ratio] in Urine | 
|  13682-0 | 3-Hydroxy,3-Methylglutarate/Creatinine [Mass Ratio] in Urine | 
|  13683-8 | 3-Hydroxyadipate/Creatinine [Mass Ratio] in Urine | 
|  13684-6 | Beta hydroxybutyrate/Creatinine [Mass Ratio] in Urine | 
|  13685-3 | 3-Hydroxyglutarate/Creatinine [Mass Ratio] in Urine | 
|  13686-1 | 3-Hydroxyisobutyrate/Creatinine [Mass Ratio] in Urine | 
|  13687-9 | 3-Hydroxyisovalerate/Creatinine [Mass Ratio] in Urine | 
|  13688-7 | 3-Hydroxypropionate (3-OH-C3)/Creatinine [Mass Ratio] in Urine | 
|  13689-5 | 3-Hydroxyvalerate/Creatinine [Mass Ratio] in Urine | 
|  1369-8 | Ascorbate [Mass/time] in 24 hour Urine --post dose PO | 
|  13690-3 | Deprecated Vanillylmandelate/Creatinine [Mass ratio] in Urine | 
|  13691-1 | 3-Methylcrotonylglycine/Creatinine [Mass Ratio] in Urine | 
|  13692-9 | 3-Methylglutaconate/Creatinine [Mass Ratio] in Urine | 
|  13693-7 | 3-Methylglutarate/Creatinine [Mass Ratio] in Urine | 
|  13694-5 | 3-Methylhistidine/Creatinine [Mass Ratio] in Urine | 
|  13695-2 | Gamma aminobutyrate/Creatinine [Mass Ratio] in Urine | 
|  13696-0 | 4-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine | 
|  13697-8 | 4-Hydroxyphenyllactate/Creatinine [Mass Ratio] in Urine | 
|  13698-6 | 4-Hydroxyphenylpyruvate/Creatinine [Mass Ratio] in Urine | 
|  13699-4 | 5-Hydroxyhexanoate/Creatinine [Mass Ratio] in Urine | 
|  137-0 | Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1370-6 | Carotene [Mass/volume] in Serum --post 15000 U carotene QDx3 for 3 day poly | 
|  13700-0 | 5-Oxoproline/Creatinine [Mass Ratio] in Urine | 
|  13701-8 | Acetoacetate/Creatinine [Mass Ratio] in Urine | 
|  13702-6 | Aconitate/Creatinine [Mass Ratio] in Urine | 
|  13703-4 | Adipate/Creatinine [Mass Ratio] in Urine | 
|  13704-2 | Alanine/Creatinine [Mass Ratio] in Urine | 
|  13705-9 | Albumin/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13706-7 | Amylase/Creatinine [Mass Ratio] in Urine | 
|  13707-5 | Anserine/Creatinine [Mass Ratio] in Urine | 
|  13708-3 | Arginine/Creatinine [Mass Ratio] in Urine | 
|  13709-1 | Argininosuccinate/Creatinine [Mass Ratio] in Urine | 
|  1371-4 | Bromsulphthalein [Mass/volume] in Serum or Plasma | 
|  13710-9 | Asparagine/Creatinine [Mass Ratio] in Urine | 
|  13711-7 | Aspartate/Creatinine [Mass Ratio] in Urine | 
|  13712-5 | Azelate/Creatinine [Mass Ratio] in Urine | 
|  13713-3 | Benzoate/Creatinine [Mass Ratio] in Urine | 
|  13714-1 | Beta alanine/Creatinine [Mass Ratio] in Urine | 
|  13715-8 | C peptide/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13716-6 | C peptide/Creatinine [Mass Ratio] in Urine | 
|  13717-4 | Calcium/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13718-2 | Carnitine free (C0)/Creatinine [Mass Ratio] in Urine | 
|  13719-0 | Carnitine/Creatinine [Mass Ratio] in Urine | 
|  1372-2 | Calcitonin [Mass/volume] in Serum or Plasma --90 seconds post 0.5 ug/kg pentagastrin IV | 
|  13720-8 | Carnosine/Creatinine [Mass Ratio] in Urine | 
|  13721-6 | Chloride/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13722-4 | Citrate/Creatinine [Mass Ratio] in Urine | 
|  13723-2 | Citrulline/Creatinine [Mass Ratio] in Urine | 
|  13724-0 | Cystathionine/Creatinine [Mass Ratio] in Urine | 
|  13725-7 | Cystine/Creatinine [Mass Ratio] in Urine | 
|  13726-5 | Decadienediate/Creatinine [Mass Ratio] in Urine | 
|  13727-3 | Decenedioate/Creatinine [Mass Ratio] in Urine | 
|  13728-1 | Delta aminolevulinate/Creatinine [Mass Ratio] in Urine | 
|  13729-9 | Deoxypyridinoline/Creatinine [Mass Ratio] in Urine | 
|  1373-0 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV | 
|  13730-7 | Deoxypyridinoline/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13731-5 | Deoxypyridinoline/Creatinine [Mass Ratio] in 2 hour Urine | 
|  13732-3 | Dodecanedioate/Creatinine [Mass Ratio] in Urine | 
|  13733-1 | Dopamine/Creatinine [Mass Ratio] in Urine | 
|  13734-9 | Epinephrine/Creatinine [Mass Ratio] in Urine | 
|  13735-6 | Epinephrine+Norepinephrine/Creatinine [Mass Ratio] in Urine | 
|  13736-4 | Estradiol (E2)/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13737-2 | Estriol (E3)/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13738-0 | Estrogen/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13739-8 | Estrone (E1)/Creatinine [Mass Ratio] in 24 hour Urine | 
|  1374-8 | Calcitonin [Mass/volume] in Serum or Plasma --3 hours post 15 mg/kg calcium gluconate IV | 
|  13740-6 | Ethanolamine/Creatinine [Mass Ratio] in Urine | 
|  13741-4 | Ethylmalonate/Creatinine [Mass Ratio] in Urine | 
|  13742-2 | Formate/Creatinine [Mass Ratio] in Urine | 
|  13743-0 | Fumarate/Creatinine [Mass Ratio] in Urine | 
|  13744-8 | Galactose/Creatinine [Mass Ratio] in Urine | 
|  13745-5 | Glutaconate/Creatinine [Mass Ratio] in Urine | 
|  13746-3 | Glutamate/Creatinine [Mass Ratio] in Urine | 
|  13747-1 | Glutamine/Creatinine [Mass Ratio] in Urine | 
|  13748-9 | Glutarate/Creatinine [Mass Ratio] in Urine | 
|  13749-7 | Glycerate/Creatinine [Mass Ratio] in Urine | 
|  1375-5 | Calcitonin [Mass/volume] in Serum or Plasma --4 hours post 15 mg/kg calcium gluconate IV | 
|  13750-5 | Glycine/Creatinine [Mass Ratio] in Urine | 
|  13751-3 | Glycolate/Creatinine [Mass Ratio] in Urine | 
|  13752-1 | Glyoxylate/Creatinine [Mass Ratio] in Urine | 
|  13753-9 | Hexanoylglycine/Creatinine [Mass Ratio] in Urine | 
|  13754-7 | Hippurate/Creatinine [Mass Ratio] in Urine | 
|  13755-4 | Histamine/Creatinine [Mass Ratio] in Urine | 
|  13756-2 | Histamine/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13757-0 | Histidine/Creatinine [Mass Ratio] in Urine | 
|  13758-8 | Homocysteine/Creatinine [Mass Ratio] in Urine | 
|  13759-6 | Homocystine/Creatinine [Mass Ratio] in Urine | 
|  1376-3 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 0.5 ug/kg pentagastrin IV | 
|  13760-4 | Homovanillate/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13761-2 | Hydroxydecanedioate/Creatinine [Mass Ratio] in Urine | 
|  13762-0 | Hydroxylysine/Creatinine [Mass Ratio] in Urine | 
|  13763-8 | Hydroxyproline/Creatinine [Mass Ratio] in Urine | 
|  13764-6 | Isocitrate/Creatinine [Mass Ratio] in Urine | 
|  13765-3 | Isoleucine/Creatinine [Mass Ratio] in Urine | 
|  13766-1 | Isovalerylglycine/Creatinine [Mass Ratio] in Urine | 
|  13767-9 | Lactate/Creatinine [Mass Ratio] in Urine | 
|  13768-7 | Leucine/Creatinine [Mass Ratio] in Urine | 
|  13769-5 | Lysine/Creatinine [Mass Ratio] in Urine | 
|  1377-1 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV | 
|  13770-3 | Malate/Creatinine [Mass Ratio] in Urine | 
|  13771-1 | Metanephrines/Creatinine [Mass Ratio] in Urine | 
|  13772-9 | Methionine/Creatinine [Mass Ratio] in Urine | 
|  13773-7 | 2-Methylcitrate/Creatinine [Mass Ratio] in Urine | 
|  13774-5 | Methylhippurate/Creatinine [Mass Ratio] in Urine | 
|  13775-2 | Methylmalonate/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13776-0 | Methylmalonate/Creatinine [Mass Ratio] in Urine | 
|  13777-8 | Methylsuccinate/Creatinine [Mass Ratio] in Urine | 
|  13778-6 | Mevalonate/Creatinine [Mass Ratio] in Urine | 
|  13779-4 | N-acetyl-L-aspartate/Creatinine [Mass Ratio] in Urine | 
|  1378-9 | Calcitonin [Mass/volume] in Serum or Plasma --pre 0.5 ug/kg pentagastrin IV | 
|  13780-2 | N-acetyltyrosine/Creatinine [Mass Ratio] in Urine | 
|  13781-0 | N-methylhistamine/Creatinine [Mass Ratio] in Urine | 
|  13782-8 | Norepinephrine/Creatinine [Mass Ratio] in Urine | 
|  13783-6 | Normetanephrine/Creatinine [Mass Ratio] in Urine | 
|  13784-4 | Octanoate (C8:0)/Creatinine [Mass Ratio] in Urine | 
|  13785-1 | Octenedioate (C8:1)/Creatinine [Mass Ratio] in Urine | 
|  13786-9 | Ornithine/Creatinine [Mass Ratio] in Urine | 
|  13787-7 | Orotate/Creatinine [Mass Ratio] in Urine | 
|  13788-5 | Oxalate/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13789-3 | Phosphoethanolamine/Creatinine [Mass Ratio] in Urine | 
|  1379-7 | Calcitonin [Mass/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV | 
|  13790-1 | Para nitrophenol/Creatinine [Mass Ratio] in Urine | 
|  13791-9 | Phenylacetate/Creatinine [Mass Ratio] in Urine | 
|  13792-7 | Phenyllactate/Creatinine [Mass Ratio] in Urine | 
|  13793-5 | Phenylpropionylglycine/Creatinine [Mass Ratio] in Urine | 
|  13794-3 | Phenylpyruvate/Creatinine [Mass Ratio] in Urine | 
|  13795-0 | Phosphate/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13796-8 | Phosphoserine/Creatinine [Mass Ratio] in Urine | 
|  13797-6 | Porphobilinogen/Creatinine [Mass Ratio] in Urine | 
|  13798-4 | Potassium/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13799-2 | Proline/Creatinine [Mass Ratio] in Urine | 
|  138-8 | Ceftizoxime [Susceptibility] by Disk diffusion (KB) | 
|  1380-5 | Calcium/Phosphate parathyroid-challenge test [Mass Ratio] in Serum | 
|  13800-8 | Propionylglycine/Creatinine [Mass Ratio] in Urine | 
|  13801-6 | Protein/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13802-4 | Pyridinoline/Creatinine [Mass Ratio] in Urine | 
|  13803-2 | Pyridinoline/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13804-0 | Pyridinoline/Creatinine [Mass Ratio] in 2 hour Urine | 
|  13805-7 | Pyruvate/Creatinine [Mass Ratio] in Urine | 
|  13806-5 | Sarcosine/Creatinine [Mass Ratio] in Urine | 
|  13807-3 | Sebacate (C8)/Creatinine [Mass Ratio] in Urine | 
|  13808-1 | Serine/Creatinine [Mass Ratio] in Urine | 
|  13809-9 | Sodium/Creatinine [Mass Ratio] in 24 hour Urine | 
|  1381-3 | Calcium [Moles/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV | 
|  13810-7 | Suberate/Creatinine [Mass Ratio] in Urine | 
|  13811-5 | Suberylglycine/Creatinine [Mass Ratio] in Urine | 
|  13812-3 | Succinate/Creatinine [Mass Ratio] in Urine | 
|  13813-1 | Succinylacetone/Creatinine [Mass Ratio] in Urine | 
|  13814-9 | Taurine/Creatinine [Mass Ratio] in Urine | 
|  13815-6 | Threonine/Creatinine [Mass Ratio] in Urine | 
|  13816-4 | Tiglylglycine/Creatinine [Mass Ratio] in Urine | 
|  13817-2 | Tryptophan/Creatinine [Mass Ratio] in Urine | 
|  13818-0 | Tyrosine/Creatinine [Mass Ratio] in Urine | 
|  13819-8 | Uracil/Creatinine [Mass Ratio] in Urine | 
|  1382-1 | Calcium [Moles/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV | 
|  13820-6 | Urate/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13821-4 | Urea nitrogen/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13822-2 | Valine/Creatinine [Mass Ratio] in Urine | 
|  13823-0 | Antimony/Creatinine [Mass Ratio] in Urine | 
|  13824-8 | Arsenic/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13825-5 | Arsenic.inorganic/Creatinine [Mass Ratio] in Urine | 
|  13826-3 | Barium/Creatinine [Mass Ratio] in Urine | 
|  13827-1 | Beryllium/Creatinine [Mass Ratio] in Urine | 
|  13828-9 | Cadmium/Creatinine [Mass Ratio] in 24 hour Urine | 
|  13829-7 | Copper/Creatinine [Mass Ratio] in Urine | 
|  1383-9 | Calcium [Moles/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV | 
|  13830-5 | Phenylglyoxylate/Creatinine [Mass Ratio] in Urine | 
|  13831-3 | Vanadium/Creatinine [Mass Ratio] in Urine | 
|  13832-1 | Dimethylbenzene/Creatinine [Mass Ratio] in Urine | 
|  13833-9 | Finch feather IgE Ab [Units/volume] in Serum | 
|  13834-7 | Total IgE [Units/volume] in Serum by Radioallergosorbent test (RAST) | 
|  13835-4 | Monocytes/100 leukocytes in Peritoneal fluid by Manual count | 
|  13836-2 | Neutrophils/100 leukocytes in Peritoneal fluid by Manual count | 
|  13837-0 | CD10 blasts/100 blasts in Blood | 
|  13838-8 | CD13 blasts/100 blasts in Blood | 
|  13839-6 | CD14 blasts/100 blasts in Blood | 
|  1384-7 | Calcium [Moles/volume] in Blood --post calcium infusion | 
|  13840-4 | CD19 blasts/100 blasts in Blood | 
|  13841-2 | CD2 blasts/100 blasts in Blood | 
|  13842-0 | CD20 blasts/100 blasts in Blood | 
|  13843-8 | CD33 blasts/100 blasts in Blood | 
|  13844-6 | CD34 blasts/100 blasts in Blood | 
|  13845-3 | CD5 blasts/100 blasts in Blood | 
|  13846-1 | CD7 blasts/100 blasts in Blood | 
|  13847-9 | Terminal Deoxyribonucleotidyl Transferase blasts/100 blasts in Blood by Immunoperoxidase stain | 
|  13848-7 | CD3+CD26+ cells [#/volume] in Blood | 
|  13849-5 | Deprecated CD3+CD26+ cells/100 cells in Blood | 
|  1385-4 | Catecholamines Free fractionated [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO | 
|  13850-3 | CD5+CD25+ cells [#/volume] in Blood | 
|  13851-1 | CD5+CD25+ cells/100 cells in Blood | 
|  13852-9 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM | 
|  13853-7 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 25 mg captopril PO | 
|  13854-5 | Aldosterone [Mass/volume] in Serum or Plasma --2 hours post 25 mg captopril PO | 
|  13855-2 | Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM | 
|  13856-0 | Androstenedione [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM | 
|  13857-8 | Androstenedione [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM | 
|  13858-6 | Androstenedione [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM | 
|  13859-4 | C peptide [Mass/volume] in Serum or Plasma --10 minutes post 1 mg glucagon IV | 
|  1386-2 | Catecholamines Free fractionated [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO | 
|  13860-2 | C peptide [Mass/volume] in Serum or Plasma --15 minutes post 1 mg glucagon IV | 
|  13861-0 | C peptide [Mass/volume] in Serum or Plasma --5 minutes post 1 mg glucagon IV | 
|  13862-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin | 
|  13863-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin | 
|  13864-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin | 
|  13865-1 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO | 
|  13866-9 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 50 g lactose PO | 
|  13867-7 | Renin [Enzymatic activity/volume] in Plasma --1 hour post 25 mg captopril PO | 
|  13868-5 | Renin [Enzymatic activity/volume] in Plasma --2 hours post 25 mg captopril PO | 
|  13869-3 | Thyrotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose TRH IV | 
|  1387-0 | Catecholamines Free fractionated [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO | 
|  13870-1 | Thyrotropin [Mass/volume] in Serum or Plasma --15 minutes post dose TRH IV | 
|  13871-9 | Thyrotropin [Mass/volume] in Serum or Plasma --2 hours post dose TRH IV | 
|  13872-7 | 11-Deoxycortisol [Mass/time] in 24 hour Urine | 
|  13873-5 | Albumin.glycated/Albumin.total in Serum or Plasma | 
|  13874-3 | Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma | 
|  13875-0 | Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma | 
|  13876-8 | Beta-2 transferrin [Presence] in Body fluid | 
|  13877-6 | Bilirubin.total [Presence] in Amniotic fluid | 
|  13878-4 | Collagen type 1 IgG Ab [Units/volume] in Serum | 
|  13879-2 | Collagen type 2 IgG Ab [Units/volume] in Serum | 
|  1388-8 | Catecholamines Free fractionated [Mass/volume] in Plasma --pre 300 ug clonidine PO | 
|  13880-0 | Collagen type 4 IgG Ab [Units/volume] in Serum | 
|  13881-8 | Deoxypyridinoline Free/Creatinine [Molar ratio] in Urine | 
|  13882-6 | Androstanolone Free/Androstanolone.total in Serum or Plasma | 
|  13883-4 | Estradiol (E2).bioavailable/Estradiol (E2).total in Serum or Plasma | 
|  13884-2 | Estradiol (E2).bioavailable [Mass/volume] in Serum or Plasma | 
|  13885-9 | Deprecated Estrogen/Creatinine [Mass ratio] in 24 hour Urine | 
|  13886-7 | Lactate dehydrogenase 1/Lactate dehydrogenase.total in Urine by Electrophoresis | 
|  13887-5 | Lactate dehydrogenase 2/Lactate dehydrogenase.total in Urine by Electrophoresis | 
|  13888-3 | Lactate dehydrogenase 3/Lactate dehydrogenase.total in Urine by Electrophoresis | 
|  13889-1 | Lactate dehydrogenase 4/Lactate dehydrogenase.total in Urine by Electrophoresis | 
|  1389-6 | Cortisol Free [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day | 
|  13890-9 | Lactate dehydrogenase 5/Lactate dehydrogenase.total in Urine by Electrophoresis | 
|  13891-7 | Motilin [Mass/volume] in Serum or Plasma | 
|  13892-5 | Nitrosonaphthol [Presence] in Urine | 
|  13893-3 | Phenylalanine [Presence] in Urine | 
|  13894-1 | Pregnenolone [Mass/time] in 24 hour Urine | 
|  13895-8 | Sodium [Moles/volume] in Milk | 
|  13896-6 | Insulin-like growth factor-I [Units/volume] in Blood | 
|  13897-4 | Thyrotropin.beta subunit [Mass/volume] in Serum or Plasma | 
|  13898-2 | Trichloroacetate [Mass/volume] in Serum or Plasma | 
|  13899-0 | Deprecated Triglyceride [Mass/volume] in fluid | 
|  139-6 | Ceftizoxime [Susceptibility] by Serum bactericidal titer | 
|  1390-4 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day | 
|  13900-6 | Deprecated Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma | 
|  13901-4 | Tyrosine [Presence] in Urine | 
|  13902-2 | Urate [Mass/volume] in Cerebral spinal fluid | 
|  13903-0 | Vasopressin [Mass/volume] in Urine | 
|  13904-8 | Meclizine [Mass/volume] in Serum or Plasma | 
|  13905-5 | Meclofenamate [Mass/volume] in Serum or Plasma | 
|  13906-3 | Deprecated Mesoridazine | 
|  13907-1 | Norethindrone [Mass/volume] in Serum or Plasma | 
|  13908-9 | Oxipurinol [Mass/volume] in Serum or Plasma | 
|  13909-7 | Tamoxifen [Mass/volume] in Serum or Plasma | 
|  1391-2 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  13910-5 | Deprecated HLA-B22 [Presence] | 
|  13911-3 | HLA-B27 related Ag [Presence] | 
|  13912-1 | Deprecated HLA-B42 [Presence] | 
|  13913-9 | Adenovirus Ab [Titer] in Serum by Immunofluorescence | 
|  13914-7 | Adenovirus IgG Ab [Units/volume] in Serum | 
|  13915-4 | Adenovirus IgM Ab [Titer] in Serum | 
|  13916-2 | Bordetella parapertussis Ag [Presence] in Unspecified specimen by Immunofluorescence | 
|  13917-0 | Coccidioides immitis Ab [Titer] in Cerebral spinal fluid by Complement fixation | 
|  13918-8 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence | 
|  13919-6 | Hepatitis B virus core IgG Ab [Units/volume] in Serum by Immunoassay | 
|  1392-0 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  13920-4 | HIV 2 p41 Ab [Presence] in Serum by Immunoblot (IB) | 
|  13921-2 | Mumps virus [Presence] in Unspecified specimen by Organism specific culture | 
|  13922-0 | Trichinella spiralis IgA Ab [Presence] in Serum by Immunoassay | 
|  13923-8 | Trichinella spiralis IgM Ab [Presence] in Serum by Immunoassay | 
|  13924-6 | Calcitonin Ab [Presence] in Serum | 
|  13925-3 | Cytokeratin Ab [Presence] in Serum | 
|  13926-1 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum | 
|  13927-9 | Pancreatic islet cell Ab [Titer] in Serum | 
|  13928-7 | Parathyrin Ab [Presence] in Serum | 
|  13929-5 | Rheumatoid factor [Titer] in Synovial fluid by Sheep Cell Agglutination | 
|  1393-8 | Cortisol Free [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day | 
|  13930-3 | Rheumatoid factor [Titer] in Synovial fluid by Agglutination | 
|  13931-1 | Striated muscle Ab [Presence] in Serum | 
|  13932-9 | Testes IgG Ab [Titer] in Serum | 
|  13933-7 | Benzodiazepines [Mass/mass] in Hair | 
|  13934-5 | Butanol [Mass/volume] in Blood | 
|  13935-2 | Dichlorodifluoromethane [Mass/volume] in Blood | 
|  13936-0 | Diethyl ether [Mass/volume] in Blood | 
|  13937-8 | Ethyl acetate [Mass/volume] in Blood | 
|  13938-6 | Trichloroethane [Mass/volume] in Blood | 
|  13939-4 | Deprecated Trichlorotrifluoroethane [Mass/volume] in Blood | 
|  1394-6 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 50 ug corticotropin IM 3 day | 
|  13940-2 | Dimethylbenzene [Mass/volume] in Blood | 
|  13941-0 | Lymphocytes/100 leukocytes in Body fluid by Manual count | 
|  13942-8 | Spermatozoa Motile [Presence] in Semen by Light microscopy | 
|  13943-6 | Fructose [Presence] in Semen | 
|  13944-4 | Leukocyte phosphatase [Enzymatic activity/volume] in control Leukocytes by Light microscopy | 
|  13945-1 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 
|  13946-9 | Complement+Immunoglobulin [Presence] in Red Blood Cells | 
|  13947-7 | Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay | 
|  13948-5 | Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay | 
|  13949-3 | Cytomegalovirus IgG Ab [Presence] in Serum by Immunoassay | 
|  1395-3 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  13950-1 | Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay | 
|  13951-9 | Hepatitis A virus Ab [Presence] in Serum by Immunoassay | 
|  13952-7 | Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay | 
|  13953-5 | Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay | 
|  13954-3 | Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay | 
|  13955-0 | Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay | 
|  13956-8 | Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by Probe and target amplification method | 
|  13957-6 | Clostridium difficile toxin A [Presence] in Stool by Immunoassay | 
|  13958-4 | Arsenic [Presence] in 24 hour Urine | 
|  13959-2 | Calcium.ionized [Moles/volume] in Serum or Plasma by calculation | 
|  1396-1 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  13960-0 | Coproporphyrin [Presence] in 24 hour Urine | 
|  13961-8 | Mercury [Presence] in 24 hour Urine | 
|  13962-6 | Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma | 
|  13963-4 | Orotate [Moles/volume] in Urine | 
|  13964-2 | Methylmalonate [Moles/volume] in Serum or Plasma | 
|  13965-9 | Homocysteine [Moles/volume] in Serum or Plasma | 
|  13966-7 | Cystine [Moles/time] in 24 hour Urine | 
|  13967-5 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma | 
|  13968-3 | Penicillin [Susceptibility] by Disk diffusion (KB) | 
|  13969-1 | Creatine kinase.MB [Mass/volume] in Serum or Plasma | 
|  1397-9 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting | 
|  13970-9 | Delta tocopherol [Mass/volume] in Serum or Plasma | 
|  13971-7 | Histoplasma capsulatum Ag [Units/volume] in Urine by Immunoassay | 
|  13972-5 | Alpha 1 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis | 
|  13973-3 | Prealbumin/Protein.total in Cerebral spinal fluid by Electrophoresis | 
|  13974-1 | Albumin/Protein.total in Cerebral spinal fluid by Electrophoresis | 
|  13975-8 | Alpha 2 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis | 
|  13976-6 | Beta globulin/Protein.total in Cerebral spinal fluid by Electrophoresis | 
|  13977-4 | Gamma globulin/Protein.total in Cerebral spinal fluid by Electrophoresis | 
|  13978-2 | Alpha 1 globulin/Protein.total in Serum or Plasma by Electrophoresis | 
|  13979-0 | Prealbumin/Protein.total in Serum or Plasma by Electrophoresis | 
|  1398-7 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV | 
|  13980-8 | Albumin/Protein.total in Serum or Plasma by Electrophoresis | 
|  13981-6 | Alpha 2 globulin/Protein.total in Serum or Plasma by Electrophoresis | 
|  13982-4 | Beta globulin/Protein.total in Serum or Plasma by Electrophoresis | 
|  13983-2 | Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis | 
|  13984-0 | Alpha 1 globulin/Protein.total in 24 hour Urine by Electrophoresis | 
|  13985-7 | Prealbumin/Protein.total in 24 hour Urine by Electrophoresis | 
|  13986-5 | Albumin/Protein.total in 24 hour Urine by Electrophoresis | 
|  13987-3 | Alpha 2 globulin/Protein.total in 24 hour Urine by Electrophoresis | 
|  13988-1 | Beta globulin/Protein.total in 24 hour Urine by Electrophoresis | 
|  13989-9 | Gamma globulin/Protein.total in 24 hour Urine by Electrophoresis | 
|  1399-5 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst | 
|  13990-7 | Alpha 1 globulin/Protein.total in Urine by Electrophoresis | 
|  13991-5 | Prealbumin/Protein.total in Urine by Electrophoresis | 
|  13992-3 | Albumin/Protein.total in Urine by Electrophoresis | 
|  13993-1 | Alpha 2 globulin/Protein.total in Urine by Electrophoresis | 
|  13994-9 | Beta globulin/Protein.total in Urine by Electrophoresis | 
|  13995-6 | Gamma globulin/Protein.total in Urine by Electrophoresis | 
|  13996-4 | Hydroxyproline/Creatinine [Molar ratio] in 24 hour Urine | 
|  13997-2 | Neuronal nuclear type 1 Ab [Titer] in Serum | 
|  13998-0 | Neuronal nuclear type 2 Ab [Titer] in Serum | 
|  13999-8 | Transferrin.carbohydrate deficient [Units/volume] in Serum or Plasma | 
|  14-1 | Amikacin [Susceptibility] by Serum bactericidal titer | 
|  140-4 | Ceftriaxone [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1400-1 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV | 
|  14000-4 | Urea nitrogen [Mass/volume] in Cerebral spinal fluid | 
|  14001-2 | IgE [Units/volume] in Cord blood | 
|  14002-0 | IgM [Units/volume] in Cord blood | 
|  14003-8 | Carbon dioxide [Partial pressure] in Cord blood | 
|  14004-6 | Prostaglandin A [Mass/time] in 24 hour Urine | 
|  14005-3 | Prostaglandin E1 [Mass/time] in 24 hour Urine | 
|  14006-1 | Prostaglandin E2 [Mass/time] in 24 hour Urine | 
|  14007-9 | Prostaglandin F2 alpha [Mass/time] in 24 hour Urine | 
|  14008-7 | Phosphatidylcholine IgG Ab [Units/volume] in Serum by Immunoassay | 
|  14009-5 | Phosphatidylcholine IgM Ab [Units/volume] in Serum by Immunoassay | 
|  1401-9 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM rapid | 
|  14010-3 | Phosphatidylcholine IgA Ab [Units/volume] in Serum by Immunoassay | 
|  14011-1 | Deprecated Platelet associated IgA Ab [Units/volume] in Blood | 
|  14012-9 | Platelet associated IgG Ab [Units/volume] in Blood by Flow cytometry (FC) | 
|  14013-7 | Platelet associated IgM Ab [Units/volume] in Blood by Flow cytometry (FC) | 
|  14014-5 | Thyroxine (T4).prealbumin bound [Mass/volume] in Serum or Plasma | 
|  14015-2 | Thyroxine (T4).prealbumin bound/Prealbumin [Mass Ratio] in Serum or Plasma | 
|  14016-0 | Thyroxine.thyroxine binding globulin bound [Mass/volume] in Serum or Plasma | 
|  14017-8 | CD22 cells/100 cells in Blood | 
|  14018-6 | CD23 cells/100 cells in Blood | 
|  14019-4 | HTLV I+II gp46 Ab [Presence] in Serum or Plasma by Immunoblot (IB) | 
|  1402-7 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IV rapid | 
|  14020-2 | HTLV I+II p19 Ab [Presence] in Serum or Plasma by Immunoblot (IB) | 
|  14021-0 | HTLV I+II p24 Ab [Presence] in Serum or Plasma by Immunoblot (IB) | 
|  14022-8 | HTLV I+II p26 Ab [Presence] in Serum by Immunoblot (IB) | 
|  14023-6 | HTLV I+II p28 Ab [Presence] in Serum by Immunoblot (IB) | 
|  14024-4 | HTLV I+II p32 Ab [Presence] in Serum by Immunoblot (IB) | 
|  14025-1 | HTLV I+II p36 Ab [Presence] in Serum by Immunoblot (IB) | 
|  14026-9 | HTLV I+II p53 Ab [Presence] in Serum by Immunoblot (IB) | 
|  14027-7 | HTLV I+II rgp21 Ab [Presence] in Serum or Plasma by Immunoblot (IB) | 
|  14028-5 | Deprecated HTLV I+II rgp46-I Ab [Presence] in Serum by Immunoblot (IB) | 
|  14029-3 | Deprecated HTLV I+II rgp46-II Ab [Presence] in Serum by Immunoblot (IB) | 
|  1403-5 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM | 
|  14030-1 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay | 
|  14031-9 | Ciprofloxacin [Mass/volume] in Serum or Plasma --peak | 
|  14032-7 | Ciprofloxacin [Mass/volume] in Serum or Plasma --trough | 
|  14033-5 | 1,4-Dioxane [Mass/volume] in Blood by Gas chromatography | 
|  14034-3 | Rheumatoid factor [Units/volume] in Cerebral spinal fluid | 
|  14035-0 | Japanese Cedar IgE Ab [Units/volume] in Serum | 
|  14036-8 | Dermatophagoides microceras IgE Ab [Units/volume] in Serum | 
|  14037-6 | Fox IgE Ab [Units/volume] in Serum | 
|  14038-4 | Pacific Squid IgE Ab [Units/volume] in Serum | 
|  14039-2 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Microscopy | 
|  1404-3 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV | 
|  14040-0 | Carbon dioxide, total [Moles/volume] in Stool | 
|  14041-8 | Choriogonadotropin.beta subunit [Units/volume] in Cerebral spinal fluid | 
|  14042-6 | Corticosterone [Mass/time] in 24 hour Urine | 
|  14043-4 | Cortisol Free [Mass/time] in 12 hour Urine | 
|  14044-2 | Cortisone [Mass/time] in 24 hour Urine | 
|  14045-9 | D-Lactate [Moles/volume] in Serum or Plasma | 
|  14046-7 | D-Lactate [Moles/volume] in Urine | 
|  14047-5 | Androstanolone Free [Mass/volume] in Serum or Plasma | 
|  14048-3 | Elastase.pancreatic [Mass/volume] in Serum | 
|  14049-1 | Epidermal growth factor [Mass/volume] in Serum or Plasma | 
|  1405-0 | Deprecated Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV | 
|  14050-9 | Epidermal growth factor receptor [Moles/mass] in Tissue | 
|  14051-7 | Estrogen binding protein [Mass/volume] in Serum or Plasma | 
|  14052-5 | Formate [Mass/volume] in Urine | 
|  14053-3 | Homocystine [Presence] in Urine | 
|  14054-1 | Prostaglandin D2 [Mass/time] in 24 hour Urine | 
|  14055-8 | Sodium [Moles/mass] in Stool | 
|  14056-6 | Carbamazepine 10,11-epoxide free [Mass/volume] in Serum or Plasma | 
|  14057-4 | Carbamazepine free [Mass/volume] in Saliva (oral fluid) | 
|  14058-2 | Deprecated Ciprofloxacin [Mass/volume] in Serum or Plasma --peak | 
|  14059-0 | Deprecated Ciprofloxacin [Mass/volume] in Serum or Plasma --trough | 
|  1406-8 | Cortisol [Mass/volume] in Serum or Plasma --1 minute post 1 ug/kg CRH IV | 
|  14060-8 | Cyclobenzaprine [Presence] in Urine | 
|  14061-6 | Cyclobenzaprine [Mass/volume] in Urine | 
|  14062-4 | Dexamethasone [Mass/volume] in Serum or Plasma | 
|  14063-2 | Dezocine [Presence] in Urine | 
|  14064-0 | Diethylstilbestrol [Mass/volume] in Serum or Plasma | 
|  14065-7 | Diflunisal [Mass/volume] in Serum or Plasma | 
|  14066-5 | Dihydrocodeine [Presence] in Urine | 
|  14067-3 | Dihydrocodeine [Mass/volume] in Blood | 
|  14068-1 | Triamterene+Hydrochlorothiazide [Mass/volume] in Serum or Plasma | 
|  14069-9 | Estazolam [Mass/volume] in Serum or Plasma | 
|  1407-6 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  14070-7 | Fluphenazine [Presence] in Urine | 
|  14071-5 | Ibuprofen [Presence] in Urine | 
|  14072-3 | Monoacetyldapsone [Mass/volume] in Serum or Plasma | 
|  14073-1 | Phenytoin [Mass/volume] in Saliva (oral fluid) | 
|  14074-9 | Spironolactone [Mass/volume] in Serum or Plasma | 
|  14075-6 | Sulfapyridine [Mass/volume] in Serum or Plasma | 
|  14076-4 | Complement total hemolytic CH100 [Presence] in Serum or Plasma by Immune diffusion (ID) | 
|  14077-2 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | 
|  14078-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | 
|  14079-8 | Brucella canis IgG Ab [Titer] in Serum by Immunofluorescence | 
|  1408-4 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 40 ug corticotropin IM BID 3 day | 
|  14080-6 | Brucella canis IgM Ab [Titer] in Serum by Immunofluorescence | 
|  14081-4 | Coliform bacteria [Presence] in Water | 
|  14082-2 | Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoblot (IB) | 
|  14083-0 | Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence | 
|  14084-8 | Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence | 
|  14085-5 | Herpes simplex virus 2 [Presence] in Isolate by Immunofluorescence | 
|  14086-3 | Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  14087-1 | Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  14088-9 | Deprecated Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  14089-7 | Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  1409-2 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug corticotropin IM | 
|  14090-5 | Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  14091-3 | Deprecated Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  14092-1 | HIV 1 Ab [Presence] in Serum by Immunofluorescence | 
|  14093-9 | Bacteria identified in Water by Culture | 
|  14094-7 | Trypanosoma cruzi IgG Ab [Titer] in Serum | 
|  14095-4 | Fibronectin aggregate IgG Ab [Units/volume] in Serum | 
|  14096-2 | Intercalated disk Ab [Titer] in Serum by Immunofluorescence | 
|  14097-0 | Antimony [Mass/time] in 24 hour Urine | 
|  14098-8 | Dimethylsulfoxide [Mass/volume] in Serum or Plasma | 
|  14099-6 | Nickel [Mass/volume] in Urine | 
|  141-2 | Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1410-0 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  14100-2 | Strontium [Presence] in Urine | 
|  14101-0 | Strychnine [Mass/volume] in Gastric fluid | 
|  14102-8 | Strychnine [Mass/volume] in Blood | 
|  14103-6 | Epithelial cells [Presence] in Stool by Light microscopy | 
|  14104-4 | Barley smut+Wheat smut IgE Ab [Units/volume] in Serum | 
|  14105-1 | Leukocytes [Presence] in Nose by Light microscopy | 
|  14106-9 | Lymphocytes [#/volume] in Cerebral spinal fluid by Manual count | 
|  14107-7 | Segmented neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count | 
|  14108-5 | CD16C+CD56+ cells [#/volume] in Blood | 
|  14109-3 | CD16C+CD56+ cells/100 cells in Blood | 
|  1411-8 | Cortisol [Mass/volume] in Serum or Plasma --26 hours post 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  14110-1 | Deprecated CD22 cells/100 cells in Blood | 
|  14111-9 | Deprecated CD23 cells/100 lymphocytes in Blood | 
|  14112-7 | CD25+CD19+ cells/100 cells in Blood | 
|  14113-5 | CD56 cells [#/volume] in Blood | 
|  14114-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM | 
|  14115-0 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine | 
|  14116-8 | IgG synthesis rate [Mass/time] in Serum and CSF by calculation | 
|  14117-6 | IgG clearance/Albumin clearance [Ratio] in Serum and CSF | 
|  14118-4 | Lactate [Mass/volume] in Serum or Plasma | 
|  14119-2 | Lactate dehydrogenase 1/Lactate dehydrogenase 2 [Enzymatic activity ratio] in Serum or Plasma | 
|  1412-6 | Cortisol [Mass/volume] in Serum or Plasma --26 hours post 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  14120-0 | Deprecated Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma | 
|  14121-8 | Pyruvate [Moles/volume] in Blood | 
|  14122-6 | Pyruvate [Moles/volume] in Cerebral spinal fluid | 
|  14123-4 | Thyroxine (T4).albumin bound/Albumin [Mass Ratio] in Serum or Plasma | 
|  14124-2 | Bacteria [Presence] in Semen by Light microscopy | 
|  14125-9 | Entamoeba histolytica [Presence] in Stool by Trichrome stain | 
|  14126-7 | HIV 1 gp120+gp160 Ab [Presence] in Serum by Immunoblot (IB) | 
|  14127-5 | Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture | 
|  14128-3 | Rabies virus Ab [Titer] in Serum | 
|  14129-1 | Respiratory syncytial virus [Presence] in Nose by Organism specific culture | 
|  1413-4 | Cortisol [Mass/volume] in Serum or Plasma --2 days post 500 ug corticotropin IM | 
|  14130-9 | Estrogen receptor [Moles/mass] in Tissue | 
|  14131-7 | PM-1 Ab [Presence] in Serum | 
|  14132-5 | Color of Gastric fluid | 
|  14133-3 | Silver Maple IgE Ab [Units/volume] in Serum | 
|  14134-1 | Deprecated Free Hemoglobin [Mass/volume] in Serum | 
|  14135-8 | CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood | 
|  14136-6 | CD34 cells [#/volume] in Blood | 
|  14137-4 | Glucose [Mass/volume] in Serum or Plasma --5.5 hours post 75 g glucose PO | 
|  14138-2 | Ketones [Presence] in Urine --30 minutes post XXX challenge | 
|  14139-0 | Ketones [Presence] in Urine --4 hours post XXX challenge | 
|  1414-2 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst | 
|  14140-8 | Ketones [Presence] in Urine --5 hours post XXX challenge | 
|  14141-6 | Ketones [Presence] in Urine --6 hours post XXX challenge | 
|  14142-4 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge | 
|  14143-2 | Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge | 
|  14144-0 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | 
|  14145-7 | Somatotropin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge | 
|  14146-5 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  14147-3 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge | 
|  14148-1 | 18-Hydroxycortisol [Mass/time] in 24 hour Urine | 
|  14149-9 | Corticotropin Big Fragment [Mass/volume] in Serum or Plasma | 
|  1415-9 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV | 
|  14150-7 | Deprecated Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma | 
|  14151-5 | Bicarbonate [Moles/volume] in Cord blood | 
|  14152-3 | Bilirubin.direct [Mass/volume] in Body fluid | 
|  14153-1 | Carnitine esters/Creatinine [Mass Ratio] in Urine | 
|  14154-9 | Cholesterol sulfate [Mass/volume] in Serum | 
|  14155-6 | Cholesterol in LDL [Percentile] | 
|  14156-4 | Coproporphyrin [Mass/mass] in 24 hour Stool | 
|  14157-2 | Coproporphyrin [Mass/volume] in Serum or Plasma | 
|  14158-0 | Cortisol [Mass/time] in 24 hour Urine | 
|  14159-8 | Cortisone [Mass/volume] in Serum or Plasma | 
|  1416-7 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM rapid | 
|  14160-6 | Estrone (E1).unconjugated/Estrone (E1).total in Serum or Plasma | 
|  14161-4 | Deprecated Formaldehyde in Nonbiological fluid | 
|  14162-2 | Gamma melanocyte stimulating hormone [Mass/volume] in Serum or Plasma | 
|  14163-0 | IgA.secretory [Mass/volume] in Serum or Plasma | 
|  14164-8 | Immunosuppressive acidic protein [Mass/volume] in Serum or Plasma | 
|  14165-5 | Lactate [Moles/volume] in Body fluid | 
|  14166-3 | Methane [Mass/volume] in Blood | 
|  14167-1 | N-methylimidazoleacetate [Mass/time] in 24 hour Urine | 
|  14168-9 | Palatinase [Enzymatic activity/mass] in Tissue | 
|  14169-7 | Peptide histidine isoleucine [Mass/volume] in Plasma | 
|  1417-5 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IV rapid | 
|  14170-5 | Pituitary glucoprotein hormone.alpha subunit [Mass/volume] in Serum | 
|  14171-3 | Porphyrins [Mass/mass] in 24 hour Stool | 
|  14172-1 | Potassium [Moles/volume] in Synovial fluid | 
|  14173-9 | Progesterone Free [Mass/time] in 24 hour Urine | 
|  14174-7 | Prostaglandin F2 alpha [Mass/volume] in Serum or Plasma | 
|  14175-4 | Protoporphyrin [Mass/mass] in 24 hour Stool | 
|  14176-2 | Pyrroles [Mass/volume] in Urine | 
|  14177-0 | Growth hormone-releasing hormone [Mass/volume] in Serum or Plasma | 
|  14178-8 | Sucrase [Enzymatic activity/mass] in Tissue | 
|  14179-6 | Tissue polypeptide Ag [Mass/volume] in Serum or Plasma | 
|  1418-3 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM | 
|  14180-4 | Uroporphyrin [Mass/volume] in Red Blood Cells | 
|  14181-2 | Uroporphyrin [Mass/mass] in 24 hour Stool | 
|  14182-0 | Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunologic method | 
|  14183-8 | Aprobarbital [Mass/volume] in Urine | 
|  14184-6 | Atropine [Presence] in Urine | 
|  14185-3 | Methimazole [Mass/volume] in Serum or Plasma | 
|  14186-1 | Methylprednisolone [Mass/volume] in Serum or Plasma | 
|  14187-9 | OKT3 [Mass/volume] in Serum or Plasma | 
|  14188-7 | Omeprazole [Mass/volume] in Serum or Plasma | 
|  14189-5 | Phenyltoloxamine [Mass/volume] in Urine | 
|  1419-1 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV | 
|  14190-3 | Phenytoin Free [Mass/volume] in Saliva (oral fluid) | 
|  14191-1 | Prazosin [Mass/volume] in Serum or Plasma | 
|  14192-9 | Triazolam [Presence] in Urine | 
|  14193-7 | Tripelennamine [Presence] in Urine | 
|  14194-5 | Spermatozoa Progressive/100 spermatozoa in Semen | 
|  14195-2 | Complement C3b Inactive [Mass/volume] in Plasma | 
|  14196-0 | Reticulocytes [#/volume] in Blood | 
|  14197-8 | Blastomyces dermatitidis exoantigen [Identifier] in Isolate | 
|  14198-6 | Chlamydophila psittaci Ab [Titer] in Serum by Immunofluorescence | 
|  14199-4 | Chlamydia trachomatis B IgA Ab [Titer] in Serum by Immunofluorescence | 
|  142-0 | Ceftriaxone [Susceptibility] by Disk diffusion (KB) | 
|  1420-9 | Deprecated Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV | 
|  14200-0 | Chlamydia trachomatis B IgG Ab [Titer] in Serum by Immunofluorescence | 
|  14201-8 | Chlamydia trachomatis B IgM Ab [Titer] in Serum by Immunofluorescence | 
|  14202-6 | Chlamydia trachomatis C IgA Ab [Titer] in Serum by Immunofluorescence | 
|  14203-4 | Chlamydia trachomatis C IgG Ab [Titer] in Serum by Immunofluorescence | 
|  14204-2 | Chlamydia trachomatis C IgM Ab [Titer] in Serum by Immunofluorescence | 
|  14205-9 | Coccidioides immitis Ag [Presence] in Isolate by Immune diffusion (ID) | 
|  14206-7 | Coccidioides immitis exoantigen [Identifier] in Isolate | 
|  14207-5 | Streptococcal DNAse B [Titer] in Serum | 
|  14208-3 | Filaria IgG4 Ab [Units/volume] in Serum | 
|  14209-1 | Francisella tularensis IgA Ab [Presence] in Serum | 
|  1421-7 | Cortisol [Mass/volume] in Serum or Plasma --32 hours post 40 ug corticotropin IM BID 3 day | 
|  14210-9 | Giardia lamblia Ag [Presence] in Stool by Immunofluorescence | 
|  14211-7 | Hepatitis E virus IgG Ab [Presence] in Serum | 
|  14212-5 | Hepatitis E virus IgM Ab [Presence] in Serum | 
|  14213-3 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunofluorescence | 
|  14214-1 | Histoplasma capsulatum exoantigen [Identifier] in Isolate | 
|  14215-8 | HTLV I g46 Ab [Presence] in Serum | 
|  14216-6 | HTLV 1 gp46 Ab [Presence] in Serum | 
|  14217-4 | HTLV I p19 Ab [Presence] in Serum | 
|  14218-2 | HTLV I p24 Ab [Presence] in Serum | 
|  14219-0 | HTLV I p26 Ab [Presence] in Serum | 
|  1422-5 | Cortisol [Mass/volume] in Serum or Plasma --3 days post 500 ug corticotropin IM | 
|  14220-8 | HTLV I p28 Ab [Presence] in Serum | 
|  14221-6 | HTLV I p32 Ab [Presence] in Serum | 
|  14222-4 | HTLV I p36 Ab [Presence] in Serum | 
|  14223-2 | HTLV I p53 Ab [Presence] in Serum | 
|  14224-0 | HTLV I rgp21 Ab [Presence] in Serum | 
|  14225-7 | HTLV II g46 Ab [Presence] in Serum | 
|  14226-5 | Nocardia sp identified in Isolate by Organism specific culture | 
|  14227-3 | Salmonella typhi H D Ab [Titer] in Serum | 
|  14228-1 | Estrogen receptor/100 cells in Tissue by Immune stain | 
|  14229-9 | P53 protein Ag [Presence] in Tissue by Immune stain | 
|  1423-3 | Cortisol [Mass/volume] in Serum or Plasma --45 minutes post 1 ug/kg CRH IV | 
|  14230-7 | Progesterone receptor/100 cells in Tissue by Immune stain | 
|  14231-5 | H2a-H2b DNA IgG Ab [Units/volume] in Serum | 
|  14232-3 | Adrenal Ab [Presence] in Serum | 
|  14233-1 | Beta tubulin IgG Ab [Titer] in Serum | 
|  14234-9 | Beta tubulin IgM Ab [Titer] in Serum | 
|  14235-6 | Jo-1 extractable nuclear Ab [Titer] in Serum | 
|  14236-4 | Mitochondria Ab [Presence] in Serum | 
|  14237-2 | Myelin basic protein IgA Ab [Units/volume] in Serum | 
|  14238-0 | Myelin basic protein IgG Ab [Units/volume] in Serum | 
|  14239-8 | Myelin basic protein IgM Ab [Units/volume] in Serum | 
|  1424-1 | Cortisol [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV | 
|  14240-6 | Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid | 
|  14241-4 | Parietal cell Ab [Presence] in Serum | 
|  14242-2 | Phosphatidylcholine IgA Ab [Presence] in Serum | 
|  14243-0 | Phosphatidylcholine IgG Ab [Presence] in Serum | 
|  14244-8 | Phosphatidylcholine IgM Ab [Presence] in Serum | 
|  14245-5 | Phosphatidylserine IgG Ab [Units/volume] in Serum | 
|  14246-3 | Phosphatidylserine IgM Ab [Units/volume] in Serum | 
|  14247-1 | Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  14248-9 | Purkinje cells Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  14249-7 | Purkinje cells Ab [Presence] in Serum by Immunofluorescence | 
|  1425-8 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  14250-5 | Purkinje cells IgG Ab [Units/volume] in Serum by Immunofluorescence | 
|  14251-3 | Mitochondria M2 IgG Ab [Units/volume] in Serum | 
|  14252-1 | Smooth muscle Ab [Presence] in Serum | 
|  14253-9 | Somatotropin Ab [Presence] in Serum or Plasma | 
|  14254-7 | Ganglioside GQ1b IgG Ab [Titer] in Serum | 
|  14255-4 | Thyrotropin blocking Ab [Units/volume] in Serum | 
|  14256-2 | Tetrachlorodiphenylethane [Mass/mass] in Tissue | 
|  14257-0 | Tetrachlorodiphenylethane [Mass/volume] in Serum or Plasma | 
|  14258-8 | 1,4-Dioxane [Mass/volume] in Blood | 
|  14259-6 | 1-Pentanol [Mass/volume] in Blood | 
|  1426-6 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 40 ug corticotropin IM BID 3 day | 
|  14260-4 | Bromoform [Mass/volume] in Blood | 
|  14261-2 | Codeine [Presence] in Gastric fluid | 
|  14262-0 | Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue | 
|  14263-8 | Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue | 
|  14264-6 | Enflurane [Mass/volume] in Blood | 
|  14265-3 | Isobutyl acetate [Mass/volume] in Blood | 
|  14266-1 | Methoxyflurane [Mass/volume] in Blood | 
|  14267-9 | Methylenedioxymethamphetamine [Presence] in Urine | 
|  14268-7 | Butyl acetate [Mass/volume] in Blood | 
|  14269-5 | Sec-butyl acetate [Mass/volume] in Blood | 
|  1427-4 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  14270-3 | Tert-butyl acetate [Mass/volume] in Blood | 
|  14271-1 | Character of Synovial fluid | 
|  14272-9 | Liver kidney microsomal Ab [Presence] in Serum | 
|  14273-7 | Reticulin IgA Ab [Presence] in Serum | 
|  14274-5 | Uroporphyrin [Mass/volume] in Serum or Plasma | 
|  14275-2 | Immune complex [Units/volume] in Serum or Plasma by C3b binding assay | 
|  14276-0 | Hemoglobin F distribution [Interpretation] in Blood by Kleihauer-Betke method | 
|  14277-8 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence | 
|  14278-6 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence | 
|  1428-2 | Cortisol [Mass/volume] in Serum or Plasma --50 hours post 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  14282-8 | Acylcarnitine [Moles/volume] in Serum or Plasma | 
|  14283-6 | Acylcarnitine [Moles/volume] in Urine | 
|  14284-4 | Beta glucuronidase [Moles/volume] in Serum or Plasma | 
|  14285-1 | Carnitine free (C0) [Moles/volume] in Urine | 
|  14286-9 | Carnitine free (C0) [Moles/volume] in Serum or Plasma | 
|  14287-7 | Carnitine [Moles/volume] in Urine | 
|  14288-5 | Carnitine [Moles/volume] in Serum or Plasma | 
|  14289-3 | Deprecated Coproporphyrin [Presence] in 24 hour Urine | 
|  1429-0 | Cortisol [Mass/volume] in Serum or Plasma --50 hours post 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  14290-1 | Deprecated Erythrocytes [Units/volume] in Urine sediment by Manual count | 
|  14291-9 | Follitropin [Moles/volume] in Serum or Plasma --baseline | 
|  14292-7 | IgE [Moles/volume] in Serum | 
|  14293-5 | Insulin [Moles/volume] in Serum or Plasma --baseline | 
|  14294-3 | Lysosomal enzymes screen [Identifier] in Plasma and Urine | 
|  14295-0 | Organic acids/Creatinine [Molar ratio] in Urine | 
|  14296-8 | Thyroperoxidase Ab [Moles/volume] in Serum or Plasma | 
|  14297-6 | Thyrotropin [Moles/volume] in Serum or Plasma | 
|  14298-4 | Plasma units available [#] | 
|  14299-2 | Cryoprecipitate units available [#] | 
|  143-8 | Ceftriaxone [Susceptibility] by Serum bactericidal titer | 
|  1430-8 | Cortisol [Mass/volume] in Serum or Plasma --56 hours post 40 ug corticotropin IM BID 3 day | 
|  14300-8 | Plateletpheresis units available [#] | 
|  14301-6 | Platelet concentrate units available [#] | 
|  14302-4 | Packed erythrocytes units available [#] | 
|  14303-2 | Transfuse plateletpheresis [Volume] | 
|  14304-0 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | 
|  14305-7 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | 
|  14306-5 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | 
|  14307-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | 
|  14308-1 | Amphetamines [Presence] in Urine by Screen method >1000 ng/mL | 
|  14309-9 | Amphetamines [Presence] in Urine by Confirm method >200 ng/mL | 
|  1431-6 | Cortisol [Mass/volume] in Serum or Plasma --5 minutes post 1 ug/kg CRH IV | 
|  14310-7 | Phencyclidine [Presence] in Urine by Screen method >25 ng/mL | 
|  14311-5 | Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL | 
|  14312-3 | Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL | 
|  14313-1 | Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method | 
|  14314-9 | Benzoylecgonine [Presence] in Urine by Screen method | 
|  14315-6 | Benzoylecgonine [Presence] in Urine by Confirmatory method | 
|  14316-4 | Benzodiazepines [Presence] in Urine by Screen method | 
|  14317-2 | Microscopic observation [Identifier] in Genital specimen by Wet preparation | 
|  14318-0 | Microscopic observation [Identifier] in Cervix by Wet preparation | 
|  14319-8 | Microscopic observation [Identifier] in Vaginal fluid by Wet preparation | 
|  1432-4 | Cortisol [Mass/volume] in Serum or Plasma --72 hours post 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  14320-6 | Deprecated Bacteria identified in Urine by Culture @1:100 | 
|  14321-4 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Latex agglutination | 
|  14322-2 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Latex agglutination | 
|  14323-0 | Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid by Latex agglutination | 
|  14324-8 | Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination | 
|  14325-5 | Bacteria identified in Unspecified specimen by Environmental culture | 
|  14326-3 | Eosinophils/100 leukocytes in Stool by Manual count | 
|  14327-1 | Epithelial cells.squamous [Presence] in Sputum by Light microscopy | 
|  14328-9 | Leukocytes [Presence] in Sputum by Light microscopy | 
|  14329-7 | Mucus [Presence] in Sputum by Light microscopy | 
|  1433-2 | Cortisol [Mass/volume] in Serum or Plasma --72 hours post 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  14330-5 | Polymorphonuclear cells/100 leukocytes in Stool by Manual count | 
|  14331-3 | Erythrocytes [Units/volume] in Stool by Manual count | 
|  14332-1 | Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  14333-9 | Lead [Presence] in 24 hour Urine | 
|  14334-7 | Lithium [Moles/volume] in Serum or Plasma | 
|  14335-4 | Optical density of Amniotic fluid by Spectrophotometry | 
|  14336-2 | Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography | 
|  14337-0 | Phenytoin.total/Phenytoin.free [Mass Ratio] in Serum or Plasma | 
|  14338-8 | Prealbumin [Mass/volume] in Serum or Plasma | 
|  14339-6 | IgG/Protein.total in Cerebral spinal fluid | 
|  1434-0 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 1 mg dexamethasone PO overnight | 
|  14340-4 | Gammopathy [Interpretation] in Serum or Plasma by Electrophoresis | 
|  14341-2 | Globulin/Protein.total in 24 hour Urine by Electrophoresis | 
|  14342-0 | Deprecated Catecholamines/Creatinine [Mass ratio] in Urine | 
|  14343-8 | Eosinophils/100 leukocytes in Peritoneal fluid by Manual count | 
|  14344-6 | Eosinophils/100 leukocytes in Pleural fluid by Manual count | 
|  14345-3 | Specific gravity of Amniotic fluid by Refractometry | 
|  14346-1 | Specific gravity of Cerebral spinal fluid by Refractometry | 
|  14347-9 | Specific gravity of Gastric fluid by Refractometry | 
|  14348-7 | Specific gravity of Peritoneal fluid by Refractometry | 
|  14349-5 | Specific gravity of Pleural fluid by Refractometry | 
|  1435-7 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  14350-3 | Specific gravity of Synovial fluid by Refractometry | 
|  14351-1 | Specific gravity of Stool by Refractometry | 
|  14352-9 | Specific gravity of Water by Refractometry | 
|  14353-7 | Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Kinyoun modified | 
|  14354-5 | Microscopic observation [Identifier] in Wound by Acid fast stain.Kinyoun modified | 
|  14355-2 | Microscopic observation [Identifier] in Cervix by KOH preparation | 
|  14356-0 | Microscopic observation [Identifier] in Vaginal fluid by KOH preparation | 
|  14357-8 | Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain | 
|  14358-6 | Microscopic observation [Identifier] in Aspirate by Gram stain | 
|  14359-4 | Microscopic observation [Identifier] in Peritoneal fluid by Gram stain | 
|  1436-5 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyrapone PO | 
|  14360-2 | Microscopic observation [Identifier] in Pleural fluid by Gram stain | 
|  14361-0 | Microscopic observation [Identifier] in Vaginal fluid by Gram stain | 
|  14362-8 | Microscopic observation [Identifier] in Throat by Gram stain | 
|  14363-6 | Microscopic observation [Identifier] in Synovial fluid by Gram stain | 
|  14364-4 | Microscopic observation [Identifier] in Eye by Gram stain | 
|  14365-1 | Microscopic observation [Identifier] in Ear by Gram stain | 
|  14366-9 | Trichomonas vaginalis [Presence] in Cervix by Wet preparation | 
|  14367-7 | Trichomonas vaginalis [Presence] in Vaginal fluid by Wet preparation | 
|  14368-5 | Trichomonas vaginalis [Presence] in Urethra by Wet preparation | 
|  14369-3 | Yeast [Presence] in Cervix by Wet preparation | 
|  1437-3 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  14370-1 | Yeast [Presence] in Vaginal fluid by Wet preparation | 
|  14371-9 | Yeast [Presence] in Urethra by Wet preparation | 
|  14372-7 | Erythrocytes [#/volume] in Gastric fluid by Manual count | 
|  14373-5 | Leukocytes [#/volume] in Gastric fluid by Manual count | 
|  14374-3 | Polymorphonuclear cells/100 leukocytes in Pleural fluid by Manual count | 
|  14375-0 | Polymorphonuclear cells/100 leukocytes in Peritoneal fluid by Manual count | 
|  14376-8 | Polymorphonuclear cells/100 leukocytes in Synovial fluid by Manual count | 
|  14377-6 | Polymorphonuclear cells/100 leukocytes in Semen by Manual count | 
|  14378-4 | Polymorphonuclear cells/100 leukocytes in Urine by Manual count | 
|  14379-2 | Polymorphonuclear cells/100 leukocytes in Gastric fluid by Manual count | 
|  1438-1 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 40 ug corticotropin IM BID 3 day | 
|  14380-0 | Mononuclear cells/100 leukocytes in Pleural fluid by Manual count | 
|  14381-8 | Mononuclear cells/100 leukocytes in Peritoneal fluid by Manual count | 
|  14382-6 | Mononuclear cells/100 leukocytes in Synovial fluid by Manual count | 
|  14383-4 | Mononuclear cells/100 leukocytes in Semen by Manual count | 
|  14384-2 | Mononuclear cells/100 leukocytes in Urine sediment by Manual count | 
|  14385-9 | Mononuclear cells/100 leukocytes in Gastric fluid by Manual count | 
|  14386-7 | Glucose [Mass/volume] in Gastric fluid | 
|  14387-5 | Protein [Mass/volume] in Gastric fluid | 
|  14388-3 | Amylase [Enzymatic activity/volume] in Synovial fluid | 
|  14389-1 | Amylase [Enzymatic activity/volume] in Cerebral spinal fluid | 
|  1439-9 | Cortisol [Mass/volume] in Serum or Plasma --9.5 hours post 8 mg dexamethasone PO overnight high dose | 
|  14390-9 | Amylase [Enzymatic activity/volume] in Dialysis fluid | 
|  14391-7 | Amylase [Enzymatic activity/volume] in Gastric fluid | 
|  14392-5 | Amylase [Enzymatic activity/volume] in Amniotic fluid | 
|  14393-3 | Urea nitrogen [Mass/volume] in Amniotic fluid | 
|  14394-1 | Urea nitrogen [Mass/volume] in Pleural fluid | 
|  14395-8 | Deprecated Urea nitrogen [Mass/volume] in Peritoneal fluid | 
|  14396-6 | Urea nitrogen [Mass/volume] in Synovial fluid | 
|  14397-4 | Urea nitrogen [Mass/volume] in Gastric fluid | 
|  14398-2 | Creatinine [Mass/volume] in Cerebral spinal fluid | 
|  14399-0 | Creatinine [Mass/volume] in Pleural fluid | 
|  144-6 | Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1440-7 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 1 mg dexamethasone PO overnight | 
|  14400-6 | Deprecated Creatinine [Mass/volume] in Peritoneal fluid | 
|  14401-4 | Creatinine [Mass/volume] in Synovial fluid | 
|  14402-2 | Creatinine [Mass/volume] in Gastric fluid | 
|  14403-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid | 
|  14404-8 | Phosphate [Mass/volume] in Pleural fluid | 
|  14405-5 | Phosphate [Mass/volume] in Peritoneal fluid | 
|  14406-3 | Phosphate [Mass/volume] in Synovial fluid | 
|  14407-1 | Phosphate [Mass/volume] in Gastric fluid | 
|  14408-9 | Phosphate [Mass/volume] in Amniotic fluid | 
|  14409-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Pleural fluid | 
|  1441-5 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 3 g metyrapone PO overnight | 
|  14410-5 | Aspartate aminotransferase [Enzymatic activity/volume] in Peritoneal fluid | 
|  14411-3 | Aspartate aminotransferase [Enzymatic activity/volume] in Synovial fluid | 
|  14412-1 | Aspartate aminotransferase [Enzymatic activity/volume] in Gastric fluid | 
|  14413-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Urine | 
|  14414-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Dialysis fluid | 
|  14415-4 | Calcium [Moles/volume] in Amniotic fluid | 
|  14416-2 | Calcium [Moles/volume] in Pleural fluid | 
|  14417-0 | Calcium [Moles/volume] in Peritoneal fluid | 
|  14418-8 | Calcium [Moles/volume] in Synovial fluid | 
|  14419-6 | Calcium [Moles/volume] in Gastric fluid | 
|  1442-3 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 8 mg dexamethasone PO overnight high dose | 
|  14420-4 | Bilirubin.total [Mass/volume] in Dialysis fluid | 
|  14421-2 | Bilirubin.total [Mass/volume] in Pleural fluid | 
|  14422-0 | Bilirubin.total [Mass/volume] in Peritoneal fluid | 
|  14423-8 | Bilirubin.total [Mass/volume] in Synovial fluid | 
|  14424-6 | Bilirubin.total [Mass/volume] in Gastric fluid | 
|  14425-3 | Globulin [Mass/volume] in Amniotic fluid | 
|  14426-1 | Globulin [Mass/volume] in Cerebral spinal fluid | 
|  14427-9 | Globulin [Mass/volume] in Pleural fluid | 
|  14428-7 | Globulin [Mass/volume] in Peritoneal fluid | 
|  14429-5 | Globulin [Mass/volume] in Semen | 
|  1443-1 | Cortisol [Mass/volume] in Serum or Plasma --pre 1 ug/kg CRH IV | 
|  14430-3 | Globulin [Mass/volume] in Synovial fluid | 
|  14431-1 | Globulin [Mass/volume] in Urine | 
|  14432-9 | Albumin/Globulin [Mass Ratio] in Amniotic fluid | 
|  14433-7 | Albumin/Globulin [Mass Ratio] in Cerebral spinal fluid | 
|  14434-5 | Albumin/Globulin [Mass Ratio] in Pleural fluid | 
|  14435-2 | Albumin/Globulin [Mass Ratio] in Peritoneal fluid | 
|  14436-0 | Albumin/Globulin [Mass Ratio] in Semen | 
|  14437-8 | Albumin/Globulin [Mass Ratio] in Synovial fluid | 
|  14438-6 | Cholesterol [Mass/volume] in Amniotic fluid | 
|  14439-4 | Cholesterol [Mass/volume] in Cerebral spinal fluid | 
|  1444-9 | Cortisol [Mass/volume] in Serum or Plasma --pre 12 hour fast | 
|  14440-2 | Deprecated Cholesterol [Mass/volume] in Pleural fluid | 
|  14441-0 | Cholesterol [Mass/volume] in Peritoneal fluid | 
|  14442-8 | Cholesterol [Mass/volume] in Semen | 
|  14443-6 | Cholesterol [Mass/volume] in Synovial fluid | 
|  14444-4 | Cholesterol [Mass/volume] in Urine | 
|  14445-1 | Triglyceride [Mass/volume] in Amniotic fluid | 
|  14446-9 | Triglyceride [Mass/volume] in Cerebral spinal fluid | 
|  14447-7 | Triglyceride [Mass/volume] in Peritoneal fluid | 
|  14448-5 | Triglyceride [Mass/volume] in Semen | 
|  14449-3 | Triglyceride [Mass/volume] in Synovial fluid | 
|  1445-6 | Cortisol [Mass/volume] in Serum or Plasma --pre 1 mg dexamethasone PO overnight | 
|  14450-1 | Triglyceride [Mass/volume] in Urine | 
|  14451-9 | Virus identified in Eye by Culture | 
|  14452-7 | Virus identified in Cervix by Culture | 
|  14453-5 | Virus identified in Vaginal fluid by Culture | 
|  14454-3 | Virus identified in Nose by Culture | 
|  14455-0 | Virus identified in Pleural fluid by Culture | 
|  14456-8 | Virus identified in Peritoneal fluid by Culture | 
|  14457-6 | Virus identified in Urine by Culture | 
|  14458-4 | Virus identified in Sputum by Culture | 
|  14459-2 | Virus identified in Penis by Culture | 
|  1446-4 | Cortisol [Mass/volume] in Serum or Plasma --pre 3 g metyrapone PO overnight | 
|  14460-0 | Virus identified in Urethra by Culture | 
|  14461-8 | Chlamydia trachomatis [Presence] in Blood by Organism specific culture | 
|  14462-6 | Chlamydia trachomatis [Presence] in Cerebral spinal fluid by Organism specific culture | 
|  14463-4 | Chlamydia trachomatis [Presence] in Cervix by Organism specific culture | 
|  14464-2 | Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture | 
|  14465-9 | Chlamydia trachomatis [Presence] in Urethra by Organism specific culture | 
|  14466-7 | Deprecated Chlamydia trachomatis [Presence] in Penis by Organism specific culture | 
|  14467-5 | Chlamydia trachomatis [Presence] in Urine sediment by Organism specific culture | 
|  14468-3 | Chlamydia trachomatis Ag [Presence] in Blood by Immunoassay | 
|  14469-1 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunoassay | 
|  1447-2 | Cortisol [Mass/volume] in Serum or Plasma --pre 40 ug corticotropin IM 3 day | 
|  14470-9 | Chlamydia trachomatis Ag [Presence] in Cervix by Immunoassay | 
|  14471-7 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunoassay | 
|  14472-5 | Chlamydia trachomatis Ag [Presence] in Urethra by Immunoassay | 
|  14473-3 | Deprecated Chlamydia trachomatis Ag [Presence] in Penis by Immunoassay | 
|  14474-1 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunoassay | 
|  14475-8 | Bacteria identified in Cervix by Aerobe culture | 
|  14476-6 | Deprecated Bacteria identified in Vaginal fluid by Aerobe culture | 
|  14477-4 | Bacteria identified in Urethra by Aerobe culture | 
|  14478-2 | Bacteria identified in Penis by Aerobe culture | 
|  14479-0 | Diphtheria identified in Throat by Organism specific culture | 
|  1448-0 | Cortisol [Mass/volume] in Serum or Plasma --pre 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  14480-8 | Diphtheria identified in Sputum by Organism specific culture | 
|  14481-6 | Diphtheria identified in Nose by Organism specific culture | 
|  14482-4 | Diphtheria identified in Skin by Organism specific culture | 
|  14483-2 | Diphtheria identified in Bronchial specimen by Organism specific culture | 
|  14484-0 | Mycoplasma sp and Ureaplasma sp [Identifier] in Cervix by Organism specific culture | 
|  14485-7 | Mycoplasma sp and Ureaplasma sp [Identifier] in Vaginal fluid by Organism specific culture | 
|  14486-5 | Mycoplasma sp and Ureaplasma sp [Identifier] in Penis by Organism specific culture | 
|  14487-3 | Mycoplasma sp and Ureaplasma sp [Identifier] in Urethra by Organism specific culture | 
|  14488-1 | Virus identified in Cerebral spinal fluid by Immunofluorescence | 
|  14489-9 | Virus identified in Blood by Immunofluorescence | 
|  1449-8 | Cortisol [Mass/volume] in Serum or Plasma --pre 8 mg dexamethasone PO overnight high dose | 
|  14490-7 | Virus identified in Semen by Immunofluorescence | 
|  14491-5 | Virus identified in Throat by Immunofluorescence | 
|  14492-3 | Virus identified in Eye by Immunofluorescence | 
|  14493-1 | Virus identified in Cervix by Immunofluorescence | 
|  14494-9 | Virus identified in Vaginal fluid by Immunofluorescence | 
|  14495-6 | Virus identified in Urine sediment by Immunofluorescence | 
|  14496-4 | Virus identified in Sputum by Immunofluorescence | 
|  14497-2 | Virus identified in Penis by Immunofluorescence | 
|  14498-0 | Virus identified in Urethra by Immunofluorescence | 
|  14499-8 | Human papilloma virus Ag [Presence] in Cervix | 
|  145-3 | Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1450-6 | Cortisol [Mass/volume] in Serum or Plasma --pre 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  14500-3 | Human papilloma virus Ag [Presence] in Vaginal fluid | 
|  14501-1 | Human papilloma virus Ag [Presence] in Penis | 
|  14502-9 | Human papilloma virus Ag [Presence] in Urethra | 
|  14503-7 | Human papilloma virus 16+18 Ag [Presence] in Cervix | 
|  14504-5 | Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid | 
|  14505-2 | Human papilloma virus 16+18 Ag [Presence] in Penis | 
|  14506-0 | Human papilloma virus 16+18 Ag [Presence] in Urethra | 
|  14507-8 | Chlamydia trachomatis Ag [Presence] in Blood by Immunofluorescence | 
|  14508-6 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  14509-4 | Chlamydia trachomatis Ag [Presence] in Cervix by Immunofluorescence | 
|  1451-4 | Cortisol [Mass/volume] in Serum or Plasma --pre dose insulin IV | 
|  14510-2 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunofluorescence | 
|  14511-0 | Chlamydia trachomatis Ag [Presence] in Urethra by Immunofluorescence | 
|  14512-8 | Deprecated Chlamydia trachomatis Ag [Presence] in Penis by Immunofluorescence | 
|  14513-6 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunofluorescence | 
|  14514-4 | Pneumocystis jiroveci Ag [Presence] in Blood by Immunofluorescence | 
|  14515-1 | Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  14516-9 | Pneumocystis jiroveci Ag [Presence] in Semen by Immunofluorescence | 
|  14517-7 | Pneumocystis jiroveci Ag [Presence] in Stool by Immunofluorescence | 
|  14518-5 | Pneumocystis jiroveci Ag [Presence] in Throat by Immunofluorescence | 
|  14519-3 | Pneumocystis jiroveci Ag [Presence] in Eye by Immunofluorescence | 
|  1452-2 | Creatinine [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day | 
|  14520-1 | Pneumocystis jiroveci Ag [Presence] in Nose by Immunofluorescence | 
|  14521-9 | Pneumocystis jiroveci Ag [Presence] in Urine by Immunofluorescence | 
|  14522-7 | Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence | 
|  14523-5 | Rubella virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  14524-3 | Rubella virus Ag [Presence] in Throat by Immunofluorescence | 
|  14525-0 | Rubella virus Ag [Presence] in Skin by Immunofluorescence | 
|  14526-8 | Rubella virus Ag [Presence] in Eye by Immunofluorescence | 
|  14527-6 | Rubella virus Ag [Presence] in Nose by Immunofluorescence | 
|  14528-4 | Rubella virus Ag [Presence] in Sputum by Immunofluorescence | 
|  14529-2 | Rubella virus Ag [Presence] in Cervix by Immunofluorescence | 
|  1453-0 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day | 
|  14530-0 | Rubella virus Ag [Presence] in Vaginal fluid by Immunofluorescence | 
|  14531-8 | Rubella virus Ag [Presence] in Urine sediment by Immunofluorescence | 
|  14532-6 | Rubella virus Ag [Presence] in Penis by Immunofluorescence | 
|  14533-4 | Rubella virus Ag [Presence] in Urethra by Immunofluorescence | 
|  14534-2 | Measles virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  14535-9 | Measles virus Ag [Presence] in Throat by Immunofluorescence | 
|  14536-7 | Measles virus Ag [Presence] in Skin by Immunofluorescence | 
|  14537-5 | Measles virus Ag [Presence] in Eye by Immunofluorescence | 
|  14538-3 | Measles virus Ag [Presence] in Nose by Immunofluorescence | 
|  14539-1 | Measles virus Ag [Presence] in Sputum by Immunofluorescence | 
|  1454-8 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  14540-9 | Measles virus Ag [Presence] in Cervix by Immunofluorescence | 
|  14541-7 | Measles virus Ag [Presence] in Vaginal fluid by Immunofluorescence | 
|  14542-5 | Measles virus Ag [Presence] in Urine sediment by Immunofluorescence | 
|  14543-3 | Measles virus Ag [Presence] in Penis by Immunofluorescence | 
|  14544-1 | Measles virus Ag [Presence] in Urethra by Immunofluorescence | 
|  14545-8 | Mumps virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  14546-6 | Mumps virus Ag [Presence] in Throat by Immunofluorescence | 
|  14547-4 | Mumps virus Ag [Presence] in Skin by Immunofluorescence | 
|  14548-2 | Mumps virus Ag [Presence] in Eye by Immunofluorescence | 
|  14549-0 | Mumps virus Ag [Presence] in Nose by Immunofluorescence | 
|  1455-5 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  14550-8 | Mumps virus Ag [Presence] in Sputum by Immunofluorescence | 
|  14551-6 | Mumps virus Ag [Presence] in Cervix by Immunofluorescence | 
|  14552-4 | Mumps virus Ag [Presence] in Vaginal fluid by Immunofluorescence | 
|  14553-2 | Mumps virus Ag [Presence] in Urine sediment by Immunofluorescence | 
|  14554-0 | Mumps virus Ag [Presence] in Penis by Immunofluorescence | 
|  14555-7 | Mumps virus Ag [Presence] in Urethra by Immunofluorescence | 
|  14556-5 | Mycobacterium tuberculosis DNA [Presence] in Sputum by Probe and target amplification method | 
|  14557-3 | Mycobacterium tuberculosis DNA [Presence] in Bronchial specimen by Probe and target amplification method | 
|  14558-1 | Mycobacterium tuberculosis DNA [Presence] in Gastric fluid by Probe and target amplification method | 
|  14559-9 | Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by Probe and target amplification method | 
|  1456-3 | Creatinine [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day | 
|  14560-7 | Mycobacterium tuberculosis DNA [Presence] in Urine by Probe and target amplification method | 
|  14561-5 | Mycobacterium tuberculosis DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method | 
|  14562-3 | Mycobacterium tuberculosis DNA [Presence] in Semen by Probe and target amplification method | 
|  14563-1 | Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen | 
|  14564-9 | Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen | 
|  14565-6 | Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen | 
|  14566-4 | Calcitriol [Moles/volume] in Serum or Plasma | 
|  14567-2 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma | 
|  14568-0 | 17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine | 
|  14569-8 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma | 
|  1457-1 | Creatinine [Mass/volume] in 24 hour Urine --pre 40 ug corticotropin IM 3 day | 
|  14570-6 | 17-Hydroxyprogesterone [Moles/volume] in Urine | 
|  14571-4 | 17-Hydroxyprogesterone [Moles/time] in 24 hour Urine | 
|  14572-2 | 17-Ketosteroids [Moles/time] in 24 hour Urine | 
|  14573-0 | 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine | 
|  14574-8 | 8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma | 
|  14575-5 | Blood group antibody investigation [Interpretation] in Plasma or RBC | 
|  14576-3 | Blood group antibody investigation [Interpretation] in Plasma or RBC by Senior review | 
|  14577-1 | ABO and Rh group [Type] in Blood from donor | 
|  14578-9 | ABO group [Type] in Blood from Blood product unit | 
|  14579-7 | ABO group [Type] in Blood from donor | 
|  1458-9 | Creatinine [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  14580-5 | ABO group [Type] in Blood from newborn | 
|  14581-3 | Acetaminophen [Moles/volume] in Serum or Plasma | 
|  14582-1 | Acetone [Moles/volume] in Serum or Plasma | 
|  14583-9 | Acidity.titratable [Mass/volume] in Gastric fluid | 
|  14584-7 | Adenosine monophosphate.cyclic [Moles/time] in 24 hour Urine | 
|  14585-4 | Albumin/Creatinine [Molar ratio] in Urine | 
|  14586-2 | Aldosterone [Moles/volume] in Serum or Plasma | 
|  14587-0 | Aldosterone [Moles/time] in 24 hour Urine | 
|  14588-8 | Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma | 
|  14589-6 | Amylase isoenzymes [Interpretation] in Serum or Plasma | 
|  1459-7 | Creatinine [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  14590-4 | Alpha tocopherol [Moles/volume] in Serum or Plasma | 
|  14591-2 | Alprazolam [Moles/volume] in Serum or Plasma | 
|  14592-0 | Aluminum [Moles/volume] in 24 hour Urine | 
|  14593-8 | Aluminum [Moles/volume] in Serum or Plasma | 
|  14594-6 | Amitriptyline+Nortriptyline [Presence] in Gastric fluid | 
|  14595-3 | Amitriptyline+Nortriptyline [Presence] in Serum or Plasma | 
|  14596-1 | Amitriptyline+Nortriptyline [Presence] in Urine | 
|  14597-9 | Amitriptyline [Moles/volume] in Serum or Plasma | 
|  14598-7 | Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma | 
|  14599-5 | Ammonium [Presence] in Stone | 
|  146-1 | Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB) | 
|  1460-5 | Cobalamin (Vitamin B12) [Mass/time] in 24 hour Urine --post dose cyanocobalamin | 
|  14600-1 | Amoxapine [Moles/volume] in Serum or Plasma | 
|  14601-9 | Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma | 
|  14602-7 | Deprecated Amoxapine+8-Hydroxyamoxapine [Molecules/volume] in Serum or Plasma | 
|  14603-5 | Androstenedione [Moles/volume] in Serum or Plasma | 
|  14604-3 | Blood group antibodies identified in Serum or Plasma from Blood product unit | 
|  14605-0 | Blood group antibodies identified in Serum or Plasma from donor | 
|  14606-8 | Blood group antibody screen [Presence] in Serum or Plasma by Prewarmed | 
|  14607-6 | Nuclear Ab [Presence] in Body fluid | 
|  14608-4 | Nuclear Ab [Presence] in Pleural fluid | 
|  14609-2 | Nuclear Ab [Presence] in Peritoneal fluid | 
|  1461-3 | Epinephrine [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO | 
|  14610-0 | Nuclear Ab [Presence] in Synovial fluid | 
|  14611-8 | Nuclear Ab pattern [Interpretation] in Serum | 
|  14612-6 | Nuclear Ab [Titer] in Pericardial fluid | 
|  14613-4 | Nuclear Ab [Titer] in Body fluid | 
|  14614-2 | Nuclear Ab [Titer] in Pleural fluid | 
|  14615-9 | Nuclear Ab [Titer] in Peritoneal fluid | 
|  14616-7 | Nuclear Ab [Titer] in Synovial fluid | 
|  14617-5 | Appearance of Pericardial fluid | 
|  14618-3 | Appearance of Stone | 
|  14619-1 | Appearance of Plasma | 
|  1462-1 | Epinephrine [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO | 
|  14620-9 | Appearance of Pleural fluid | 
|  14621-7 | Appearance of Peritoneal fluid | 
|  14622-5 | Ascorbate [Moles/volume] in Serum or Plasma | 
|  14623-3 | Barbital [Presence] in Serum or Plasma | 
|  14624-1 | Barbiturates [Presence] in Gastric fluid | 
|  14625-8 | Basophils/100 leukocytes in Bronchial specimen by Manual count | 
|  14626-6 | Beta-2-Microglobulin [Moles/volume] in Serum | 
|  14627-4 | Bicarbonate [Moles/volume] in Venous blood | 
|  14628-2 | Bile acid [Moles/volume] in Serum | 
|  14629-0 | Bilirubin.direct [Moles/volume] in Serum or Plasma | 
|  1463-9 | Epinephrine [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO | 
|  14630-8 | Bilirubin.indirect [Moles/volume] in Serum or Plasma | 
|  14631-6 | Bilirubin.total [Moles/volume] in Serum or Plasma | 
|  14632-4 | Deprecated Buffy coat | 
|  14633-2 | C peptide [Moles/volume] in Serum or Plasma | 
|  14634-0 | C reactive protein [Titer] in Serum or Plasma | 
|  14635-7 | Calcidiol [Moles/volume] in Serum or Plasma | 
|  14636-5 | Calcium [Presence] in Stone | 
|  14637-3 | Calcium [Moles/time] in 24 hour Urine | 
|  14638-1 | Calculus analysis [Interpretation] in Stone | 
|  14639-9 | Carbamazepine [Moles/volume] in Serum or Plasma | 
|  1464-7 | Epinephrine [Mass/volume] in Plasma --pre 300 ug clonidine PO | 
|  14640-7 | Carbon dioxide, total [Moles/volume] in Dialysis fluid | 
|  14641-5 | Carbonate [Presence] in Stone | 
|  14642-3 | Carotene [Moles/volume] in Serum | 
|  14643-1 | Catecholamines Free [Moles/time] in 24 hour Urine | 
|  14644-9 | Chlorpromazine [Presence] in Gastric fluid | 
|  14645-6 | Chlorpromazine [Moles/volume] in Serum or Plasma | 
|  14646-4 | Cholesterol in HDL [Moles/volume] in Serum or Plasma | 
|  14647-2 | Cholesterol [Moles/volume] in Serum or Plasma | 
|  14648-0 | Chylomicrons [Moles/volume] in Serum or Plasma | 
|  14649-8 | Cimetidine [Presence] in Gastric fluid | 
|  1465-4 | Epinephrine [Mass/volume] in Plasma --supine | 
|  14650-6 | Citrate [Moles/time] in 24 hour Urine | 
|  14651-4 | Clobazam [Moles/volume] in Serum or Plasma | 
|  14652-2 | Clomipramine [Moles/volume] in Serum or Plasma | 
|  14653-0 | Clomipramine [Moles/volume] in Urine | 
|  14654-8 | Clomipramine+Norclomipramine [Moles/volume] in Serum or Plasma | 
|  14655-5 | Clonazepam [Moles/volume] in Serum or Plasma | 
|  14656-3 | Clozapine [Moles/volume] in Serum or Plasma | 
|  14657-1 | Clozapine+Norclozapine [Moles/volume] in Serum or Plasma | 
|  14658-9 | Cold agglutinin [Titer] in Serum or Plasma | 
|  14659-7 | Deprecated Collection duration of Urine | 
|  1466-2 | Deprecated Follitropin [Mass/volume] in Serum or Plasma --1.5 hours post 100 g lutropin IV | 
|  14660-5 | Color of Peritoneal fluid | 
|  14661-3 | Color of Pericardial fluid | 
|  14662-1 | Color of Pleural fluid | 
|  14663-9 | Deprecated Color of Semen by Visual | 
|  14664-7 | Color of Synovial fluid | 
|  14665-4 | Copper [Moles/volume] in Serum or Plasma | 
|  14666-2 | Copper [Moles/time] in 24 hour Urine | 
|  14667-0 | Coproporphyrin 1 [Moles/volume] in Serum or Plasma | 
|  14668-8 | Coproporphyrin 1 [Moles/volume] in Stool | 
|  14669-6 | Coproporphyrin 1 [Moles/volume] in Urine | 
|  1467-0 | Follitropin [Mass/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone | 
|  14670-4 | Coproporphyrin 1/Porphyrins.total in Urine | 
|  14671-2 | Coproporphyrin 3 [Moles/volume] in Serum or Plasma | 
|  14672-0 | Coproporphyrin 3 [Moles/volume] in Stool | 
|  14673-8 | Coproporphyrin 3 [Moles/volume] in Urine | 
|  14674-6 | Corticotropin [Moles/volume] in Plasma | 
|  14675-3 | Cortisol [Moles/volume] in Serum or Plasma | 
|  14676-1 | Cortisol Free [Moles/time] in 24 hour Urine | 
|  14677-9 | Cortisol [Moles/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  14678-7 | Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen | 
|  14679-5 | Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen | 
|  1468-8 | Follitropin [Mass/volume] in Serum or Plasma --105 minutes post 100 ug lutenizing releasing hormone IV | 
|  14680-3 | Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis | 
|  14681-1 | Creatinine [Moles/volume] in Peritoneal dialysis fluid | 
|  14682-9 | Creatinine [Moles/volume] in Serum or Plasma | 
|  14683-7 | Creatinine [Moles/volume] in Urine | 
|  14684-5 | Creatinine [Moles/time] in 24 hour Urine | 
|  14685-2 | Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma | 
|  14686-0 | Cystine [Presence] in Stone | 
|  14687-8 | Transfusion date | 
|  14688-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma | 
|  14689-4 | Delta aminolevulinate [Moles/time] in 24 hour Urine | 
|  1469-6 | Follitropin [Mass/volume] in Serum or Plasma --15 minutes post 100 ug lutenizing releasing hormone IV | 
|  14690-2 | N-desalkylflurazepam [Moles/volume] in Serum or Plasma | 
|  14691-0 | Desipramine [Moles/volume] in Serum or Plasma | 
|  14692-8 | Desipramine [Moles/volume] in Urine | 
|  14693-6 | Norclobazam [Moles/volume] in Serum or Plasma | 
|  14694-4 | Norclomipramine [Moles/volume] in Serum or Plasma | 
|  14695-1 | Nordoxepin [Moles/volume] in Serum or Plasma | 
|  14696-9 | Deuteroporphyrin [Moles/volume] in Stool | 
|  14697-7 | Diazepam [Moles/volume] in Serum or Plasma | 
|  14698-5 | Digoxin [Moles/volume] in Serum or Plasma | 
|  14699-3 | Diphenhydramine+Dimenhydrinate [Presence] in Gastric fluid | 
|  147-9 | Cefuroxime Parenteral [Susceptibility] by Serum bactericidal titer | 
|  1470-4 | Follitropin [Mass/volume] in Serum or Plasma --1 hour post 100 ug lutenizing releasing hormone IV | 
|  14700-9 | Diphenhydramine+Dimenhydrinate [Presence] in Serum or Plasma | 
|  14701-7 | Diphenhydramine+Dimenhydrinate [Presence] in Urine | 
|  14702-5 | Disopyramide [Moles/volume] in Serum or Plasma | 
|  14703-3 | Dopamine [Moles/volume] in Serum or Plasma | 
|  14704-1 | Doxepin [Presence] in Gastric fluid | 
|  14705-8 | Doxepin [Moles/volume] in Serum or Plasma | 
|  14706-6 | Doxepin [Moles/volume] in Urine | 
|  14707-4 | Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma | 
|  14708-2 | Endomysium Ab [Titer] in Serum | 
|  14709-0 | Eosinophils/100 leukocytes in Bronchial specimen by Manual count | 
|  1471-2 | Follitropin [Mass/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone | 
|  14710-8 | Ephedrine+Pseudoephedrine [Presence] in Gastric fluid | 
|  14711-6 | Epinephrine [Moles/volume] in Plasma | 
|  14712-4 | Epinephrine [Moles/time] in 24 hour Urine | 
|  14713-2 | Erythrocytes [#/volume] in Pericardial fluid by Manual count | 
|  14714-0 | Erythropoietin (EPO) [Moles/volume] in Serum or Plasma | 
|  14715-7 | Estradiol (E2) [Moles/volume] in Serum or Plasma | 
|  14716-5 | Estriol (E3) [Moles/volume] in Serum or Plasma | 
|  14717-3 | Estriol (E3) [Moles/volume] in Urine | 
|  14718-1 | Estriol (E3) [Moles/time] in 24 hour Urine | 
|  14719-9 | Ethanol [Moles/volume] in Serum or Plasma | 
|  1472-0 | Follitropin [Mass/volume] in Serum or Plasma --2 hours post 100 ug lutenizing releasing hormone IV | 
|  14720-7 | Ethosuximide [Moles/volume] in Serum or Plasma | 
|  14721-5 | Ethylene glycol [Moles/volume] in Serum or Plasma | 
|  14722-3 | Extractable nuclear Ab [Presence] in Serum | 
|  14723-1 | Ferritin [Moles/volume] in Serum or Plasma | 
|  14724-9 | Ferritin [Interpretation] in Blood | 
|  14725-6 | [Type] of Body fluid | 
|  14726-4 | Fluoride [Moles/volume] in Serum or Plasma | 
|  14727-2 | Fluoxetine [Presence] in Gastric fluid | 
|  14728-0 | Fluoxetine [Moles/volume] in Serum or Plasma | 
|  14729-8 | Flurazepam [Moles/volume] in Serum or Plasma | 
|  1473-8 | Follitropin [Mass/volume] in Serum or Plasma --30 minutes post 100 ug lutenizing releasing hormone IV | 
|  14730-6 | Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma | 
|  14731-4 | Folate [Moles/volume] in Red Blood Cells | 
|  14732-2 | Folate [Moles/volume] in Serum or Plasma | 
|  14733-0 | Folate+Cyanocobalamin [Interpretation] in Serum or Blood | 
|  14734-8 | Follitropin [Moles/time] in 24 hour Urine | 
|  14735-5 | Gastrin [Moles/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin | 
|  14736-3 | Gastrin [Moles/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin | 
|  14737-1 | Gastrin [Moles/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin | 
|  14738-9 | Gastrin [Moles/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin | 
|  14739-7 | Gastrin [Moles/volume] in Serum or Plasma --2 minutes post 0.2 U/kg secretin | 
|  1474-6 | Follitropin [Mass/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone | 
|  14740-5 | Gastrin [Moles/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin | 
|  14741-3 | Gastrin [Moles/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin | 
|  14742-1 | Gastrin [Moles/volume] in Serum or Plasma --pre 0.2 U/kg secretin | 
|  14743-9 | Glucose [Moles/volume] in Capillary blood by Glucometer | 
|  14744-7 | Glucose [Moles/volume] in Cerebral spinal fluid | 
|  14745-4 | Glucose [Moles/volume] in Body fluid | 
|  14746-2 | Glucose [Moles/volume] in Peritoneal dialysis fluid | 
|  14747-0 | Glucose [Moles/volume] in Pleural fluid | 
|  14748-8 | Glucose [Moles/volume] in Peritoneal fluid | 
|  14749-6 | Glucose [Moles/volume] in Serum or Plasma | 
|  1475-3 | Follitropin [Mass/volume] in Serum or Plasma --45 minutes post 100 ug lutenizing releasing hormone IV | 
|  14750-4 | Glucose [Moles/volume] in Synovial fluid | 
|  14751-2 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO | 
|  14752-0 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose | 
|  14753-8 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO | 
|  14754-6 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO | 
|  14755-3 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g lactose PO | 
|  14756-1 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose | 
|  14757-9 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO | 
|  14758-7 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 50 g lactose PO | 
|  14759-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose | 
|  1476-1 | Follitropin [Mass/volume] in Serum or Plasma --75 minutes post 100 ug lutenizing releasing hormone IV | 
|  14760-3 | Glucose [Moles/volume] in Capillary blood --2 hours post meal | 
|  14761-1 | Glucose [Moles/volume] in Serum or Plasma --2 hours post meal | 
|  14762-9 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post 50 g lactose PO | 
|  14763-7 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose | 
|  14764-5 | Glucose [Moles/volume] in Serum or Plasma --3 hours post 100 g glucose PO | 
|  14765-2 | Glucose [Moles/volume] in Serum or Plasma --3 hours post dose glucose | 
|  14766-0 | Glucose [Moles/volume] in Serum or Plasma --4 hours post dose glucose | 
|  14767-8 | Glucose [Moles/volume] in Serum or Plasma --5 hours post dose glucose | 
|  14768-6 | Glucose [Moles/volume] in Serum or Plasma --baseline | 
|  14769-4 | Glucose [Moles/volume] in Serum or Plasma --pre 12 hour fast | 
|  1477-9 | Follitropin [Mass/volume] in Serum or Plasma --baseline | 
|  14770-2 | Fasting glucose [Moles/volume] in Capillary blood by Glucometer | 
|  14771-0 | Fasting glucose [Moles/volume] in Serum or Plasma | 
|  14772-8 | Gold [Moles/volume] in Serum or Plasma | 
|  14773-6 | Granulocytes/100 leukocytes in Bronchial specimen by Manual count | 
|  14774-4 | Haloperidol [Moles/volume] in Serum or Plasma | 
|  14775-1 | Hemoglobin [Mass/volume] in Arterial blood by Oximetry | 
|  14776-9 | Heptacarboxylate [Moles/volume] in Plasma | 
|  14777-7 | Heptacarboxylate [Moles/volume] in Stool | 
|  14778-5 | Heptacarboxylate [Moles/volume] in Urine | 
|  14779-3 | Hexacarboxylate [Moles/volume] in Plasma | 
|  1478-7 | Follitropin [Mass/volume] in Serum or Plasma --pre dose gonadotropin releasing hormone | 
|  14780-1 | Hexacarboxylate [Moles/volume] in Stool | 
|  14781-9 | Hexacarboxylate [Moles/volume] in Urine | 
|  14782-7 | Homovanillate [Moles/volume] in Urine | 
|  14783-5 | Homovanillate [Moles/time] in 24 hour Urine | 
|  14784-3 | Hydroxyproline Free [Moles/time] in 24 hour Urine | 
|  14785-0 | Hydroxyproline [Moles/time] in 24 hour Urine | 
|  14786-8 | Deprecated Arthropod identified in Unspecified specimen | 
|  14787-6 | Arthropod identified in Unspecified specimen by Permanent mount | 
|  14788-4 | Helminth+Arthropod identified in Unspecified specimen by Rearing/Culture | 
|  14789-2 | Helminth identified in Unspecified specimen by Macro/micro identification | 
|  1479-5 | Galactose [Mass/volume] in Blood --1.5 hours post 40 g galactose PO | 
|  14790-0 | Helminth identified in Unspecified specimen by Permanent mount | 
|  14791-8 | Imipramine+Desipramine [Presence] in Gastric fluid | 
|  14792-6 | Imipramine+Desipramine [Presence] in Serum or Plasma | 
|  14793-4 | Imipramine+Desipramine [Presence] in Urine | 
|  14794-2 | Imipramine+Desipramine [Moles/volume] in Serum or Plasma | 
|  14795-9 | Immunoglobulin light chains [Interpretation] in Urine | 
|  14796-7 | Insulin [Moles/volume] in Serum or Plasma | 
|  14797-5 | Iron [Interpretation] in Serum or Plasma | 
|  14798-3 | Iron [Moles/volume] in Serum or Plasma | 
|  14799-1 | Iron [Moles/time] in 24 hour Urine | 
|  148-7 | Cephalexin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1480-3 | Galactose [Mass/volume] in Blood --1 hour post 40 g galactose PO | 
|  14800-7 | Iron binding capacity [Moles/volume] in Serum or Plasma | 
|  14801-5 | Iron saturation [Molar fraction] in Serum or Plasma | 
|  14802-3 | Isopropanol [Moles/volume] in Serum or Plasma | 
|  14803-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction | 
|  14804-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction | 
|  14805-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction | 
|  14806-4 | Lactose.PO [Mass] of Dose | 
|  14807-2 | Lead [Moles/volume] in Blood | 
|  14808-0 | Lead [Moles/volume] in Urine | 
|  14809-8 | Lead [Moles/time] in 24 hour Urine | 
|  1481-1 | Galactose [Mass/volume] in Blood --2 hours post 40 g galactose PO | 
|  14810-6 | Leukocytes [#/volume] in Bronchial specimen by Manual count | 
|  14811-4 | Leukocytes [#/volume] in Pericardial fluid by Manual count | 
|  14812-2 | Lidocaine [Moles/volume] in Serum or Plasma | 
|  14813-0 | Lipoprotein.alpha [Moles/volume] in Serum or Plasma by Electrophoresis | 
|  14814-8 | Lipoprotein.beta [Moles/volume] in Serum or Plasma by Electrophoresis | 
|  14815-5 | Lipoprotein.beta [Moles/volume] in Serum or Plasma by calculation | 
|  14816-3 | Lipoprotein.pre-beta [Moles/volume] in Serum or Plasma by Electrophoresis | 
|  14817-1 | Lorazepam [Moles/volume] in Serum or Plasma | 
|  14818-9 | Lymphocytes/100 leukocytes in Pericardial fluid by Manual count | 
|  14819-7 | Lymphocytes/100 leukocytes in Bronchial specimen by Manual count | 
|  1482-9 | Galactose [Mass/volume] in Blood --30 minutes post 40 g galactose PO | 
|  14820-5 | Lymphocytes/100 leukocytes in Pleural fluid by Manual count | 
|  14821-3 | Lymphocytes/100 leukocytes in Peritoneal fluid by Manual count | 
|  14822-1 | Lymphocytes/100 leukocytes in Synovial fluid by Manual count | 
|  14823-9 | Macrophages/100 leukocytes in Bronchial specimen by Manual count | 
|  14824-7 | Magnesium [Presence] in Stone | 
|  14825-4 | Maprotiline [Moles/volume] in Serum or Plasma | 
|  14826-2 | Meperidine [Presence] in Gastric fluid | 
|  14827-0 | Mesoporphyrin [Moles/volume] in Stool | 
|  14828-8 | Mesothelial cells/100 leukocytes in Pericardial fluid by Manual count | 
|  14829-6 | Mesothelial cells/100 leukocytes in Pleural fluid by Manual count | 
|  1483-7 | Galactose [Mass/time] in 5 hour Urine --post 40 g dose PO | 
|  14830-4 | Mesothelial cells/100 leukocytes in Peritoneal fluid by Manual count | 
|  14831-2 | Metanephrine/Creatinine [Molar ratio] in Urine | 
|  14832-0 | Metanephrines [Moles/volume] in Urine | 
|  14833-8 | Metanephrines [Moles/time] in 24 hour Urine | 
|  14834-6 | Methamphetamine [Presence] in Gastric fluid | 
|  14835-3 | Methanol [Moles/volume] in Serum or Plasma | 
|  14836-1 | Methotrexate [Moles/volume] in Serum or Plasma | 
|  14837-9 | Methsuximide [Moles/volume] in Serum or Plasma | 
|  14838-7 | Toxoplasma gondii [Presence] in Tissue by Organism specific culture | 
|  14839-5 | Trypanosoma sp identified in Buffy Coat by Light microscopy | 
|  1484-5 | Gastrin [Mass/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin | 
|  14840-3 | Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation | 
|  14841-1 | Microscopic observation [Identifier] in Unspecified specimen by Iron hematoxylin stain | 
|  14842-9 | Microscopic observation [Identifier] in Unspecified specimen by Kinyoun iron hematoxylin stain | 
|  14843-7 | 6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid | 
|  14844-5 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma | 
|  14845-2 | Deprecated Monoacetylmorphine [Presence] in Urine | 
|  14846-0 | N-acetylprocainamide [Moles/volume] in Serum or Plasma | 
|  14847-8 | Neutrophils/100 leukocytes in Pericardial fluid by Manual count | 
|  14848-6 | Neutrophils/100 leukocytes in Pleural fluid by Manual count | 
|  14849-4 | Nitrazepam [Moles/volume] in Serum or Plasma | 
|  1485-2 | Gastrin [Mass/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin | 
|  14850-2 | Nitrazepam [Moles/volume] in Urine | 
|  14851-0 | Norclozapine [Moles/volume] in Serum or Plasma | 
|  14852-8 | Norepinephrine [Moles/volume] in Plasma | 
|  14853-6 | Norepinephrine [Moles/volume] in Urine | 
|  14854-4 | Norepinephrine [Moles/time] in 24 hour Urine | 
|  14855-1 | Norfluoxetine [Moles/volume] in Serum or Plasma | 
|  14856-9 | Nortriptyline [Moles/volume] in Serum or Plasma | 
|  14857-7 | Leukocytes other/100 leukocytes in Pericardial fluid by Manual count | 
|  14858-5 | Leukocytes other/100 leukocytes in Pleural fluid by Manual count | 
|  14859-3 | Leukocytes other/100 leukocytes in Peritoneal fluid by Manual count | 
|  1486-0 | Gastrin [Mass/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin | 
|  14860-1 | Leukocytes other/100 leukocytes in Synovial fluid by Manual count | 
|  14861-9 | Oxalate [Presence] in Stone | 
|  14862-7 | Oxalate [Moles/time] in 24 hour Urine | 
|  14863-5 | Oxycodone [Presence] in Gastric fluid | 
|  14864-3 | Oxygen [Partial pressure] in Cord blood | 
|  14865-0 | Parathyrin [Interpretation] in Serum or Plasma | 
|  14866-8 | Parathyrin.intact [Moles/volume] in Serum or Plasma | 
|  14867-6 | Paroxetine [Moles/volume] in Serum or Plasma | 
|  14868-4 | Pathologist report of Plasma or RBC tests | 
|  14869-2 | Pathologist review of Blood tests | 
|  1487-8 | Gastrin [Mass/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin | 
|  14870-0 | Pentacarboxylate [Moles/volume] in Plasma | 
|  14871-8 | Pentacarboxylate [Moles/volume] in Stool | 
|  14872-6 | Pentacarboxylate [Moles/volume] in Urine | 
|  14873-4 | pH of Cord blood | 
|  14874-2 | Phenobarbital [Moles/volume] in Serum or Plasma | 
|  14875-9 | Phenylalanine [Moles/volume] in Serum or Plasma | 
|  14876-7 | Phenylpropanolamine [Presence] in Gastric fluid | 
|  14877-5 | Phenytoin [Moles/volume] in Serum or Plasma | 
|  14878-3 | Phosphate [Presence] in Stone | 
|  14879-1 | Phosphate [Moles/volume] in Serum or Plasma | 
|  1488-6 | Gastrin [Mass/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin | 
|  14880-9 | Deprecated Phosphate [Molecules/volume] in Urine | 
|  14881-7 | Phosphate [Moles/time] in 24 hour Urine | 
|  14882-5 | Porphobilinogen [Moles/time] in 24 hour Urine | 
|  14883-3 | Porphyrins [Interpretation] in Serum or Plasma | 
|  14884-1 | Porphyrins [Interpretation] in Stool | 
|  14885-8 | Pregnanediol [Moles/time] in 24 hour Urine | 
|  14886-6 | Pregnanetriol [Moles/time] in 24 hour Urine | 
|  14887-4 | Primidone [Moles/volume] in Serum or Plasma | 
|  14888-2 | Procainamide [Moles/volume] in Serum or Plasma | 
|  14889-0 | Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma | 
|  1489-4 | Gastrin [Mass/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin | 
|  14890-8 | Progesterone [Moles/volume] in Serum or Plasma | 
|  14891-6 | Propranolol [Moles/volume] in Serum or Plasma | 
|  14892-4 | Propranolol [Moles/volume] in Urine | 
|  14893-2 | Propranolol [Moles/time] in 24 hour Urine | 
|  14894-0 | Propylene glycol [Presence] in Serum or Plasma | 
|  14895-7 | Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation | 
|  14896-5 | Protein Fractions [Interpretation] in Urine by Immunofixation | 
|  14897-3 | Deprecated Protein [Mass/volume] in Plasma | 
|  14898-1 | Protriptyline [Moles/volume] in Serum or Plasma | 
|  14899-9 | Quinidine [Moles/volume] in Serum or Plasma | 
|  149-5 | Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1490-2 | Gastrin [Mass/volume] in Serum or Plasma --pre 0.2 U/kg secretin | 
|  14900-5 | Ranitidine [Presence] in Gastric fluid | 
|  14901-3 | Ranitidine [Presence] in Serum or Plasma | 
|  14902-1 | Ranitidine [Presence] in Urine | 
|  14903-9 | Folate [Interpretation] in Blood | 
|  14904-7 | Reagin Ab [Presence] in Unspecified specimen by VDRL | 
|  14905-4 | Retinol [Moles/volume] in Serum or Plasma | 
|  14906-2 | Rh [Type] in Cord blood | 
|  14907-0 | Rh [Type] in Blood from Blood product unit | 
|  14908-8 | Rh [Type] in Blood from newborn | 
|  14909-6 | Salicylates [Moles/volume] in Serum or Plasma | 
|  1491-0 | Glucose [Mass/volume] in Urine --30 minutes post 100 g glucose PO | 
|  14910-4 | Serotonin [Moles/volume] in Serum | 
|  14911-2 | Sertraline [Moles/volume] in Serum or Plasma | 
|  14912-0 | Smudge cells/100 leukocytes in Blood by Manual count | 
|  14913-8 | Testosterone [Moles/volume] in Serum or Plasma | 
|  14914-6 | Testosterone Free [Moles/volume] in Serum or Plasma | 
|  14915-3 | Theophylline [Moles/volume] in Serum or Plasma | 
|  14916-1 | Thiocyanate [Moles/volume] in Serum or Plasma | 
|  14917-9 | Thioridazine [Moles/volume] in Serum or Plasma | 
|  14918-7 | Thyroglobulin [Moles/volume] in Serum or Plasma | 
|  14919-5 | Thyrotropin binding inhibitory immunoglobulins [Presence] in Serum | 
|  1492-8 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.5 g/kg glucose IV | 
|  14920-3 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma | 
|  14921-1 | Thyroxine (T4) [Moles/volume] in Serum or Plasma | 
|  14922-9 | Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum by Immunoassay | 
|  14923-7 | Toxoplasma gondii Ab [Units/volume] in Unspecified specimen | 
|  14924-5 | Transfusion reaction [Interpretation] in Plasma or RBC Narrative | 
|  14925-2 | Trazodone [Moles/volume] in Serum or Plasma | 
|  14926-0 | Triazolam [Moles/volume] in Serum or Plasma | 
|  14927-8 | Triglyceride [Moles/volume] in Serum or Plasma | 
|  14928-6 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma | 
|  14929-4 | Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma | 
|  1493-6 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting | 
|  14930-2 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma | 
|  14931-0 | Trimipramine [Moles/volume] in Serum or Plasma | 
|  14932-8 | Urate [Presence] in Stone | 
|  14933-6 | Urate [Moles/volume] in Serum or Plasma | 
|  14934-4 | Urate [Moles/volume] in Urine | 
|  14935-1 | Urate [Moles/time] in 24 hour Urine | 
|  14936-9 | Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid | 
|  14937-7 | Urea nitrogen [Moles/volume] in Serum or Plasma | 
|  14938-5 | Urea nitrogen [Moles/volume] in Urine | 
|  14939-3 | Urea nitrogen [Moles/time] in 24 hour Urine | 
|  1494-4 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 100 g glucose PO | 
|  14940-1 | Uroporphyrin 1 isomer [Moles/volume] in Serum or Plasma | 
|  14941-9 | Uroporphyrin 1 isomer [Moles/volume] in Stool | 
|  14942-7 | Uroporphyrin 1 isomer [Moles/volume] in Urine | 
|  14943-5 | Uroporphyrin 3 isomer [Moles/volume] in Serum or Plasma | 
|  14944-3 | Uroporphyrin 3 isomer [Moles/volume] in Stool | 
|  14945-0 | Uroporphyrin 3 isomer [Moles/volume] in Urine | 
|  14946-8 | Valproate [Moles/volume] in Serum or Plasma | 
|  14947-6 | Vanillylmandelate [Moles/time] in 24 hour Urine | 
|  14948-4 | Vanillylmandelate/Creatinine [Molar ratio] in Urine | 
|  14949-2 | Vasopressin [Moles/volume] in Plasma | 
|  1495-1 | Glucose [Mass/volume] in Urine --1.5 hours post 100 g glucose PO | 
|  14950-0 | Viscosity of Synovial fluid Qualitative | 
|  14951-8 | Volatile drugs positive [Identifier] in Serum or Plasma by Screen method | 
|  14952-6 | Xylose [Moles/volume] in Blood --1 hour post 25 g xylose PO | 
|  14953-4 | Xylose [Moles/volume] in Blood --2 hours post 25 g xylose PO | 
|  14954-2 | Xylose [Moles/time] in 5 hour Urine --post dose PO | 
|  14955-9 | Zinc [Moles/volume] in Serum or Plasma | 
|  14956-7 | Microalbumin [Mass/time] in 24 hour Urine | 
|  14957-5 | Microalbumin [Mass/volume] in Urine | 
|  14958-3 | Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine | 
|  14959-1 | Microalbumin/Creatinine [Mass Ratio] in Urine | 
|  1496-9 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO | 
|  14960-9 | Estradiol (E2) Free/Estradiol (E2).total in Serum or Plasma | 
|  14961-7 | CD10 Abnormal blood cells/Abnormal blood cells.total in Blood | 
|  14962-5 | CD13 Abnormal blood cells/Abnormal blood cells.total in Blood | 
|  14963-3 | CD14 Abnormal blood cells/Abnormal blood cells.total in Blood | 
|  14964-1 | CD19 Abnormal blood cells/Abnormal blood cells.total in Blood | 
|  14965-8 | CD2 Abnormal blood cells/Abnormal blood cells.total in Blood | 
|  14966-6 | CD20 Abnormal blood cells/Abnormal blood cells.total in Blood | 
|  14967-4 | CD33 Abnormal blood cells/Abnormal blood cells.total in Blood | 
|  14968-2 | CD5 Abnormal blood cells/Abnormal blood cells.total in Blood | 
|  14969-0 | CD7 Abnormal blood cells/Abnormal blood cells.total in Blood | 
|  1497-7 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV | 
|  14970-8 | Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma | 
|  14971-6 | Estrone (E1).bioavailable/Estrone (E1).total in Serum or Plasma | 
|  14972-4 | Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method | 
|  14973-2 | Mycobacterium sp DNA [Presence] in Sputum by Probe and target amplification method | 
|  14974-0 | Mycobacterium sp DNA [Presence] in Unspecified specimen by Probe and target amplification method | 
|  14975-7 | Human antimouse Ab [Mass/volume] in Serum | 
|  14976-5 | Lecithin/Sphingomyelin [Ratio] in Amniotic fluid | 
|  14977-3 | Immunoglobulin light chains.free [Type] in Urine | 
|  14978-1 | Cyclosporine [Mass/volume] in Blood by Immunoassay | 
|  14979-9 | aPTT in Platelet poor plasma by Coagulation assay | 
|  1498-5 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post 0.5 g/kg glucose IV | 
|  14980-7 | A variant subtype Ab [Presence] in Serum or Plasma from Blood product unit | 
|  14981-5 | A variant subtype Ab [Presence] in Serum or Plasma from donor | 
|  14982-3 | A variant subtype Ab [Presence] in Serum or Plasma | 
|  14983-1 | I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit | 
|  14984-9 | I (intermediate) subtype [Presence] on Red Blood Cells from donor | 
|  14985-6 | I (intermediate) subtype [Presence] on Red Blood Cells | 
|  14986-4 | little i-1 subtype [Presence] on Red Blood Cells from Blood product unit | 
|  14987-2 | little i-1 subtype [Presence] on Red Blood Cells from donor | 
|  14988-0 | little i-1 subtype [Presence] on Red Blood Cells | 
|  14989-8 | little i-2 subtype [Presence] on Red Blood Cells from Blood product unit | 
|  1499-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.5 g/kg glucose IV | 
|  14990-6 | little i-2 subtype [Presence] on Red Blood Cells from donor | 
|  14991-4 | little i-2 subtype [Presence] on Red Blood Cells | 
|  14992-2 | O group [Presence] on Red Blood Cells from Blood product unit | 
|  14993-0 | O group [Presence] on Red Blood Cells from donor | 
|  14994-8 | O group [Presence] on Red Blood Cells | 
|  14995-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO | 
|  14996-3 | Glucose [Moles/volume] in Serum or Plasma --pre 75 g glucose PO | 
|  14997-1 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV | 
|  14998-9 | Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV | 
|  14999-7 | Thyrotropin [Units/volume] in Serum or Plasma --baseline | 
|  15-8 | Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  150-3 | Cephalexin [Susceptibility] by Disk diffusion (KB) | 
|  1500-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst | 
|  15000-3 | Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV | 
|  15001-1 | Xylose [Moles/volume] in Serum or Plasma --1 hour post 25 g xylose PO | 
|  15002-9 | Xylose [Moles/volume] in Serum or Plasma --2 hours post 25 g xylose PO | 
|  15003-7 | 11-Hydroxyandrosterone [Moles/time] in 24 hour Urine | 
|  15004-5 | 11-Hydroxyetiocholanolone [Moles/time] in 24 hour Urine | 
|  15005-2 | 11-Ketoandrosterone [Moles/time] in 24 hour Urine | 
|  15006-0 | 11-Ketoetiocholanolone [Moles/time] in 24 hour Urine | 
|  15007-8 | 2,3-Diphosphoglycerate [Moles/volume] in Red Blood Cells | 
|  15008-6 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum | 
|  15009-4 | 5-Hydroxyindoleacetate [Moles/volume] in Urine | 
|  1501-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO | 
|  15010-2 | Aldosterone [Moles/volume] in Urine | 
|  15011-0 | Aldosterone [Moles/volume] in Serum or Plasma --supine | 
|  15012-8 | Aldosterone [Moles/volume] in Serum or Plasma --upright | 
|  15013-6 | Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma | 
|  15014-4 | Alkaline phosphatase.intestinal/Alkaline phosphatase.total in Serum or Plasma | 
|  15015-1 | Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma | 
|  15016-9 | Alkaline phosphatase.placental/Alkaline phosphatase.total in Serum or Plasma | 
|  15017-7 | Alkaline phosphatase.regan/Alkaline phosphatase.total in Serum or Plasma | 
|  15018-5 | Alkaline phosphatase.renal/Alkaline phosphatase.total in Serum or Plasma | 
|  15019-3 | Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid | 
|  1502-4 | Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO | 
|  15020-1 | Amylase.P1/Amylase.total in Serum or Plasma | 
|  15021-9 | Amylase.P2/Amylase.total in Serum or Plasma | 
|  15022-7 | Amylase.P3/Amylase.total in Serum or Plasma | 
|  15023-5 | Amylase S1/Amylase.total in Serum or Plasma | 
|  15024-3 | Amylase S2/Amylase.total in Serum or Plasma | 
|  15025-0 | Amylase S3/Amylase.total in Serum or Plasma | 
|  15026-8 | Androstanediol [Moles/volume] in Serum or Plasma | 
|  15027-6 | Androstenedione [Moles/volume] in Urine | 
|  15028-4 | Androstenedione [Moles/time] in 24 hour Urine | 
|  15029-2 | Androsterone [Moles/volume] in Serum or Plasma | 
|  1503-2 | Glucose [Mass/volume] in Urine --1 hour post 100 g glucose PO | 
|  15030-0 | Androsterone [Moles/time] in 24 hour Urine | 
|  15031-8 | Angiotensin I [Moles/volume] in Plasma | 
|  15032-6 | Angiotensin II [Moles/volume] in Plasma | 
|  15033-4 | Ascorbate [Moles/time] in 24 hour Urine | 
|  15034-2 | Bromide [Moles/volume] in Serum or Plasma | 
|  15035-9 | Calcitonin [Moles/volume] in Serum or Plasma | 
|  15036-7 | Catecholamines [Moles/time] in 24 hour Urine | 
|  15037-5 | Chymotrypsin [Moles/mass] in Stool | 
|  15038-3 | Citrate [Moles/volume] in Serum or Plasma | 
|  15039-1 | Deprecated Cobalamin [Molecules/volume] in Serum | 
|  1504-0 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO | 
|  15040-9 | Coproporphyrin [Moles/time] in 24 hour Stool | 
|  15041-7 | Coproporphyrin [Moles/time] in 24 hour Urine | 
|  15042-5 | Corticotropin [Units/volume] in Serum | 
|  15043-3 | Cortisol [Moles/volume] in Urine | 
|  15044-1 | Cortisol Free [Moles/volume] in Serum or Plasma | 
|  15045-8 | Creatine [Moles/volume] in Serum or Plasma | 
|  15046-6 | Creatine [Moles/volume] in Urine | 
|  15047-4 | Creatine [Moles/time] in 24 hour Urine | 
|  15048-2 | Creatine kinase.BB/Creatine kinase.total in Serum or Plasma by Electrophoresis | 
|  15049-0 | Creatine kinase.MM/Creatine kinase.total in Serum or Plasma by Electrophoresis | 
|  1505-7 | Glucose [Mass/volume] in Urine --1 hour post 50 g glucose PO | 
|  15050-8 | Creatinine [Moles/volume] in Amniotic fluid | 
|  15051-6 | Creatinine [Moles/volume] in Dialysis fluid | 
|  15052-4 | Cobalamin (Vitamin B12).unsaturated Binding Capacity [Moles/volume] in Serum or Plasma | 
|  15053-2 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/time] in 24 hour Urine | 
|  15054-0 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma | 
|  15055-7 | Deoxypyridinoline [Moles/time] in 24 hour Urine | 
|  15056-5 | Deprecated Deoxypyridinoline [Molecules/time] in 24 hour Urine | 
|  15057-3 | Androstanolone [Moles/volume] in Serum or Plasma | 
|  15058-1 | Dopamine [Moles/volume] in Urine | 
|  15059-9 | Dopamine [Moles/time] in 24 hour Urine | 
|  1506-5 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO | 
|  15060-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma | 
|  15061-5 | Erythropoietin (EPO) [Units/volume] in Serum or Plasma | 
|  15062-3 | Estradiol (E2).unconjugated [Moles/time] in 24 hour Urine | 
|  15063-1 | Estriol (E3).conjugated [Moles/volume] in Serum or Plasma | 
|  15064-9 | Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma | 
|  15065-6 | Etiocholanolone [Moles/time] in 24 hour Urine | 
|  15066-4 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma | 
|  15067-2 | Follitropin [Units/volume] in Serum or Plasma | 
|  15068-0 | Follitropin [Units] in 24 hour Urine | 
|  15069-8 | Fructosamine [Moles/volume] in Serum or Plasma | 
|  1507-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO | 
|  15070-6 | Fructose [Moles/time] in 24 hour Urine | 
|  15071-4 | Galactose [Moles/time] in 24 hour Urine | 
|  15072-2 | Gastrin [Moles/volume] in Serum or Plasma | 
|  15073-0 | Glucagon [Moles/volume] in Serum or Plasma | 
|  15074-8 | Glucose [Moles/volume] in Blood | 
|  15075-5 | Glucose [Moles/volume] in Dialysis fluid | 
|  15076-3 | Glucose [Moles/volume] in Urine | 
|  15077-1 | Glucose [Moles/time] in 24 hour Urine | 
|  15078-9 | Lactate [Moles/time] in 24 hour Urine | 
|  15079-7 | Lutropin [Units/volume] in Urine | 
|  1508-1 | Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO | 
|  15080-5 | Lutropin [Units] in 24 hour Urine | 
|  15081-3 | Prolactin [Units/volume] in Serum or Plasma | 
|  15082-1 | Methemoglobin [Mass/volume] in Blood | 
|  15083-9 | Normetanephrine [Moles/time] in 24 hour Urine | 
|  15084-7 | Osteocalcin [Moles/volume] in Serum or Plasma | 
|  15085-4 | Oxalate [Moles/volume] in Serum or Plasma | 
|  15086-2 | Oxalate [Moles/volume] in Urine | 
|  15087-0 | Parathyrin related protein [Moles/volume] in Serum or Plasma | 
|  15088-8 | Parathyrin.C-terminal [Moles/volume] in Serum or Plasma | 
|  15089-6 | Phospholipid [Moles/volume] in Serum or Plasma | 
|  1509-9 | Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO | 
|  15090-4 | Porphyrins [Moles/time] in 24 hour Stool | 
|  15091-2 | Pregnanediol [Moles/volume] in Urine | 
|  15092-0 | Pregnanetriol [Moles/volume] in Urine | 
|  15093-8 | Protoporphyrin Free [Moles/volume] in Blood | 
|  15094-6 | Testosterone [Moles/volume] in Urine | 
|  15095-3 | Testosterone [Moles/time] in 24 hour Urine | 
|  15096-1 | Uroporphyrin [Moles/time] in 24 hour Urine | 
|  15097-9 | Vanillylmandelate [Moles/volume] in Urine | 
|  15098-7 | Amikacin [Moles/volume] in Serum or Plasma --random | 
|  15099-5 | Amiodarone [Moles/volume] in Serum or Plasma | 
|  151-1 | Cephalexin [Susceptibility] by Serum bactericidal titer | 
|  1510-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV | 
|  15100-1 | Barbiturates [Moles/volume] in Serum or Plasma | 
|  15101-9 | Chloramphenicol [Moles/volume] in Serum or Plasma | 
|  15102-7 | Codeine [Moles/volume] in Serum or Plasma | 
|  15103-5 | Cyclosporine [Moles/volume] in Serum | 
|  15104-3 | Digitoxin [Moles/volume] in Serum or Plasma | 
|  15105-0 | Flecainide [Moles/volume] in Serum or Plasma | 
|  15106-8 | Gentamicin [Moles/volume] in Serum or Plasma --random | 
|  15107-6 | Imipramine [Moles/volume] in Serum or Plasma | 
|  15108-4 | Methadone [Moles/volume] in Serum or Plasma | 
|  15109-2 | Midazolam [Moles/volume] in Serum or Plasma | 
|  1511-5 | Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV | 
|  15110-0 | Morphine [Moles/volume] in Serum or Plasma | 
|  15111-8 | Tricyclic antidepressants [Moles/volume] in Serum or Plasma | 
|  15112-6 | Leukocyte phosphatase [Units/volume] in Leukocytes | 
|  15113-4 | Aluminum [Moles/volume] in Dialysis fluid | 
|  15114-2 | Arsenic [Moles/volume] in Blood | 
|  15115-9 | Arsenic [Moles/volume] in Urine | 
|  15116-7 | Deprecated Arsenic [Molecules/volume] in Urine | 
|  15117-5 | Cadmium [Moles/volume] in Blood | 
|  15118-3 | Chromium [Moles/volume] in Blood | 
|  15119-1 | Cobalt [Moles/volume] in Blood | 
|  1512-3 | Glucose [Mass/volume] in Serum or Plasma --1 minute post 0.5 g/kg glucose IV | 
|  15120-9 | Ethanol [Moles/volume] in Blood | 
|  15121-7 | Lipoprotein.alpha/total Lipoprotein in Serum or Plasma | 
|  15122-5 | Lipoprotein.beta/total Lipoprotein in Serum or Plasma | 
|  15123-3 | Lipoprotein.pre-beta/total Lipoprotein in Serum or Plasma | 
|  15124-1 | Albumin/Protein.total in Synovial fluid by Electrophoresis | 
|  15125-8 | Alpha 1 globulin/Protein.total in Synovial fluid by Electrophoresis | 
|  15126-6 | Alpha 2 globulin/Protein.total in Synovial fluid by Electrophoresis | 
|  15127-4 | Beta globulin/Protein.total in Synovial fluid by Electrophoresis | 
|  15128-2 | Gamma globulin/Protein.total in Synovial fluid by Electrophoresis | 
|  15129-0 | Deprecated Fibrin D-dimer EIA | 
|  1513-1 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post 0.5 g/kg glucose IV | 
|  15130-8 | Methionine+Tryptophan [Presence] in Serum or Plasma | 
|  15131-6 | Isoleucine+Leucine [Presence] in Serum or Plasma | 
|  15132-4 | Beta aminoisobutyrate+Proline [Presence] in Serum or Plasma | 
|  15133-2 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Serum or Plasma | 
|  15134-0 | Glutamate+Glutamine+Threonine [Presence] in Serum or Plasma | 
|  15135-7 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Serum or Plasma | 
|  15136-5 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Serum or Plasma | 
|  15137-3 | Alanine+Ethanolamine [Presence] in Serum or Plasma | 
|  15138-1 | Isoleucine+Leucine [Presence] in Urine | 
|  15139-9 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Urine | 
|  1514-9 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO | 
|  15140-7 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Urine | 
|  15141-5 | Beta aminoisobutyrate+Proline [Presence] in Urine | 
|  15142-3 | Alanine+Ethanolamine [Presence] in Urine | 
|  15143-1 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Urine | 
|  15144-9 | Glutamate+Glutamine+Threonine [Presence] in Urine | 
|  15145-6 | Methionine+Tryptophan [Presence] in Urine | 
|  15146-4 | Acetone [Units/volume] in Body fluid | 
|  15147-2 | Deprecated Acetone [Units] in 24 hour Urine Qualitative | 
|  15148-0 | Alkaline phosphatase [Enzymatic activity/volume] in Body fluid | 
|  15149-8 | Ammonia [Moles/volume] in Body fluid | 
|  1515-6 | Deprecated Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO | 
|  15150-6 | Anisocytosis [Presence] in Blood by Automated count | 
|  15151-4 | Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15152-2 | Bilirubin.conjugated [Mass/volume] in Serum or Plasma | 
|  15153-0 | Deprecated Indirect bilirubin [Mass/volume] in Serum or Plasma | 
|  15154-8 | Blasts [Presence] in Blood by Automated count | 
|  15155-5 | Calcium [Mass/volume] in Body fluid | 
|  15156-3 | Cancer Ag 125 [Units/volume] in Body fluid by Dilution | 
|  15157-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution | 
|  15158-9 | Chloride [Moles/volume] in Stool | 
|  15159-7 | Coagulation factor extrinsic pathway [Interpretation] in Platelet poor plasma Narrative | 
|  1516-4 | Glucose [Mass/volume] in Urine --2 hours post 100 g glucose PO | 
|  15160-5 | Coagulation factor Intrinsic Factor [Interpretation] in Platelet poor plasma Narrative | 
|  15161-3 | Complement C1 esterase inhibitor.functional [Presence] in Serum or Plasma | 
|  15162-1 | Complement C1q [Mass/volume] in Body fluid | 
|  15163-9 | Complement C2 [Mass/volume] in Body fluid | 
|  15164-7 | Complement C3 [Mass/volume] in Synovial fluid | 
|  15165-4 | Complement C4 [Mass/volume] in Synovial fluid | 
|  15166-2 | Complement C5 [Mass/volume] in Body fluid | 
|  15167-0 | Complement C6 [Mass/volume] in Body fluid | 
|  15168-8 | Complement total hemolytic C50 [Units/volume] in Body fluid by Immunoassay | 
|  15169-6 | Complement total hemolytic C50 [Units/volume] in Serum or Plasma by Immunoassay | 
|  1517-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO | 
|  15170-4 | Complement total hemolytic C50 [Units/volume] in Synovial fluid by Immunoassay | 
|  15171-2 | Cryoglobulin.IgA [Units/volume] in Serum | 
|  15172-0 | Cryoglobulin.IgG [Units/volume] in Serum | 
|  15173-8 | Cryoglobulin.IgM [Units/volume] in Serum | 
|  15174-6 | Cryocrit of Serum by Spun Westergren | 
|  15175-3 | Cryoproteins [Interpretation] in Serum or Plasma by Electrophoresis agarose gel | 
|  15176-1 | Cryoproteins identified in Serum or Plasma | 
|  15177-9 | DNA double strand Ab [Units/volume] in Body fluid | 
|  15178-7 | Complement factor B [Mass/volume] in Body fluid | 
|  15179-5 | Fibrin D-dimer [Presence] in Platelet poor plasma | 
|  1518-0 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO | 
|  15180-3 | Hypochromia [Presence] in Blood by Automated count | 
|  15181-1 | IgA [Mass/volume] in Body fluid | 
|  15182-9 | IgA [Presence] in Serum by Immunoelectrophoresis | 
|  15183-7 | IgG [Mass/volume] in Body fluid | 
|  15184-5 | IgG [Presence] in Serum by Immunoelectrophoresis | 
|  15185-2 | IgM [Mass/volume] in Body fluid | 
|  15186-0 | IgM [Presence] in Serum by Immunoelectrophoresis | 
|  15187-8 | Immunoglobulin light chains.lambda [Mass/volume] in 24 hour Urine | 
|  15188-6 | Immunoglobulin light chains.kappa [Mass/volume] in 24 hour Urine | 
|  15189-4 | Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda [Mass Ratio] in Serum | 
|  1519-8 | Deprecated Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO | 
|  15190-2 | Leukocytes other [Identifier] in Blood by Automated count | 
|  15191-0 | Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma | 
|  15192-8 | Variant lymphocytes [Presence] in Blood by Automated count | 
|  15193-6 | CD3-CD16+ cells [#/volume] in Blood | 
|  15194-4 | CD3-CD16+ cells/100 cells in Blood | 
|  15195-1 | CD3-CD19+ cells [#/volume] in Blood | 
|  15196-9 | CD3-CD19+ cells/100 cells in Blood | 
|  15197-7 | Lymphocytes clefted/100 leukocytes in Blood by Manual count | 
|  15198-5 | Macrocytes [Presence] in Blood by Automated count | 
|  15199-3 | Microcytes [Presence] in Blood by Automated count | 
|  152-9 | Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1520-6 | Glucose [Mass/volume] in Urine --2 hours post 75 g glucose PO | 
|  15200-9 | Osmolality of Body fluid | 
|  15201-7 | Platelets Large Fragments [#/volume] in Blood by Manual count | 
|  15202-5 | Potassium [Moles/volume] in Stool | 
|  15203-3 | Rheumatoid factor [Units/volume] in Body fluid by Nephelometry | 
|  15204-1 | Rheumatoid factor [Titer] in Serum by Nephelometry | 
|  15205-8 | Rheumatoid factor [Units/volume] in Serum by Nephelometry | 
|  15206-6 | Rheumatoid factor [Units/volume] in Synovial fluid by Nephelometry | 
|  15207-4 | Sodium [Moles/volume] in Stool | 
|  15208-2 | Taurine [Presence] in Nose | 
|  15209-0 | Saccharomonospora viridis Ab [Presence] in Serum by Immune diffusion (ID) | 
|  1521-4 | Glucose [Mass/volume] in Serum or Plasma --2 hours post meal | 
|  15210-8 | Thyroglobulin Ab [Presence] in Serum | 
|  15211-6 | Biopsy [Interpretation] in Thyroid Narrative | 
|  15212-4 | Lipase [Enzymatic activity/volume] in Body fluid | 
|  15213-2 | Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Presence] in Serum by Multidisk | 
|  15214-0 | Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Presence] in Serum by Multidisk | 
|  15215-7 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Presence] in Serum by Multidisk | 
|  15216-5 | Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk | 
|  15217-3 | Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk | 
|  15218-1 | Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk | 
|  15219-9 | Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk | 
|  1522-2 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.5 g/kg glucose IV | 
|  15220-7 | Food Allergen Mix A (Peanut+Cow milk+Egg white+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk | 
|  15221-5 | Food Allergen Mix F (Buckwheat+Soybean+Rice+Sesame seed+Wheat) IgE Ab [Presence] in Serum by Multidisk | 
|  15222-3 | Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Presence] in Serum by Multidisk | 
|  15223-1 | Food Allergen Mix B (Tarragon+Lovage+Marjoram) IgE Ab [Presence] in Serum by Multidisk | 
|  15224-9 | Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Presence] in Serum by Multidisk | 
|  15225-6 | Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Presence] in Serum by Multidisk | 
|  15226-4 | Food Allergen Mix G (Beef+Chicken meat+Pork+Plaice) IgE Ab [Presence] in Serum by Multidisk | 
|  15227-2 | Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Presence] in Serum by Multidisk | 
|  15228-0 | Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Presence] in Serum by Multidisk | 
|  15229-8 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk | 
|  1523-0 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst | 
|  15230-6 | Grass Allergen Mix C (Brome+Bermuda grass+Velvet grass+Bahia grass+Timothy+Johnson grass) IgE Ab [Presence] in Serum by Multidisk | 
|  15231-4 | Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Presence] in Serum by Multidisk | 
|  15232-2 | Regional Allergen Mix A (Common ragweed+Mugwort+Japenese cedar+Orchard grass+Timothy) IgE Ab [Presence] in Serum by Multidisk | 
|  15233-0 | Mold Allergen Mix A (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk | 
|  15234-8 | Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk | 
|  15235-5 | Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Presence] in Serum by Multidisk | 
|  15236-3 | Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Presence] in Serum by Multidisk | 
|  15237-1 | Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Presence] in Serum by Multidisk | 
|  15238-9 | Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Presence] in Serum by Multidisk | 
|  15239-7 | Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk | 
|  1524-8 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.1 U/kg insulin | 
|  15240-5 | Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk | 
|  15241-3 | Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk | 
|  15242-1 | Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Presence] in Serum by Multidisk | 
|  15243-9 | Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Presence] in Serum by Multidisk | 
|  15244-7 | Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Presence] in Serum by Multidisk | 
|  15245-4 | Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Presence] in Serum by Multidisk | 
|  15246-2 | Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk | 
|  15247-0 | Food Allergen Mix H (Pineapple+Lemon+Strawberry+Avocado) IgE Ab [Presence] in Serum by Multidisk | 
|  15248-8 | Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Presence] in Serum by Multidisk | 
|  15249-6 | Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Presence] in Serum by Multidisk | 
|  1525-5 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 100 g glucose PO | 
|  15250-4 | Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Presence] in Serum by Multidisk | 
|  15251-2 | Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk | 
|  15252-0 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Presence] in Serum by Multidisk | 
|  15253-8 | Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Presence] in Serum by Multidisk | 
|  15254-6 | Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Presence] in Serum by Multidisk | 
|  15255-3 | Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Presence] in Serum by Multidisk | 
|  15256-1 | Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Presence] in Serum by Multidisk | 
|  15257-9 | Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk | 
|  15258-7 | Regional Allergen Mix B (Common ragweed+Goosefoot or Lambs quarters+Bermuda grass+Perennial rye grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk | 
|  15259-5 | Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Presence] in Serum by Multidisk | 
|  1526-3 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO | 
|  15260-3 | Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Presence] in Serum by Multidisk | 
|  15261-1 | Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Presence] in Serum by Multidisk | 
|  15262-9 | Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Presence] in Serum by Multidisk | 
|  15263-7 | Tree Allergen Mix D (Cottonwood+Elm+Maple+Oak+Pecan tree) IgE Ab [Presence] in Serum by Multidisk | 
|  15264-5 | Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Presence] in Serum by Multidisk | 
|  15265-2 | Tree Allergen Mix E (American sycamore+Cottonwood+White oak+Willow+White elm) IgE Ab [Presence] in Serum by Multidisk | 
|  15266-0 | Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk | 
|  15267-8 | Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Presence] in Serum by Multidisk | 
|  15268-6 | Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Presence] in Serum by Multidisk | 
|  15269-4 | Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Presence] in Serum by Multidisk | 
|  1527-1 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO | 
|  15270-2 | Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Presence] in Serum by Multidisk | 
|  15271-0 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Presence] in Serum by Multidisk | 
|  15272-8 | Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Presence] in Serum by Multidisk | 
|  15273-6 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Presence] in Serum by Multidisk | 
|  15274-4 | Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Presence] in Serum by Multidisk | 
|  15275-1 | Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Presence] in Serum by Multidisk | 
|  15276-9 | Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Presence] in Serum by Multidisk | 
|  15277-7 | Deprecated Turkey feather IgE Ab [Units/volume] in Serum | 
|  15278-5 | Lovage IgE Ab [Units/volume] in Serum | 
|  15279-3 | Cardamon IgE Ab [Units/volume] in Serum | 
|  1528-9 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV | 
|  15280-1 | Mace IgE Ab [Units/volume] in Serum | 
|  15281-9 | Horse Bot Fly IgE Ab [Units/volume] in Serum | 
|  15282-7 | Deprecated Cultivated Rye IgE Ab [Units/volume] in Serum | 
|  15283-5 | Silver Birch IgE Ab [Units/volume] in Serum | 
|  15284-3 | Grey Alder IgE Ab [Units/volume] in Serum | 
|  15285-0 | London Plane IgE Ab [Units/volume] in Serum | 
|  15286-8 | Kidney - left Height by US | 
|  15287-6 | Kidney - left Width by US | 
|  15288-4 | Kidney - left Length by US | 
|  15289-2 | Kidney - right Height by US | 
|  1529-7 | Deprecated Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV | 
|  15290-0 | Kidney - right Width by US | 
|  15291-8 | Kidney - right Length by US | 
|  15292-6 | Testis - left Height by US | 
|  15293-4 | Testis - left Width by US | 
|  15294-2 | Testis - left Length by US | 
|  15295-9 | Testis - right Height by US | 
|  15296-7 | Testis - right Width by US | 
|  15297-5 | Testis - right Length by US | 
|  15298-3 | Urinary bladder Height by US | 
|  15299-1 | Urinary bladder Width by US | 
|  153-7 | Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1530-5 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO | 
|  15300-7 | Urinary bladder Length by US | 
|  15301-5 | Prostate Height by US | 
|  15302-3 | Prostate Width by US | 
|  15303-1 | Prostate Length by US | 
|  15304-9 | Kidney - left Volume by derived from height, width and length (US) | 
|  15305-6 | Kidney - right Volume by derived from height, width and length (US) | 
|  15306-4 | Testis - left Volume by derived from height, width and length (US) | 
|  15307-2 | Testis - right Volume by derived from height, width and length (US) | 
|  15308-0 | Prostate Volume by derived from height, width and length (US) | 
|  15309-8 | Urinary bladder Volume by derived from height, width and length (US) | 
|  1531-3 | Deprecated Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO | 
|  15310-6 | Kidney - left Volume by derived.from ROT (US) | 
|  15311-4 | Kidney - right Volume by derived.from ROT (US) | 
|  15312-2 | Testis - left Volume by derived.from ROT (US) | 
|  15313-0 | Testis - right Volume by derived.from ROT (US) | 
|  15314-8 | Prostate Volume by derived.from ROT (US) | 
|  15315-5 | Prostate Volume by derived by planimetry (US) | 
|  15316-3 | Volume planimetry Stepsize by - Reported | 
|  15317-1 | Kidney - left Volume by derived by automated ultrasound testing (US) | 
|  15318-9 | Kidney - right Volume by derived by automated ultrasound testing (US) | 
|  15319-7 | Testis - left Volume by derived by automated ultrasound testing (US) | 
|  1532-1 | Glucose [Mass/volume] in Urine --3 hours post 100 g glucose PO | 
|  15320-5 | Testis - right Volume by derived by automated ultrasound testing (US) | 
|  15321-3 | Urinary bladder Volume by derived by EMP (US) | 
|  15323-9 | Prostate specific Ag/Prostate volume calculated from height, width and length | 
|  15324-7 | Prostate specific Ag/Prostate volume calculated from planimetry | 
|  15325-4 | Prostate specific Ag/Prostate volume calculated | 
|  15326-2 | Prostate Adenoma Volume by derived from height, width and length (US) | 
|  15327-0 | Prostate Adenoma Volume by derived by planimetry (US) | 
|  15328-8 | Penile cavernosal artery Peak systolic flow-baseline- by US.doppler | 
|  15329-6 | Penile cavernosal artery Peak systolic flow-post XXX challenge- by US.doppler | 
|  1533-9 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO | 
|  15330-4 | Penile cavernosal artery End diastolic blood flow-baseline- by US.doppler | 
|  15331-2 | Penile cavernosal artery End diastolic blood flow-post XXX challenge- by US.doppler | 
|  15332-0 | Penile cavernosal artery Resistance index-baseline- by US.calculated | 
|  15333-8 | Penile cavernosal artery Resistance index-post XXX challenge- by US.calculated | 
|  15334-6 | Challenge | 
|  15335-3 | Penile cavernosal artery Pulsativity index by US.calculated | 
|  15336-1 | Other Antibiotic [Susceptibility] by Serum bactericidal titer | 
|  15337-9 | Other Antibiotic [Susceptibility] by Serum bactericidal titer --peak | 
|  15338-7 | Other Antibiotic [Susceptibility] by Serum bactericidal titer --trough | 
|  15339-5 | Berlin Beetle IgE Ab [Units/volume] in Serum | 
|  1534-7 | Glucose [Mass/volume] in Serum or Plasma --3 minutes post 0.5 g/kg glucose IV | 
|  15340-3 | Italian Cedar IgE Ab [Units/volume] in Serum | 
|  15341-1 | Black Fly IgE Ab [Units/volume] in Serum | 
|  15342-9 | European Hornet IgE Ab [Units/volume] in Serum | 
|  15343-7 | Blood group antibody screen [Titer] in Serum or Plasma | 
|  15344-5 | little i Ab [Titer] in Serum or Plasma | 
|  15345-2 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  15346-0 | Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | 
|  15347-8 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | 
|  15348-6 | Alkaline phosphatase.liver 1/Alkaline phosphatase.total in Serum or Plasma | 
|  15349-4 | Alkaline phosphatase.liver 2/Alkaline phosphatase.total in Serum or Plasma | 
|  1535-4 | Glucose [Mass/volume] in Serum or Plasma --40 minutes post 0.5 g/kg glucose IV | 
|  15350-2 | Amylase [Enzymatic activity/time] in 2 hour Urine | 
|  15351-0 | Apolipoprotein E2 [Presence] in Blood | 
|  15352-8 | Apolipoprotein E3 [Presence] in Blood | 
|  15353-6 | Apolipoprotein E4 [Presence] in Blood | 
|  15354-4 | Bombesin Ag [Presence] in Tissue by Immune stain | 
|  15355-1 | Estrone sulfate [Mass/volume] in Serum or Plasma | 
|  15356-9 | Globulin [Mass/time] in 24 hour Urine | 
|  15357-7 | Iron [Mass/mass] in Tissue | 
|  15358-5 | Macroamylase [Presence] in Serum or Plasma | 
|  15359-3 | dRVVT actual/normal (normalized LA screen) | 
|  1536-2 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV | 
|  15360-1 | dRVVT actual/normal [Presence] in Platelet poor plasma by Coagulation assay | 
|  15361-9 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma | 
|  15362-7 | aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assay | 
|  15363-5 | Busulfan [Mass/volume] in Serum or Plasma | 
|  15364-3 | Codeine [Mass/volume] in Meconium | 
|  15365-0 | Deprecated Codeine | 
|  15366-8 | Dextroamphetamine [Mass/volume] in Urine | 
|  15367-6 | Ganciclovir [Mass/volume] in Serum or Plasma | 
|  15368-4 | Hypoglycemics.sulfonyluric [Identifier] in Serum or Plasma | 
|  15369-2 | Lithium.saliva/Lithium.serum | 
|  1537-0 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 100 g glucose PO | 
|  15370-0 | Morphine [Mass/volume] in Meconium | 
|  15371-8 | Deprecated Morphine | 
|  15372-6 | Nordiazepam [Mass/volume] in Urine | 
|  15373-4 | Phenyltoloxamine [Mass/volume] in Blood | 
|  15374-2 | Sulfonylurea [Presence] in Serum or Plasma | 
|  15375-9 | Valproate Free [Mass/volume] in Saliva (oral fluid) | 
|  15376-7 | Spermatozoa Abnormal/100 spermatozoa in Semen | 
|  15377-5 | Cytomegalovirus Ab [Presence] in Serum by Latex agglutination | 
|  15378-3 | Fungus identified in Isolate by Culture | 
|  15379-1 | Haemophilus influenzae B Ag [Presence] in Urine | 
|  1538-8 | Glucose [Mass/volume] in Urine --4 hours post 100 g glucose PO | 
|  15380-9 | Leishmania brasilensis IgG Ab [Titer] in Serum | 
|  15381-7 | Leishmania brasilensis IgM Ab [Titer] in Serum | 
|  15382-5 | Leishmania donovani IgG Ab [Titer] in Serum | 
|  15383-3 | Leishmania donovani IgM Ab [Titer] in Serum | 
|  15384-1 | Leishmania mexicana IgG Ab [Titer] in Serum | 
|  15385-8 | Leishmania mexicana IgM Ab [Titer] in Serum | 
|  15386-6 | Leishmania tropica IgG Ab [Titer] in Serum | 
|  15387-4 | Leishmania tropica IgM Ab [Titer] in Serum | 
|  15388-2 | Mycoplasma hominis [Presence] in Unspecified specimen by Organism specific culture | 
|  15389-0 | Parainfluenza virus 1 IgG Ab [Presence] in Serum | 
|  1539-6 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO | 
|  15390-8 | Parainfluenza virus 1 IgM Ab [Presence] in Serum | 
|  15391-6 | Parainfluenza virus 1 IgM Ab [Titer] in Serum | 
|  15392-4 | Parainfluenza virus 2 IgG Ab [Presence] in Serum | 
|  15393-2 | Parainfluenza virus 2 IgM Ab [Titer] in Serum | 
|  15394-0 | Parainfluenza virus 3 IgG Ab [Presence] in Serum | 
|  15395-7 | Parainfluenza virus 3 IgM Ab [Presence] in Serum | 
|  15396-5 | Deprecated Toxoplasma gondii IgG Ab [Units/volume] in Serum | 
|  15397-3 | Trypanosoma cruzi IgM Ab [Titer] in Serum | 
|  15398-1 | Neuronal nuclear Ab [Titer] in Serum | 
|  15399-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence | 
|  154-5 | Cephaloglycin [Susceptibility] by Disk diffusion (KB) | 
|  1540-4 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 100 g glucose PO | 
|  15400-5 | Platelet IgG Ab [Presence] in Serum | 
|  15401-3 | Drugs identified in Blood by Screen method | 
|  15402-1 | Ethanol [Presence] in Meconium | 
|  15403-9 | Isopropanol [Presence] in Meconium | 
|  15404-7 | Levomethamphetamine/Amphetamines.total in Urine | 
|  15405-4 | Methamphetamine [Mass/volume] in Meconium | 
|  15406-2 | Deprecated Methamphetamine | 
|  15407-0 | Methanol [Presence] in Meconium | 
|  15408-8 | Thallium [Mass/mass] in Hair | 
|  15409-6 | Thallium [Mass/mass] in Nail | 
|  1541-2 | Glucose [Mass/volume] in Urine --5 hours post 100 g glucose PO | 
|  15410-4 | Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay | 
|  15411-2 | Ergosterol [Mass/volume] in Serum or Plasma | 
|  15412-0 | Service comment 21 | 
|  15413-8 | Service comment 22 | 
|  15414-6 | Service comment 23 | 
|  15415-3 | Service comment 24 | 
|  15416-1 | Service comment 25 | 
|  15417-9 | Service comment 26 | 
|  15418-7 | Service comment 27 | 
|  15419-5 | Service comment 28 | 
|  1542-0 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO | 
|  15420-3 | Service comment 29 | 
|  15421-1 | Service comment 30 | 
|  15422-9 | Service comment 31 | 
|  15423-7 | Service comment 32 | 
|  15424-5 | Service comment 33 | 
|  15425-2 | Service comment 34 | 
|  15426-0 | Service comment 35 | 
|  15427-8 | Service comment 36 | 
|  15428-6 | Service comment 37 | 
|  15429-4 | Service comment 38 | 
|  1543-8 | Glucose [Mass/volume] in Serum or Plasma --5 minutes post 0.5 g/kg glucose IV | 
|  15430-2 | Service comment 39 | 
|  15431-0 | Service comment 40 | 
|  15432-8 | Testosterone Free/Testosterone.total in Serum or Plasma | 
|  15433-6 | Anaplasma marginale Ab [Presence] in Serum by Agglutination | 
|  15434-4 | Avian adenovirus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15435-1 | Avian adenovirus 2 Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15436-9 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immunoassay | 
|  15437-7 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15438-5 | Avian hemorrhagic enteritis virus Ab [Presence] in Serum by Immunoassay | 
|  15439-3 | Infectious bronchitis virus Ark-99 Ab [Titer] in Serum by Hemagglutination inhibition | 
|  1544-6 | Glucose [Mass/volume] in Serum or Plasma --6 hours post 100 g glucose PO | 
|  15440-1 | Infectious bronchitis virus Mass-41 Ab [Titer] in Serum by Hemagglutination inhibition | 
|  15441-9 | Infectious bronchitis virus Conn-42 Ab [Titer] in Serum by Hemagglutination inhibition | 
|  15442-7 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immunoassay | 
|  15443-5 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15444-3 | Influenza virus A Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15445-0 | Avian leukosis virus Ag [Titer] in Serum by Immunoassay | 
|  15446-8 | Avian leukosis virus Ag [Titer] in Egg yolk by Immunoassay | 
|  15447-6 | Avian paramyxovirus 1 Ab [Presence] in Serum by Immunoassay | 
|  15448-4 | Avian paramyxovirus 1 Ab [Titer] in Serum by Hemagglutination inhibition | 
|  15449-2 | Avian paramyxovirus 2 Ab [Titer] in Serum by Hemagglutination inhibition | 
|  1545-3 | Deprecated Glucose [Mass/volume] in Serum or Plasma --6 hours post 100 g glucose PO | 
|  15450-0 | Avian paramyxovirus 3 Ab [Titer] in Serum by Hemagglutination inhibition | 
|  15451-8 | Avian pox virus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15452-6 | Avian reovirus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15453-4 | Avian reovirus Ab [Presence] in Serum by Immunoassay | 
|  15454-2 | Reticuloendotheliosis virus Ab [Presence] in Serum by Immunoassay | 
|  15455-9 | Bluetongue virus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15456-7 | Bluetongue virus Ab [Presence] in Serum by Immunoassay | 
|  15457-5 | Bordetella avium Ab [Titer] in Serum by Agglutination | 
|  15458-3 | Bordetella avium Ab [Presence] in Serum by Immunoassay | 
|  15459-1 | Bovine herpesvirus 1 Ab [Titer] in Serum by Neutralization test | 
|  1546-1 | Glucose [Mass/volume] in Urine --6 hours post 100 g glucose PO | 
|  15460-9 | Bovine leukemia virus Ab [Presence] in Serum by Immunoassay | 
|  15461-7 | Bovine leukemia virus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15462-5 | Bovine diarrhea virus 1 Ab [Titer] in Serum by Neutralization test | 
|  15463-3 | Bovine diarrhea virus 2 Ab [Titer] in Serum by Neutralization test | 
|  15464-1 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immunoassay | 
|  15465-8 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15466-6 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15467-4 | Equine herpesvirus 1 Ab [Titer] in Serum by Neutralization test | 
|  15468-2 | Equine infectious anemia virus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15469-0 | Equine influenza virus A1 Ab [Titer] in Serum by Hemagglutination inhibition | 
|  1547-9 | Glucose [Mass/volume] in Serum or Plasma --baseline | 
|  15470-8 | Equine influenza virus A2 Ab [Presence] in Serum | 
|  15471-6 | Equine influenza virus A2 Ab [Titer] in Serum by Hemagglutination inhibition | 
|  15472-4 | Equine influenza virus Ag [Presence] in Nose by Immunoassay | 
|  15473-2 | Equine arteritis virus Ab [Titer] in Serum by Neutralization test | 
|  15474-0 | Infectious bursal disease virus Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15475-7 | Infectious bursal disease virus Ab [Presence] in Serum by Immunoassay | 
|  15476-5 | Leptospira interrogans sv Bratislava Ab [Titer] in Serum by Agglutination | 
|  15477-3 | Leptospira interrogans sv Canicola Ab [Titer] in Serum by Agglutination | 
|  15478-1 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Agglutination | 
|  15479-9 | Leptospira interrogans sv Hardjo Ab [Titer] in Serum by Agglutination | 
|  1548-7 | Glucose [Mass/volume] in Serum or Plasma --pre 0.5 g/kg glucose IV | 
|  15480-7 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Agglutination | 
|  15481-5 | Leptospira interrogans sv Pomona Ab [Titer] in Serum by Agglutination | 
|  15482-3 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immune diffusion (ID) | 
|  15483-1 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immunoassay | 
|  15484-9 | Mycoplasma gallisepticum Ab [Presence] in Serum by Agglutination | 
|  15485-6 | Mycoplasma gallisepticum Ab [Presence] in Serum by Immunoassay | 
|  15486-4 | Mycoplasma gallisepticum rRNA [Presence] in Nose or Trachea by DNA probe | 
|  15487-2 | Mycoplasma meleagridis Ab [Presence] in Serum by Immunoassay | 
|  15488-0 | Mycoplasma meleagridis Ab [Presence] in Serum by Agglutination | 
|  15489-8 | Mycoplasma synoviae Ab [Presence] in Serum by Immunoassay | 
|  1549-5 | Glucose [Mass/volume] in Serum or Plasma --pre 100 g glucose PO | 
|  15490-6 | Mycoplasma synoviae Ab [Presence] in Serum by Agglutination | 
|  15491-4 | Mycoplasma synoviae rRNA [Presence] in Serum by DNA probe | 
|  15492-2 | Neospora caninum Ab [Presence] in Serum by Immunoassay | 
|  15493-0 | Parainfluenza virus 3 Ab [Titer] in Serum by Hemagglutination inhibition | 
|  15494-8 | Pasteurella multocida Ab [Presence] in Serum by Immunoassay | 
|  15495-5 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum by Immunoassay | 
|  15496-3 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum by Immunofluorescence | 
|  15497-1 | Pseudorabies virus Ab [Presence] in Serum by Immunoassay | 
|  15498-9 | Pseudorabies virus Ab [Presence] in Serum by Latex agglutination | 
|  15499-7 | Pseudorabies virus Ab [Titer] in Serum by Neutralization test | 
|  155-2 | Cephaloglycin [Susceptibility] by Serum bactericidal titer | 
|  1550-3 | Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast | 
|  15500-2 | Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum by Immunoassay | 
|  15501-0 | Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum by Immunoassay | 
|  15502-8 | Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum by Immunoassay | 
|  15503-6 | Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum by Immunoassay | 
|  15504-4 | Salmonella arizonae Ab [Presence] in Serum by Agglutination | 
|  15505-1 | Salmonella pullorum Ab [Presence] in Serum by Agglutination | 
|  15506-9 | Salmonella typhimurium Ab [Presence] in Serum by Agglutination | 
|  15507-7 | Provider-unspecified ED Progress note | 
|  15508-5 | Labor and delivery records | 
|  15509-3 | Ambulance transport, Rationale for scheduled transport | 
|  1551-1 | Glucose [Mass/volume] in Serum or Plasma --pre 50 g lactose PO | 
|  15510-1 | Ambulance transport, Distance transported Length | 
|  15511-9 | Ambulance transport, Origination site information Set | 
|  15512-7 | Ambulance transport, Destination site information Set | 
|  15513-5 | Ambulance transport, Reason for scheduled trip Set | 
|  15514-3 | Ambulance transport, Ordering practitioner identifier type | 
|  15515-0 | Ambulance transport, Medical reason for transport | 
|  15516-8 | Ambulance transport, Justification for extra attendants | 
|  15517-6 | Ambulance transport, Transport direction | 
|  15518-4 | Abalone IgE Ab RAST class [Presence] in Serum | 
|  15519-2 | Wattle IgE Ab RAST class [Presence] in Serum | 
|  1552-9 | Glucose [Mass/volume] in Serum or Plasma --pre 75 g glucose PO | 
|  15520-0 | Corticotropin IgE Ab RAST class [Presence] in Serum | 
|  15521-8 | White Alder IgE Ab RAST class [Presence] in Serum | 
|  15522-6 | Deprecated Alder Ab.IgE.RAST class | 
|  15523-4 | Smooth Alder IgE Ab RAST class [Presence] in Serum | 
|  15524-2 | Alfalfa IgE Ab RAST class [Presence] in Serum | 
|  15525-9 | Alkalase IgE Ab RAST class [Presence] in Serum | 
|  15526-7 | Allspice IgE Ab RAST class [Presence] in Serum | 
|  15527-5 | Almond IgE Ab RAST class [Presence] in Serum | 
|  15528-3 | Almond Tree IgE Ab RAST class [Presence] in Serum | 
|  15529-1 | Lactalbumin alpha IgE Ab RAST class [Presence] in Serum | 
|  1553-7 | Glucose [Mass/volume] in Serum or Plasma --pre dose insulin IV | 
|  15530-9 | Alternaria alternata IgE Ab RAST class [Presence] in Serum | 
|  15531-7 | Deprecated Alternaria alternata IgE Ab RAST class in Serum | 
|  15532-5 | Amoxicillin IgE Ab RAST class [Presence] in Serum | 
|  15533-3 | Ampicillin IgE Ab RAST class [Presence] in Serum | 
|  15534-1 | Anchovy IgE Ab RAST class [Presence] in Serum | 
|  15535-8 | Anisakis IgE Ab RAST class [Presence] in Serum | 
|  15536-6 | Anise IgE Ab RAST class [Presence] in Serum | 
|  15537-4 | Red Imported Fire Ant IgE Ab RAST class [Presence] in Serum | 
|  15538-2 | Deprecated Red Imported Fire Ant IgE Ab RAST class in Serum | 
|  15539-0 | Apple IgE Ab RAST class [Presence] in Serum | 
|  1554-5 | Glucose [Mass/volume] in Serum or Plasma --12 hours fasting | 
|  15540-8 | Apple Tree IgE Ab RAST class [Presence] in Serum | 
|  15541-6 | Apricot IgE Ab RAST class [Presence] in Serum | 
|  15542-4 | Arrowroot IgE Ab RAST class [Presence] in Serum | 
|  15543-2 | Artichoke IgE Ab RAST class [Presence] in Serum | 
|  15544-0 | Ascaris sp IgE Ab RAST class [Presence] in Serum | 
|  15545-7 | Arizona Ash IgE Ab RAST class [Presence] in Serum | 
|  15546-5 | White Ash IgE Ab RAST class [Presence] in Serum | 
|  15547-3 | Asparagus IgE Ab RAST class [Presence] in Serum | 
|  15548-1 | Aspen IgE Ab RAST class [Presence] in Serum | 
|  15549-9 | Aspergillus fumigatus IgE Ab RAST class [Presence] in Serum | 
|  1555-2 | Glucose [Mass/volume] in Urine --12 hours fasting | 
|  15550-7 | Aspergillus niger IgE Ab RAST class [Presence] in Serum | 
|  15551-5 | Avocado IgE Ab RAST class [Presence] in Serum | 
|  15552-3 | Groundsel Tree IgE Ab RAST class [Presence] in Serum | 
|  15553-1 | Bamboo shoot IgE Ab RAST class [Presence] in Serum | 
|  15554-9 | Banana IgE Ab RAST class [Presence] in Serum | 
|  15555-6 | Barley IgE Ab RAST class [Presence] in Serum | 
|  15556-4 | Barley Pollen IgE Ab RAST class [Presence] in Serum | 
|  15557-2 | Basil IgE Ab RAST class [Presence] in Serum | 
|  15558-0 | Bass, Black IgE Ab RAST class [Presence] in Serum | 
|  15559-8 | Fivehook Bassia IgE Ab RAST class [Presence] in Serum | 
|  1556-0 | Fasting glucose [Mass/volume] in Capillary blood | 
|  15560-6 | Bayberry IgE Ab RAST class [Presence] in Serum | 
|  15561-4 | Bayleaf IgE Ab RAST class [Presence] in Serum | 
|  15562-2 | Castor Bean IgE Ab RAST class [Presence] in Serum | 
|  15563-0 | Green Coffee Bean IgE Ab RAST class [Presence] in Serum | 
|  15564-8 | Green Bean IgE Ab RAST class [Presence] in Serum | 
|  15565-5 | Red Kidney Bean IgE Ab RAST class [Presence] in Serum | 
|  15566-3 | Lima Bean IgE Ab RAST class [Presence] in Serum | 
|  15567-1 | Pinto Bean IgE Ab RAST class [Presence] in Serum | 
|  15568-9 | Soybean IgE Ab RAST class [Presence] in Serum | 
|  15569-7 | White Bean IgE Ab RAST class [Presence] in Serum | 
|  1557-8 | Fasting glucose [Mass/volume] in Venous blood | 
|  15570-5 | Honey bee IgE Ab RAST class [Presence] in Serum | 
|  15571-3 | American Beech IgE Ab RAST class [Presence] in Serum | 
|  15572-1 | Beef IgE Ab RAST class [Presence] in Serum | 
|  15573-9 | Beet IgE Ab RAST class [Presence] in Serum | 
|  15574-7 | Sugar Beet Seed (Beta vulgaris seed) IgE Ab RAST class [Presence] in Serum | 
|  15575-4 | Berlin Beetle IgE Ab RAST class [Presence] in Serum | 
|  15576-2 | Lactalbumin beta IgE Ab RAST class [Presence] in Serum | 
|  15577-0 | Beta lactoglobulin IgE Ab RAST class [Presence] in Serum | 
|  15578-8 | Deprecated Birch Ab.IgE.RAST class | 
|  15579-6 | Silver Birch IgE Ab RAST class [Presence] in Serum | 
|  1558-6 | Fasting glucose [Mass/volume] in Serum or Plasma | 
|  15580-4 | Blackberry IgE Ab RAST class [Presence] in Serum | 
|  15581-2 | Blomia tropicalis IgE Ab RAST class [Presence] in Serum | 
|  15582-0 | Bloodworm IgE Ab RAST class [Presence] in Serum | 
|  15583-8 | Blueberry IgE Ab RAST class [Presence] in Serum | 
|  15584-6 | Botrytis cinerea IgE Ab RAST class [Presence] in Serum | 
|  15585-3 | Boxelder IgE Ab RAST class [Presence] in Serum | 
|  15586-1 | Brazil Nut IgE Ab RAST class [Presence] in Serum | 
|  15587-9 | Broccoli IgE Ab RAST class [Presence] in Serum | 
|  15588-7 | Bromelin IgE Ab RAST class [Presence] in Serum | 
|  15589-5 | Brussel Sprouts IgE Ab RAST class [Presence] in Serum | 
|  1559-4 | Insulin [Mass/volume] in Serum or Plasma --1.5 hours post dose tolbutamide IV | 
|  15590-3 | Bovine serum albumin (BSA) IgE Ab RAST class [Presence] in Serum | 
|  15591-1 | Buckwheat IgE Ab RAST class [Presence] in Serum | 
|  15592-9 | Budgerigar feather IgE Ab RAST class [Presence] in Serum | 
|  15593-7 | Bumble Bee IgE Ab RAST class [Presence] in Serum | 
|  15594-5 | Burrobrush IgE Ab RAST class [Presence] in Serum | 
|  15595-2 | Burweed marshelder IgE Ab RAST class [Presence] in Serum | 
|  15596-0 | Cabbage IgE Ab RAST class [Presence] in Serum | 
|  15597-8 | Cocoa IgE Ab RAST class [Presence] in Serum | 
|  15598-6 | Canary feather IgE Ab RAST class [Presence] in Serum | 
|  15599-4 | Candida albicans IgE Ab RAST class [Presence] in Serum | 
|  156-0 | Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1560-2 | Insulin [Mass/volume] in Serum or Plasma --1 hour post dose tolbutamide IV | 
|  15600-0 | Deprecated Melon IgE Ab RAST class in Serum | 
|  15601-8 | Starfruit IgE Ab RAST class [Presence] in Serum | 
|  15602-6 | Caraway IgE Ab RAST class [Presence] in Serum | 
|  15603-4 | Careless Weed IgE Ab RAST class [Presence] in Serum | 
|  15604-2 | Carob IgE Ab RAST class [Presence] in Serum | 
|  15605-9 | Carrot IgE Ab RAST class [Presence] in Serum | 
|  15606-7 | Casein IgE Ab RAST class [Presence] in Serum | 
|  15607-5 | Cashew Nut IgE Ab RAST class [Presence] in Serum | 
|  15608-3 | Deprecated Cat IgE Ab RAST class in Serum | 
|  15609-1 | Cat dander IgE Ab RAST class [Presence] in Serum | 
|  1561-0 | Insulin [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO | 
|  15610-9 | Deprecated Cat epithelium IgE Ab RAST class in Serum | 
|  15611-7 | Catfish IgE Ab RAST class [Presence] in Serum | 
|  15612-5 | Cauliflower IgE Ab RAST class [Presence] in Serum | 
|  15613-3 | Italian Cedar IgE Ab RAST class [Presence] in Serum | 
|  15614-1 | Japanese Cedar IgE Ab RAST class [Presence] in Serum | 
|  15615-8 | Mountain Juniper IgE Ab RAST class [Presence] in Serum | 
|  15616-6 | Red Cedar IgE Ab RAST class [Presence] in Serum | 
|  15617-4 | Saltcedar IgE Ab RAST class [Presence] in Serum | 
|  15618-2 | Celery IgE Ab RAST class [Presence] in Serum | 
|  15619-0 | Acremonium sp IgE Ab RAST class [Presence] in Serum | 
|  1562-8 | Insulin [Mass/volume] in Serum or Plasma --2.5 hours post dose tolbutamide IV | 
|  15620-8 | Chaetomium globosum IgE Ab RAST class [Presence] in Serum | 
|  15621-6 | Chamomile IgE Ab RAST class [Presence] in Serum | 
|  15622-4 | American Cheese IgE Ab RAST class [Presence] in Serum | 
|  15623-2 | Cheese cheddar type IgE Ab RAST class [Presence] in Serum | 
|  15624-0 | Cottage Cheese IgE Ab RAST class [Presence] in Serum | 
|  15625-7 | Mozzarella Cheese IgE Ab RAST class [Presence] in Serum | 
|  15626-5 | Parmesan Cheese IgE Ab RAST class [Presence] in Serum | 
|  15627-3 | Swiss Cheese IgE Ab RAST class [Presence] in Serum | 
|  15628-1 | Cherry IgE Ab RAST class [Presence] in Serum | 
|  15629-9 | Chestnut IgE Ab RAST class [Presence] in Serum | 
|  1563-6 | Insulin [Mass/volume] in Serum or Plasma --2 hours post dose tolbutamide IV | 
|  15630-7 | Horse Chestnut IgE Ab RAST class [Presence] in Serum | 
|  15631-5 | Deprecated Chestnut IgE Ab RAST class in Serum | 
|  15632-3 | Chestnut Pollen IgE Ab RAST class [Presence] in Serum | 
|  15633-1 | Chicken feather IgE Ab RAST class [Presence] in Serum | 
|  15634-9 | Chicken meat IgE Ab RAST class [Presence] in Serum | 
|  15635-6 | Chicory IgE Ab RAST class [Presence] in Serum | 
|  15636-4 | Chinchilla IgE Ab RAST class [Presence] in Serum | 
|  15637-2 | Chloramin T IgE Ab RAST class [Presence] in Serum | 
|  15638-0 | Chortoglyphus arcuatus IgE Ab RAST class [Presence] in Serum | 
|  15639-8 | Deprecated Chymofast IgE Ab RAST class in Serum | 
|  1564-4 | Insulin [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO | 
|  15640-6 | Chymopapain IgE Ab RAST class [Presence] in Serum | 
|  15641-4 | Cinnamon IgE Ab RAST class [Presence] in Serum | 
|  15642-2 | Cladosporium herbarum IgE Ab RAST class [Presence] in Serum | 
|  15643-0 | Clam IgE Ab RAST class [Presence] in Serum | 
|  15644-8 | Clove IgE Ab RAST class [Presence] in Serum | 
|  15645-5 | Clover IgE Ab RAST class [Presence] in Serum | 
|  15646-3 | Cocklebur IgE Ab RAST class [Presence] in Serum | 
|  15647-1 | Cockroach IgE Ab RAST class [Presence] in Serum | 
|  15648-9 | Deprecated Cocoa IgE Ab RAST class in Serum | 
|  15649-7 | Coconut IgE Ab RAST class [Presence] in Serum | 
|  1565-1 | Insulin [Mass/volume] in Serum or Plasma --30 minutes post dose tolbutamide IV | 
|  15650-5 | Codfish IgE Ab RAST class [Presence] in Serum | 
|  15651-3 | Coffee IgE Ab RAST class [Presence] in Serum | 
|  15652-1 | Cola IgE Ab RAST class [Presence] in Serum | 
|  15653-9 | Corn IgE Ab RAST class [Presence] in Serum | 
|  15654-7 | Cultivated Corn IgE Ab RAST class [Presence] in Serum | 
|  15655-4 | Cultivated Cotton IgE Ab RAST class [Presence] in Serum | 
|  15656-2 | Cotton fibers IgE Ab RAST class [Presence] in Serum | 
|  15657-0 | Cotton western IgE Ab RAST class [Presence] in Serum | 
|  15658-8 | Cottonseed IgE Ab RAST class [Presence] in Serum | 
|  15659-6 | Cottonwood IgE Ab RAST class [Presence] in Serum | 
|  1566-9 | Insulin [Mass/volume] in Serum or Plasma --3 hours post dose tolbutamide IV | 
|  15660-4 | Western Cottonwood IgE Ab RAST class [Presence] in Serum | 
|  15661-2 | Cow dander IgE Ab RAST class [Presence] in Serum | 
|  15662-0 | Cow epithelium IgE Ab RAST class [Presence] in Serum | 
|  15663-8 | Crab IgE Ab RAST class [Presence] in Serum | 
|  15664-6 | Cranberry IgE Ab RAST class [Presence] in Serum | 
|  15665-3 | Crawfish IgE Ab RAST class [Presence] in Serum | 
|  15666-1 | Cryptococcus terreus IgE Ab RAST class [Presence] in Serum | 
|  15667-9 | Cucumber IgE Ab RAST class [Presence] in Serum | 
|  15668-7 | Curry IgE Ab RAST class [Presence] in Serum | 
|  15669-5 | Curvularia lunata IgE Ab RAST class [Presence] in Serum | 
|  1567-7 | Insulin [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO | 
|  15670-3 | Curvularia specifera IgE Ab RAST class [Presence] in Serum | 
|  15671-1 | Arizona Cypress IgE Ab RAST class [Presence] in Serum | 
|  15672-9 | Bald Cypress IgE Ab RAST class [Presence] in Serum | 
|  15673-7 | Italian Cypress IgE Ab RAST class [Presence] in Serum | 
|  15674-5 | Daisy IgE Ab RAST class [Presence] in Serum | 
|  15675-2 | Ox-eye daisy IgE Ab RAST class [Presence] in Serum | 
|  15676-0 | Dandelion IgE Ab RAST class [Presence] in Serum | 
|  15677-8 | Daphnia (fish feed) IgE Ab RAST class [Presence] in Serum | 
|  15678-6 | Date Palm Pollen IgE Ab RAST class [Presence] in Serum | 
|  15679-4 | Deer epithelium IgE Ab RAST class [Presence] in Serum | 
|  1568-5 | Insulin [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO | 
|  15680-2 | American house dust mite IgE Ab RAST class [Presence] in Serum | 
|  15681-0 | Dermatophagoides microceras IgE Ab RAST class [Presence] in Serum | 
|  15682-8 | European house dust mite IgE Ab RAST class [Presence] in Serum | 
|  15683-6 | Dill IgE Ab RAST class [Presence] in Serum | 
|  15684-4 | Yellow Dock IgE Ab RAST class [Presence] in Serum | 
|  15685-1 | Dog dander IgE Ab RAST class [Presence] in Serum | 
|  15686-9 | Dog epithelium IgE Ab RAST class [Presence] in Serum | 
|  15687-7 | Duck feather IgE Ab RAST class [Presence] in Serum | 
|  15688-5 | Echinococcus sp IgE Ab RAST class [Presence] in Serum | 
|  15689-3 | Egg white IgE Ab RAST class [Presence] in Serum | 
|  1569-3 | Insulin [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO | 
|  15690-1 | Whole Egg IgE Ab RAST class [Presence] in Serum | 
|  15691-9 | Egg yolk IgE Ab RAST class [Presence] in Serum | 
|  15692-7 | Eggplant IgE Ab RAST class [Presence] in Serum | 
|  15693-5 | Marsh Elder IgE Ab RAST class [Presence] in Serum | 
|  15694-3 | Elder IgE Ab RAST class [Presence] in Serum | 
|  15695-0 | Deprecated Elderberry IgE Ab RAST class in Serum | 
|  15696-8 | Elk or Moose Meat IgE Ab RAST class [Presence] in Serum | 
|  15697-6 | White Elm IgE Ab RAST class [Presence] in Serum | 
|  15698-4 | Chinese Elm IgE Ab RAST class [Presence] in Serum | 
|  15699-2 | Endive IgE Ab RAST class [Presence] in Serum | 
|  157-8 | Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1570-1 | Insulin [Mass/volume] in Serum or Plasma --baseline | 
|  15700-8 | Epicoccum purpurascens IgE Ab RAST class [Presence] in Serum | 
|  15701-6 | Epidermophyton floccosum IgE Ab RAST class [Presence] in Serum | 
|  15702-4 | Ethylene oxide IgE Ab RAST class [Presence] in Serum | 
|  15703-2 | Gum-Tree IgE Ab RAST class [Presence] in Serum | 
|  15704-0 | Euroglyphus maynei IgE Ab RAST class [Presence] in Serum | 
|  15705-7 | Dog Fennel IgE Ab RAST class [Presence] in Serum | 
|  15706-5 | Fennel Fresh IgE Ab RAST class [Presence] in Serum | 
|  15707-3 | Fennel Seed IgE Ab RAST class [Presence] in Serum | 
|  15708-1 | Ferret epithelium IgE Ab RAST class [Presence] in Serum | 
|  15709-9 | Meadow Fescue IgE Ab RAST class [Presence] in Serum | 
|  1571-9 | Insulin [Mass/volume] in Serum or Plasma --pre dose tolbutamide IV | 
|  15710-7 | Finch feather IgE Ab RAST class [Presence] in Serum | 
|  15711-5 | Douglas Fir IgE Ab RAST class [Presence] in Serum | 
|  15712-3 | Firebush IgE Ab RAST class [Presence] in Serum | 
|  15713-1 | Fiscus sp IgE Ab RAST class [Presence] in Serum | 
|  15714-9 | Flea IgE Ab RAST class [Presence] in Serum | 
|  15715-6 | Flounder IgE Ab RAST class [Presence] in Serum | 
|  15716-4 | Black Fly IgE Ab RAST class [Presence] in Serum | 
|  15717-2 | Horse Fly IgE Ab RAST class [Presence] in Serum | 
|  15718-0 | Formaldehyde IgE Ab RAST class [Presence] in Serum | 
|  15719-8 | Fox IgE Ab RAST class [Presence] in Serum | 
|  1572-7 | Insulin [Mass/volume] in Serum or Plasma --pre 75 g glucose PO | 
|  15720-6 | Meadow Foxtail IgE Ab RAST class [Presence] in Serum | 
|  15721-4 | Fusarium culmorum IgE Ab RAST class [Presence] in Serum | 
|  15722-2 | Fusarium moniliforme IgE Ab RAST class [Presence] in Serum | 
|  15723-0 | Fusarium solani IgE Ab RAST class [Presence] in Serum | 
|  15724-8 | Garlic IgE Ab RAST class [Presence] in Serum | 
|  15725-5 | Gelatin IgE Ab RAST class [Presence] in Serum | 
|  15726-3 | Geotrichum candidum IgE Ab RAST class [Presence] in Serum | 
|  15727-1 | Gerbil IgE Ab RAST class [Presence] in Serum | 
|  15728-9 | Ginger IgE Ab RAST class [Presence] in Serum | 
|  15729-7 | Gluten IgE Ab RAST class [Presence] in Serum | 
|  1573-5 | Insulin [Mass/volume] in Serum or Plasma --12 hours fasting | 
|  15730-5 | Glycyphagus domesticus IgE Ab RAST class [Presence] in Serum | 
|  15731-3 | Goat epithelium IgE Ab RAST class [Presence] in Serum | 
|  15732-1 | Goat milk IgE Ab RAST class [Presence] in Serum | 
|  15733-9 | Goldenrod IgE Ab RAST class [Presence] in Serum | 
|  15734-7 | Goose feather IgE Ab RAST class [Presence] in Serum | 
|  15735-4 | Grape IgE Ab RAST class [Presence] in Serum | 
|  15736-2 | Grapefruit IgE Ab RAST class [Presence] in Serum | 
|  15737-0 | Bahia grass IgE Ab RAST class [Presence] in Serum | 
|  15738-8 | Bermuda grass IgE Ab RAST class [Presence] in Serum | 
|  15739-6 | Canadian blue grass IgE Ab RAST class [Presence] in Serum | 
|  1574-3 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day | 
|  15740-4 | Brome IgE Ab RAST class [Presence] in Serum | 
|  15741-2 | False oat grass IgE Ab RAST class [Presence] in Serum | 
|  15742-0 | Gramma grass (Bouteloua gracilis) IgE Ab RAST class [Presence] in Serum | 
|  15743-8 | Johnson grass IgE Ab RAST class [Presence] in Serum | 
|  15744-6 | Kentucky blue grass IgE Ab RAST class [Presence] in Serum | 
|  15745-3 | Koehlers grass IgE Ab RAST class [Presence] in Serum | 
|  15746-1 | Cocksfoot IgE Ab RAST class [Presence] in Serum | 
|  15747-9 | Quack grass IgE Ab RAST class [Presence] in Serum | 
|  15748-7 | Red top grass IgE Ab RAST class [Presence] in Serum | 
|  15749-5 | Perennial rye grass IgE Ab RAST class [Presence] in Serum | 
|  1575-0 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day | 
|  15750-3 | Deprecated Grass rye Italian IgE Ab RAST class in Serum | 
|  15751-1 | Wild rye grass IgE Ab RAST class [Presence] in Serum | 
|  15752-9 | Salt grass IgE Ab RAST class [Presence] in Serum | 
|  15753-7 | Sorghum grass IgE Ab RAST class [Presence] in Serum | 
|  15754-5 | Sudan grass IgE Ab RAST class [Presence] in Serum | 
|  15755-2 | Sweet Vernal grass IgE Ab RAST class [Presence] in Serum | 
|  15756-0 | Velvet grass IgE Ab RAST class [Presence] in Serum | 
|  15757-8 | Guar gum IgE Ab RAST class [Presence] in Serum | 
|  15758-6 | Guava IgE Ab RAST class [Presence] in Serum | 
|  15759-4 | Guinea pig epithelium IgE Ab RAST class [Presence] in Serum | 
|  1576-8 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  15760-2 | Gum arabic IgE Ab RAST class [Presence] in Serum | 
|  15761-0 | Sweet gum IgE Ab RAST class [Presence] in Serum | 
|  15762-8 | Hackberry tree IgE Ab RAST class [Presence] in Serum | 
|  15763-6 | Haddock IgE Ab RAST class [Presence] in Serum | 
|  15764-4 | Halibut IgE Ab RAST class [Presence] in Serum | 
|  15765-1 | Hamster epithelium IgE Ab RAST class [Presence] in Serum | 
|  15766-9 | Hazelnut IgE Ab RAST class [Presence] in Serum | 
|  15767-7 | Hazelnut Pollen IgE Ab RAST class [Presence] in Serum | 
|  15768-5 | Helminthosporium sp IgE Ab RAST class [Presence] in Serum | 
|  15769-3 | Setomelanomma rostrata IgE Ab RAST class [Presence] in Serum | 
|  1577-6 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  15770-1 | Eastern Hemlock IgE Ab RAST class [Presence] in Serum | 
|  15771-9 | Water Hemp IgE Ab RAST class [Presence] in Serum | 
|  15772-7 | Herring IgE Ab RAST class [Presence] in Serum | 
|  15773-5 | Pecan or Hickory Nut IgE Ab RAST class [Presence] in Serum | 
|  15774-3 | Pecan or Hickory Tree IgE Ab RAST class [Presence] in Serum | 
|  15775-0 | Shellbark Hickory IgE Ab RAST class [Presence] in Serum | 
|  15776-8 | White Hickory IgE Ab RAST class [Presence] in Serum | 
|  15777-6 | Honey IgE Ab RAST class [Presence] in Serum | 
|  15778-4 | Honeysuckle IgE Ab RAST class [Presence] in Serum | 
|  15779-2 | Hop IgE Ab RAST class [Presence] in Serum | 
|  1578-4 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day | 
|  15780-0 | Horn beam IgE Ab RAST class [Presence] in Serum | 
|  15781-8 | Hornet IgE Ab RAST class [Presence] in Serum | 
|  15782-6 | Whitefaced Hornet IgE Ab RAST class [Presence] in Serum | 
|  15783-4 | Yellow Hornet IgE Ab RAST class [Presence] in Serum | 
|  15784-2 | Horse dander IgE Ab RAST class [Presence] in Serum | 
|  15785-9 | Horse epithelium IgE Ab RAST class [Presence] in Serum | 
|  15786-7 | Horse serum proteins IgE Ab RAST class [Presence] in Serum | 
|  15787-5 | Horseradish IgE Ab RAST class [Presence] in Serum | 
|  15788-3 | House dust IgE Ab RAST class [Presence] in Serum | 
|  15789-1 | House dust Greer IgE Ab RAST class [Presence] in Serum | 
|  1579-2 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 50 ug corticotropin IM 3 day | 
|  15790-9 | House dust Hausstaub IgE Ab RAST class [Presence] in Serum | 
|  15791-7 | House dust Hollister Stier IgE Ab RAST class [Presence] in Serum | 
|  15792-5 | Insulin bovine IgE Ab RAST class [Presence] in Serum | 
|  15793-3 | Insulin human IgE Ab RAST class [Presence] in Serum | 
|  15794-1 | Insulin porcine IgE Ab RAST class [Presence] in Serum | 
|  15795-8 | Iodinebush IgE Ab RAST class [Presence] in Serum | 
|  15796-6 | Isocyanate HDI IgE Ab RAST class [Presence] in Serum | 
|  15797-4 | Isocyanate MDI IgE Ab RAST class [Presence] in Serum | 
|  15798-2 | Isocyanate TDI IgE Ab RAST class [Presence] in Serum | 
|  15799-0 | Ispaghula laxative IgE Ab RAST class [Presence] in Serum | 
|  158-6 | Cephaloridine [Susceptibility] by Disk diffusion (KB) | 
|  1580-0 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h | 
|  15800-6 | Juniper IgE Ab RAST class [Presence] in Serum | 
|  15801-4 | Kapok IgE Ab RAST class [Presence] in Serum | 
|  15802-2 | Kiwifruit IgE Ab RAST class [Presence] in Serum | 
|  15803-0 | Lamb IgE Ab RAST class [Presence] in Serum | 
|  15804-8 | Deprecated Mutton IgE Ab RAST class in Serum | 
|  15805-5 | Goosefoot IgE Ab RAST class [Presence] in Serum | 
|  15806-3 | Latex IgE Ab RAST class [Presence] in Serum | 
|  15807-1 | Latex glove extract IgE Ab RAST class [Presence] in Serum | 
|  15808-9 | Latex glove extract ammoniated IgE Ab RAST class [Presence] in Serum | 
|  15809-7 | Latex glove extract buffered IgE Ab RAST class [Presence] in Serum | 
|  1581-8 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h | 
|  15810-5 | Legume IgE Ab RAST class [Presence] in Serum | 
|  15811-3 | Lemon IgE Ab RAST class [Presence] in Serum | 
|  15812-1 | Lenscale IgE Ab RAST class [Presence] in Serum | 
|  15813-9 | Lentils IgE Ab RAST class [Presence] in Serum | 
|  15814-7 | Lepidoglyphus destructor IgE Ab RAST class [Presence] in Serum | 
|  15815-4 | Lettuce IgE Ab RAST class [Presence] in Serum | 
|  15816-2 | Lilac IgE Ab RAST class [Presence] in Serum | 
|  15817-0 | Easter lily IgE Ab RAST class [Presence] in Serum | 
|  15818-8 | Lime IgE Ab RAST class [Presence] in Serum | 
|  15819-6 | Linden IgE Ab RAST class [Presence] in Serum | 
|  1582-6 | Lactose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO | 
|  15820-4 | Liver beef IgE Ab RAST class [Presence] in Serum | 
|  15821-2 | Lobster IgE Ab RAST class [Presence] in Serum | 
|  15822-0 | Spiny lobster IgE Ab RAST class [Presence] in Serum | 
|  15823-8 | Black Locust IgE Ab RAST class [Presence] in Serum | 
|  15824-6 | Lupin IgE Ab RAST class [Presence] in Serum | 
|  15825-3 | Lycopodium spp IgE Ab RAST class [Presence] in Serum | 
|  15826-1 | Lysozyme IgE Ab RAST class [Presence] in Serum | 
|  15827-9 | Mackerel IgE Ab RAST class [Presence] in Serum | 
|  15828-7 | Chub Mackerel IgE Ab RAST class [Presence] in Serum | 
|  15829-5 | Scad IgE Ab RAST class [Presence] in Serum | 
|  1583-4 | Lactose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO | 
|  15830-3 | Deprecated Corn IgE Ab RAST class in Serum | 
|  15831-1 | Malt IgE Ab RAST class [Presence] in Serum | 
|  15832-9 | Mango IgE Ab RAST class [Presence] in Serum | 
|  15833-7 | Coastal Maple IgE Ab RAST class [Presence] in Serum | 
|  15834-5 | Red Maple IgE Ab RAST class [Presence] in Serum | 
|  15835-2 | Silver Maple IgE Ab RAST class [Presence] in Serum | 
|  15836-0 | Maple sugar IgE Ab RAST class [Presence] in Serum | 
|  15837-8 | Mare milk IgE Ab RAST class [Presence] in Serum | 
|  15838-6 | Marjoram IgE Ab RAST class [Presence] in Serum | 
|  15839-4 | Maxatase IgE Ab RAST class [Presence] in Serum | 
|  1584-2 | Lactose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO | 
|  15840-2 | Whiff IgE Ab RAST class [Presence] in Serum | 
|  15841-0 | Cajeput tree IgE Ab RAST class [Presence] in Serum | 
|  15842-8 | Deprecated Melon IgE Ab RAST class in Serum. | 
|  15843-6 | Mesquite IgE Ab RAST class [Presence] in Serum | 
|  15844-4 | Mexican tea IgE Ab RAST class [Presence] in Serum | 
|  15845-1 | Green Nimitti IgE Ab RAST class [Presence] in Serum | 
|  15846-9 | Milk IgE Ab RAST class [Presence] in Serum | 
|  15847-7 | Cow milk boiled IgE Ab RAST class [Presence] in Serum | 
|  15848-5 | Milk powder IgE Ab RAST class [Presence] in Serum | 
|  15849-3 | Common Millet IgE Ab RAST class [Presence] in Serum | 
|  1585-9 | Lactose [Mass/volume] in Serum or Plasma --pre 12 hour fast | 
|  15850-1 | Foxtail Millet IgE Ab RAST class [Presence] in Serum | 
|  15851-9 | Cockspur IgE Ab RAST class [Presence] in Serum | 
|  15852-7 | Mink epithelium IgE Ab RAST class [Presence] in Serum | 
|  15853-5 | Mint IgE Ab RAST class [Presence] in Serum | 
|  15854-3 | Cheese mold type IgE Ab RAST class [Presence] in Serum | 
|  15855-0 | Chrysonilia sitophila IgE Ab RAST class [Presence] in Serum | 
|  15856-8 | Aedes mosquito IgE Ab RAST class [Presence] in Serum | 
|  15857-6 | Moth IgE Ab RAST class [Presence] in Serum | 
|  15858-4 | Mediterranean flour moth IgE Ab RAST class [Presence] in Serum | 
|  15859-2 | Mouse epithelium IgE Ab RAST class [Presence] in Serum | 
|  1586-7 | Lead [Mass/volume] in Urine --post EDTA therapy | 
|  15860-0 | Mouse serum proteins IgE Ab RAST class [Presence] in Serum | 
|  15861-8 | Mouse urine proteins IgE Ab RAST class [Presence] in Serum | 
|  15862-6 | Mucor racemosus IgE Ab RAST class [Presence] in Serum | 
|  15863-4 | Mugwort IgE Ab RAST class [Presence] in Serum | 
|  15864-2 | White mulberry IgE Ab RAST class [Presence] in Serum | 
|  15865-9 | Deprecated White mulberry IgE Ab RAST class in Serum | 
|  15866-7 | Mushroom IgE Ab RAST class [Presence] in Serum | 
|  15867-5 | Deprecated Melon IgE Ab Ab RAST class in Serum | 
|  15868-3 | Deprecated Blue mussel IgE Ab RAST class in Serum | 
|  15869-1 | Blue mussel IgE Ab RAST class [Presence] in Serum | 
|  1587-5 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --1.5 hours post 100 g lutropin IV | 
|  15870-9 | Mustard IgE Ab RAST class [Presence] in Serum | 
|  15871-7 | Nectarine IgE Ab RAST class [Presence] in Serum | 
|  15872-5 | Nettle IgE Ab RAST class [Presence] in Serum | 
|  15873-3 | Nigrospora sphaerica IgE Ab RAST class [Presence] in Serum | 
|  15874-1 | Nutmeg IgE Ab RAST class [Presence] in Serum | 
|  15875-8 | White Oak IgE Ab RAST class [Presence] in Serum | 
|  15876-6 | California Black Oak IgE Ab RAST class [Presence] in Serum | 
|  15877-4 | Coastal Oak IgE Ab RAST class [Presence] in Serum | 
|  15878-2 | Gamble Oak IgE Ab RAST class [Presence] in Serum | 
|  15879-0 | Jerusalem oak IgE Ab RAST class [Presence] in Serum | 
|  1588-3 | Lutropin [Mass/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone | 
|  15880-8 | Virginia Live Oak IgE Ab RAST class [Presence] in Serum | 
|  15881-6 | Red Oak IgE Ab RAST class [Presence] in Serum | 
|  15882-4 | Valley Oak IgE Ab RAST class [Presence] in Serum | 
|  15883-2 | Deprecated Virginia Live Oak IgE Ab RAST class in Serum | 
|  15884-0 | Deprecated White Oak IgE Ab RAST class in Serum | 
|  15885-7 | Oat IgE Ab RAST class [Presence] in Serum | 
|  15886-5 | Oat pollen IgE Ab RAST class [Presence] in Serum | 
|  15887-3 | Deprecated Oat pollen IgE Ab RAST class in Serum | 
|  15888-1 | Octopus IgE Ab RAST class [Presence] in Serum | 
|  15889-9 | Oidiodendrum spp IgE Ab RAST class [Presence] in Serum | 
|  1589-1 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --105 minutes post 100 g lutropin IV | 
|  15890-7 | Okra IgE Ab RAST class [Presence] in Serum | 
|  15891-5 | Deprecated Olive IgE Ab RAST class [Presence] in Serum | 
|  15892-3 | Olive Pollen IgE Ab RAST class [Presence] in Serum | 
|  15893-1 | Onion IgE Ab RAST class [Presence] in Serum | 
|  15894-9 | Orange IgE Ab RAST class [Presence] in Serum | 
|  15895-6 | Oregano IgE Ab RAST class [Presence] in Serum | 
|  15896-4 | Orris root IgE Ab RAST class [Presence] in Serum | 
|  15897-2 | Ovalbumin IgE Ab RAST class [Presence] in Serum | 
|  15898-0 | Ovomucoid IgE Ab RAST class [Presence] in Serum | 
|  15899-8 | Oyster IgE Ab RAST class [Presence] in Serum | 
|  159-4 | Cephaloridine [Susceptibility] by Serum bactericidal titer | 
|  1590-9 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --15 minutes post 100 g lutropin IV | 
|  15900-4 | Queen Palm IgE Ab RAST class [Presence] in Serum | 
|  15901-2 | Papaya (Carica papaya) IgE Ab RAST class [Presence] in Serum | 
|  15902-0 | Paprika IgE Ab RAST class [Presence] in Serum | 
|  15903-8 | Parakeet feather IgE Ab RAST class [Presence] in Serum | 
|  15904-6 | Budgerigar droppings IgE Ab RAST class [Presence] in Serum | 
|  15905-3 | Deprecated Budgerigar feather IgE Ab RAST class in Serum | 
|  15906-1 | Budgerigar serum proteins IgE Ab RAST class [Presence] in Serum | 
|  15907-9 | Parrot droppings IgE Ab RAST class [Presence] in Serum | 
|  15908-7 | Parrot feather IgE Ab RAST class [Presence] in Serum | 
|  15909-5 | Parrot serum proteins IgE Ab RAST class [Presence] in Serum | 
|  1591-7 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --1 hour post 100 g lutropin IV | 
|  15910-3 | Parsley IgE Ab RAST class [Presence] in Serum | 
|  15911-1 | Parsnip IgE Ab RAST class [Presence] in Serum | 
|  15912-9 | Passion fruit IgE Ab RAST class [Presence] in Serum | 
|  15913-7 | Pea IgE Ab RAST class [Presence] in Serum | 
|  15914-5 | Black-eye pea IgE Ab RAST class [Presence] in Serum | 
|  15915-2 | Chick Pea IgE Ab RAST class [Presence] in Serum | 
|  15916-0 | Peach IgE Ab RAST class [Presence] in Serum | 
|  15917-8 | Peanut IgE Ab RAST class [Presence] in Serum | 
|  15918-6 | Pear IgE Ab RAST class [Presence] in Serum | 
|  15919-4 | Deprecated Pecan or Hickory Nut IgE Ab RAST class in Serum | 
|  1592-5 | Lutropin [Mass/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone | 
|  15920-2 | Deprecated Pecan or Hickory Tree IgE Ab RAST class in Serum | 
|  15921-0 | Penicillin G IgE Ab RAST class [Presence] in Serum | 
|  15922-8 | Penicillin V IgE Ab RAST class [Presence] in Serum | 
|  15923-6 | Penicillium frequentans IgE Ab RAST class [Presence] in Serum | 
|  15924-4 | Penicillium notatum IgE Ab RAST class [Presence] in Serum | 
|  15925-1 | Black Pepper IgE Ab RAST class [Presence] in Serum | 
|  15926-9 | Cayenne IgE Ab RAST class [Presence] in Serum | 
|  15927-7 | Chili Pepper IgE Ab RAST class [Presence] in Serum | 
|  15928-5 | Green Pepper IgE Ab RAST class [Presence] in Serum | 
|  15929-3 | Pepper tree IgE Ab RAST class [Presence] in Serum | 
|  1593-3 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --2 hours post 100 g lutropin IV | 
|  15930-1 | Perch IgE Ab RAST class [Presence] in Serum | 
|  15931-9 | Phoma betae IgE Ab RAST class [Presence] in Serum | 
|  15932-7 | Phospholipase IgE Ab RAST class [Presence] in Serum | 
|  15933-5 | Phthalic anhydride IgE Ab RAST class [Presence] in Serum | 
|  15934-3 | Pigeon droppings IgE Ab RAST class [Presence] in Serum | 
|  15935-0 | Pigeon feather IgE Ab RAST class [Presence] in Serum | 
|  15936-8 | Common Pigweed IgE Ab RAST class [Presence] in Serum | 
|  15937-6 | Rough Pigweed IgE Ab RAST class [Presence] in Serum | 
|  15938-4 | Spiny Pigweed IgE Ab RAST class [Presence] in Serum | 
|  15939-2 | Austrian Pine IgE Ab RAST class [Presence] in Serum | 
|  1594-1 | Lutropin [Mass/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone | 
|  15940-0 | Loblolly Pine IgE Ab RAST class [Presence] in Serum | 
|  15941-8 | Long Leaf Pine IgE Ab RAST class [Presence] in Serum | 
|  15942-6 | Pine IgE Ab RAST class [Presence] in Serum | 
|  15943-4 | Pine Nut IgE Ab RAST class [Presence] in Serum | 
|  15944-2 | Short Leaf Pine IgE Ab RAST class [Presence] in Serum | 
|  15945-9 | Slash Pine IgE Ab RAST class [Presence] in Serum | 
|  15946-7 | Virginia Scrub Pine IgE Ab RAST class [Presence] in Serum | 
|  15947-5 | Eastern White Pine IgE Ab RAST class [Presence] in Serum | 
|  15948-3 | Pineapple IgE Ab RAST class [Presence] in Serum | 
|  15949-1 | Pistachio IgE Ab RAST class [Presence] in Serum | 
|  1595-8 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --30 minutes post 100 g lutropin IV | 
|  15950-9 | Malassezia furfur IgE Ab RAST class [Presence] in Serum | 
|  15951-7 | Plaice IgE Ab RAST class [Presence] in Serum | 
|  15952-5 | English plantain IgE Ab RAST class [Presence] in Serum | 
|  15953-3 | Plum IgE Ab RAST class [Presence] in Serum | 
|  15954-1 | Black Cottonwood IgE Ab RAST class [Presence] in Serum | 
|  15955-8 | Poppy Seed IgE Ab RAST class [Presence] in Serum | 
|  15956-6 | Pork IgE Ab RAST class [Presence] in Serum | 
|  15957-4 | Potato IgE Ab RAST class [Presence] in Serum | 
|  15958-2 | Sweet potato IgE Ab RAST class [Presence] in Serum | 
|  15959-0 | Povertyweed IgE Ab RAST class [Presence] in Serum | 
|  1596-6 | Lutropin [Mass/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone | 
|  15960-8 | Privet IgE Ab RAST class [Presence] in Serum | 
|  15961-6 | Protamine IgE Ab RAST class [Presence] in Serum | 
|  15962-4 | Prune IgE Ab RAST class [Presence] in Serum | 
|  15963-2 | Psyllium seed IgE Ab RAST class [Presence] in Serum | 
|  15964-0 | Aureobasidium pullulans IgE Ab RAST class [Presence] in Serum | 
|  15965-7 | Deprecated Pullularia pullulans IgE Ab RAST class in Serum | 
|  15966-5 | Pumpkin IgE Ab RAST class [Presence] in Serum | 
|  15967-3 | Pumpkin Seed IgE Ab RAST class [Presence] in Serum | 
|  15968-1 | Pyrethrum IgE Ab RAST class [Presence] in Serum | 
|  15969-9 | Rabbit meat IgE Ab RAST class [Presence] in Serum | 
|  1597-4 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --45 minutes post 100 g lutropin IV | 
|  15970-7 | Rabbit Bush IgE Ab RAST class [Presence] in Serum | 
|  15971-5 | Rabbit epithelium IgE Ab RAST class [Presence] in Serum | 
|  15972-3 | Rabbit serum proteins IgE Ab RAST class [Presence] in Serum | 
|  15973-1 | Rabbit urine proteins IgE Ab RAST class [Presence] in Serum | 
|  15974-9 | Radish IgE Ab RAST class [Presence] in Serum | 
|  15975-6 | Common Ragweed IgE Ab RAST class [Presence] in Serum | 
|  15976-4 | Desert Ragweed IgE Ab RAST class [Presence] in Serum | 
|  15977-2 | False ragweed IgE Ab RAST class [Presence] in Serum | 
|  15978-0 | Giant Ragweed IgE Ab RAST class [Presence] in Serum | 
|  15979-8 | Deprecated Common Ragweed IgE Ab RAST class in Serum | 
|  1598-2 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --75 minutes post 100 g lutropin IV | 
|  15980-6 | Southern Ragweed IgE Ab RAST class [Presence] in Serum | 
|  15981-4 | Western Ragweed IgE Ab RAST class [Presence] in Serum | 
|  15982-2 | Rapeseed IgE Ab RAST class [Presence] in Serum | 
|  15983-0 | Raspberry IgE Ab RAST class [Presence] in Serum | 
|  15984-8 | Rat epithelium IgE Ab RAST class [Presence] in Serum | 
|  15985-5 | Rat serum proteins IgE Ab RAST class [Presence] in Serum | 
|  15986-3 | Rat urine proteins IgE Ab RAST class [Presence] in Serum | 
|  15987-1 | Redwood IgE Ab RAST class [Presence] in Serum | 
|  15988-9 | Canary grass IgE Ab RAST class [Presence] in Serum | 
|  15989-7 | Common Reed IgE Ab RAST class [Presence] in Serum | 
|  1599-0 | Lutropin [Mass/volume] in Serum or Plasma --baseline | 
|  15990-5 | Reindeer epithelium IgE Ab RAST class [Presence] in Serum | 
|  15991-3 | Rhizopus nigricans IgE Ab RAST class [Presence] in Serum | 
|  15992-1 | Rhodotorula spp IgE Ab RAST class [Presence] in Serum | 
|  15993-9 | Rhubarb IgE Ab RAST class [Presence] in Serum | 
|  15994-7 | Rice IgE Ab RAST class [Presence] in Serum | 
|  15995-4 | Wild Rice IgE Ab RAST class [Presence] in Serum | 
|  15996-2 | Rose Hip IgE Ab RAST class [Presence] in Serum | 
|  15997-0 | Cultivated Rye IgE Ab RAST class [Presence] in Serum | 
|  15998-8 | Rye IgE Ab RAST class [Presence] in Serum | 
|  15999-6 | Deprecated Cultivated Rye IgE Ab RAST class in Serum | 
|  16-6 | Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  160-2 | Cephalothin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1600-6 | Lutropin [Mass/volume] in Serum or Plasma --pre dose gonadotropin releasing hormone | 
|  16000-2 | Deprecated rye Perennial IgE Ab RAST class in Serum | 
|  16001-0 | Safflower IgE Ab RAST class [Presence] in Serum | 
|  16002-8 | Sage IgE Ab RAST class [Presence] in Serum | 
|  16003-6 | Common Sagebrush IgE Ab RAST class [Presence] in Serum | 
|  16004-4 | Deprecated Sagebrush IgE Ab RAST class in Serum | 
|  16005-1 | Saline fish feed IgE Ab RAST class [Presence] in Serum | 
|  16006-9 | Salmon IgE Ab RAST class [Presence] in Serum | 
|  16007-7 | Saltbush IgE Ab RAST class [Presence] in Serum | 
|  16008-5 | Sardine (pilchard) IgE Ab RAST class [Presence] in Serum | 
|  16009-3 | Savinase IgE Ab RAST class [Presence] in Serum | 
|  1601-4 | Norepinephrine [Mass/volume] in Plasma --supine | 
|  16010-1 | Deprecated Lenscale IgE Ab RAST class in Serum | 
|  16011-9 | Scallop IgE Ab RAST class [Presence] in Serum | 
|  16012-7 | Scotch broom IgE Ab RAST class [Presence] in Serum | 
|  16013-5 | Sericin IgE Ab RAST class [Presence] in Serum | 
|  16014-3 | Sesame Seed IgE Ab RAST class [Presence] in Serum | 
|  16015-0 | Sheep epithelium IgE Ab RAST class [Presence] in Serum | 
|  16016-8 | Sheep Sorrel IgE Ab RAST class [Presence] in Serum | 
|  16017-6 | Sheep wool IgE Ab RAST class [Presence] in Serum | 
|  16018-4 | Shrimp IgE Ab RAST class [Presence] in Serum | 
|  16019-2 | Silk IgE Ab RAST class [Presence] in Serum | 
|  1602-2 | Norepinephrine [Mass/volume] in Plasma --10 minutes post standing | 
|  16020-0 | Silk waste IgE Ab RAST class [Presence] in Serum | 
|  16021-8 | Silver IgE Ab RAST class [Presence] in Serum | 
|  16022-6 | Bermuda grass smut IgE Ab RAST class [Presence] in Serum | 
|  16023-4 | Johnson grass smut IgE Ab RAST class [Presence] in Serum | 
|  16024-2 | Escargot IgE Ab RAST class [Presence] in Serum | 
|  16025-9 | Red Snapper IgE Ab RAST class [Presence] in Serum | 
|  16026-7 | Sole IgE Ab RAST class [Presence] in Serum | 
|  16027-5 | Spinach IgE Ab RAST class [Presence] in Serum | 
|  16028-3 | Spondylocladium citrovirens IgE Ab RAST class [Presence] in Serum | 
|  16029-1 | Spruce IgE Ab RAST class [Presence] in Serum | 
|  1603-0 | Norepinephrine [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO | 
|  16030-9 | Squash IgE Ab RAST class [Presence] in Serum | 
|  16031-7 | Squid IgE Ab RAST class [Presence] in Serum | 
|  16032-5 | Pacific Squid IgE Ab RAST class [Presence] in Serum | 
|  16033-3 | Stemphylium botryosum IgE Ab RAST class [Presence] in Serum | 
|  16034-1 | Stemphylium solani IgE Ab RAST class [Presence] in Serum | 
|  16035-8 | Acarus siro IgE Ab RAST class [Presence] in Serum | 
|  16037-4 | Tyrophagus putrescentiae IgE Ab RAST class [Presence] in Serum | 
|  16038-2 | Strawberry IgE Ab RAST class [Presence] in Serum | 
|  16039-0 | Succinylcholine IgE Ab RAST class [Presence] in Serum | 
|  1604-8 | Norepinephrine [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO | 
|  16040-8 | Sugar Cane IgE Ab RAST class [Presence] in Serum | 
|  16041-6 | Sunflower Pollen IgE Ab RAST class [Presence] in Serum | 
|  16042-4 | Sunflower Seed IgE Ab RAST class [Presence] in Serum | 
|  16043-2 | Swine epithelium IgE Ab RAST class [Presence] in Serum | 
|  16044-0 | Swine urine proteins IgE Ab RAST class [Presence] in Serum | 
|  16045-7 | Swordfish IgE Ab RAST class [Presence] in Serum | 
|  16046-5 | American Sycamore IgE Ab RAST class [Presence] in Serum | 
|  16047-3 | Mandarin IgE Ab RAST class [Presence] in Serum | 
|  16048-1 | Tapioca IgE Ab RAST class [Presence] in Serum | 
|  16049-9 | Tarragon IgE Ab RAST class [Presence] in Serum | 
|  1605-5 | Norepinephrine [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO | 
|  16050-7 | Tea IgE Ab RAST class [Presence] in Serum | 
|  16051-5 | Tetramin IgE Ab RAST class [Presence] in Serum | 
|  16052-3 | Saltwort IgE Ab RAST class [Presence] in Serum | 
|  16053-1 | Thyme IgE Ab RAST class [Presence] in Serum | 
|  16054-9 | Timothy IgE Ab RAST class [Presence] in Serum | 
|  16055-6 | Deprecated Tobacco IgE Ab RAST class in Serum | 
|  16056-4 | Tobacco IgE Ab RAST class [Presence] in Serum | 
|  16057-2 | Tomato IgE Ab RAST class [Presence] in Serum | 
|  16058-0 | Tragacanth IgE Ab RAST class [Presence] in Serum | 
|  16059-8 | Trichoderma viride IgE Ab RAST class [Presence] in Serum | 
|  1606-3 | Norepinephrine [Mass/volume] in Plasma --pre 300 ug clonidine PO | 
|  16060-6 | Trichophyton sp IgE Ab RAST class [Presence] in Serum | 
|  16061-4 | Trichophyton rubrum IgE Ab RAST class [Presence] in Serum | 
|  16062-2 | Trichosporon spp IgE Ab RAST class [Presence] in Serum | 
|  16063-0 | Trimellitic anhydride (TMA) IgE Ab RAST class [Presence] in Serum | 
|  16064-8 | Trout IgE Ab RAST class [Presence] in Serum | 
|  16065-5 | Tuna IgE Ab RAST class [Presence] in Serum | 
|  16066-3 | Turkey meat IgE Ab RAST class [Presence] in Serum | 
|  16067-1 | Turnip IgE Ab RAST class [Presence] in Serum | 
|  16069-7 | Ulocladium chartarum IgE Ab RAST class [Presence] in Serum | 
|  1607-1 | Osmolality of Urine--12 hours post fluid fast | 
|  16070-5 | Barley smut IgE Ab RAST class [Presence] in Serum | 
|  16071-3 | Vanilla IgE Ab RAST class [Presence] in Serum | 
|  16072-1 | Veal IgE Ab RAST class [Presence] in Serum | 
|  16073-9 | Wall pellitory IgE Ab RAST class [Presence] in Serum | 
|  16074-7 | Walnut IgE Ab RAST class [Presence] in Serum | 
|  16075-4 | Black Walnut IgE Ab RAST class [Presence] in Serum | 
|  16076-2 | Black Walnut Pollen IgE Ab RAST class [Presence] in Serum | 
|  16077-0 | English Walnut Pollen IgE Ab RAST class [Presence] in Serum | 
|  16078-8 | California Walnut Pollen IgE Ab RAST class [Presence] in Serum | 
|  16079-6 | Deprecated California Walnut Pollen IgE Ab RAST class in Serum | 
|  1608-9 | Osmolality of Urine--8 hours post fluid fast | 
|  16080-4 | Paper wasp IgE Ab RAST class [Presence] in Serum | 
|  16081-2 | Deprecated Paper Wasp IgE Ab RAST class in Serum | 
|  16082-0 | Yellow Jacket IgE Ab RAST class [Presence] in Serum | 
|  16083-8 | Watermelon IgE Ab RAST class [Presence] in Serum | 
|  16084-6 | Grain weevel IgE Ab RAST class [Presence] in Serum | 
|  16085-3 | Wheat IgE Ab RAST class [Presence] in Serum | 
|  16086-1 | Cultivated Wheat IgE Ab RAST class [Presence] in Serum | 
|  16087-9 | Deprecated Cultivated Wheat IgE Ab RAST class in Serum | 
|  16088-7 | Wheat Stem Rust IgE Ab RAST class [Presence] in Serum | 
|  16089-5 | Cow whey IgE Ab RAST class [Presence] in Serum | 
|  1609-7 | Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV | 
|  16090-3 | Whitefish IgE Ab RAST class [Presence] in Serum | 
|  16091-1 | Willow IgE Ab RAST class [Presence] in Serum | 
|  16092-9 | Black Willow IgE Ab RAST class [Presence] in Serum | 
|  16093-7 | Pussy Willow IgE Ab RAST class [Presence] in Serum | 
|  16094-5 | Wingscale IgE Ab RAST class [Presence] in Serum | 
|  16095-2 | Wormwood IgE Ab RAST class [Presence] in Serum | 
|  16096-0 | Baker's yeast IgE Ab RAST class [Presence] in Serum | 
|  16097-8 | Deprecated Bakers Yeast IgE Ab RAST class in Serum | 
|  16098-6 | Brewer's yeast IgE Ab RAST class [Presence] in Serum | 
|  16099-4 | Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  161-0 | Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1610-5 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose L-dopa PO | 
|  16100-0 | Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  16101-8 | Cumin IgE Ab [Units/volume] in Serum | 
|  16102-6 | Bovine Gelatin IgE Ab [Units/volume] in Serum | 
|  16103-4 | Porcine Gelatin IgE Ab [Units/volume] in Serum | 
|  16104-2 | Paper Mulberry IgE Ab [Units/volume] in Serum | 
|  16105-9 | Pheasant IgE Ab [Units/volume] in Serum | 
|  16106-7 | CD8+CD28+ cells [#/volume] in Blood | 
|  16107-5 | CD8+HLA-DR+ cells [#/volume] in Blood | 
|  16108-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin IM | 
|  16109-1 | Prolactin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | 
|  1611-3 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV | 
|  16110-9 | 11-Deoxycorticosterone [Mass/time] in 24 hour Urine | 
|  16111-7 | Epinephrine+Norepinephrine [Mass/time] in 24 hour Urine | 
|  16112-5 | Estrogen receptor [Interpretation] in Tissue | 
|  16113-3 | Progesterone receptor [Interpretation] in Tissue | 
|  16114-1 | Amitriptyline [Mass/volume] in Urine | 
|  16115-8 | Doxepin [Mass/mass] in Tissue | 
|  16116-6 | Tetrahydrocortisone [Mass/time] in 24 hour Urine | 
|  16117-4 | Babesia microti IgG Ab [Titer] in Serum | 
|  16118-2 | Babesia microti IgM Ab [Titer] in Serum | 
|  16119-0 | Brucella abortus IgG Ab [Titer] in Serum | 
|  1612-1 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV | 
|  16120-8 | Brucella abortus IgM Ab [Titer] in Serum | 
|  16121-6 | Colorado tick fever virus IgG Ab [Titer] in Serum | 
|  16122-4 | Colorado tick fever virus IgM Ab [Titer] in Serum | 
|  16123-2 | Cryptococcus sp Ab [Titer] in Cerebral spinal fluid | 
|  16124-0 | Cryptococcus sp Ab [Titer] in Serum | 
|  16125-7 | Helicobacter pylori IgA Ab [Presence] in Serum | 
|  16126-5 | Helicobacter pylori IgG Ab [Presence] in Serum | 
|  16127-3 | Helicobacter pylori IgM Ab [Presence] in Serum | 
|  16128-1 | Hepatitis C virus Ab [Presence] in Serum | 
|  16129-9 | Hepatitis C virus IgG Ab [Presence] in Serum | 
|  1613-9 | Prolactin [Mass/volume] in Serum or Plasma --2 hours post dose L-dopa PO | 
|  16130-7 | Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by Probe and target amplification method | 
|  16131-5 | Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by Probe and target amplification method | 
|  16132-3 | HIV 1 p15+p18 Ab [Presence] in Serum by Immunoblot (IB) | 
|  16133-1 | Legionella pneumophila IgM Ab [Titer] in Serum by Immunofluorescence | 
|  16134-9 | Neisseria meningitidis [Presence] in Unspecified specimen by Organism specific culture | 
|  16135-6 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum | 
|  16136-4 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum | 
|  16137-2 | Centromere Ab [Presence] in Serum | 
|  16138-0 | Ganglioside GM1 IgA Ab [Titer] in Serum | 
|  16139-8 | Neuronal nuclear Ab [Titer] in Cerebral spinal fluid | 
|  1614-7 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV | 
|  16140-6 | Tellurium [Mass/volume] in Blood | 
|  16141-4 | Nitrogen [Mass/time] in 24 hour Stool | 
|  16142-2 | Fat [Mass/time] in 24 hour Stool | 
|  16143-0 | Deprecated Butane [Mass/volume] in Blood | 
|  16144-8 | Droperidol [Presence] in Serum or Plasma | 
|  16145-5 | Mescaline [Mass/volume] in Serum or Plasma | 
|  16146-3 | Psilocin [Mass/volume] in Serum or Plasma | 
|  16147-1 | Aldosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  16148-9 | Aldosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  16149-7 | Aldosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  1615-4 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV | 
|  16150-5 | Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma | 
|  16151-3 | Dechlorane [Presence] in Serum or Plasma | 
|  16152-1 | Gastrin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  16153-9 | Gastrin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  16154-7 | Gastrin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  16155-4 | Gastrin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  16156-2 | Gastrin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  16157-0 | Gastrin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  16158-8 | Gastrin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  16159-6 | Gastrin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  1616-2 | Deprecated Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV | 
|  16160-4 | Gastrin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge | 
|  16161-2 | Gastrin [Mass/volume] in Serum or Plasma --post XXX challenge | 
|  16162-0 | Parathyrin.intact [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | 
|  16163-8 | Parathyrin.intact [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  16164-6 | Parathyrin.intact [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | 
|  16165-3 | Glucose [Mass/volume] in Serum or Plasma --10 AM specimen | 
|  16166-1 | Glucose [Mass/volume] in Serum or Plasma --11 AM specimen | 
|  16167-9 | Glucose [Mass/volume] in Serum or Plasma --2 PM specimen | 
|  16168-7 | Glucose [Mass/volume] in Serum or Plasma --3 PM specimen | 
|  16169-5 | Glucose [Mass/volume] in Serum or Plasma --4 PM specimen | 
|  1617-0 | Prolactin [Mass/volume] in Serum or Plasma --3 hours post dose L-dopa PO | 
|  16170-3 | Glucose [Mass/volume] in Serum or Plasma --5 PM specimen | 
|  16171-1 | Cocaethylene [Mass/mass] in Hair | 
|  16172-9 | Magnesium [Mass/mass] in Hair | 
|  16173-7 | Amyl ether [Mass/volume] in Blood | 
|  16174-5 | Bartonella henselae IgG Ab [Presence] in Cerebral spinal fluid | 
|  16175-2 | Bartonella henselae IgM Ab [Presence] in Cerebral spinal fluid | 
|  16176-0 | Bartonella quintana IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  16177-8 | Bartonella quintana IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  16178-6 | Beryllium [Mass/mass] in Tissue | 
|  16179-4 | Polychlorinated biphenyl (PCB) [Mass/mass] in Tissue | 
|  1618-8 | Prolactin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV | 
|  16180-2 | Zinc [Mass/mass] in Tissue | 
|  16181-0 | Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method | 
|  16182-8 | Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability | 
|  16183-6 | Phenolphthalein [Mass/volume] in Stool | 
|  16184-4 | Temazepam [Mass/volume] in Stool | 
|  16185-1 | Chlordiazepoxide [Mass/volume] in Stool | 
|  16186-9 | Hydroxyalprazolam [Mass/volume] in Stool | 
|  16187-7 | Alprazolam [Mass/volume] in Stool | 
|  16188-5 | Creatinine [Mass/volume] in Serum or Plasma --2 hour specimen | 
|  16189-3 | Creatinine [Mass/volume] in Serum or Plasma --4 hour specimen | 
|  1619-6 | Prolactin [Mass/volume] in Serum or Plasma --pre dose L-dopa PO | 
|  16190-1 | Amobarbital [Presence] in Urine by Confirmatory method | 
|  16191-9 | Butabarbital [Presence] in Urine by Confirmatory method | 
|  16192-7 | Phenobarbital [Presence] in Urine by Confirmatory method | 
|  16193-5 | Pentobarbital [Presence] in Urine by Confirmatory method | 
|  16194-3 | Secobarbital [Presence] in Urine by Confirmatory method | 
|  16195-0 | Benzodiazepines [Presence] in Urine by Confirmatory method | 
|  16196-8 | Morphine [Presence] in Urine by Confirmatory method | 
|  16197-6 | Codeine [Presence] in Urine by Confirmatory method | 
|  16198-4 | Diamorphine [Presence] in Urine by Confirmatory method | 
|  16199-2 | Methadone [Presence] in Urine by Confirmatory method | 
|  162-8 | Cephalothin [Susceptibility] by Disk diffusion (KB) | 
|  1620-4 | Prolactin [Mass/volume] in Serum or Plasma --pre dose TRH IV | 
|  16200-8 | Propoxyphene [Presence] in Urine by Confirmatory method | 
|  16201-6 | Oxazepam [Mass/volume] in Urine by Confirmatory method | 
|  16202-4 | Nordiazepam [Presence] in Urine by Confirmatory method | 
|  16203-2 | Alprazolam [Presence] in Urine by Confirmatory method | 
|  16204-0 | Clonazepam [Presence] in Urine by Confirmatory method | 
|  16205-7 | Lorazepam [Presence] in Urine by Confirmatory method | 
|  16206-5 | Temazepam [Presence] in Urine by Confirmatory method | 
|  16207-3 | Meperidine [Presence] in Urine by Confirmatory method | 
|  16208-1 | Buprenorphine [Presence] in Urine by Confirmatory method | 
|  16209-9 | Chlorpheniramine [Presence] in Urine by Confirmatory method | 
|  1621-2 | Prolactin [Mass/volume] in Serum or Plasma --pre dose insulin IV | 
|  16210-7 | Diethylpropion [Presence] in Urine by Confirmatory method | 
|  16211-5 | Dihydrocodeine [Presence] in Urine by Confirmatory method | 
|  16212-3 | Ethylamphetamine [Presence] in Urine by Confirmatory method | 
|  16213-1 | Levorphanol [Presence] in Urine by Confirmatory method | 
|  16214-9 | Lysergate diethylamide [Presence] in Urine by Confirmatory method | 
|  16215-6 | Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  16216-4 | Methylephedrine [Presence] in Urine by Confirmatory method | 
|  16217-2 | Methyprylon [Presence] in Urine by Confirmatory method | 
|  16218-0 | Nalbuphine [Presence] in Urine by Confirmatory method | 
|  16219-8 | Pentazocine [Presence] in Urine by Confirmatory method | 
|  1622-0 | Renin [Enzymatic activity/volume] in Plasma --5 hours post 600 ug furosemide PO | 
|  16220-6 | Phenmetrazine [Presence] in Urine by Confirmatory method | 
|  16221-4 | Phenothiazines [Presence] in Urine by Confirmatory method | 
|  16222-2 | Phentermine [Presence] in Urine by Confirmatory method | 
|  16223-0 | Thiopental [Presence] in Urine by Confirmatory method | 
|  16224-8 | Triazolam [Presence] in Urine by Confirmatory method | 
|  16225-5 | Amitriptyline [Presence] in Urine by Confirmatory method | 
|  16226-3 | Benzoylecgonine [Mass/volume] in Urine by Confirmatory method | 
|  16227-1 | Diazepam [Mass/volume] in Urine by Confirmatory method | 
|  16228-9 | Nordiazepam [Mass/volume] in Urine by Confirmatory method | 
|  16229-7 | Clonazepam [Mass/volume] in Urine by Confirmatory method | 
|  1623-8 | Renin [Enzymatic activity/volume] in Plasma --pre 600 ug furosemide PO | 
|  16230-5 | N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method | 
|  16231-3 | Flurazepam [Mass/volume] in Urine by Confirmatory method | 
|  16232-1 | Triazolam [Mass/volume] in Urine by Confirmatory method | 
|  16233-9 | Midazolam [Mass/volume] in Urine by Confirmatory method | 
|  16234-7 | Amphetamine [Mass/volume] in Urine by Confirmatory method | 
|  16235-4 | Methamphetamine [Mass/volume] in Urine by Confirmatory method | 
|  16236-2 | Butabarbital [Mass/volume] in Urine by Confirmatory method | 
|  16237-0 | Butalbital [Mass/volume] in Urine by Confirmatory method | 
|  16238-8 | Secobarbital [Mass/volume] in Urine by Confirmatory method | 
|  16239-6 | Amobarbital [Mass/volume] in Urine by Confirmatory method | 
|  1624-6 | Retinol [Mass/volume] in Serum or Plasma --3 hours post 5000 units | 
|  16240-4 | Pentobarbital [Mass/volume] in Urine by Confirmatory method | 
|  16241-2 | Phenobarbital [Mass/volume] in Urine by Confirmatory method | 
|  16242-0 | Propoxyphene [Mass/volume] in Urine by Confirmatory method | 
|  16243-8 | Cannabinoids [Mass/volume] in Blood by Confirmatory method | 
|  16244-6 | Methaqualone [Mass/volume] in Urine by Confirmatory method | 
|  16245-3 | Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  16246-1 | Methadone [Mass/volume] in Urine by Confirmatory method | 
|  16247-9 | Dextromethorphan [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  16248-7 | 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  16249-5 | Oxycodone [Mass/volume] in Urine by Confirmatory method | 
|  1625-3 | Retinol [Mass/volume] in Serum or Plasma --6 hours post 5000 units | 
|  16250-3 | Codeine [Mass/volume] in Urine by Confirmatory method | 
|  16251-1 | Morphine [Mass/volume] in Urine by Confirmatory method | 
|  16252-9 | Hydrocodone [Mass/volume] in Urine by Confirmatory method | 
|  16253-7 | Meperidine [Mass/volume] in Urine by Confirmatory method | 
|  16254-5 | Phencyclidine [Mass/volume] in Urine by Confirmatory method | 
|  16255-2 | Troponin I.cardiac [Units/volume] in Serum or Plasma | 
|  16257-8 | Sodium urate crystals [Presence] in Stone by Infrared spectroscopy | 
|  16258-6 | Ammonium urate crystals [Presence] in Stone by Infrared spectroscopy | 
|  16259-4 | Urate dihydrate crystals [Presence] in Stone by Infrared spectroscopy | 
|  1626-1 | Retinol [Mass/volume] in Serum or Plasma --pre 5000 units | 
|  16260-2 | Triamterene crystals [Presence] in Stone by Infrared spectroscopy | 
|  16261-0 | Calcium bilirubinate crystals [Presence] in Stone by Infrared spectroscopy | 
|  16262-8 | Newberyite crystals [Presence] in Stone by Infrared spectroscopy | 
|  16263-6 | Calcium oxalate dihydrate crystals [Presence] in Stone by Infrared spectroscopy | 
|  16264-4 | Calcium oxalate monohydrate crystals [Presence] in Stone by Infrared spectroscopy | 
|  16265-1 | Triple phosphate crystals [Presence] in Stone by Infrared spectroscopy | 
|  16266-9 | Calcium hydrogen phosphate crystals [Presence] in Stone by Infrared spectroscopy | 
|  16267-7 | Calcium carbonate crystals [Presence] in Stone by Infrared spectroscopy | 
|  16268-5 | Calcium phosphate crystals [Presence] in Stone by Infrared spectroscopy | 
|  16269-3 | Urate crystals [Presence] in Stone by Infrared spectroscopy | 
|  1627-9 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV | 
|  16270-1 | Calcium [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  16271-9 | Calcium [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | 
|  16272-7 | Calcium [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | 
|  16273-5 | Calcium [Mass/mass] in Red Blood Cells | 
|  16274-3 | Deprecated Cells.CD4/Cells.C4 | 
|  16275-0 | Bartonella sp DNA [Presence] in Blood by Probe and target amplification method | 
|  16276-8 | Bartonella henselae DNA [Presence] in Blood by Probe and target amplification method | 
|  16277-6 | Bartonella quintana DNA [Presence] in Blood by Probe and target amplification method | 
|  16278-4 | Mycobacterium tuberculosis DNA [Presence] in Blood by Probe and target amplification method | 
|  16279-2 | Toxoplasma gondii DNA [Presence] in Blood by Probe and target amplification method | 
|  1628-7 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post 1 g/kg glucose PO | 
|  16280-0 | Human papilloma virus DNA [Presence] in Unspecified specimen by Probe with amplification | 
|  16281-8 | Trazodone [Units/volume] in Urine | 
|  16282-6 | Acetaminophen [Units/volume] in Urine | 
|  16283-4 | Escherichia coli verotoxin [Presence] in Unspecified specimen | 
|  16284-2 | Polio virus Ab [Units/volume] in Serum | 
|  16285-9 | Creatinine/Protein [Mass Ratio] in Urine | 
|  16286-7 | Deprecated Testosterone Free/Testosterone.total in Serum or Plasma | 
|  16287-5 | Deprecated Sulfatide Ab | 
|  16288-3 | Deprecated Monosialoganglioside GM1 Ab.IgG+IgM | 
|  16289-1 | Deprecated Monosialoganglioside GM1 Ab | 
|  1629-5 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV | 
|  16290-9 | Neutrophils [Presence] in Stool | 
|  16291-7 | Herpes simplex virus 1 [Presence] in Unspecified specimen by Organism specific culture | 
|  16292-5 | 1,4-Dioxane [Mass/volume] in Urine | 
|  16293-3 | 11-Deoxycorticosteroids [Mass/volume] in Plasma | 
|  16294-1 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --post XXX challenge | 
|  16295-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --post XXX challenge | 
|  16296-6 | 11-Hydroxyandrosterone [Mass/volume] in Serum or Plasma | 
|  16297-4 | 17-Hydroxypregnenolone [Mass/volume] in Urine | 
|  16298-2 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge | 
|  16299-0 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --6 hours post XXX challenge | 
|  163-6 | Cephalothin [Susceptibility] by Serum bactericidal titer | 
|  1630-3 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post 1 g/kg glucose PO | 
|  16300-6 | 17-Ketogenic steroids [Mass/time] in 72 hour Urine | 
|  16301-4 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --baseline | 
|  16302-2 | 1-Methylhistidine [Presence] in Urine | 
|  16303-0 | 2-Hexanol [Mass/volume] in Urine | 
|  16304-8 | 2-Hexanol/Creatinine [Mass Ratio] in Urine | 
|  16305-5 | 2-Methoxyethanol [Mass/volume] in Blood | 
|  16306-3 | 3-Methylhistidine [Presence] in Urine | 
|  16307-1 | Acetate [Mass/volume] in Dialysis fluid | 
|  16308-9 | Acetazolamide [Units/volume] in Serum or Plasma | 
|  16309-7 | Acetazolamide [Units/volume] in Urine | 
|  1631-1 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV | 
|  16310-5 | Acetone [Presence] in Body fluid | 
|  16311-3 | Acetone [Mass/volume] in Body fluid | 
|  16312-1 | Acetonitrile [Mass/volume] in Serum or Plasma | 
|  16313-9 | Acetylene [Mass/volume] in Blood | 
|  16314-7 | Acetylsalicylate [Presence] in Urine | 
|  16315-4 | Acid phosphatase [Enzymatic activity/volume] in Blood by Tartrate inhibited | 
|  16316-2 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Blood | 
|  16317-0 | Prostatic acid phosphatase [Presence] in Vaginal fluid | 
|  16318-8 | Acrylamide [Mass/volume] in Urine | 
|  16319-6 | Acrylamide [Mass/volume] in Serum or Plasma | 
|  1632-9 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post 1 g/kg glucose PO | 
|  16320-4 | Acyclovir [Susceptibility] by Serum bactericidal titer | 
|  16321-2 | Deprecated Acyl carnitine [Mass/volume] in Serum or Plasma | 
|  16322-0 | Biperiden [Mass/volume] in Serum or Plasma | 
|  16323-8 | Alanine [Presence] in Urine | 
|  16324-6 | Alanine aminotransferase [Enzymatic activity/volume] in Red Blood Cells | 
|  16325-3 | Alanine aminotransferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma | 
|  16327-9 | Allyl alcohol [Mass/volume] in Blood | 
|  16328-7 | Benzyl alcohol [Presence] in Blood | 
|  16329-5 | Aldosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  1633-7 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV | 
|  16330-3 | Aldosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  16331-1 | Aldosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  16332-9 | Aldosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  16333-7 | Aldrin [Mass/volume] in Blood | 
|  16334-5 | Alfentanil [Mass/volume] in Urine | 
|  16335-2 | Hydrocarbons Aliphatic [Identifier] in Blood | 
|  16336-0 | Deprecated Alkaline phosphatase.placental [Enzymatic activity/volume] in Serum or Plasma | 
|  16337-8 | Alkaline phosphatase [Enzymatic activity/volume] in Urine | 
|  16338-6 | Alpha aminoadipate [Presence] in Urine | 
|  16339-4 | Alpha aminoisobutyrate [Presence] in Urine | 
|  1634-5 | Somatotropin [Mass/volume] in Serum or Plasma --52 hours post 250 ug L-dopa TID 2day PO | 
|  16340-2 | Alpha aminoisobutyrate [Mass/volume] in Urine | 
|  16341-0 | Alpha aminoisobutyrate [Presence] in Plasma | 
|  16342-8 | Alpha aminoisobutyrate [Mass/volume] in Plasma | 
|  16343-6 | Alpha aminoisobutyrate [Mass/volume] in Cerebral spinal fluid | 
|  16344-4 | Alpha aminoisobutyrate [Mass/volume] in Amniotic fluid | 
|  16345-1 | Alpha aminobutyrate [Presence] in Urine | 
|  16346-9 | Alpha chlordane [Mass/volume] in Urine | 
|  16347-7 | Alpha chlordane [Mass/volume] in Blood | 
|  16348-5 | Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method | 
|  16349-3 | Aluminum [Mass/volume] in Body fluid | 
|  1635-2 | Somatotropin [Mass/volume] in Serum or Plasma --pre 1 g/kg glucose PO | 
|  16350-1 | Amantadine [Susceptibility] by Serum bactericidal titer | 
|  16351-9 | Amiloride [Units/volume] in Serum or Plasma | 
|  16352-7 | Amiloride [Units/volume] in Urine | 
|  16353-5 | Amino beta guanidinopropionate [Presence] in Urine | 
|  16354-3 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Urine | 
|  16355-0 | Amino beta guanidinopropionate [Presence] in Plasma | 
|  16356-8 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Plasma | 
|  16357-6 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid | 
|  16358-4 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid | 
|  16359-2 | Deprecated Amiodarone+Desethylamiodarone [Mass/volume] in Serum or Plasma | 
|  1636-0 | Somatotropin [Mass/volume] in Serum or Plasma --pre 250 ug L-dopa TID 2day PO | 
|  16360-0 | Amitriptyline [Mass/volume] in Serum or Plasma --peak | 
|  16361-8 | Amitriptyline [Mass/volume] in Serum or Plasma --trough | 
|  16362-6 | Ammonia [Moles/volume] in Plasma | 
|  16363-4 | Ammonia [Moles/mass] in Tissue | 
|  16364-2 | Amobarbital [Mass/volume] in Gastric fluid | 
|  16365-9 | Amoxicillin+Clavulanate [Mass/volume] in Serum or Plasma | 
|  16366-7 | Diethylpropion [Mass/volume] in Serum or Plasma | 
|  16367-5 | Deprecated Amphetamine/Methamphetamine [Mass ratio] in Urine Qualitative | 
|  16369-1 | Amphetamines [Presence] in Urine by Confirmatory method | 
|  1637-8 | Somatotropin [Mass/volume] in Serum or Plasma --pre dose insulin IV | 
|  16370-9 | Amphotericin B [Mass/volume] in Urine | 
|  16373-3 | Amyl ether [Presence] in Blood | 
|  16374-1 | Amyl nitrite [Mass/volume] in Serum or Plasma | 
|  16378-2 | Androstenedione [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  16379-0 | Androstenedione [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  1638-6 | Testosterone [Mass/volume] in Serum or Plasma --96 hours post 5000 U HCG IM | 
|  16380-8 | Androstenedione [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  16381-6 | Androstenedione [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  16382-4 | Androstenedione [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  16383-2 | Androstenedione [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  16384-0 | Androstenedione [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  16385-7 | Androstenedione [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  16386-5 | Deprecated Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  16387-3 | Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  16388-1 | Anticonvulsants [Identifier] in Urine | 
|  16389-9 | Antidepressants [Identifier] in Serum or Plasma | 
|  1639-4 | Testosterone [Mass/volume] in Serum or Plasma --pre 5000 U HCG IM | 
|  16390-7 | Antidiuretics [Identifier] in Urine | 
|  16391-5 | Antimony [Presence] in Urine | 
|  16392-3 | Nuclear Ab [Presence] in Serum by Rodent substrate | 
|  16393-1 | Nuclear Ab [Units/volume] in Serum by Rodent substrate | 
|  16394-9 | Nuclear Ab [Presence] in Body fluid by Immunofluorescence | 
|  16395-6 | Antipsychotics [Identifier] in Urine | 
|  164-4 | Cephapirin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1640-2 | Thyrotropin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV | 
|  16400-4 | Appearance of Seminal plasma | 
|  16401-2 | Arginine [Presence] in Urine | 
|  16402-0 | Aromatic solvents [Identifier] in Blood | 
|  16403-8 | Arsenic [Presence] in Serum or Plasma | 
|  16404-6 | Arsenic [Presence] in Urine | 
|  16405-3 | Arylamidase [Presence] in Urine | 
|  16406-1 | Arylamidase [Enzymatic activity/volume] in Urine | 
|  16407-9 | Asbestos identified in Sputum by Light microscopy | 
|  16408-7 | Ascorbate [Mass/volume] in Urine | 
|  16409-5 | Ascorbate [Mass/volume] in Serum or Plasma --post dose | 
|  1641-0 | Thyrotropin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV | 
|  16410-3 | Asparagine [Presence] in Urine | 
|  16411-1 | Aspartate [Presence] in Urine | 
|  16412-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells | 
|  16414-5 | Aspergillus amstelodami Ab [Units/volume] in Serum | 
|  16415-2 | Aspergillus flavus Ab [Presence] in Cerebral spinal fluid | 
|  16416-0 | Aspergillus terreus Ab [Units/volume] in Serum | 
|  16417-8 | Aspergillus versicolor Ab [Units/volume] in Serum | 
|  16418-6 | Azatadine [Presence] in Urine | 
|  16419-4 | Azathioprine [Mass/volume] in Serum or Plasma | 
|  1642-8 | Thyrotropin [Mass/volume] in Serum or Plasma --baseline | 
|  16420-2 | Azithromycin [Mass/volume] in Serum or Plasma | 
|  16421-0 | Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  16422-8 | Azlocillin [Mass/volume] in Urine | 
|  16423-6 | Aztreonam [Mass/volume] in Urine | 
|  16424-4 | Deprecated Sulfasalazine [Mass/volume] in Serum or Plasma | 
|  16425-1 | Babesia sp IgM Ab [Units/volume] in Serum by Immunofluorescence | 
|  16426-9 | Babesia sp IgM Ab [Titer] in Serum | 
|  16427-7 | Babesia microti Ab [Titer] in Serum | 
|  16428-5 | Bacitracin [Mass/volume] in Serum or Plasma | 
|  16429-3 | Barbiturates [Presence] in Urine by Confirmatory method | 
|  1643-6 | Thyrotropin [Mass/volume] in Serum or Plasma --pre dose TRH IV | 
|  16430-1 | Barbiturates [Units/volume] in Urine | 
|  16431-9 | Barium [Presence] in Urine | 
|  16432-7 | Barium [Mass/volume] in Blood | 
|  16433-5 | Basement membrane Ab [Presence] in Serum | 
|  16434-3 | Basement membrane Ab [Units/volume] in Serum by Immunofluorescence | 
|  16435-0 | Deprecated White Bean IgE Ab [Units/volume] in Serum | 
|  16436-8 | Deprecated Bean string IgE Ab [Units/volume] in Serum | 
|  16437-6 | Bendroflumethiazide [Units/volume] in Urine | 
|  16438-4 | Benzaldehyde [Presence] in Urine | 
|  16439-2 | Benzene [Presence] in Blood | 
|  1644-4 | Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting | 
|  16440-0 | Benzene ring IgE Ab [Units/volume] in Serum | 
|  16441-8 | Benzene ring IgG Ab [Units/volume] in Serum | 
|  16442-6 | Benzene ring IgM Ab [Units/volume] in Serum | 
|  16443-4 | Benzonatate [Mass/volume] in Serum | 
|  16444-2 | Benzophenone [Mass/volume] in Serum or Plasma | 
|  16446-7 | Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method | 
|  16447-5 | Cocaine [Units/volume] in Serum or Plasma | 
|  16448-3 | Cocaine [Units/volume] in Urine | 
|  16449-1 | Benzthiazide [Mass/volume] in Serum or Plasma | 
|  1645-1 | Xylose [Mass/volume] in Blood --2 hours post 25 g xylose PO | 
|  16450-9 | Benzylhydrazine [Mass/volume] in Serum or Plasma | 
|  16451-7 | Beryllium [Presence] in Urine | 
|  16452-5 | Beta alanine [Presence] in Urine | 
|  16453-3 | Beta aminoisobutyrate [Presence] in Urine | 
|  16454-1 | Beta galactosidase [Enzymatic activity/volume] in Blood | 
|  16455-8 | Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid | 
|  16456-6 | Beta hydroxybutyrate [Moles/volume] in Urine | 
|  16457-4 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes | 
|  16458-2 | Bethanechol [Mass/volume] in Serum or Plasma | 
|  16459-0 | Bicarbonate [Moles/volume] in Body fluid | 
|  1646-9 | Xylose [Mass/time] in 5 hour Urine --post dose PO | 
|  16460-8 | Bicarbonate [Moles/volume] in Cerebral spinal fluid | 
|  16461-6 | Bicarbonate [Moles/volume] in Red Blood Cells | 
|  16462-4 | Bicarbonate [Moles/volume] in Amniotic fluid | 
|  16463-2 | Bile acid.dihydroxy [Mass/volume] in Serum | 
|  16464-0 | Bile acid [Units/volume] in Exhaled gas | 
|  16465-7 | Bile acid [Mass/volume] in Urine | 
|  16466-5 | Bile acid.trihydroxy [Mass/volume] in Serum | 
|  16467-3 | Bismuth [Presence] in Blood | 
|  16468-1 | Bismuth [Presence] in Urine | 
|  16469-9 | Bismuth/Creatinine [Mass Ratio] in Urine | 
|  1647-7 | Tuberculosis reaction wheal [Diameter] --3 days post 25 TU intradermal | 
|  16470-7 | Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation | 
|  16471-5 | Blastomyces dermatitidis Ab [Units/volume] in Serum | 
|  16472-3 | Blastomyces dermatitidis rRNA [Presence] in Serum by DNA probe | 
|  16473-1 | Bordetella parapertussis Ab [Units/volume] in Serum | 
|  16474-9 | Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation | 
|  16475-6 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay | 
|  16476-4 | Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay | 
|  16477-2 | Borrelia burgdorferi Ab [Presence] in Body fluid | 
|  16478-0 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoassay | 
|  16479-8 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay | 
|  1648-5 | Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal | 
|  16480-6 | Borrelia burgdorferi IgG Ab [Presence] in Serum by Immunoassay | 
|  16481-4 | Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid by Immunoassay | 
|  16482-2 | Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid by Immunoassay | 
|  16483-0 | Borrelia hermsii [Presence] in Unspecified specimen by Organism specific culture | 
|  16484-8 | Boysenberry IgE Ab [Units/volume] in Serum | 
|  16485-5 | Bromodiphenhydramine [Mass/volume] in Urine | 
|  16486-3 | Brucella abortus IgA+IgG+IgM Ab [Units/volume] in Serum | 
|  16487-1 | Brucella abortus IgG Ab [Units/volume] in Serum by Agglutination | 
|  16488-9 | Brucella abortus IgG Ab [Units/volume] in Serum by Complement fixation | 
|  16489-7 | Brucella melitensis Ab [Units/volume] in Serum by Latex agglutination | 
|  1649-3 | Calcitriol [Mass/volume] in Serum or Plasma | 
|  16490-5 | Brucella suis Ab [Units/volume] in Serum by Latex agglutination | 
|  16491-3 | Brush border Ab [Presence] in Serum by Immunofluorescence | 
|  16492-1 | Bufotenine [Units/volume] in Urine | 
|  16493-9 | Bufotenine [Units/volume] in Serum or Plasma | 
|  16494-7 | Bumetanide [Units/volume] in Urine | 
|  16495-4 | Buprenorphine [Units/volume] in Serum or Plasma | 
|  16496-2 | Buprenorphine [Units/volume] in Urine | 
|  16497-0 | Butabarbital [Mass/volume] in Gastric fluid | 
|  16498-8 | Butalbital [Units/volume] in Gastric fluid | 
|  16499-6 | Butorphanol [Mass/volume] in Urine by Confirmatory method | 
|  165-1 | Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1650-1 | 1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes | 
|  16500-1 | Butyrate (C4) [Mass/volume] in Stool | 
|  16501-9 | C peptide [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  16502-7 | C peptide [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  16503-5 | C reactive protein [Mass/volume] in Body fluid | 
|  16504-3 | Calcitonin [Mass/volume] in Serum or Plasma --1.5 minutes post XXX challenge | 
|  16505-0 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  16506-8 | Calcitonin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | 
|  16507-6 | Calcitonin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge | 
|  16508-4 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge | 
|  16509-2 | Calcitonin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  1651-9 | 1-Methylhistidine [Presence] in Serum or Plasma | 
|  16510-0 | Calcitonin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  16511-8 | Calcitonin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  16512-6 | Calcium.ionized [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  16513-4 | Calcium.ionized [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  16514-2 | Calcium.ionized [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  16515-9 | Calcium.ionized [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  16516-7 | Calcium.ionized [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  16517-5 | Calcium.ionized [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  16518-3 | Calcium [Mass/time] in 2 hour Urine | 
|  16519-1 | Calcium [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  1652-7 | 1-Methylhistidine [Mass/volume] in Serum or Plasma | 
|  16520-9 | Calcium [Moles/volume] in Urine --2nd specimen post XXX challenge | 
|  16521-7 | Calcium [Moles/volume] in Urine --3rd specimen post XXX challenge | 
|  16522-5 | Calcium [Moles/volume] in Urine --4th specimen post XXX challenge | 
|  16523-3 | Calcium [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge | 
|  16524-1 | Calcium [Moles/volume] in Serum or Plasma --6 hours post XXX challenge | 
|  16525-8 | Calcium/Phosphate [Mass Ratio] in Serum or Plasma | 
|  16526-6 | Calcium/Protein [Mass Ratio] in Serum or Plasma | 
|  16527-4 | Calcium/Sodium [Mass Ratio] in Serum or Plasma | 
|  16528-2 | Campylobacter coli rRNA [Units/volume] in Serum by DNA probe | 
|  16529-0 | Campylobacter jejuni rRNA [Units/volume] in Serum by DNA probe | 
|  1653-5 | 1-Methylhistidine [Mass/volume] in Urine | 
|  16530-8 | Campylobacter jejuni rRNA [Presence] in Serum by DNA probe | 
|  16531-6 | Campylobacter lari rRNA [Units/volume] in Serum by DNA probe | 
|  16532-4 | Campylobacter lari rRNA [Presence] in Serum by DNA probe | 
|  16533-2 | Helicobacter pylori Ab [Titer] in Serum | 
|  16534-0 | Campylobacter sp rRNA [Presence] in Serum by DNA probe | 
|  16535-7 | Canary droppings IgE Ab [Units/volume] in Serum | 
|  16536-5 | Canary serum proteins Ab [Units/volume] in Serum | 
|  16537-3 | Candida albicans Ab [Units/volume] in Serum by Immune diffusion (ID) | 
|  16538-1 | Candida sp IgA Ab [Units/volume] in Saliva (oral fluid) | 
|  16539-9 | Candida sp Ag [Presence] in Serum | 
|  1654-3 | 1-Naphthalene [Mass/volume] in Urine | 
|  16540-7 | Deprecated Cannabinoids [Presence] in Serum or Plasma by Confirm method | 
|  16542-3 | Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  16543-1 | Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method | 
|  16544-9 | Canrenone [Units/volume] in Urine | 
|  16545-6 | Capreomycin [Mass/volume] in Serum or Plasma | 
|  16546-4 | Captopril [Mass/volume] in Serum or Plasma | 
|  16547-2 | Carbamate pesticides [Type] in Urine | 
|  16548-0 | Carbamazepine [Mass/volume] in Urine | 
|  16549-8 | Carbinoxamine [Presence] in Urine | 
|  1655-0 | Deprecated 11-Deoxy/11-Oxy steroids in Urine | 
|  16550-6 | Carbohydrates [Identifier] in Urine | 
|  16551-4 | Carbon dioxide, total [Moles/volume] in Capillary blood | 
|  16553-0 | Carnitine [Mass/mass] in Tissue | 
|  16555-5 | Carnitine [Mass/volume] in Cerebral spinal fluid | 
|  16556-3 | Carnitine [Mass/volume] in Amniotic fluid | 
|  16557-1 | Carnosine [Presence] in Urine | 
|  16558-9 | Catecholamines [Mass/volume] in Plasma --2 hours post XXX challenge | 
|  16559-7 | Catecholamines [Mass/volume] in Plasma --3 hours post XXX challenge | 
|  1656-8 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma | 
|  16560-5 | Catecholamines [Mass/volume] in Plasma --5th specimen post XXX challenge | 
|  16561-3 | Catecholamines [Mass/volume] in Plasma --6th specimen post XXX challenge | 
|  16562-1 | Cathartic laxatives [Identifier] in Urine | 
|  16563-9 | Cathepsin D in Serum or Plasma | 
|  16564-7 | Cefaclor [Mass/volume] in Serum or Plasma | 
|  16565-4 | Cefadroxil [Mass/volume] in Serum or Plasma | 
|  16566-2 | Cefazolin [Mass/volume] in Urine | 
|  16567-0 | Cefixime [Mass/volume] in Serum or Plasma | 
|  16568-8 | Cefuroxime IgE Ab [Units/volume] in Serum | 
|  16569-6 | Ceftriaxone IgE Ab [Mass/volume] in Serum | 
|  1657-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma | 
|  16570-4 | Centromere Ab [Presence] in Serum by Immunofluorescence | 
|  16571-2 | Cephadrine [Mass/volume] in Serum or Plasma | 
|  16572-0 | Cephaloridine [Mass/volume] in Serum or Plasma | 
|  16573-8 | Deprecated Cerebroside sulfatase [Presence] in Serum or Plasma | 
|  16574-6 | Deprecated Cerebroside sulfatase [Enzymatic activity/mass] in Tissue | 
|  16575-3 | Deprecated Cerebroside sulfatase B in urine | 
|  16576-1 | Deprecated Cerebroside sulfatase B in amniotic fluid | 
|  16577-9 | Deprecated Cerebroside sulfatase B in serum or plasma | 
|  16578-7 | Deprecated Cerebroside sulfatase B in tissue | 
|  16579-5 | Deprecated Cerebroside sulfatase B in blood | 
|  1658-4 | 11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma | 
|  16580-3 | Deprecated Cerebroside sulfatase B in leukocytes | 
|  16581-1 | Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  16582-9 | Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  16583-7 | Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  16584-5 | Chlamydophila pneumoniae rRNA [Presence] in Sputum by DNA probe | 
|  16585-2 | Chlamydophila pneumoniae rRNA [Presence] in Serum or Plasma by DNA probe | 
|  16586-0 | Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  16587-8 | Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  16588-6 | Chlamydophila psittaci IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  16589-4 | Chlamydia sp Ab [Units/volume] in Serum by Immunofluorescence | 
|  1659-2 | 11-Hydroxyandrosterone [Mass/volume] in Urine | 
|  16590-2 | Chlamydia sp Ab [Units/volume] in Serum by Complement fixation | 
|  16591-0 | Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | 
|  16592-8 | Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | 
|  16593-6 | Chlamydia sp Ag [Presence] in Urine | 
|  16594-4 | Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | 
|  16595-1 | Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | 
|  16596-9 | Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | 
|  16597-7 | Chlamydia trachomatis B IgG Ab [Units/volume] in Serum | 
|  16598-5 | Chlamydia trachomatis C IgG Ab [Units/volume] in Serum | 
|  16599-3 | Chlamydia trachomatis DNA [Presence] in Blood by Probe and target amplification method | 
|  166-9 | Cephapirin [Susceptibility] by Disk diffusion (KB) | 
|  1660-0 | 11-Hydroxyetiocholanolone [Mass/volume] in Serum | 
|  16600-9 | Chlamydia trachomatis rRNA [Presence] in Genital specimen by DNA probe | 
|  16601-7 | Chlamydia trachomatis rRNA [Presence] in Urine by DNA probe | 
|  16602-5 | Deprecated Chlamydia trachomatis rRNA [Presence] in Urine by DNA probe | 
|  16603-3 | Chloramphenicol [Mass/volume] in Serum or Plasma --peak | 
|  16604-1 | Chloramphenicol [Mass/volume] in Serum or Plasma --trough | 
|  16605-8 | Chlorocycline [Mass/volume] in Urine | 
|  16606-6 | Chlorine [Mass/volume] in Dialysis fluid | 
|  16607-4 | Chlorine [Mass/volume] in Water | 
|  16608-2 | Chlorpheniramine [Units/volume] in Urine | 
|  16609-0 | Chlorphentermine [Units/volume] in Blood | 
|  1661-8 | 11-Ketoandrosterone [Mass/volume] in Serum | 
|  16610-8 | Chlorphentermine [Units/volume] in Urine | 
|  16611-6 | Chlorpyrifos [Mass/volume] in Urine | 
|  16612-4 | Chlorthalidone [Mass/volume] in Serum or Plasma | 
|  16613-2 | Cholesterol crystals [Presence] in Stone by Infrared spectroscopy | 
|  16614-0 | Cholesterol crystals [Presence] in Body fluid by Light microscopy | 
|  16615-7 | Cholesterol.total/Cholesterol in LDL [Mass Ratio] in Serum or Plasma | 
|  16616-5 | Cholesterol in HDL/Cholesterol in LDL [Mass Ratio] in Serum or Plasma | 
|  16617-3 | Choriogonadotropin.intact [Moles/volume] in Semen | 
|  16618-1 | Cladosporium herbarum Ab [Units/volume] in Serum | 
|  16619-9 | Clarithromycin [Mass/volume] in Serum or Plasma | 
|  1662-6 | 11-Ketoetiocholanolone [Mass/volume] in Serum | 
|  16620-7 | Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  16621-5 | Clindamycin [Mass/volume] in Serum or Plasma --peak | 
|  16622-3 | Clindamycin [Mass/volume] in Serum or Plasma --trough | 
|  16623-1 | Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  16624-9 | Clomipramine [Units/volume] in Milk | 
|  16625-6 | Clomipramine [Mass/volume] in Milk | 
|  16626-4 | Clostridium tetani Ab [Units/volume] in Serum --1st specimen | 
|  16627-2 | Clostridium tetani Ab [Units/volume] in Serum --2nd specimen | 
|  16628-0 | Cloxacillin [Mass/volume] in Serum or Plasma | 
|  16629-8 | Deprecated Activated partial thrombplastin time (aPTT) in Blood from control by Coagulation assay | 
|  1663-4 | 11-Oxycorticosterone [Mass/volume] in Serum | 
|  16630-6 | aPTT in control Blood by Coagulation 1:1 saline | 
|  16631-4 | aPTT in Blood by Coagulation 1:1 saline | 
|  16632-2 | Cocaethylene [Mass/volume] in Urine by Confirmatory method | 
|  16633-0 | Cocaine [Presence] in Blood | 
|  16634-8 | Coccidioides immitis Ab [Units/volume] in Cerebral spinal fluid | 
|  16635-5 | Coccidioides immitis IgA Ab [Units/volume] in Serum by Immunoassay | 
|  16636-3 | Coccidioides immitis IgA Ab [Units/volume] in Cerebral spinal fluid | 
|  16637-1 | Coccidioides immitis IgE Ab [Units/volume] in Serum | 
|  16638-9 | Coccidioides immitis IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  16639-7 | Coccidioides immitis IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  1664-2 | 17-Hydroxycorticosteroids [Mass/volume] in Amniotic fluid | 
|  16640-5 | Coccidioides reaction wheal [Diameter] | 
|  16641-3 | Cockatiel droppings Ab [Units/volume] in Serum | 
|  16642-1 | Cockatiel droppings IgG Ab [Units/volume] in Serum | 
|  16643-9 | Cockatoo droppings Ab [Units/volume] in Serum | 
|  16644-7 | Codeine Free [Presence] in Serum or Plasma by Confirmatory method | 
|  16645-4 | Colistin [Mass/volume] in Serum or Plasma | 
|  16647-0 | Collagen Ab [Units/volume] in Serum | 
|  16648-8 | Copper [Mass/volume] in Body fluid | 
|  16649-6 | Coproporphyrinogen oxidase [Enzymatic activity/volume] in Red Blood Cells | 
|  1665-9 | 17-Hydroxycorticosteroids [Mass/volume] in Plasma | 
|  16650-4 | Cilantro IgE Ab [Units/volume] in Serum | 
|  16651-2 | Corticosterone [Mass/volume] in Serum or Plasma --post XXX challenge | 
|  16652-0 | Corticotropin [Mass/volume] in Amniotic fluid by Radioimmunoassay (RIA) | 
|  16653-8 | Corticotropin Canine [Mass/volume] in Plasma | 
|  16654-6 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1.5 hours post XXX challenge | 
|  16655-3 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --10 minutes post XXX challenge | 
|  16656-1 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --15 minutes post XXX challenge | 
|  16657-9 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 hour post XXX challenge | 
|  16658-7 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 minute post XXX challenge | 
|  16659-5 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2.5 hours post XXX challenge | 
|  1666-7 | 17-Hydroxycorticosteroids [Mass/volume] in Urine | 
|  16660-3 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --20 minutes post XXX challenge | 
|  16661-1 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2 hours post XXX challenge | 
|  16662-9 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --30 minutes post XXX challenge | 
|  16663-7 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --3 hours post XXX challenge | 
|  16664-5 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --45 minutes post XXX challenge | 
|  16665-2 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --5 minutes post XXX challenge | 
|  16666-0 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --9th specimen post XXX challenge | 
|  16667-8 | Cortisol Free [Mass/time] in 48 hour Urine | 
|  16668-6 | Cortisol Free [Mass/time] in 72 hour Urine | 
|  16669-4 | Cortisol [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  1667-5 | 17-Hydroxyketosteroids [Mass/volume] in Urine | 
|  16670-2 | Cortisol [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge | 
|  16671-0 | Cortisol [Mass/volume] in Serum or Plasma --1 minute post XXX challenge | 
|  16672-8 | Cortisol [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge | 
|  16673-6 | Cortisol [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge | 
|  16674-4 | Cortisol [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge | 
|  16675-1 | Cortisol [Mass/volume] in Serum or Plasma --80 minutes post XXX challenge | 
|  16676-9 | Corynebacterium diphtheriae [Presence] in Unspecified specimen by Organism specific culture | 
|  16677-7 | Coxiella burnetii IgG Ab [Units/volume] in Serum | 
|  16678-5 | Coxiella burnetii IgM Ab [Units/volume] in Serum | 
|  16679-3 | Coxsackievirus A Ab [Units/volume] in Serum | 
|  1668-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma | 
|  16680-1 | Coxsackievirus A IgG Ab [Units/volume] in Serum | 
|  16681-9 | Coxsackievirus A IgM Ab [Units/volume] in Serum | 
|  16682-7 | Coxsackievirus A2 Ab [Titer] in Cerebral spinal fluid | 
|  16683-5 | Coxsackievirus A4 Ab [Titer] in Cerebral spinal fluid | 
|  16684-3 | Coxsackievirus B Ab [Units/volume] in Serum | 
|  16685-0 | Coxsackievirus B IgG Ab [Units/volume] in Serum by Neutralization test | 
|  16686-8 | Coxsackievirus B IgM Ab [Units/volume] in Serum by Neutralization test | 
|  16687-6 | Creatine [Mass/volume] in Vitreous fluid | 
|  16688-4 | Creatine kinase [Enzymatic activity/volume] in Body fluid | 
|  16689-2 | Creatinine [Mass/time] in 48 hour Urine | 
|  1669-1 | Deprecated 17-Hydroxyprogesterone [Mass/volume] in Serum | 
|  16690-0 | Creatinine [Mass/time] in 72 hour Urine | 
|  16691-8 | Cresols [Identifier] in Unspecified specimen | 
|  16692-6 | Cryptococcus sp Ag [Presence] in Body fluid | 
|  16693-4 | Cryptococcus sp Ag [Presence] in Urine | 
|  16694-2 | Cumene [Presence] in Blood | 
|  16695-9 | Cobalamin (Vitamin B12) [Mass/volume] in Blood | 
|  16696-7 | Cobalamin (Vitamin B12) [Mass/volume] in Urine --post XXX challenge | 
|  16697-5 | Cyclohexane [Presence] in Blood | 
|  16698-3 | Cyclohexanol [Mass/volume] in Blood | 
|  16699-1 | Cyclohexanol [Mass/volume] in Urine | 
|  167-7 | Cephapirin [Susceptibility] by Serum bactericidal titer | 
|  1670-9 | 17-Hydroxyprogesterone [Mass/volume] in Urine | 
|  16700-7 | Cyclohexanol/Creatinine [Mass Ratio] in Urine | 
|  16701-5 | Cyclopropane [Presence] in Blood | 
|  16702-3 | Cycloserine [Mass/volume] in Urine | 
|  16703-1 | Cyclosporine [Mass/volume] in Plasma | 
|  16704-9 | Cyproheptadine [Mass/volume] in Serum or Plasma | 
|  16705-6 | Cystathionine [Presence] in Urine | 
|  16706-4 | Taenia solium larva IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  16707-2 | Taenia solium larva IgM Ab [Units/volume] in Serum | 
|  16708-0 | Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid | 
|  16709-8 | Cystine [Units/volume] in Urine | 
|  1671-7 | 17-Ketogenic steroids [Mass/volume] in Blood | 
|  16710-6 | Cystine crystals [Presence] in Stone by Infrared spectroscopy | 
|  16711-4 | Cystine+Homocystine [Presence] in Urine | 
|  16712-2 | Cytomegalovirus Ab [Units/volume] in Body fluid | 
|  16713-0 | Cytomegalovirus Ab [Units/volume] in Cerebral spinal fluid | 
|  16714-8 | Cytomegalovirus Ab [Units/volume] in Serum by Latex agglutination | 
|  16715-5 | Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunofluorescence | 
|  16716-3 | Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | 
|  16717-1 | Cytomegalovirus Ag [Presence] in Urine by Immunoassay | 
|  16718-9 | Cytomegalovirus Ag [Presence] in Blood | 
|  16719-7 | Cytomegalovirus inclusion bodies [Presence] in Urine by Microscopic observation | 
|  1672-5 | Deprecated 17-Ketogenic steroids [Mass/volume] in Blood | 
|  16720-5 | Dechlorane [Presence] in Blood | 
|  16721-3 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Saliva (oral fluid) | 
|  16722-1 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge | 
|  16723-9 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  16724-7 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | 
|  16725-4 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | 
|  16726-2 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | 
|  16727-0 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | 
|  16728-8 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  16729-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  1673-3 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine | 
|  16730-4 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  16731-2 | Deprecated Dehydroepiandrosterone.unconjugated [Mass/volume] in Serum or Plasma | 
|  16732-0 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  16733-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  16734-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --baseline | 
|  16735-3 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --post XXX challenge | 
|  16736-1 | Dengue virus 1 Ab [Titer] in Serum | 
|  16737-9 | Dengue virus 2 Ab [Titer] in Serum | 
|  16738-7 | Dengue virus 3 Ab [Titer] in Serum | 
|  16739-5 | Dengue virus 4 Ab [Titer] in Serum | 
|  1674-1 | 18-Hydroxycorticosterone [Mass/volume] in Serum or Plasma | 
|  16740-3 | Dengue virus Ab [Presence] in Serum | 
|  16741-1 | American house dust mite IgG Ab [Presence] in Blood | 
|  16742-9 | European house dust mite IgG Ab [Presence] in Blood | 
|  16743-7 | Deprecated Nordiazepam [Presence] in Serum or Plasma | 
|  16744-5 | Deprecated Nordiazepam [Presence] in Urine | 
|  16745-2 | Deprecated Desmethylmethsuximide [Mass/volume] in Serum or Plasma | 
|  16746-0 | Nortrimipramine [Mass/volume] in Serum or Plasma | 
|  16747-8 | Dextromoramide [Presence] in Serum or Plasma | 
|  16748-6 | Propoxyphene [Presence] in Serum or Plasma by Confirmatory method | 
|  16749-4 | Propoxyphene + Norpropoxyphene [Units/volume] in Urine | 
|  1675-8 | 2,3-Diphosphoglycerate [Mass/volume] in Red Blood Cells | 
|  16750-2 | Dezocine [Mass/volume] in Serum or Plasma | 
|  16751-0 | Dezocine [Mass/volume] in Blood | 
|  16752-8 | Deprecated Diacetate [Presence] in Urine | 
|  16753-6 | Deprecated Dialtrazene | 
|  16754-4 | Diamorphine [Mass/volume] in Unknown substance | 
|  16755-1 | Diamorphine [Mass/volume] in Urine by Confirmatory method | 
|  16756-9 | Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  16757-7 | Diazepam+Nordiazepam [Mass/volume] in Serum or Plasma | 
|  16758-5 | Dicamba [Mass/volume] in Serum or Plasma | 
|  16759-3 | Dicamba [Mass/volume] in Urine | 
|  1676-6 | 2,3-Diphosphoglycerate [Mass/volume] in Serum | 
|  16760-1 | Deprecated Dicarboxylporphyrin [Mass/volume] in Blood | 
|  16761-9 | Protoporphyrin [Mass/volume] in Stool | 
|  16762-7 | Dichlorobenzene [Mass/volume] in Blood | 
|  16763-5 | Dichlorodiphenyldichloroethylene [Mass/volume] in Urine | 
|  16764-3 | Dichlorodiphenyldichloroethylene [Mass/volume] in Blood | 
|  16765-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Milk | 
|  16766-8 | Dichloroethane [Presence] in Blood | 
|  16767-6 | Deprecated 2,4-Dichlorophenoxyacetate [Mass/volume] in Urine | 
|  16768-4 | Dichlorvos [Mass/volume] in Urine | 
|  16769-2 | Dicloxacillin [Mass/volume] in Urine | 
|  1677-4 | Alpha hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 
|  16770-0 | Dicoumarol [Mass/volume] in Urine | 
|  16771-8 | Dicyclomine [Mass/volume] in Serum or Plasma | 
|  16772-6 | Dieldrin [Mass/volume] in Urine | 
|  16773-4 | Dieldrin [Mass/volume] in Blood | 
|  16774-2 | Diethylcarbamazepine [Mass/volume] in Serum or Plasma | 
|  16775-9 | Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method | 
|  16776-7 | Diltiazem [Mass/volume] in Urine | 
|  16777-5 | Dimethylacetamide [Presence] in Urine | 
|  16778-3 | Dinitrophenol [Presence] in Serum or Plasma | 
|  16779-1 | Dinitrophenol [Mass/volume] in Urine | 
|  1678-2 | 20-Hydroxyprogesterone [Mass/volume] in Serum | 
|  16780-9 | Disopyramide [Mass/volume] in Urine | 
|  16781-7 | Disulfiram [Presence] in Urine | 
|  16782-5 | Deprecated DNA double strand Ab [Presence] in Serum by Farr method | 
|  16784-1 | Dopamine [Mass/volume] in Urine --2nd specimen post XXX challenge | 
|  16785-8 | Dopamine [Mass/volume] in Urine --3rd specimen post XXX challenge | 
|  16786-6 | Dopamine [Mass/volume] in Urine --4th specimen post XXX challenge | 
|  16787-4 | Dopamine [Mass/volume] in Urine --5th specimen post XXX challenge | 
|  16788-2 | Dopamine [Mass/volume] in Urine --6th specimen post XXX challenge | 
|  16789-0 | Dopamine [Mass/volume] in Urine --7th specimen post XXX challenge | 
|  1679-0 | 24r-Hydroxycalcidiol [Mass/volume] in Serum or Plasma | 
|  16790-8 | Deprecated Doxepin+Desmethyldoxepin [Mass/volume] in Serum or Plasma | 
|  16791-6 | Doxylamine [Mass/volume] in Serum or Plasma | 
|  16792-4 | Doxylamine [Mass/volume] in Urine | 
|  16793-2 | Drugs identified in Unknown substance by Screen method | 
|  16794-0 | Echinococcus sp IgM Ab [Units/volume] in Serum | 
|  16795-7 | Echovirus Ab [Units/volume] in Serum | 
|  16796-5 | Echovirus Ab [Units/volume] in Serum by Complement fixation | 
|  16797-3 | Echovirus 1 Ab [Units/volume] in Serum by Complement fixation | 
|  16798-1 | Echovirus 14 Ab [Units/volume] in Serum | 
|  16799-9 | Deprecated Echovirus 140 Ab by complement fixation | 
|  168-5 | Cephradine [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1680-8 | 3-Alpha-Androstanediol glucuronide [Mass/volume] in Serum | 
|  16800-5 | Echovirus 19 Ab [Units/volume] in Serum by Complement fixation | 
|  16801-3 | Echovirus 3 Ab [Units/volume] in Serum by Complement fixation | 
|  16802-1 | Echovirus 30 Ab [Units/volume] in Serum | 
|  16803-9 | Echovirus 4 Ab [Units/volume] in Serum by Complement fixation | 
|  16804-7 | Echovirus 40 Ab [Units/volume] in Serum | 
|  16805-4 | Echovirus 6 Ab [Units/volume] in Serum by Complement fixation | 
|  16806-2 | Echovirus 6+18+30 Ab [Units/volume] in Serum | 
|  16807-0 | Echovirus 9 Ab [Units/volume] in Serum by Complement fixation | 
|  16808-8 | Anaplasma phagocytophilum IgG Ab [Units/volume] in Serum | 
|  16809-6 | Anaplasma phagocytophilum IgM Ab [Units/volume] in Serum | 
|  1681-6 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Blood | 
|  16811-2 | Arachidate (C20:0) [Mass/volume] in Serum or Plasma | 
|  16812-0 | Emetine [Presence] in Serum or Plasma | 
|  16813-8 | Emetine [Units/volume] in Serum or Plasma | 
|  16814-6 | Endomysium Ab [Presence] in Serum by Immunofluorescence | 
|  16815-3 | Endomysium Ab [Units/volume] in Serum by Immunofluorescence | 
|  16816-1 | Enoxacin [Mass/volume] in Urine | 
|  16817-9 | Entamoeba histolytica Ab [Presence] in Serum by Immune diffusion (ID) | 
|  16818-7 | Entamoeba histolytica Ab [Units/volume] in Cerebral spinal fluid | 
|  16819-5 | Entamoeba histolytica Ab [Units/volume] in Serum by Immunofluorescence | 
|  1682-4 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 
|  16820-3 | Entamoeba histolytica Ab [Units/volume] in Serum by Complement fixation | 
|  16821-1 | Epinephrine [Mass/volume] in Plasma --4 hours post XXX challenge | 
|  16822-9 | Epithelial cells [Presence] in Nose by Light microscopy | 
|  16823-7 | Epstein Barr virus early Ab [Units/volume] in Serum by Immunoassay | 
|  16824-5 | Epstein Barr virus nuclear Ab [Presence] in Cerebral spinal fluid | 
|  16825-2 | Epstein Barr virus nuclear IgG Ab [Presence] in Body fluid | 
|  16826-0 | Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  16827-8 | Epstein Barr virus capsid IgG Ab [Presence] in Cerebral spinal fluid | 
|  16828-6 | Erythrocytes [#/volume] in Seminal plasma by Manual count | 
|  16829-4 | Erythromycin [Mass/volume] in Urine | 
|  1683-2 | 3-Hydroxyisovalerate [Mass/volume] in Urine | 
|  16830-2 | Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  16832-8 | Escherichia coli enterotoxic identified in Stool by Organism specific culture | 
|  16833-6 | Escherichia coli K1 Ag [Presence] in Unspecified specimen by Immunoassay | 
|  16834-4 | Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination | 
|  16835-1 | Escherichia coli shiga-like identified in Stool by Organism specific culture | 
|  16836-9 | Escherichia coli verotoxic identified in Stool by Organism specific culture | 
|  16838-5 | Estriol (E3) [Mass/volume] in Body fluid | 
|  1684-0 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in Urine | 
|  16840-1 | Ethacrynate [Mass/volume] in Serum or Plasma | 
|  16841-9 | Ethambutol+Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  16842-7 | Ethanol [Mass/volume] in Unknown substance | 
|  16843-5 | Ethanol [Mass/volume] in Body fluid | 
|  16844-3 | Ethinamate [Presence] in Serum or Plasma by Confirmatory method | 
|  16845-0 | Ethionamide [Mass/volume] in Serum or Plasma | 
|  16847-6 | Ethoheptazine [Presence] in Serum or Plasma | 
|  16848-4 | Ethoheptazine [Mass/volume] in Serum or Plasma | 
|  16849-2 | Ethyl benzene [Mass/volume] in Urine | 
|  1685-7 | 3-Methylhistidine [Presence] in Serum or Plasma | 
|  16850-0 | Ethylene oxide [Mass/volume] in Blood | 
|  16851-8 | Ethylmorphine [Units/volume] in Urine | 
|  16852-6 | Etodolac [Mass/volume] in Serum or Plasma | 
|  16853-4 | Fat [Mass] in Stool | 
|  16855-9 | Fat [Mass/time] in 48 hour Stool | 
|  16856-7 | Fat.microscopic observation [Identifier] in Synovial fluid by Sudan IV stain | 
|  16857-5 | Fenclorvos [Presence] in Blood | 
|  16858-3 | Fentanyl [Mass/volume] in Body fluid | 
|  16859-1 | Fibrinogen [Presence] in Platelet poor plasma | 
|  1686-5 | 3-Methylhistidine [Mass/volume] in Serum or Plasma | 
|  16860-9 | Fibrinopeptide A Ag [Units/volume] in Peritoneal fluid by Immunologic method | 
|  16861-7 | Fibrinopeptide A Ag [Units/volume] in Platelet poor plasma by Immunologic method | 
|  16862-5 | Fibrinopeptide B Ag [Units/volume] in Platelet poor plasma by Immunologic method | 
|  16863-3 | Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by Immunologic method | 
|  16864-1 | Fibrinopeptide B beta (1-42) Ag [Units/volume] in Platelet poor plasma by Immunologic method | 
|  16865-8 | Fibrinopeptide B beta (15-42) Ag [Units/volume] in Platelet poor plasma by Immunologic method | 
|  16866-6 | Fibrinopeptide B beta (43-47) Ag [Units/volume] in Platelet poor plasma by Immunologic method | 
|  16867-4 | Fibronectin aggregate IgG Ab [Mass/volume] in Serum | 
|  16868-2 | Finch droppings IgE Ab [Presence] in Serum | 
|  16869-0 | Deprecated Flurbiprofen [Mass/volume] in Serum or Plasma | 
|  1687-3 | 3-Methylhistidine [Mass/volume] in Urine | 
|  16870-8 | Fluconazole [Mass/volume] in Urine | 
|  16871-6 | Fluoride [Units/volume] in Bone | 
|  16872-4 | Fluorocarbons [Identifier] in Serum or Plasma | 
|  16873-2 | Follitropin [Moles/volume] in Serum or Plasma --105 minutes post XXX challenge | 
|  16874-0 | Formate+Formaldehyde [Mass/volume] in Blood | 
|  16875-7 | Francisella tularensis Ab [Titer] in Serum | 
|  16876-5 | Francisella tularensis IgA Ab [Presence] in Serum by Latex agglutination | 
|  16877-3 | Francisella tularensis IgG Ab [Presence] in Serum by Latex agglutination | 
|  16878-1 | Francisella tularensis IgM Ab [Units/volume] in Serum | 
|  16879-9 | Francisella tularensis Ag [Presence] in Serum by Immunofluorescence | 
|  1688-1 | 4-Pyridoxate [Mass/volume] in Serum or Plasma | 
|  16881-5 | Gallium [Mass/volume] in Blood | 
|  16882-3 | Gamma aminobutyrate [Presence] in Urine | 
|  16883-1 | Deprecated Gamma aminobutyrate [Mass/volume] in Urine | 
|  16884-9 | Deprecated Gamma aminobutyrate [Presence] in Serum or Plasma | 
|  16885-6 | Deprecated Gamma aminobutyrate [Mass/volume] in Serum or Plasma | 
|  16886-4 | Deprecated Gamma aminobutyrate [Mass/volume] in Cerebral spinal fluid | 
|  16887-2 | Gamma aminobutyrate [Mass/volume] in Amniotic fluid | 
|  16888-0 | Gamma chlordane [Mass/volume] in Urine | 
|  1689-9 | 5'-Nucleotidase [Enzymatic activity/volume] in Amniotic fluid | 
|  16890-6 | Gastrin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  16891-4 | Gastrin [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge | 
|  16892-2 | Gastrin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge | 
|  16893-0 | Gastrin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge | 
|  16894-8 | Gastrin [Mass/volume] in Serum or Plasma --25 minutes post XXX challenge | 
|  16895-5 | Gastrin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | 
|  16896-3 | Gastrin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge | 
|  16898-9 | Giardia lamblia 65 Ag [Presence] in Stool | 
|  16899-7 | Giardia lamblia Ag [Presence] in Unspecified specimen | 
|  169-3 | Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1690-7 | 5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma | 
|  16900-3 | Gliadin Ab [Units/volume] in Saliva (oral fluid) | 
|  16901-1 | Gliadin IgA Ab [Presence] in Serum | 
|  16902-9 | Gliadin IgG Ab [Presence] in Serum | 
|  16903-7 | Glucose [Mass/volume] in Vitreous fluid | 
|  16904-5 | Glucose [Presence] in Urine --1st specimen post XXX challenge | 
|  16905-2 | Glucose [Presence] in Urine --2nd specimen post XXX challenge | 
|  16906-0 | Glucose [Presence] in Urine --3rd specimen post XXX challenge | 
|  16907-8 | Glucose [Presence] in Urine --4th specimen post XXX challenge | 
|  16908-6 | Glucose [Presence] in Urine --5th specimen post XXX challenge | 
|  16909-4 | Glucose [Presence] in Urine --6th specimen post XXX challenge | 
|  1691-5 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/volume] in Serum | 
|  16910-2 | Glucose [Presence] in Urine --7th specimen post XXX challenge | 
|  16911-0 | Glucose [Presence] in Urine --8th specimen post XXX challenge | 
|  16912-8 | Glucose [Presence] in Urine --9th specimen post XXX challenge | 
|  16913-6 | Fasting glucose [Presence] in Urine | 
|  16914-4 | Glucose [Mass/volume] in Serum or Plasma --post XXX challenge | 
|  16915-1 | Glucose [Mass/volume] in Serum or Plasma --post meal | 
|  16916-9 | Glutamate [Presence] in Urine | 
|  16917-7 | Glutamine [Presence] in Urine | 
|  16918-5 | Glutathione [Mass/volume] in Serum or Plasma | 
|  16919-3 | Glycine [Presence] in Urine | 
|  1692-3 | 5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid | 
|  16920-1 | Glycoproteins [Presence] in Serum or Plasma | 
|  16921-9 | St. Augustine grass IgE Ab [Units/volume] in Serum | 
|  16922-7 | Wild rye grass IgE Ab [Units/volume] in Serum | 
|  16923-5 | Guaifenesin [Mass/volume] in Serum or Plasma | 
|  16924-3 | Haemophilus influenzae IgG Ab [Units/volume] in Serum | 
|  16925-0 | Haemophilus influenzae A Ag [Presence] in Urine | 
|  16926-8 | Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid | 
|  16927-6 | Haemophilus influenzae B IgG Ab [Units/volume] in Serum | 
|  16928-4 | Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum | 
|  16929-2 | Helicobacter pylori Ab [Units/volume] in Serum by Immunofluorescence | 
|  1693-1 | 5-Hydroxyindoleacetate [Mass/volume] in Serum | 
|  16930-0 | Helminth IgE Ab [Units/volume] in Serum | 
|  16931-8 | Hematocrit/Hemoglobin [Ratio] of Blood by Automated count | 
|  16932-6 | Hemoglobin A3/Hemoglobin.total in Blood by Electrophoresis | 
|  16933-4 | Hepatitis B virus core Ab [Presence] in Serum | 
|  16934-2 | Hepatitis B virus polymerase DNA [Presence] in Blood by Probe and target amplification method | 
|  16935-9 | Hepatitis B virus surface Ab [Units/volume] in Serum | 
|  16936-7 | Hepatitis C virus IgG Ab [Units/volume] in Serum | 
|  16937-5 | Hepatitis G virus RNA [Presence] in Serum by Probe and target amplification method | 
|  16938-3 | Heptacarboxylporphyrin [Mass/volume] in Stool | 
|  16939-1 | Heptachlor [Mass/volume] in Urine | 
|  1694-9 | 5-Hydroxyindoleacetate [Mass/volume] in Urine | 
|  16940-9 | Heptachlorepoxide [Mass/volume] in Urine | 
|  16941-7 | Herbicide [Identifier] in Unspecified specimen | 
|  16942-5 | Herpes simplex virus Ab [Presence] in Serum by Immunoblot (IB) | 
|  16943-3 | Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  16944-1 | Herpes simplex virus IgM Ab [Units/volume] in Serum | 
|  16945-8 | Herpes simplex virus Ag [Presence] in Unspecified specimen | 
|  16947-4 | Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  16948-2 | Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  16949-0 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --1st specimen | 
|  1695-6 | 5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine | 
|  16950-8 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --2nd specimen | 
|  16952-4 | Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method | 
|  16953-2 | Herpes simplex virus 1 DNA [Presence] in Serum or Plasma by Probe and target amplification method | 
|  16954-0 | Herpes simplex virus 2 Ab [Presence] in Serum | 
|  16955-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot (IB) | 
|  16956-5 | Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  16957-3 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --1st specimen | 
|  16958-1 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --2nd specimen | 
|  16959-9 | Herpes simplex virus 2 DNA [Presence] in Serum or Plasma by Probe and target amplification method | 
|  1696-4 | 5-Methyltetrahydrofolate homocysteine methyltransferase [Enzymatic activity/volume] in Serum | 
|  16960-7 | Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method | 
|  16962-3 | Heterophile Ab [Presence] in Synovial fluid by Latex agglutination | 
|  16963-1 | Hexacarboxylporphyrin [Mass/volume] in Blood | 
|  16964-9 | Hexacarboxylporphyrin [Mass/volume] in Stool | 
|  16965-6 | Lindane [Mass/volume] in Blood | 
|  16966-4 | Hexachloroethane [Mass/volume] in Blood | 
|  16967-2 | Hexokinase 1 [Enzymatic activity/volume] in Red Blood Cells | 
|  16968-0 | Hexokinase 3 [Enzymatic activity/volume] in Red Blood Cells | 
|  16969-8 | Histone H2a+H2b Ab [Units/volume] in Serum by Immunofluorescence | 
|  1697-2 | 6-Phosphogluconate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells | 
|  16970-6 | Histoplasma capsulatum Ab [Presence] in Serum by Complement fixation | 
|  16971-4 | Histoplasma capsulatum IgA Ab [Presence] in Serum by Immune diffusion (ID) | 
|  16972-2 | Histoplasma capsulatum IgE Ab [Presence] in Serum by Immune diffusion (ID) | 
|  16973-0 | Histoplasma capsulatum IgM Ab [Presence] in Serum by Immune diffusion (ID) | 
|  16974-8 | HIV 1 Ab [Presence] in Cerebral spinal fluid | 
|  16975-5 | HIV 1 IgG Ab [Presence] in Serum | 
|  16976-3 | HIV 1 Ag [Units/volume] in Serum | 
|  16977-1 | HIV 1 Ag [Presence] in Cerebral spinal fluid | 
|  16978-9 | HIV 1 p24 Ab [Units/volume] in Serum | 
|  16979-7 | HIV 1 p24 Ag [Units/volume] in Cerebral spinal fluid | 
|  1698-0 | 8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma | 
|  16980-5 | HTLV II DNA [Presence] in Unspecified specimen by Probe and target amplification method | 
|  16981-3 | HTLV I DNA [Presence] in Unspecified specimen by Probe and target amplification method | 
|  16982-1 | HTLV I+II Ab [Presence] in Serum by Immunoblot (IB) | 
|  16983-9 | Hydralazine [Presence] in Urine | 
|  16984-7 | Hydrastine [Presence] in Urine | 
|  16985-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose glucose | 
|  16986-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose glucose | 
|  16987-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose glucose | 
|  16988-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose glucose | 
|  16989-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hours post dose glucose | 
|  1699-8 | Alpha-L-iduronidase [Enzymatic activity/mass] in Tissue | 
|  16990-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose glucose | 
|  16991-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4.5 hours post dose glucose | 
|  16992-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4 hours post dose glucose | 
|  16993-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5.5 hours post dose glucose | 
|  16994-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5 hours post dose glucose | 
|  16995-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --6 hours post dose glucose | 
|  16996-1 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose glucose | 
|  16997-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose glucose | 
|  16998-7 | Hydromorphone [Mass/volume] in Urine by Confirmatory method | 
|  16999-5 | Hydroquinone [Mass/volume] in Urine | 
|  17-4 | Amoxicillin [Susceptibility] by Disk diffusion (KB) | 
|  170-1 | Cephradine [Susceptibility] by Disk diffusion (KB) | 
|  1700-4 | Acetaldehyde [Mass/volume] in Blood | 
|  17000-1 | Hydroxylysine [Presence] in Urine | 
|  17001-9 | Hydroxyproline [Presence] in Urine | 
|  17002-7 | Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  17003-5 | Serotonin [Mass/volume] in Urine | 
|  17004-3 | Hypoxanthine [Mass/volume] in Urine | 
|  17005-0 | IgA subclass 1 [Mass/volume] in Cerebral spinal fluid | 
|  17006-8 | IgA subclass 2 [Mass/volume] in Cerebral spinal fluid | 
|  17007-6 | IgG [Presence] in Serum | 
|  17008-4 | IgG/Beta tubulin [Mass Ratio] in Serum | 
|  17009-2 | IgM [Presence] in Serum | 
|  1701-2 | Acetaldehyde [Mass/volume] in Serum or Plasma | 
|  17010-0 | Imipenem [Mass/volume] in Serum or Plasma | 
|  17012-6 | Influenza virus A Ab [Units/volume] in Cerebral spinal fluid | 
|  17013-4 | Influenza virus A+B Ab [Units/volume] in Serum by Immunofluorescence | 
|  17014-2 | Influenza virus B Ab [Units/volume] in Cerebral spinal fluid | 
|  17015-9 | Influenza virus B IgG Ab [Units/volume] in Serum | 
|  17016-7 | Influenza virus B IgM Ab [Units/volume] in Serum | 
|  17017-5 | Insulin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge | 
|  17018-3 | Insulin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge | 
|  17019-1 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | 
|  1702-0 | Acetoacetate [Mass/volume] in Urine | 
|  17020-9 | Intercellular substance Ab [Presence] in Serum by Immunofluorescence | 
|  17021-7 | Intercellular substance Ab [Units/volume] in Serum by Immunofluorescence | 
|  17022-5 | Interleukin 1+2 [Units/volume] in Serum or Plasma | 
|  17023-3 | Deprecated Interleukin 7 [Units/volume] in Serum or Plasma | 
|  17024-1 | Iodine.inorganic [Mass/volume] in Serum or Plasma | 
|  17025-8 | Iron [Mass/volume] in Water | 
|  17026-6 | Isocyanate IgE Ab [Units/volume] in Serum | 
|  17027-4 | Isocyanate IgG Ab [Units/volume] in Serum | 
|  17028-2 | Isocyanate IgM Ab [Units/volume] in Serum | 
|  17029-0 | Isoleucine [Presence] in Urine | 
|  1703-8 | Acetoacetate [Mass/volume] in Cerebral spinal fluid | 
|  17030-8 | Isopropyl ether [Presence] in Blood | 
|  17031-6 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunofluorescence | 
|  17032-4 | Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence | 
|  17033-2 | Ketamine [Presence] in Urine by Confirmatory method | 
|  17034-0 | Ketoprofen [Mass/volume] in Serum or Plasma | 
|  17035-7 | Ketorolac [Mass/volume] in Serum or Plasma | 
|  17036-5 | La Crosse virus Ab [Titer] in Serum | 
|  17037-3 | La Crosse virus Ab [Titer] in Cerebral spinal fluid | 
|  17038-1 | La Crosse virus IgG Ab [Titer] in Serum | 
|  17039-9 | La Crosse virus IgM Ab [Titer] in Serum | 
|  1704-6 | Acetoacetate [Presence] in Serum or Plasma | 
|  17040-7 | Labetalol [Presence] in Serum or Plasma | 
|  17041-5 | Lactate dehydrogenase [Presence] in Urine | 
|  17042-3 | Lactoglobulin IgE Ab [Units/volume] in Serum | 
|  17043-1 | Lactose [Mass/volume] in Urine | 
|  17044-9 | Lamellar bodies [Presence] in Amniotic fluid | 
|  17045-6 | Latex IgE Ab [Units/volume] in Blood | 
|  17046-4 | Latex IgG Ab [Units/volume] in Serum | 
|  17047-2 | Latex Bencard IgE Ab [Units/volume] in Serum | 
|  17048-0 | Latex glove extract IgE Ab [Units/volume] in Blood | 
|  17049-8 | Latex glove extract ammoniated IgE Ab [Units/volume] in Blood | 
|  1705-3 | Acetoacetate [Mass/volume] in Serum or Plasma | 
|  17050-6 | Latex glove extract buffered IgE Ab [Units/volume] in Blood | 
|  17051-4 | Laxatives [Identifier] in Urine | 
|  17052-2 | Lead [Presence] in Blood | 
|  17053-0 | Legionella longbeachae 1 IgG Ab [Presence] in Serum | 
|  17054-8 | Legionella longbeachae 1 IgM Ab [Presence] in Serum | 
|  17055-5 | Legionella longbeachae 2 IgG Ab [Presence] in Serum | 
|  17056-3 | Legionella longbeachae 2 IgM Ab [Presence] in Serum | 
|  17057-1 | Legionella pneumophila Ag [Presence] in Unspecified specimen | 
|  17058-9 | Legionella pneumophila Ag [Presence] in Urine by Latex agglutination | 
|  17059-7 | Legionella pneumophila Ag [Presence] in Urine by Immunofluorescence | 
|  1706-1 | Acetonitrile [Mass/volume] in Blood | 
|  17060-5 | Legionella pneumophila 1 Ab [Titer] in Serum | 
|  17061-3 | Legionella pneumophila 1 IgM Ab [Units/volume] in Serum | 
|  17062-1 | Legionella pneumophila 2 Ab [Titer] in Serum | 
|  17063-9 | Legionella pneumophila 2 IgM Ab [Units/volume] in Serum | 
|  17064-7 | Legionella pneumophila 3 Ab [Titer] in Serum | 
|  17065-4 | Legionella pneumophila 3 IgM Ab [Units/volume] in Serum | 
|  17066-2 | Legionella pneumophila 4 Ab [Titer] in Serum | 
|  17067-0 | Legionella pneumophila 4 IgM Ab [Units/volume] in Serum | 
|  17068-8 | Legionella pneumophila 5 Ab [Titer] in Serum | 
|  17069-6 | Legionella pneumophila 5 IgM Ab [Units/volume] in Serum | 
|  1707-9 | Acetylcholine [Mass/volume] in Serum | 
|  17070-4 | Legionella pneumophila 6 Ab [Titer] in Serum | 
|  17071-2 | Legionella pneumophila 7 Ab [Presence] in Serum | 
|  17072-0 | Legionella pneumophila 8 Ab [Presence] in Serum | 
|  17073-8 | Legionella pneumophila 9 Ab [Presence] in Serum | 
|  17074-6 | Leucine [Units/volume] in Amniotic fluid | 
|  17075-3 | Lidocaine [Mass/volume] in Urine | 
|  17076-1 | Lidocaine [Mass/volume] in Body fluid | 
|  17077-9 | Deprecated Lindane [Mass/volume] in Blood | 
|  17078-7 | Fatty acids.esterified [Mass/volume] in Serum or Plasma | 
|  17079-5 | Fatty acids.long chain [Identifier] in Serum or Plasma | 
|  1708-7 | Acetylcholinesterase [Enzymatic activity/volume] in Amniotic fluid | 
|  17080-3 | Fatty acids.very long chain [Identifier] in Serum or Plasma | 
|  17081-1 | Deprecated Triglyceride [Mass/volume] in Serum or Plasma --post CFst | 
|  17082-9 | Lipoprotein.alpha [Mass/volume] in Body fluid | 
|  17083-7 | Lipoprotein.beta [Mass/volume] in Body fluid | 
|  17084-5 | Lipoprotein.pre-beta [Mass/volume] in Body fluid | 
|  17085-2 | Lipoproteins [Presence] in Serum or Plasma | 
|  17086-0 | Lithium [Mass/volume] in Body fluid | 
|  17087-8 | Loperamide [Mass/volume] in Serum or Plasma | 
|  17088-6 | Lorazepam [Mass/volume] in Urine by Confirmatory method | 
|  17089-4 | Lorcainide [Mass/volume] in Serum or Plasma | 
|  1709-5 | Acetylcholinesterase [Enzymatic activity/volume] in Red Blood Cells | 
|  17090-2 | Loxapine+8-Hydroxyloxapine [Mass/volume] in Serum or Plasma | 
|  17091-0 | Lumpfish roe IgE Ab [Units/volume] in Serum | 
|  17092-8 | Lupus erythematosus factor [Presence] in Serum by Latex agglutination | 
|  17094-4 | Lutropin [Moles/volume] in Serum or Plasma --105 minutes post XXX challenge | 
|  17095-1 | Lutropin [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge | 
|  17096-9 | Kappa lymphocytes/100 lymphocytes in Blood | 
|  17097-7 | CD10+CD20+ cells/100 cells in Blood | 
|  17098-5 | CD100 cells/100 cells in Blood | 
|  17099-3 | CD102 cells/100 cells in Blood | 
|  171-9 | Cephradine [Susceptibility] by Serum bactericidal titer | 
|  1710-3 | Acetylcholinesterase [Enzymatic activity/volume] in Serum or Plasma | 
|  17100-9 | CD103 cells/100 cells in Blood | 
|  17101-7 | CD104 cells/100 cells in Blood | 
|  17102-5 | CD105 cells/100 cells in Blood | 
|  17103-3 | CD106 cells/100 cells in Blood | 
|  17104-1 | CD107a cells/100 cells in Blood | 
|  17105-8 | CD107b cells/100 cells in Blood | 
|  17106-6 | CD115 cells/100 cells in Blood | 
|  17107-4 | CD117 cells/100 cells in Blood | 
|  17108-2 | CD118 cells/100 cells in Blood | 
|  17109-0 | CD11a cells/100 cells in Blood | 
|  1711-1 | Acid phosphatase [Enzymatic activity/volume] in Blood | 
|  17110-8 | CD11b cells/100 cells in Blood | 
|  17111-6 | CD12 cells/100 cells in Blood | 
|  17112-4 | CD120A cells/100 cells in Blood | 
|  17113-2 | CD120B cells/100 cells in Blood | 
|  17114-0 | CD122 cells/100 cells in Blood | 
|  17115-7 | CD126 cells/100 cells in Blood | 
|  17116-5 | CD128 cells/100 cells in Blood | 
|  17117-3 | CD15 cells/100 cells in Blood | 
|  17118-1 | CD16B cells/100 cells in Blood | 
|  17119-9 | CD16-CD34+ cells/100 cells in Blood | 
|  1712-9 | Prostatic acid phosphatase [Enzymatic activity/volume] in Vaginal fluid | 
|  17120-7 | CD17 cells/100 cells in Blood | 
|  17121-5 | CD18 cells/100 cells in Blood | 
|  17122-3 | CD19+Kappa+ cells/100 cells in Blood | 
|  17123-1 | CD19+Lambda+ cells/100 cells in Blood | 
|  17124-9 | CD2+CD20+ cells/100 cells in Blood | 
|  17125-6 | CD22+CD19+ cells/100 cells in Blood | 
|  17126-4 | CD24 cells/100 cells in Blood | 
|  17127-2 | CD26 cells/100 cells in Blood | 
|  17128-0 | CD27 cells/100 cells in Blood | 
|  17129-8 | CD28 cells/100 cells in Blood | 
|  1713-7 | Prostatic acid phosphatase [Enzymatic activity/volume] in Semen | 
|  17130-6 | CD29 cells/100 cells in Blood | 
|  17131-4 | CD3+CD69+ cells/100 cells in Blood | 
|  17132-2 | CD3+IL2R1+ cells/100 cells in Blood | 
|  17133-0 | CD3+CD16+ cells/100 cells in Blood | 
|  17135-5 | CD3+CD56+ cells/100 cells in Blood | 
|  17136-3 | CD3+DR+ cells/100 cells in Blood | 
|  17137-1 | CD30 cells/100 cells in Blood | 
|  17138-9 | CD31 cells/100 cells in Blood | 
|  17139-7 | CD32 cells/100 cells in Blood | 
|  1714-5 | Prostatic acid phosphatase [Enzymatic activity/volume] in Serum | 
|  17140-5 | CD34+DR+ cells/100 cells in Blood | 
|  17141-3 | CD36 cells/100 cells in Blood | 
|  17142-1 | CD37 cells/100 cells in Blood | 
|  17143-9 | CD39 cells/100 cells in Blood | 
|  17144-7 | CD4+CD69+ cells/100 cells in Blood | 
|  17145-4 | Deprecated CD4+2H4 cells/100 cells in Blood | 
|  17146-2 | CD4+CD8+ cells/100 cells in Blood | 
|  17147-0 | CD40 cells/100 cells in Blood | 
|  17148-8 | CD41 cells/100 cells in Blood | 
|  17149-6 | CD42a cells/100 cells in Blood | 
|  1715-2 | Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma | 
|  17150-4 | CD42b cells/100 cells in Blood | 
|  17151-2 | CD42c cells/100 cells in Blood | 
|  17152-0 | CD42d cells/100 cells in Blood | 
|  17153-8 | CD4+CD45RA+ cells/CD8 Cells [# Ratio] in Blood | 
|  17154-6 | CD43 cells/100 cells in Blood | 
|  17155-3 | CD44 cells/100 cells in Blood | 
|  17156-1 | CD44R cells/100 cells in Blood | 
|  17157-9 | CD45RA cells/100 cells in Blood | 
|  17158-7 | CD45RB cells/100 cells in Blood | 
|  17159-5 | CD45RO cells/100 cells in Blood | 
|  1716-0 | Acidity.titratable [Mass/volume] in Urine | 
|  17160-3 | CD46 cells/100 cells in Blood | 
|  17161-1 | CD47 cells/100 cells in Blood | 
|  17162-9 | CD48 cells/100 cells in Blood | 
|  17163-7 | CD49a cells/100 cells in Blood | 
|  17164-5 | CD49b cells/100 cells in Blood | 
|  17165-2 | CD49c cells/100 cells in Blood | 
|  17166-0 | CD49d cells/100 cells in Blood | 
|  17167-8 | CD49e cells/100 cells in Blood | 
|  17168-6 | CD49f cells/100 cells in Blood | 
|  17169-4 | CD5+CD2- cells/100 cells in Blood | 
|  1717-8 | Acylcarnitine [Mass/volume] in Serum or Plasma | 
|  17170-2 | CD50 cells/100 cells in Blood | 
|  17171-0 | CD51 cells/100 cells in Blood | 
|  17172-8 | CD52 cells/100 cells in Blood | 
|  17173-6 | CD53 cells/100 cells in Blood | 
|  17174-4 | CD54 cells/100 cells in Blood | 
|  17175-1 | CD55 cells/100 cells in Blood | 
|  17176-9 | CD58 cells/100 cells in Blood | 
|  17177-7 | CD59 cells/100 cells in Blood | 
|  17178-5 | CD6 cells/100 cells in Blood | 
|  17179-3 | CD62E cells/100 cells in Blood | 
|  1718-6 | Acyl CoA dehydrogenase [Enzymatic activity/volume] in Serum | 
|  17180-1 | CD62L cells/100 cells in Blood | 
|  17181-9 | CD62P cells/100 cells in Blood | 
|  17182-7 | CD63 cells/100 cells in Blood | 
|  17183-5 | CD64 cells/100 cells in Blood | 
|  17184-3 | CD66a cells/100 cells in Blood | 
|  17185-0 | CD66b cells/100 cells in Blood | 
|  17186-8 | CD66c cells/100 cells in Blood | 
|  17187-6 | CD66d cells/100 cells in Blood | 
|  17188-4 | CD66e cells/100 cells in Blood | 
|  17189-2 | CD68 cells/100 cells in Blood | 
|  1719-4 | Adenine [Mass/volume] in Serum | 
|  17190-0 | CD69 cells/100 cells in Blood | 
|  17191-8 | CD3-CD7+cells/100 cells in Blood | 
|  17192-6 | CD72 cells/100 cells in Blood | 
|  17193-4 | CD73 cells/100 cells in Blood | 
|  17194-2 | CD74 cells/100 cells in Blood | 
|  17195-9 | CD77 cells/100 cells in Blood | 
|  17196-7 | CD79a cells/100 cells in Blood | 
|  17197-5 | CD79b cells/100 cells in Blood | 
|  17198-3 | CD8+CD28+ cells/100 cells in Blood | 
|  17199-1 | CD80 cells/100 cells in Blood | 
|  172-7 | Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1720-2 | Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells | 
|  17200-7 | CD82 cells/100 cells in Blood | 
|  17201-5 | CD83 cells/100 cells in Blood | 
|  17202-3 | CD85 cells/100 cells in Blood | 
|  17203-1 | CD86 cells/100 cells in Blood | 
|  17204-9 | CD87 cells/100 cells in Blood | 
|  17205-6 | CD88 cells/100 cells in Blood | 
|  17206-4 | CD9 cells/100 cells in Blood | 
|  17207-2 | CD91 cells/100 cells in Blood | 
|  17208-0 | CD93 cells/100 cells in Blood | 
|  17209-8 | CD94 cells/100 cells in Blood | 
|  1721-0 | Adenosine triphosphate [Mass/volume] in Blood | 
|  17210-6 | CD95 cells/100 cells in Blood | 
|  17211-4 | CD96 cells/100 cells in Blood | 
|  17212-2 | CD97 cells/100 cells in Blood | 
|  17213-0 | CD98 cells/100 cells in Blood | 
|  17214-8 | CD99 cells/100 cells in Blood | 
|  17215-5 | CV lymphocytes/100 lymphocytes in Blood | 
|  17216-3 | Cytoplasmic CD3 cells/100 cells in Blood | 
|  17217-1 | Cytoplasmic CD79 cells/100 cells in Blood | 
|  17218-9 | Cytoplasmic Ig mu cells/100 cells in Blood | 
|  17219-7 | Cytoplasmic Ig cells/100 cells in Blood | 
|  1722-8 | Adenosine deaminase [Enzymatic activity/volume] in Blood | 
|  17220-5 | FMC7 cells/100 cells in Blood | 
|  17221-3 | CD235a cells/100 cells in Blood | 
|  17222-1 | HLE lymphocytes/100 lymphocytes in Blood | 
|  17223-9 | Deprecated CD14 cells/100 cells in Blood | 
|  17224-7 | Lambda lymphocytes/100 lymphocytes in Blood | 
|  17225-4 | SMIg lymphocytes/100 lymphocytes in Blood | 
|  17226-2 | SmIg-Cd79 cells/100 cells in Blood | 
|  17227-0 | Lymphocytes/100 leukocytes in Synovial fluid by Automated count | 
|  17228-8 | Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid | 
|  17229-6 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid | 
|  1723-6 | Adenosine deaminase binding protein [Mass/volume] in Urine | 
|  17230-4 | Lysine [Presence] in Urine | 
|  17231-2 | Lysosomal enzymes [Identifier] in Plasma | 
|  17232-0 | Lysozyme [Enzymatic activity/volume] in Tear | 
|  17234-6 | Magnesium.plasma/Magnesium.RBC [Molar ratio] in Blood | 
|  17235-3 | Magnesium [Moles/volume] in Leukocytes | 
|  17236-1 | Magnesium [Moles/volume] in Stool | 
|  17237-9 | Magnesium [Moles/mass] in Hair | 
|  17238-7 | Malignin Ab [Units/volume] in Serum | 
|  1724-4 | Adenosine diphosphate [Mass/volume] in Serum | 
|  17241-1 | Prolactin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | 
|  17242-9 | Prolactin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge | 
|  17243-7 | Prolactin [Mass/volume] in Serum or Plasma --pre XXX challenge | 
|  17244-5 | Manganese [Mass/mass] in Hair | 
|  17245-2 | Deprecated Meclizine [Mass/volume] in Serum or Plasma | 
|  17246-0 | Mefenamate [Mass/volume] in Serum or Plasma | 
|  17247-8 | Melanin [Units/volume] in Urine | 
|  17248-6 | Melanin [Units/volume] in Serum or Plasma | 
|  17249-4 | Menthol [Mass/volume] in Blood | 
|  1725-1 | Adenosine monophosphate deaminase [Enzymatic activity/volume] in Serum | 
|  17250-2 | Mephobarbital [Mass/volume] in Urine by Confirmatory method | 
|  17251-0 | Mepivacaine [Presence] in Serum or Plasma | 
|  17252-8 | Mercaptopurine [Presence] in Serum or Plasma | 
|  17253-6 | Mercury [Mass/volume] in Milk | 
|  17254-4 | Mercury [Mass/volume] in Food | 
|  17255-1 | Mercury [Mass/volume] in Dialysis fluid | 
|  17256-9 | Mesoridazine [Mass/volume] in Urine | 
|  17257-7 | Mesothelial cells [Presence] in Body fluid by Light microscopy | 
|  17258-5 | Metandienone [Mass/volume] in Serum or Plasma | 
|  17259-3 | Methadone.long acting metabolite [Mass/volume] in Serum or Plasma | 
|  1726-9 | Adenosine monophosphate.cyclic [Mass/volume] in Serum or Plasma | 
|  17260-1 | Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  17261-9 | Methapyrilene [Mass/volume] in Urine | 
|  17263-5 | Methemalbumin [Presence] in Serum or Plasma | 
|  17264-3 | Methionine [Presence] in Urine | 
|  17265-0 | Methocarbamol [Units/volume] in Serum or Plasma | 
|  17266-8 | Methotrexate [Mass/volume] in Urine | 
|  17267-6 | Methoxychlor [Mass/volume] in Urine | 
|  17268-4 | Deprecated Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma | 
|  17269-2 | Methyl isobutyl ketone [Mass/volume] in Urine | 
|  1727-7 | Adenosine monophosphate.cyclic [Mass/time] in 24 hour Urine | 
|  17270-0 | Methylacrylate [Mass/volume] in Serum or Plasma | 
|  17271-8 | Deprecated 1,1,1-Trichloroethane [Mass/volume] in Serum or Plasma | 
|  17272-6 | Methylenedianiline [Mass/volume] in Blood | 
|  17273-4 | Methylephedrine [Units/volume] in Urine | 
|  17274-2 | Methylergonovine [Mass/volume] in Serum or Plasma | 
|  17275-9 | Methylfentanyl [Mass/volume] in Serum or Plasma | 
|  17276-7 | 2-Methylpentane [Mass/volume] in Blood | 
|  17277-5 | Metolazone [Mass/volume] in Serum or Plasma | 
|  17278-3 | Miconazole [Mass/volume] in Serum or Plasma | 
|  17279-1 | Bacteria identified in Pleural fluid by Aerobe culture | 
|  1728-5 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Serum or Plasma | 
|  17280-9 | Microscopic observation [Identifier] in Tissue by Malaria thick smear | 
|  17281-7 | Microscopic observation [Identifier] in Sputum by KOH preparation | 
|  17282-5 | Minoxidil [Mass/volume] in Serum or Plasma | 
|  17283-3 | Mirtazapine [Mass/volume] in Serum or Plasma | 
|  17284-1 | Mitochondria Ab [Presence] in Serum by Immunofluorescence | 
|  17285-8 | Mitochondria Ab [Units/volume] in Serum by Immunofluorescence | 
|  17286-6 | Monocytes/100 leukocytes in Synovial fluid by Manual count | 
|  17287-4 | Monocytes/100 leukocytes in Urine by Manual count | 
|  17288-2 | Ganglioside GM1 Ab [Presence] in Serum by Immunofluorescence | 
|  17289-0 | Monosodium glutamate (MSG) IgE Ab [Units/volume] in Serum | 
|  1729-3 | Adenosine triphosphatase [Enzymatic activity/volume] in Red Blood Cells | 
|  17290-8 | Morphine [Presence] in Serum or Plasma by Confirmatory method | 
|  17291-6 | Deprecated Mulberry tree IgE Ab [Units/volume] in Serum | 
|  17292-4 | Mumps virus Ab [Units/volume] in Cerebral spinal fluid | 
|  17293-2 | Mumps virus IgG+IgM Ab [Units/volume] in Serum | 
|  17294-0 | Mushroom toxins [Identifier] in Urine | 
|  17296-5 | Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by DNA probe | 
|  17297-3 | Deprecated Mycobacterium tuberculosum rRNA [Presence] in Unspecified specimen by DNA probe | 
|  17298-1 | Deprecated Mycobacterium tuberculosis rRNA [Presence] in Unspecified specimen by DNA probe | 
|  17299-9 | Mycoplasma fermentans Ab [Presence] in Serum | 
|  173-5 | Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1730-1 | Adenosine triphosphatase [Enzymatic activity/volume] in Semen | 
|  17300-5 | Mycoplasma hominis Ab [Titer] in Serum by Complement fixation | 
|  17301-3 | Mycoplasma hominis Ab [Presence] in Serum | 
|  17302-1 | Mycoplasma pneumoniae Ab [Presence] in Serum | 
|  17303-9 | Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid | 
|  17304-7 | Mycoplasma pneumoniae IgG+IgM Ab [Units/volume] in Serum | 
|  17305-4 | Myelin IgA Ab [Presence] in Serum | 
|  17306-2 | Myelin IgG Ab [Presence] in Serum | 
|  17307-0 | Myelin IgM Ab [Presence] in Serum | 
|  17308-8 | Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunoblot (IB) | 
|  1731-9 | Adenylate kinase [Enzymatic activity/volume] in Serum | 
|  17310-4 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunofluorescence | 
|  17311-2 | Myelin associated glycoprotein IgA Ab [Units/volume] in Serum | 
|  17312-0 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum | 
|  17313-8 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum by Immunofluorescence | 
|  17314-6 | Myelin associated glycoprotein IgM Ab [Units/volume] in Serum by Immunoassay | 
|  17315-3 | Myelin basic protein Ab [Mass/volume] in Serum | 
|  17316-1 | Myeloperoxidase Ab [Presence] in Serum | 
|  17317-9 | N-acetylprocainamide [Mass/volume] in Urine | 
|  17318-7 | Nalbuphine [Mass/volume] in Serum or Plasma | 
|  17319-5 | Nalidixate [Mass/volume] in Serum or Plasma | 
|  1732-7 | Adenylosuccinate lyase [Enzymatic activity/volume] in Serum | 
|  17320-3 | Nefazodone [Mass/volume] in Urine | 
|  17321-1 | Neisseria meningitidis A+Y Ag [Presence] in Urine | 
|  17322-9 | Neisseria meningitidis Ab [Presence] in Serum | 
|  17323-7 | Neisseria meningitidis Ag [Presence] in Urine | 
|  17324-5 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination | 
|  17325-2 | Neisseria meningitidis C+w135 Ag [Presence] in Urine | 
|  17326-0 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  17327-8 | Neisseria meningitidis B Ab [Units/volume] in Serum | 
|  17328-6 | Neisseria meningitidis B Ag [Presence] in Urine by Latex agglutination | 
|  17329-4 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  1733-5 | Adipate [Mass/volume] in Urine | 
|  17330-2 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid | 
|  17331-0 | Neisseria meningitidis polyvalent Ab [Units/volume] in Serum | 
|  17332-8 | Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid | 
|  17333-6 | Neisseria meningitidis w135 Ag [Presence] in Serum or Plasma by Latex agglutination | 
|  17334-4 | Neopterin/Creatinine [Mass Ratio] in Urine | 
|  17335-1 | Neostigmine [Mass/volume] in Serum or Plasma | 
|  17336-9 | Neuronal Ab [Presence] in Serum by Immunofluorescence | 
|  17337-7 | Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  17338-5 | Neuronal Ab [Units/volume] in Serum by Immunofluorescence | 
|  17339-3 | Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | 
|  1734-3 | Aldosterone renal clearance in 24 hour | 
|  17340-1 | Neuronal IgG Ab [Presence] in Body fluid by Immunoassay | 
|  17341-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | 
|  17342-7 | Neuronal nuclear type 2 Ab [Units/volume] in Serum | 
|  17343-5 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid | 
|  17344-3 | Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence | 
|  17345-0 | Deprecated Neutrophil Ab [Units/volume] in Serum | 
|  17346-8 | Neutrophil Ab [Presence] in Serum by Immunofluorescence | 
|  17347-6 | Neutrophil Ab [Units/volume] in Serum by Immunofluorescence | 
|  17348-4 | Neutrophil IgA Ab [Units/volume] in Serum | 
|  17349-2 | Neutrophil IgG Ab [Units/volume] in Serum | 
|  1735-0 | Alanine [Mass/volume] in Cerebral spinal fluid | 
|  17350-0 | Neutrophil IgM Ab [Units/volume] in Serum | 
|  17351-8 | Neutrophil cytoplasmic Ab [Presence] in Serum | 
|  17352-6 | Neutrophil cytoplasmic Ab [Interpretation] in Serum | 
|  17353-4 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence | 
|  17354-2 | Neutrophil cytoplasmic IgA Ab [Presence] in Serum | 
|  17355-9 | Neutrophil cytoplasmic IgG Ab [Presence] in Serum | 
|  17356-7 | Neutrophil cytoplasmic IgM Ab [Presence] in Serum | 
|  17357-5 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence | 
|  17358-3 | Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum | 
|  17359-1 | Neutrophils [#/volume] in Semen by Manual count | 
|  1736-8 | Alanine [Presence] in Serum or Plasma | 
|  17360-9 | Heptane [Mass/volume] in Blood | 
|  17361-7 | Deprecated Hexane [Mass/volume] in Blood | 
|  17362-5 | Nicotinamide [Presence] in Urine | 
|  17363-3 | Nitrazepam [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  17364-1 | Nitrophenol [Presence] in Urine | 
|  17365-8 | Nitroprusside [Mass/volume] in Serum or Plasma | 
|  17366-6 | Nizatidine [Mass/volume] in Serum or Plasma | 
|  17367-4 | Nomifensine [Mass/volume] in Serum or Plasma | 
|  17368-2 | Norepinephrine [Mass/volume] in Plasma --standing | 
|  17369-0 | Norepinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge | 
|  1737-6 | Alanine [Mass/volume] in Serum or Plasma | 
|  17370-8 | Norepinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge | 
|  17371-6 | Norepinephrine [Mass/volume] in Urine --4th specimen post XXX challenge | 
|  17372-4 | Norepinephrine [Mass/volume] in Urine --5th specimen post XXX challenge | 
|  17373-2 | Norepinephrine [Mass/volume] in Urine --6th specimen post XXX challenge | 
|  17374-0 | Norepinephrine [Mass/volume] in Urine --7th specimen post XXX challenge | 
|  17375-7 | Norflunitrazepam [Mass/volume] in Blood | 
|  17376-5 | Norpropoxyphene [Presence] in Urine by Confirmatory method | 
|  17377-3 | Norpropoxyphene [Mass/volume] in Urine by Confirmatory method | 
|  17378-1 | Novobiocin [Mass/volume] in Serum or Plasma | 
|  17379-9 | Propanol [Mass/volume] in Blood | 
|  1738-4 | Alanine [Mass/volume] in Urine | 
|  17380-7 | Nuclear Ab.histone reactive [Presence] in Serum | 
|  17381-5 | Uroporphyrin [Mass/time] in 24 hour Stool | 
|  17382-3 | Octadecanoate (C18:0) [Mass/volume] in Serum or Plasma | 
|  17384-9 | Opiates [Mass/volume] in Urine by Confirmatory method | 
|  17385-6 | Organic acids [Units/volume] in Urine | 
|  17386-4 | Organic acids [Units/volume] in Blood | 
|  17387-2 | Organic acids [Units/volume] in Serum or Plasma | 
|  17388-0 | Organochlorine pesticides [Type] in Urine | 
|  17389-8 | Ornithine [Presence] in Urine | 
|  1739-2 | Alanine [Mass/time] in 24 hour Urine | 
|  17390-6 | Orphenadrine [Mass/volume] in Urine | 
|  17391-4 | Orthocresol [Mass/volume] in Blood | 
|  17392-2 | Osmium [Mass/volume] in Urine | 
|  17393-0 | Ovary Ab [Presence] in Serum | 
|  17394-8 | Oxychlordane [Mass/volume] in Urine | 
|  17395-5 | Oxymorphone [Mass/volume] in Urine by Confirmatory method | 
|  17396-3 | Oxytetracycline [Mass/volume] in Serum or Plasma | 
|  17397-1 | Oxytriphylline [Mass/volume] in Serum or Plasma | 
|  17398-9 | Human papilloma virus 11 Ag [Presence] in Unspecified specimen | 
|  17399-7 | Human papilloma virus 16 Ag [Presence] in Unspecified specimen | 
|  174-3 | Chloramphenicol [Susceptibility] by Disk diffusion (KB) | 
|  1740-0 | Alanine aminopeptidase [Mass/volume] in Serum | 
|  17400-3 | Human papilloma virus 16+18 Ag [Presence] in Unspecified specimen | 
|  17401-1 | Human papilloma virus 18 Ag [Presence] in Unspecified specimen | 
|  17402-9 | Human papilloma virus 31 Ag [Presence] in Unspecified specimen | 
|  17403-7 | Human papilloma virus 31+33+35 Ag [Presence] in Unspecified specimen | 
|  17404-5 | Human papilloma virus 33 Ag [Presence] in Unspecified specimen | 
|  17405-2 | Human papilloma virus 42 Ag [Presence] in Unspecified specimen | 
|  17406-0 | Human papilloma virus 43 Ag [Presence] in Unspecified specimen | 
|  17407-8 | Human papilloma virus 44 Ag [Presence] in Unspecified specimen | 
|  17408-6 | Human papilloma virus 45 Ag [Presence] in Unspecified specimen | 
|  17409-4 | Human papilloma virus 5 Ag [Presence] in Unspecified specimen | 
|  1741-8 | Alanine aminotransferase [Enzymatic activity/volume] in Amniotic fluid | 
|  17410-2 | Human papilloma virus 51 Ag [Presence] in Unspecified specimen | 
|  17411-0 | Human papilloma virus 6 Ag [Presence] in Unspecified specimen | 
|  17412-8 | Human papilloma virus 6+11 Ag [Presence] in Unspecified specimen | 
|  17413-6 | Papova virus SV 40 Ab [Units/volume] in Serum | 
|  17414-4 | Parainfluenza virus 1+2+3 Ag [Presence] in Unspecified specimen | 
|  17415-1 | Parainfluenza virus A Ab [Units/volume] in Serum | 
|  17416-9 | Parakeet droppings Ab [Units/volume] in Serum | 
|  17417-7 | Parakeet droppings IgG Ab [Units/volume] in Serum | 
|  17418-5 | Parakeet serum Ab [Units/volume] in Serum | 
|  17419-3 | Parathion [Mass/volume] in Urine | 
|  1742-6 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 
|  17420-1 | Parrot droppings Ab [Units/volume] in Serum | 
|  17421-9 | Parrot serum Ab [Units/volume] in Serum | 
|  17422-7 | Parvovirus B19 IgG+IgM Ab [Units/volume] in Serum | 
|  17423-5 | Deprecated Parvovirus B19 IgM Ab [Presence] in Serum | 
|  17424-3 | 1,4-Dichlorobenzene [Mass/volume] in Blood | 
|  17426-8 | Penicillium roqueforti IgE Ab [Units/volume] in Serum | 
|  17427-6 | Penicillium sp Ab [Units/volume] in Serum | 
|  17428-4 | Pentacarboxylporphyrins [Mass/time] in 24 hour Stool | 
|  17429-2 | Pentachlorophenol [Mass/volume] in Blood | 
|  1743-4 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P | 
|  17430-0 | Pentane [Mass/volume] in Blood | 
|  17431-8 | Pentobarbital [Mass/volume] in Gastric fluid | 
|  17432-6 | Tetrachloroethylene [Mass/volume] in Serum or Plasma | 
|  17433-4 | pH of Unspecified specimen | 
|  17434-2 | Phenazopyridine [Mass/volume] in Serum or Plasma | 
|  17435-9 | Pheniramine [Mass/volume] in Urine | 
|  17436-7 | Phenobarbital [Mass/volume] in Gastric fluid | 
|  17437-5 | Phenolphthalein [Mass/volume] in Urine | 
|  17438-3 | Phenolphthalein [Mass/volume] in Blood | 
|  17439-1 | Phenols [Mass/volume] in Blood | 
|  1744-2 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by Without P-5'-P | 
|  17440-9 | Phenothiazines [Units/volume] in Serum or Plasma | 
|  17441-7 | Phenothiazines [Units/volume] in Urine | 
|  17442-5 | Phenylephrine [Mass/volume] in Serum or Plasma | 
|  17443-3 | Phenylpropanolamine [Mass/volume] in Urine | 
|  17444-1 | Phenytoin [Mass/volume] in Urine | 
|  17445-8 | Phoma herbarum IgG Ab [Units/volume] in Serum | 
|  17446-6 | Phoma sp IgE Ab [Units/volume] in Serum | 
|  17447-4 | Phosphate [Presence] in Stool | 
|  17448-2 | Phosphatidylethanolamine IgA Ab [Presence] in Serum | 
|  17449-0 | Phosphatidylethanolamine IgG Ab [Presence] in Serum | 
|  1745-9 | Albumin [Mass/volume] in Amniotic fluid | 
|  17450-8 | Phosphatidylethanolamine IgM Ab [Presence] in Serum | 
|  17451-6 | Phosphatidylglycerol IgA Ab [Presence] in Serum | 
|  17452-4 | Phosphatidylglycerol IgG Ab [Presence] in Serum | 
|  17453-2 | Phosphatidylglycerol IgM Ab [Presence] in Serum | 
|  17454-0 | Phosphatidylinositol IgA Ab [Presence] in Serum | 
|  17455-7 | Phosphatidylinositol IgG Ab [Presence] in Serum | 
|  17456-5 | Phosphatidylinositol IgM Ab [Presence] in Serum | 
|  17457-3 | Phosphoethanolamine [Presence] in Urine | 
|  17458-1 | Phosphoethanolamine [Presence] in Serum or Plasma | 
|  17459-9 | Phospholipid IgA Ab [Units/volume] in Serum by Immunoassay | 
|  1746-7 | Albumin [Mass/volume] in Cerebral spinal fluid | 
|  17460-7 | Phosphoserine [Presence] in Urine | 
|  17461-5 | Phosphoserine [Presence] in Serum or Plasma | 
|  17462-3 | Picloram [Mass/volume] in Urine | 
|  17463-1 | Pigeon droppings Ab [Units/volume] in Serum | 
|  17464-9 | Pigeon feather IgE Ab [Presence] in Serum | 
|  17465-6 | Pigeon serum IgE Ab [Presence] in Serum | 
|  17466-4 | Deprecated Plasminogen activator inhibitor 1 Ag [Units/volume] in Platelet poor plasma by Immunologic method | 
|  17467-2 | Plasminogen activator inhibitor 2 Ag [Units/volume] in Platelet poor plasma by Immunoassay | 
|  17468-0 | Plutonium [Mass/volume] in Urine | 
|  17469-8 | PM-1 Ab [Units/volume] in Serum | 
|  1747-5 | Albumin [Mass/volume] in Body fluid | 
|  17470-6 | PM-1 Ab [Presence] in Serum by Immunofluorescence | 
|  17471-4 | PM-1 Ab [Units/volume] in Serum by Immunofluorescence | 
|  17472-2 | Polybrominated biphenyl [Mass/volume] in Serum or Plasma | 
|  17473-0 | Polymyxin B [Mass/volume] in Serum or Plasma | 
|  17474-8 | Porphobilinogen [Moles/volume] in Serum or Plasma | 
|  17475-5 | Porphyrins [Units/volume] in Urine | 
|  17476-3 | Porphyrins [Units/volume] in Red Blood Cells | 
|  17477-1 | Porphyrins [Units/volume] in Stool | 
|  17478-9 | Porphyrins [Presence] in Body fluid | 
|  17479-7 | Prazepam [Mass/volume] in Urine by Confirmatory method | 
|  1748-3 | Albumin [Mass/volume] in Pleural fluid | 
|  17480-5 | Pregnenolone [Mass/volume] in Urine | 
|  17481-3 | Probenecid [Units/volume] in Urine | 
|  17482-1 | Procainamide [Mass/volume] in Urine | 
|  17483-9 | Progesterone [Mass/volume] in Urine | 
|  17484-7 | Progesterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge | 
|  17485-4 | Progesterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge | 
|  17486-2 | Progesterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | 
|  17487-0 | Progesterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge | 
|  17488-8 | Progesterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | 
|  17489-6 | Progesterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | 
|  1749-1 | Albumin [Mass/volume] in Peritoneal fluid | 
|  17490-4 | Progesterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | 
|  17491-2 | Proinsulin [Mass/volume] in Serum or Plasma --baseline | 
|  17492-0 | Proline [Presence] in Urine | 
|  17493-8 | Prostaglandin E [Mass/volume] in Serum or Plasma | 
|  17494-6 | Prostaglandin F2 alpha [Mass/volume] in Urine | 
|  17495-3 | Prostaglandins [Mass/volume] in Urine | 
|  17496-1 | Alpha 1 globulin [Mass/volume] in Body fluid by Electrophoresis | 
|  17497-9 | Alpha 2 globulin [Mass/volume] in Body fluid by Electrophoresis | 
|  17498-7 | Beta globulin [Mass/volume] in Body fluid by Electrophoresis | 
|  17499-5 | Gamma globulin [Mass/volume] in Body fluid by Electrophoresis | 
|  175-0 | Chloramphenicol [Susceptibility] by Serum bactericidal titer | 
|  1750-9 | Albumin [Mass/volume] in Semen | 
|  17501-8 | Protoporphyrin [Mass/volume] in Serum or Plasma | 
|  17502-6 | Pseudomonas aeruginosa Ab [Units/volume] in Serum | 
|  17504-2 | Psilocybin [Presence] in Urine | 
|  17505-9 | Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma | 
|  17506-7 | Quinacrine [Mass/volume] in Serum or Plasma | 
|  17507-5 | Quinidine [Mass/volume] in Urine | 
|  17508-3 | Quinine [Units/volume] in Urine | 
|  17509-1 | Marsh Ragweed IgE Ab [Units/volume] in Serum | 
|  1751-7 | Albumin [Mass/volume] in Serum or Plasma | 
|  17510-9 | Raisin IgE Ab [Units/volume] in Serum | 
|  17511-7 | Red dye IgE Ab [Units/volume] in Serum | 
|  17512-5 | Redfish IgE Ab [Units/volume] in Serum | 
|  17513-3 | Renin [Enzymatic activity/volume] in Plasma --5 hours post XXX challenge | 
|  17514-1 | Renin [Enzymatic activity/volume] in Plasma --9th specimen post XXX challenge | 
|  17515-8 | Renin [Enzymatic activity/volume] in Plasma --baseline | 
|  17516-6 | Renin [Enzymatic activity/volume] in Plasma --supine | 
|  17517-4 | Respiratory syncytial virus IgG Ab [Titer] in Cerebral spinal fluid | 
|  17518-2 | Respiratory syncytial virus IgG Ab [Titer] in Serum | 
|  17519-0 | Respiratory syncytial virus IgM Ab [Titer] in Cerebral spinal fluid | 
|  1752-5 | Albumin [Mass/volume] in Synovial fluid | 
|  17520-8 | Respiratory syncytial virus identified in Unspecified specimen by Organism specific culture | 
|  17521-6 | Reticulin Ab [Presence] in Serum | 
|  17522-4 | Reticulin IgA Ab [Titer] in Serum by Immunofluorescence | 
|  17523-2 | Reticulin IgG Ab [Titer] in Serum | 
|  17524-0 | Reticulin IgG Ab [Titer] in Serum by Immunofluorescence | 
|  17525-7 | Retinoate esters [Mass/volume] in Serum or Plasma | 
|  17526-5 | Retinyl esters [Mass/volume] in Serum or Plasma | 
|  17527-3 | Retinol Free [Mass/volume] in Serum or Plasma | 
|  17528-1 | Retinol [Mass/volume] in Serum or Plasma --3 hours post dose | 
|  17529-9 | Retinol [Mass/volume] in Serum or Plasma --6 hours post dose | 
|  1753-3 | Albumin [Presence] in Urine | 
|  17530-7 | Retrovirus identified in Unspecified specimen by Organism specific culture | 
|  17531-5 | Rh [Type] in Amniotic fluid | 
|  17532-3 | Rheumatoid arthritis nuclear Ab [Presence] in Serum | 
|  17533-1 | Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immunofluorescence | 
|  17534-9 | Rheumatoid factor [Units/volume] in Body fluid by Immunoassay | 
|  17535-6 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunofluorescence | 
|  17536-4 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence | 
|  17537-2 | Rickettsia spotted fever group RNA [Presence] in Serum by Probe and target amplification method | 
|  17538-0 | Rickettsia spotted fever group RNA [Presence] in Serum by DNA probe | 
|  17539-8 | Rickettsia typhi Ab [Units/volume] in Serum by Latex agglutination | 
|  1754-1 | Albumin [Mass/volume] in Urine | 
|  17540-6 | Rickettsia typhi IgA Ab [Units/volume] in Serum by Immunofluorescence | 
|  17541-4 | Rickettsia typhi IgG Ab [Presence] in Serum by Immunoassay | 
|  17544-8 | Bartonella quintana IgG Ab [Presence] in Cerebral spinal fluid | 
|  17545-5 | Bartonella quintana IgM Ab [Presence] in Cerebral spinal fluid | 
|  17546-3 | Bartonella quintana rRNA [Presence] in Unspecified specimen by DNA probe | 
|  17547-1 | Rotavirus Ag [Presence] in Stool | 
|  17548-9 | Rotavirus RNA [Presence] in Unspecified specimen by DNA probe | 
|  17549-7 | Rubella virus Ab [Units/volume] in Cerebral spinal fluid | 
|  1755-8 | Albumin [Mass/time] in 24 hour Urine | 
|  17550-5 | Rubella virus Ab [Units/volume] in Serum by Latex agglutination | 
|  17551-3 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | 
|  17552-1 | Rubella virus IgM Ab [Presence] in Cerebral spinal fluid | 
|  17553-9 | Measles virus Ab [Units/volume] in Cerebral spinal fluid | 
|  17554-7 | Measles virus IgA Ab [Units/volume] in Serum | 
|  17555-4 | Measles virus Ab [Units/volume] in Serum --1st specimen | 
|  17556-2 | Measles virus Ab [Units/volume] in Serum --2nd specimen | 
|  17557-0 | Saccharomonospora viridis IgG Ab [Units/volume] in Serum | 
|  17558-8 | Saint Louis encephalitis virus Ab [Units/volume] in Cerebral spinal fluid | 
|  17559-6 | Salicylates [Presence] in Blood | 
|  1756-6 | Albumin in CSF/Albumin in Serum or Plasma | 
|  17560-4 | Salicylates [Presence] in Gastric fluid | 
|  17561-2 | Salmon roe IgE Ab [Units/volume] in Serum | 
|  17562-0 | Salmonella sp Ab [Presence] in Serum | 
|  17563-8 | Salmonella sp identified in Unspecified specimen by Organism specific culture | 
|  17564-6 | Salmonella typhi O D Ab [Presence] in Serum by Latex agglutination | 
|  17565-3 | Salmonella typhi H D Ab [Presence] in Serum by Latex agglutination | 
|  17566-1 | Salmonella typhi O Ab [Presence] in Serum | 
|  17567-9 | Sasapyrine [Mass/volume] in Serum or Plasma | 
|  17568-7 | Sarcosine [Presence] in Urine | 
|  17569-5 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunofluorescence | 
|  1757-4 | Albumin renal clearance in 24 hour | 
|  17570-3 | SCL-70 extractable nuclear IgG Ab [Presence] in Serum by Immunoassay | 
|  17571-1 | Scopolamine [Mass/volume] in Urine | 
|  17572-9 | 2-Butanol [Mass/volume] in Blood | 
|  17573-7 | Secobarbital [Mass/volume] in Gastric fluid | 
|  17574-5 | Selenium [Mass/volume] in Body fluid | 
|  17575-2 | Serine [Presence] in Urine | 
|  17576-0 | Shigella sp identified in Unspecified specimen by Organism specific culture | 
|  17577-8 | Ganglioside GQ1a IgM Ab [Presence] in Serum | 
|  17578-6 | Ganglioside GQ1b Ab [Presence] in Serum | 
|  17579-4 | Ganglioside GQ1b IgG Ab [Presence] in Serum | 
|  1758-2 | Albumin.glycated [Mass/volume] in Serum or Plasma | 
|  17580-2 | Ganglioside GQ1b IgG Ab [Presence] in Cerebral spinal fluid | 
|  17581-0 | Ganglioside GQ1b IgM Ab [Presence] in Serum | 
|  17582-8 | Silver [Mass/volume] in Dialysis fluid | 
|  17583-6 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunofluorescence | 
|  17584-4 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence | 
|  17585-1 | Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum by Immunoassay | 
|  17586-9 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunofluorescence | 
|  17587-7 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence | 
|  17588-5 | Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum by Immunoassay | 
|  17589-3 | Smith extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) | 
|  1759-0 | Albumin/Globulin [Mass Ratio] in Serum or Plasma | 
|  17590-1 | Smith extractable nuclear Ab [Titer] in Serum by Immunoassay | 
|  17591-9 | Smith extractable nuclear Ab [Presence] in Serum by Immunofluorescence | 
|  17592-7 | Smith extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence | 
|  17593-5 | Smooth muscle Ab [Presence] in Sweat | 
|  17594-3 | Deprecated Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge | 
|  17595-0 | Deprecated Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge | 
|  17597-6 | Somatotropin [Mass/volume] in Serum or Plasma --52 hours post XXX challenge | 
|  17598-4 | Specific gravity of Synovial fluid | 
|  17599-2 | Volume of 24 hour Peritoneal dialysis fluid | 
|  176-8 | Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1760-8 | Alcohol dehydrogenase [Enzymatic activity/volume] in Serum | 
|  17600-8 | Volume of 6 hour Urine | 
|  17601-6 | Volume of 24 hour Sputum | 
|  17602-4 | Volume of Seminal plasma | 
|  17603-2 | Volume of 24 hour Stool | 
|  17604-0 | Volume of 24 hour Sweat | 
|  17605-7 | Volume of 24 hour Unspecified specimen | 
|  17606-5 | Volume of Stool | 
|  17607-3 | Volume of Cerebral spinal fluid | 
|  17608-1 | Weight [Mass/time] of 48 hour Stool | 
|  17609-9 | Weight [Mass/time] of 72 hour Stool | 
|  1761-6 | Aldolase [Enzymatic activity/volume] in Serum or Plasma | 
|  17610-7 | Spermatozoa Motile [Presence] in Semen --30 minutes post collection | 
|  17611-5 | Stimulants [Identifier] in Serum or Plasma | 
|  17612-3 | Deprecated Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --1st specimen | 
|  17613-1 | Deprecated Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --2nd specimen | 
|  17614-9 | Streptococcus pneumoniae 12 Ab [Presence] in Serum | 
|  17615-6 | Deprecated Streptococcus pneumoniae 12 Ab [Units/volume] in Serum --1st specimen | 
|  17616-4 | Deprecated Streptococcus pneumoniae 12 Ab [Ratio] in Serum --2nd specimen/1st specimen | 
|  17617-2 | Streptococcus pneumoniae 14 Ab [Units/volume] in Serum by Immunoassay --1st specimen | 
|  17618-0 | Streptococcus pneumoniae 14 Ab [Units/volume] in Serum by Immunoassay --2nd specimen | 
|  17619-8 | Streptococcus pneumoniae 14 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen | 
|  1762-4 | Aldosterone [Mass/volume] in Blood | 
|  17620-6 | Deprecated Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --1st specimen | 
|  17621-4 | Deprecated Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --2nd specimen | 
|  17622-2 | Streptocuccus pneumoniae 18 Ab [Units/volume] in Serum --1st specimen | 
|  17623-0 | Deprecated Streptococcus pneumoniae 19 Ab [Units/volume] in Serum --2nd specimen | 
|  17624-8 | Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --1st specimen | 
|  17625-5 | Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --2nd specimen | 
|  17626-3 | Deprecated Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --1st specimen | 
|  17627-1 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum by Immunoassay --1st specimen | 
|  17628-9 | Deprecated Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --2nd specimen | 
|  17629-7 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum by Immunoassay --2nd specimen | 
|  1763-2 | Aldosterone [Mass/volume] in Serum or Plasma | 
|  17630-5 | Streptococcus pneumoniae 3 Ab [Ratio] in Serum --2nd specimen/1st specimen | 
|  17631-3 | Deprecated Streptococcus pneumoniae 36a+6b IgG Ab [Units/volume] in Serum | 
|  17632-1 | Streptococcus pneumoniae 4 IgG Ab [Units/volume] in Serum | 
|  17633-9 | Deprecated Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --1st specimen | 
|  17634-7 | Deprecated Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --2nd specimen | 
|  17635-4 | Streptococcus pneumoniae 56 IgG Ab [Units/volume] in Serum | 
|  17636-2 | Deprecated Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --1st specimen | 
|  17637-0 | Deprecated Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --2nd specimen | 
|  17638-8 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum by Immunoassay --1st specimen | 
|  17639-6 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum by Immunoassay --2nd specimen | 
|  1764-0 | Aldosterone [Mass/volume] in Urine | 
|  17640-4 | Streptococcus pneumoniae 51 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen | 
|  17641-2 | Streptococcus pneumoniae 8 Ab [Presence] in Serum | 
|  17642-0 | Streptococcus pneumoniae 8 Ab [Presence] in Serum by Immunoassay | 
|  17643-8 | Streptococcus pneumoniae 9 Ab [Presence] in Serum by Immunoassay | 
|  17644-6 | Streptococcus pneumoniae 9 Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen | 
|  17645-3 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum by Immunoassay --1st specimen | 
|  17646-1 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum by Immunoassay --2nd specimen | 
|  17647-9 | Streptococcus pneumoniae Ab [Units/volume] in Serum | 
|  17648-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Immunoassay | 
|  17649-5 | Streptococcus pneumoniae IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen | 
|  1765-7 | Aldosterone [Mass/time] in 24 hour Urine | 
|  17650-3 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen | 
|  17651-1 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen | 
|  17652-9 | Streptococcus pneumoniae Ag [Presence] in Unspecified specimen by Latex agglutination | 
|  17653-7 | Deprecated Streptococcus pneumoniae group A Ag | 
|  17654-5 | Deprecated Streptococcus pneumoniae group B Ab by Immunoassay | 
|  17655-2 | Deprecated Streptococcus pneumoniae group B Ag in urine by immunofluorescence | 
|  17656-0 | Streptococcus pyogenes [Presence] in Unspecified specimen by Organism specific culture | 
|  17657-8 | Streptolysin O Ab [Units/volume] in Synovial fluid | 
|  17658-6 | Strontium/Creatinine [Mass Ratio] in Urine | 
|  17659-4 | Strychnine [Units/volume] in Serum or Plasma | 
|  1766-5 | Aldosterone receptors [#] in Leukocytes | 
|  17660-2 | Strychnine [Units/volume] in Urine | 
|  17661-0 | Succinylcholine [Mass/volume] in Serum or Plasma | 
|  17662-8 | Succinylpurines [Presence] in Urine | 
|  17663-6 | Sulfadiazine IgE Ab [Units/volume] in Serum | 
|  17664-4 | Sulfalazine IgE Ab [Units/volume] in Serum | 
|  17665-1 | Sulfamedraxozole IgE Ab [Units/volume] in Serum | 
|  17666-9 | Sulfate [Mass/volume] in Dialysis fluid | 
|  17667-7 | Sulfate.organic/Sulfate.total in Urine | 
|  17668-5 | Sulfatide IgG Ab [Units/volume] in Serum by Immunofluorescence | 
|  17669-3 | Sulfatide IgG Ab [Units/volume] in Serum by Immunoassay | 
|  1767-3 | Aldosterone [Mass/volume] in Serum or Plasma --supine | 
|  17670-1 | Sulfatide IgM Ab [Units/volume] in Serum by Immunofluorescence | 
|  17671-9 | Sulfatide IgM Ab [Units/volume] in Serum by Immunoassay | 
|  17672-7 | Sulfide [Mass/volume] in Urine | 
|  17673-5 | Sulfisoxazole IgE Ab [Units/volume] in Serum | 
|  17674-3 | Sulfonamide [Units/volume] in Serum or Plasma | 
|  17675-0 | Sulfonamide [Units/volume] in Urine | 
|  17676-8 | Sulindac sulfide metabolite [Mass/volume] in Serum or Plasma | 
|  17677-6 | Deprecated Helianthus annuus Ab.IgE | 
|  17678-4 | Taurine [Presence] in Urine | 
|  17679-2 | Taurine [Presence] in Cerebral spinal fluid | 
|  1768-1 | Aldosterone [Mass/volume] in Serum or Plasma --upright | 
|  17681-8 | Tellurium [Presence] in Urine | 
|  17682-6 | Terpineol [Presence] in Blood | 
|  17683-4 | 2-Methyl-2-Propanol [Mass/volume] in Blood | 
|  17685-9 | Testosterone Free [Mass/volume] in Dialysis fluid | 
|  17686-7 | Testosterone.weakly bound [Mass/volume] in Serum or Plasma | 
|  17687-5 | Testosterone/Epitestosterone [Mass Ratio] in Serum or Plasma | 
|  17688-3 | Testosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge | 
|  17689-1 | Testosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge | 
|  1769-9 | Fatty acids.nonesterified [Mass/volume] in Serum or Plasma | 
|  17690-9 | Testosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | 
|  17691-7 | Testosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge | 
|  17692-5 | Testosterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge | 
|  17693-3 | Testosterone [Mass/volume] in Serum or Plasma --4 days post XXX challenge | 
|  17694-1 | Deprecated Coproporphyrin [Mass/time] in 24 hour Stool | 
|  17695-8 | Tetrachlorodiphenylethane [Mass/volume] in Blood | 
|  17696-6 | Tetrachlorodiphenylethane [Mass/volume] in Urine | 
|  17697-4 | Tetrachloroethane [Mass/volume] in Blood | 
|  17698-2 | Tetraethyl lead [Mass/volume] in Blood | 
|  17699-0 | Thebaine [Mass/volume] in Serum or Plasma | 
|  177-6 | Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1770-7 | Aliphatic carboxylate, C14-C26.absorption [Mass/volume] in Serum or Plasma | 
|  17700-6 | Theophylline [Mass/volume] in Urine | 
|  17701-4 | Thiazides [Mass/volume] in Urine | 
|  17703-0 | Thorium [Mass/volume] in Urine | 
|  17704-8 | Threonine [Presence] in Urine | 
|  17705-5 | Thyroglobulin IgM Ab [Units/volume] in Serum | 
|  17706-3 | Thyroperoxidase Ab [Titer] in Cerebral spinal fluid by Latex agglutination | 
|  17707-1 | Thyroperoxidase IgM Ab [Units/volume] in Serum or Plasma | 
|  17708-9 | Thyroid stimulating immunoglobulins [Presence] in Serum | 
|  17709-7 | Ticlopidine [Presence] in Urine | 
|  1771-5 | Aliphatic carboxylate, C14-C26.esters [Mass/volume] in Serum or Plasma | 
|  17710-5 | Tin/Creatinine [Mass Ratio] in Urine | 
|  17712-1 | Toluene diisocyanate [Mass/volume] in Blood | 
|  17713-9 | Topiramate [Mass/volume] in Serum or Plasma | 
|  17714-7 | Toxaphene [Mass/volume] in Serum or Plasma | 
|  17715-4 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid by Immunoassay | 
|  17716-2 | Toxoplasma gondii IgE Ab [Units/volume] in Serum | 
|  17717-0 | Toxoplasma gondii IgG+IgM Ab [Presence] in Serum | 
|  17718-8 | Tramadol [Presence] in Urine by Confirmatory method | 
|  17719-6 | Tramadol [Mass/volume] in Urine | 
|  1772-3 | Aliphatic carboxylate, C14-C26.esters [Mass/volume] in Stool | 
|  17720-4 | Trans nonachlor [Mass/volume] in Urine | 
|  17721-2 | Trans nonachlor [Mass/volume] in Blood | 
|  17723-8 | Treponema pallidum Ab [Presence] in Serum by Immobilization | 
|  17724-6 | Treponema pallidum Ab [Units/volume] in Serum by Immunofluorescence | 
|  17725-3 | Treponema pallidum Ab [Units/volume] in Serum by Latex agglutination | 
|  17726-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence | 
|  17727-9 | Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence | 
|  17728-7 | Treponema pallidum IgM Ab [Units/volume] in Serum by Immunofluorescence | 
|  17729-5 | Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence | 
|  1773-1 | Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma | 
|  17730-3 | Triamterene [Units/volume] in Urine | 
|  17732-9 | Trichinella spiralis Ab [Presence] in Serum by Latex agglutination | 
|  17733-7 | Trichinella spiralis IgA Ab [Presence] in Serum | 
|  17734-5 | Trichinella spiralis IgG Ab [Units/volume] in Serum | 
|  17735-2 | Trichinella spiralis IgM Ab [Presence] in Serum | 
|  17736-0 | Trichloroacetate [Mass/volume] in Blood | 
|  17737-8 | Trichloroethane [Mass/volume] in Urine | 
|  17738-6 | Chloral hydrate [Presence] in Urine | 
|  17739-4 | Chloral hydrate [Presence] in Urine by Confirmatory method | 
|  1774-9 | Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma | 
|  17740-2 | Trichlorophenoxyacetate [Presence] in Blood | 
|  17741-0 | Trichlorophenoxyacetate [Mass/volume] in Serum or Plasma | 
|  17742-8 | Trichlorothiazide [Presence] in Urine | 
|  17743-6 | Triiodothyronine resin uptake (T3RU) in Serum or Plasma --1 hour post XXX challenge | 
|  17744-4 | Trimellitic anhydride (TMA) IgG Ab [Units/volume] in Serum | 
|  17745-1 | Trimellitic anhydride (TMA) IgM Ab [Units/volume] in Serum | 
|  17746-9 | Trimeprazine [Presence] in Serum or Plasma | 
|  17747-7 | Trimethoprim [Mass/volume] in Urine | 
|  17748-5 | Trimethylamine [Presence] in Urine | 
|  17749-3 | Tromethamine [Mass/volume] in Serum or Plasma | 
|  1775-6 | Alkaline phosphatase [Mass/volume] in Body fluid | 
|  17750-1 | Trypsinogen [Enzymatic activity/volume] in Serum or Plasma | 
|  17751-9 | Tryptamine [Mass/volume] in Serum or Plasma | 
|  17752-7 | Tryptophan [Presence] in Urine | 
|  17753-5 | Tungsten [Mass/volume] in Serum or Plasma | 
|  17754-3 | Tyrosine [Presence] in Blood | 
|  17755-0 | Urate [Mass/time] in 2 hour Urine | 
|  17756-8 | Urate [Mass/time] in 4 hour Urine | 
|  17757-6 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid | 
|  17758-4 | Urea nitrogen [Mass/volume] in Vitreous fluid | 
|  17759-2 | Urea nitrogen [Mass/volume] in Arterial blood --post dialysis | 
|  1776-4 | Alkaline phosphatase [Mass/volume] in Urine | 
|  17760-0 | Urea nitrogen [Mass/volume] in Venous blood --pre dialysis | 
|  17761-8 | Urobilinogen [Mass/time] in 48 hour Stool | 
|  17762-6 | Valproate [Mass/volume] in Urine | 
|  17763-4 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunofluorescence | 
|  17764-2 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  17765-9 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence | 
|  17766-7 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunofluorescence | 
|  17767-5 | Verapamil [Mass/volume] in Urine | 
|  17768-3 | Vinyl chloride [Mass/volume] in Blood | 
|  17769-1 | Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid | 
|  1777-2 | Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma | 
|  17770-9 | Western equine encephalitis virus Ab [Titer] in Serum | 
|  17771-7 | Whitefish roe IgE Ab [Units/volume] in Serum | 
|  17772-5 | Dimethylbenzene [Mass/volume] in Urine | 
|  17773-3 | Yeast [Presence] in Stool by Light microscopy | 
|  17774-1 | Yellow dye IgE Ab [Units/volume] in Serum | 
|  17775-8 | Yersinia sp IgA Ab [Units/volume] in Serum | 
|  17776-6 | Yersinia sp IgG Ab [Units/volume] in Serum | 
|  17777-4 | Yersinia sp IgM Ab [Units/volume] in Serum | 
|  17778-2 | Zinc [Mass/volume] in Leukocytes | 
|  1778-0 | Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma | 
|  17780-8 | Helicobacter pylori Ag [Presence] in Stool by Immunoassay | 
|  17781-6 | 21-Hydroxylase Ab [Units/volume] in Serum | 
|  17782-4 | Lipoprotein.beta.subparticle [Entitic length] in Serum or Plasma | 
|  17783-2 | Hemosiderin [Presence] in Urine by Light microscopy | 
|  17784-0 | Parasites in Blood by Light microscopy | 
|  17785-7 | Radioactive iodine.thyroid/Radioactive iodine dose [Ratio] | 
|  17786-5 | Thyrotropin [Interpretation] in Unspecified specimen--post dose TRH | 
|  17787-3 | Thyroid gland NM Study report | 
|  17788-1 | Large unstained cells/100 leukocytes in Blood by Automated count | 
|  17789-9 | Large unstained cells [#/volume] in Blood by Automated count | 
|  1779-8 | Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma | 
|  17790-7 | Leukocytes Left Shift [Presence] in Blood by Automated count | 
|  17791-5 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum | 
|  17792-3 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum | 
|  17793-1 | Immunoglobulin light chains [Mass/volume] in 24 hour Urine | 
|  17794-9 | Osmolality of Hyperal solution | 
|  17795-6 | Potassium [Moles/volume] in Hyperal solution | 
|  17796-4 | Sodium [Moles/volume] in Hyperal solution | 
|  17797-2 | Thyroid colloidal Ab [Units/volume] in Serum | 
|  17798-0 | Amikacin [Mass/volume] in Cerebral spinal fluid | 
|  17799-8 | Promyelocytes/100 leukocytes in Body fluid | 
|  178-4 | Chlortetracycline [Susceptibility] by Disk diffusion (KB) | 
|  1780-6 | Alkaline phosphatase.placental [Enzymatic activity/volume] in Serum or Plasma | 
|  17800-4 | Myelocytes/100 leukocytes in Body fluid | 
|  17801-2 | Metamyelocytes/100 leukocytes in Body fluid | 
|  17802-0 | Prolymphocytes/100 leukocytes in Body fluid | 
|  17803-8 | Plasma cells/100 leukocytes in Body fluid | 
|  17804-6 | Promonocytes/100 leukocytes in Body fluid | 
|  17805-3 | Procainamide [Mass/volume] in Body fluid | 
|  17806-1 | N-acetylprocainamide [Mass/volume] in Body fluid | 
|  17807-9 | Cyclosporine [Mass/volume] in Body fluid | 
|  17808-7 | Tobramycin [Mass/volume] in Urine | 
|  17809-5 | Hematocrit [Volume Fraction] of Urine | 
|  1781-4 | Alkaline phosphatase.regan [Enzymatic activity/volume] in Serum or Plasma | 
|  17810-3 | Prealbumin/Protein.total in Body fluid by Electrophoresis | 
|  17811-1 | Alpha 1 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration | 
|  17812-9 | Alpha 1 globulin/Protein.total in Body fluid by Electrophoresis | 
|  17813-7 | Alpha 2 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration | 
|  17814-5 | Alpha 2 globulin/Protein.total in Body fluid by Electrophoresis | 
|  17815-2 | Beta globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration | 
|  17816-0 | Beta globulin/Protein.total in Body fluid by Electrophoresis | 
|  17817-8 | Gamma globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration | 
|  17818-6 | Gamma globulin/Protein.total in Body fluid by Electrophoresis | 
|  17819-4 | Albumin/Protein.total by Electrophoresis in Urine collected for unspecified duration | 
|  1782-2 | Alkaline phosphatase.renal [Enzymatic activity/volume] in Serum or Plasma | 
|  17820-2 | Albumin/Protein.total in Body fluid by Electrophoresis | 
|  17821-0 | Oligoclonal bands [Interpretation] in Body fluid by Electrophoresis Narrative | 
|  17822-8 | CD3+CD4+ (T4 helper) cells/100 cells in Body fluid | 
|  17823-6 | CD45 (Lymphs) cells/100 cells in Body fluid | 
|  17824-4 | CD3+CD8+ (T8 suppressor cells) cells/100 cells in Body fluid | 
|  17825-1 | CD41a cells/100 cells in Blood | 
|  17826-9 | CD3 cells/100 cells in Body fluid | 
|  17827-7 | CD2 cells/100 cells in Body fluid | 
|  17828-5 | CD16 cells/100 cells in Body fluid | 
|  17829-3 | CD19 cells/100 cells in Body fluid | 
|  1783-0 | Alkaline phosphatase [Enzymatic activity/volume] in Blood | 
|  17830-1 | Centromere Ab [Units/volume] in Body fluid | 
|  17831-9 | Deprecated 5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  17832-7 | Deprecated 5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC) | 
|  17833-5 | Basophils/100 leukocytes in Synovial fluid | 
|  17834-3 | Eosinophils/100 leukocytes in Synovial fluid | 
|  17835-0 | Monocytes/100 leukocytes in Synovial fluid | 
|  17836-8 | Neutrophils/100 leukocytes in Synovial fluid | 
|  17837-6 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Serum | 
|  17838-4 | Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma | 
|  17839-2 | Alpha fucosidase [Enzymatic activity/volume] in Blood | 
|  1784-8 | Alpha amino acid nitrogen [Mass/volume] in Plasma | 
|  17840-0 | Alpha-L-iduronidase [Enzymatic activity/volume] in Blood | 
|  17841-8 | Amylase [Enzymatic activity/time] in 12 hour Urine | 
|  17842-6 | Cancer Ag 27-29 [Units/volume] in Serum or Plasma | 
|  17843-4 | Cancer Ag 72-4 [Units/volume] in Serum or Plasma | 
|  17844-2 | Estradiol (E2).albumin bound [Mass/volume] in Serum or Plasma | 
|  17845-9 | Lipoprotein.alpha [Presence] in Serum or Plasma | 
|  17846-7 | Lipoprotein.beta [Presence] in Serum or Plasma | 
|  17847-5 | Lipoprotein.pre-beta [Presence] in Serum or Plasma | 
|  17848-3 | Reticulocytes/1000 erythrocytes in Blood by Manual | 
|  17849-1 | Reticulocytes/100 erythrocytes in Blood by Automated count | 
|  1785-5 | Alpha amino acid nitrogen [Mass/time] in 24 hour Urine | 
|  17850-9 | Herpes simplex virus 1 IgG Ab [Presence] in Serum | 
|  17851-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum | 
|  17852-5 | Ureaplasma urealyticum [Presence] in Unspecified specimen by Organism specific culture | 
|  17853-3 | Ganglioside GM1b IgG Ab [Titer] in Serum | 
|  17854-1 | Ganglioside GM1b IgM Ab [Titer] in Serum | 
|  17855-8 | Hemoglobin A1c/Hemoglobin.total in Blood by calculation | 
|  17856-6 | Hemoglobin A1c/Hemoglobin.total in Blood by HPLC | 
|  17857-4 | Rheumatoid factor [Titer] in Serum | 
|  17858-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Body fluid | 
|  17859-0 | Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay | 
|  1786-3 | Alpha aminobutyrate [Mass/volume] in Cerebral spinal fluid | 
|  17860-8 | 3-Methylhistidine [Mass/volume] in 24 hour Urine | 
|  17861-6 | Calcium [Mass/volume] in Serum or Plasma | 
|  17862-4 | Calcium [Mass/volume] in Urine | 
|  17863-2 | Calcium.ionized [Mass/volume] in Serum or Plasma | 
|  17864-0 | Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) | 
|  17865-7 | Glucose [Mass/volume] in Serum or Plasma --8 hours fasting | 
|  17866-5 | Carnitine/Creatinine [Ratio] in Urine | 
|  17867-3 | Carnitine free (C0)/Creatinine [Ratio] in Urine | 
|  17868-1 | Acylcarnitine/Creatinine [Ratio] in Urine | 
|  17869-9 | Orotate/Creatinine [Molar ratio] in Urine | 
|  1787-1 | Alpha aminobutyrate [Presence] in Serum or Plasma | 
|  17870-7 | Orotidine/Creatinine [Molar ratio] in Urine | 
|  17871-5 | Hemoglobin H [Presence] in Blood by Heat denaturation | 
|  17872-3 | Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL | 
|  17873-1 | Bacteria # 2 identified in Bone by Aerobe culture | 
|  17874-9 | Bacteria # 3 identified in Bone by Aerobe culture | 
|  17875-6 | Bacteria # 4 identified in Bone by Aerobe culture | 
|  17876-4 | Bacteria # 5 identified in Bone by Aerobe culture | 
|  17877-2 | Bacteria # 6 identified in Bone by Aerobe culture | 
|  17878-0 | Bacteria # 2 identified in Bronchial specimen by Aerobe culture | 
|  17879-8 | Bacteria # 3 identified in Bronchial specimen by Aerobe culture | 
|  1788-9 | Alpha aminobutyrate [Mass/volume] in Serum or Plasma | 
|  17880-6 | Bacteria # 4 identified in Bronchial specimen by Aerobe culture | 
|  17881-4 | Bacteria # 5 identified in Bronchial specimen by Aerobe culture | 
|  17882-2 | Bacteria # 6 identified in Bronchial specimen by Aerobe culture | 
|  17883-0 | Bacteria # 2 identified in Genital specimen by Aerobe culture | 
|  17884-8 | Bacteria # 3 identified in Genital specimen by Aerobe culture | 
|  17885-5 | Bacteria # 4 identified in Genital specimen by Aerobe culture | 
|  17886-3 | Bacteria # 5 identified in Genital specimen by Aerobe culture | 
|  17887-1 | Bacteria # 6 identified in Genital specimen by Aerobe culture | 
|  17888-9 | Bacteria # 2 identified in Nose by Aerobe culture | 
|  17889-7 | Bacteria # 3 identified in Nose by Aerobe culture | 
|  1789-7 | Deprecated Alpha aminobutyrate [Mass/volume] in Serum | 
|  17890-5 | Bacteria # 4 identified in Nose by Aerobe culture | 
|  17891-3 | Bacteria # 5 identified in Nose by Aerobe culture | 
|  17892-1 | Bacteria # 6 identified in Nose by Aerobe culture | 
|  17893-9 | Bacteria # 2 identified in Sputum by Aerobe culture | 
|  17894-7 | Bacteria # 3 identified in Sputum by Aerobe culture | 
|  17895-4 | Bacteria # 4 identified in Sputum by Aerobe culture | 
|  17896-2 | Bacteria # 5 identified in Sputum by Aerobe culture | 
|  17897-0 | Bacteria # 6 identified in Sputum by Aerobe culture | 
|  17898-8 | Bacteria identified in Throat by Aerobe culture | 
|  17899-6 | Bacteria # 2 identified in Throat by Aerobe culture | 
|  179-2 | Chlortetracycline [Susceptibility] by Serum bactericidal titer | 
|  1790-5 | Alpha aminobutyrate [Mass/volume] in Urine | 
|  17900-2 | Bacteria # 3 identified in Throat by Aerobe culture | 
|  17901-0 | Bacteria # 4 identified in Throat by Aerobe culture | 
|  17902-8 | Bacteria # 5 identified in Throat by Aerobe culture | 
|  17903-6 | Bacteria # 6 identified in Throat by Aerobe culture | 
|  17904-4 | Bacteria # 2 identified in Tissue by Aerobe culture | 
|  17905-1 | Bacteria # 3 identified in Tissue by Aerobe culture | 
|  17906-9 | Bacteria # 4 identified in Tissue by Aerobe culture | 
|  17907-7 | Bacteria # 5 identified in Tissue by Aerobe culture | 
|  17908-5 | Bacteria # 6 identified in Tissue by Aerobe culture | 
|  17909-3 | Bacteria identified in Wound deep by Aerobe culture | 
|  1791-3 | Alpha aminoadipate [Presence] in Plasma | 
|  17910-1 | Bacteria # 2 identified in Wound deep by Aerobe culture | 
|  17911-9 | Bacteria # 3 identified in Wound deep by Aerobe culture | 
|  17912-7 | Bacteria # 4 identified in Wound deep by Aerobe culture | 
|  17913-5 | Bacteria # 5 identified in Wound deep by Aerobe culture | 
|  17914-3 | Bacteria # 6 identified in Wound deep by Aerobe culture | 
|  17915-0 | Bacteria identified in Wound shallow by Aerobe culture | 
|  17916-8 | Bacteria # 2 identified in Wound shallow by Aerobe culture | 
|  17917-6 | Bacteria # 3 identified in Wound shallow by Aerobe culture | 
|  17918-4 | Bacteria # 4 identified in Wound shallow by Aerobe culture | 
|  17919-2 | Bacteria # 5 identified in Wound shallow by Aerobe culture | 
|  1792-1 | Alpha aminoadipate [Mass/volume] in Plasma | 
|  17920-0 | Bacteria # 6 identified in Wound shallow by Aerobe culture | 
|  17921-8 | Bacteria # 2 identified in Nose by Anaerobe culture | 
|  17922-6 | Bacteria # 3 identified in Nose by Anaerobe culture | 
|  17923-4 | Bacteria # 2 identified in Tissue by Anaerobe culture | 
|  17924-2 | Bacteria # 3 identified in Tissue by Anaerobe culture | 
|  17925-9 | Bacteria identified in Wound deep by Anaerobe culture | 
|  17926-7 | Bacteria # 2 identified in Wound deep by Anaerobe culture | 
|  17927-5 | Bacteria # 3 identified in Wound deep by Anaerobe culture | 
|  17928-3 | Bacteria identified in Blood by Aerobe culture | 
|  17929-1 | Bacteria # 2 identified in Blood by Aerobe culture | 
|  1793-9 | Alpha aminoadipate [Mass/volume] in Urine | 
|  17930-9 | Bacteria # 3 identified in Blood by Aerobe culture | 
|  17931-7 | Bacteria # 4 identified in Blood by Aerobe culture | 
|  17932-5 | Bacteria # 5 identified in Blood by Aerobe culture | 
|  17933-3 | Bacteria # 6 identified in Blood by Aerobe culture | 
|  17934-1 | Bacteria identified in Blood by Anaerobe culture | 
|  17935-8 | Bacteria # 2 identified in Blood by Anaerobe culture | 
|  17936-6 | Bacteria # 3 identified in Blood by Anaerobe culture | 
|  17937-4 | Bacteria # 2 identified in Burn by Culture | 
|  17938-2 | Bacteria # 3 identified in Burn by Culture | 
|  17939-0 | Bacteria # 4 identified in Burn by Culture | 
|  1794-7 | Amylase [Enzymatic activity/volume] in Duodenal fluid | 
|  17940-8 | Bacteria # 5 identified in Burn by Culture | 
|  17941-6 | Bacteria # 6 identified in Burn by Culture | 
|  17942-4 | Bacteria # 2 identified in Line specimen by IV Line culture | 
|  17943-2 | Bacteria # 3 identified in Line specimen by IV Line culture | 
|  17944-0 | Bacteria # 4 identified in Line specimen by IV Line culture | 
|  17945-7 | Bacteria # 5 identified in Line specimen by IV Line culture | 
|  17946-5 | Bacteria # 6 identified in Line specimen by IV Line culture | 
|  17947-3 | Fungus # 2 identified in Unspecified specimen by Culture | 
|  17948-1 | Fungus # 3 identified in Unspecified specimen by Culture | 
|  17949-9 | Fungus # 4 identified in Unspecified specimen by Culture | 
|  1795-4 | Amylase [Enzymatic activity/volume] in Body fluid | 
|  17950-7 | Deprecated Bacteria identified in Body fluid by Aerobe culture | 
|  17951-5 | Bacteria # 2 identified in Body fluid by Aerobe culture | 
|  17952-3 | Bacteria # 3 identified in Body fluid by Aerobe culture | 
|  17953-1 | Bacteria # 4 identified in Body fluid by Aerobe culture | 
|  17954-9 | Bacteria # 5 identified in Body fluid by Aerobe culture | 
|  17955-6 | Bacteria # 6 identified in Body fluid by Aerobe culture | 
|  17956-4 | Bacteria identified in Body fluid by Anaerobe culture | 
|  17957-2 | Bacteria # 2 identified in Body fluid by Anaerobe culture | 
|  17958-0 | Bacteria # 3 identified in Body fluid by Anaerobe culture | 
|  17959-8 | Bacteria # 2 identified in Peritoneal fluid by Culture | 
|  1796-2 | Amylase [Enzymatic activity/volume] in Pleural fluid | 
|  17960-6 | Bacteria # 3 identified in Peritoneal fluid by Culture | 
|  17961-4 | Bacteria # 4 identified in Peritoneal fluid by Culture | 
|  17962-2 | Bacteria # 5 identified in Peritoneal fluid by Culture | 
|  17963-0 | Bacteria # 6 identified in Peritoneal fluid by Culture | 
|  17964-8 | Bacteria # 2 identified in Stool by Culture | 
|  17965-5 | Bacteria # 3 identified in Stool by Culture | 
|  17966-3 | Bacteria # 4 identified in Stool by Culture | 
|  17967-1 | Bacteria # 5 identified in Stool by Culture | 
|  17968-9 | Bacteria # 6 identified in Stool by Culture | 
|  17969-7 | Deprecated Bacteria identified in Urine by Aerobe culture | 
|  1797-0 | Amylase [Enzymatic activity/volume] in Peritoneal fluid | 
|  17970-5 | Bacteria # 2 identified in Urine by Culture | 
|  17971-3 | Bacteria # 3 identified in Urine by Culture | 
|  17972-1 | Bacteria # 4 identified in Urine by Culture | 
|  17973-9 | Bacteria # 5 identified in Urine by Culture | 
|  17974-7 | Bacteria # 6 identified in Urine by Culture | 
|  17975-4 | Virus # 2 identified in Unspecified specimen by Culture | 
|  17976-2 | Virus # 3 identified in Unspecified specimen by Culture | 
|  17977-0 | Left atrial Apical 4 chamber [Area] by US 2D | 
|  17978-8 | Mitral valve Peak A wave by US.doppler | 
|  17979-6 | Anterior mitral valve leaflet A-C interval by US.M-mode | 
|  1798-8 | Amylase [Enzymatic activity/volume] in Serum or Plasma | 
|  17980-4 | Anterior mitral valve leaflet A-C slope [Velocity] by US.M-mode | 
|  17981-2 | Aortic valve Acceleration by US.doppler | 
|  17982-0 | Pulmonic valve Acceleration by US.doppler | 
|  17983-8 | Tricuspid valve Acceleration by US.doppler | 
|  17984-6 | Aortic valve area method | 
|  17985-3 | Left atrial AP dimension.left atrium/AP dimension.aorta root by US | 
|  17986-1 | Left ventricular Maximum Apical 2 chamber.diastole [Volume] by US 2D modified | 
|  17987-9 | Left ventricular Apical 2 chamber.systole.minimum [Volume] by US 2D modified | 
|  17988-7 | Right atrial Apical 4 chamber [Area] by US 2D | 
|  17989-5 | Left ventricular Maximum Apical 4 chamber.diastole [Volume] by US 2D modified | 
|  1799-6 | Amylase [Enzymatic activity/volume] in Urine | 
|  17990-3 | Left ventricular Apical 4 chamber.systole.minimum [Volume] by US 2D modified | 
|  17991-1 | Left ventricular Cardiac echo volume method | 
|  17992-9 | Aorta root Cardiac output by US.doppler | 
|  17993-7 | Mitral valve Cardiac output by US.doppler | 
|  17994-5 | Pulmonary artery Cardiac output by US | 
|  17995-2 | Aorta Maximum coarctation gradient [Pressure] by US.doppler | 
|  17996-0 | Aortic valve Maximum cusp separation [Length] by US | 
|  17997-8 | Anterior mitral valve leaflet D-E excursion [Length] by US.M-mode | 
|  17998-6 | Aortic valve regurgitant jet Deceleration [Time] by US.doppler | 
|  17999-4 | Mitral valve Deceleration [Time] by US.doppler | 
|  18-2 | Amoxicillin [Susceptibility] by Serum bactericidal titer | 
|  180-0 | Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1800-2 | Amylase [Enzymatic activity/time] in 24 hour Urine | 
|  18000-0 | Tricuspid valve Deceleration [Time] by US.doppler | 
|  18001-8 | Mitral valve Deceleration.pressure.half time by US.doppler | 
|  18002-6 | Mitral valve Deceleration slope [Acceleration] by US.doppler | 
|  18003-4 | Aortic valve regurgitant jet Deceleration time slope by US.doppler | 
|  18004-2 | Atrial septum Defect diameter by US | 
|  18005-9 | Ventricular septal Defect diameter by US | 
|  18006-7 | Inferior vena cava Diameter by US | 
|  18007-5 | Superior vena cava Diameter by US | 
|  18008-3 | Ventricular septal Defect.gradient.systole.maximum [Pressure] by US.doppler | 
|  18009-1 | Ventricular septal Defect.gradient.systole.mean [Pressure] by US.doppler | 
|  1801-0 | Amylase renal clearance in 24 hour | 
|  18010-9 | Aorta Diameter by US | 
|  18011-7 | Aorta arch and Neck Diameter by US | 
|  18012-5 | Ascending thoracic aorta Diameter by US | 
|  18013-3 | Descending thoracic aorta Diameter by US | 
|  18014-1 | Aorta isthmus Diameter by US | 
|  18015-8 | Aorta root annulo-aortic junction Diameter by US | 
|  18016-6 | Aortic valve annulus Diameter by US | 
|  18017-4 | Mitral valve annulus Diameter by US | 
|  18018-2 | Left ventricular outflow tract Diameter by US | 
|  18019-0 | Left pulmonary artery Diameter by US | 
|  1802-8 | Amylase.P1 [Enzymatic activity/volume] in Serum or Plasma | 
|  18020-8 | Main pulmonary artery Diameter by US | 
|  18021-6 | Right pulmonary artery Diameter by US | 
|  18022-4 | Pulmonic valve annulus Diameter by US | 
|  18023-2 | Tricuspid valve annulus Diameter by US | 
|  18024-0 | Left atrial Diameter anterior-posterior systole by US.M-mode | 
|  18025-7 | Heart Diameter anterior-posterior systole/Aortic root diameter by US | 
|  18026-5 | Left ventricular End-diastolic volume by US | 
|  18027-3 | Left ventricular End-diastolic volume by US.2D+Calculated by single-plane ellipse method | 
|  18028-1 | Left ventricular End-diastolic volume by US.2D+Calculated by biplane ellipse method | 
|  18029-9 | Left ventricular End-diastolic volume by US 2D modified | 
|  1803-6 | Amylase.P2 [Enzymatic activity/volume] in Serum or Plasma | 
|  18030-7 | Tricuspid valve Peak A wave by US.doppler | 
|  18031-5 | Tricuspid valve Peak E wave by US.doppler | 
|  18032-3 | Tricuspid valve Pressure half time during diastole by US.doppler | 
|  18033-1 | Left ventricular Diastole-systole [Volume] by US | 
|  18034-9 | Tricuspid valve regurgitant jet dP/dT (1 M/S to 3 M/S).systole [Pressure rate] by US.doppler | 
|  18035-6 | Mitral valve regurgitant jet dP/dT (1M/S to 3 M/S) [Pressure rate] by US.doppler continuous wave | 
|  18036-4 | Anterior mitral valve leaflet E point to septal separation [Time] by US.M-mode | 
|  18037-2 | Mitral valve Peak E wave by US.doppler | 
|  18038-0 | Mitral valve Peak E wave/Peak A wave by US.doppler | 
|  18039-8 | Tricuspid valve Peak E wave/Peak A wave by US.doppler | 
|  1804-4 | Amylase.P3 [Enzymatic activity/volume] in Serum or Plasma | 
|  18040-6 | Anterior mitral valve leaflet E-F slope [Velocity] by US.M-mode | 
|  18041-4 | Aortic valve Ejection time by US.doppler | 
|  18042-2 | Pulmonic valve Ejection time by US.doppler | 
|  18043-0 | Left ventricular Ejection fraction by US | 
|  18044-8 | Left ventricular Ejection fraction by US.2D+Calculated by single-plane ellipse method | 
|  18045-5 | Left ventricular Ejection fraction by US.2D+Calculated by biplane ellipse method | 
|  18046-3 | Left ventricular Ejection fraction by US 2D modified | 
|  18047-1 | Left ventricular Ejection fraction by US 2D modified biplane | 
|  18048-9 | Left ventricular Ejection fraction by US 2D modified single-plane | 
|  18049-7 | Left ventricular Ejection fraction by US.M-mode+Calculated by Teichholz method | 
|  1805-1 | Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma | 
|  18050-5 | Inferior vena cava Fractional collapse by US --inspiration | 
|  18051-3 | Left ventricular Fractional shortening minor axis by US | 
|  18052-1 | Right ventricular anterior wall Fractional thickening freewall by US | 
|  18053-9 | Left ventricular posterior wall Thickening.fractional change by US | 
|  18054-7 | Interventricular septum Fractional thickness; fractional change by US 2D | 
|  18055-4 | Tricuspid valve Maximum gradient during diastole [Pressure] by US.doppler | 
|  18056-2 | Tricuspid valve Mean gradient during diastole [Pressure] by US.doppler | 
|  18057-0 | Mitral valve Peak gradient [Pressure] by US.doppler | 
|  18058-8 | Pulmonic valve Peak gradient [Pressure] by US.doppler | 
|  18059-6 | Mitral valve Mean gradient [Pressure] by US.doppler | 
|  1806-9 | Amylase S1 [Enzymatic activity/volume] in Serum or Plasma | 
|  18060-4 | Pulmonic valve Mean gradient [Pressure] by US.doppler | 
|  18061-2 | Aortic valve Maximum gradient during systole [Pressure] by US.doppler derived full Bernoulli | 
|  18062-0 | Aortic valve Maximum gradient during systole [Pressure] by US.doppler+Calculated by simplified Bernoulli | 
|  18063-8 | Aortic valve Mean systole gradient [Pressure] by US.doppler+Calculated by simplified Bernoulli | 
|  18064-6 | Left ventricular outflow tract Maximum gradient during systole [Pressure] by US.doppler | 
|  18065-3 | Tricuspid valve regurgitant jet Maximum gradient during systole [Pressure] by US.doppler | 
|  18066-1 | Aortic valve Mean systole gradient [Pressure] by US.doppler derived full Bernoulli | 
|  18067-9 | Cardiac echo imaging device Image quality by US | 
|  18068-7 | Left ventricular Pre ejection time by US | 
|  18069-5 | Right atrial Intrachamber mean systole pressure by Estimated from jugular venous distention | 
|  1807-7 | Amylase S2 [Enzymatic activity/volume] in Serum or Plasma | 
|  18070-3 | Right atrial Intrachamber mean systole pressure by US | 
|  18071-1 | Left ventricular Isovolumic relaxation time by US.doppler | 
|  18072-9 | Left ventricular Major axis apical 2 chamber diastole [Length] by US 2D | 
|  18073-7 | Left ventricular Major axis apical 2 chamber systole [Length] by US 2D | 
|  18074-5 | Left ventricular Major axis apical 4 chamber diastole [Length] by US 2D | 
|  18075-2 | Left ventricular Major axis apical 4 chamber systole [Length] by US 2D | 
|  18076-0 | Left ventricular Major axis apical systole [Length] by US 2D | 
|  18077-8 | Left ventricular Major axis apical diastole [Length] by US 2D | 
|  18078-6 | Right ventricular Major axis diastole maximum [Length] by US 2D | 
|  18079-4 | Right ventricular Minimum major axis during systole [Length] by US 2D | 
|  1808-5 | Amylase S3 [Enzymatic activity/volume] in Serum or Plasma | 
|  18080-2 | Right ventricular outflow tract Peak systolic flow by US.doppler | 
|  18081-0 | Left ventricular Minor axis at end diastole.apical 4 chamber [Length] by US 2D | 
|  18082-8 | Left ventricular Minor axis at end systole.apical 4 chamber [Length] by US.M-mode | 
|  18083-6 | Left ventricular Internal diameter minor axis diastole by US 2D | 
|  18084-4 | Right ventricular Minor axis at end diastole [Length] by US 2D | 
|  18085-1 | Left ventricular Internal diameter minor axis systole by US 2D | 
|  18086-9 | Right ventricular Minor axis at end systole [Length] by US 2D | 
|  18087-7 | Left ventricular Myocardial mass by US | 
|  18088-5 | Left ventricular Myocardial mass by US.M-mode | 
|  18089-3 | Aortic valve Orifice [Area] by US | 
|  1809-3 | Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma | 
|  18090-1 | Aortic valve Orifice [Area] by US.continuity | 
|  18091-9 | Aortic valve Orifice [Area] by US.continuity.VTI+Area | 
|  18092-7 | Aortic valve Orifice [Area] by US.continuity.VTI+Diameter | 
|  18093-5 | Aortic valve Orifice [Area] by US.continuity.Vmax+Area | 
|  18094-3 | Aortic valve Orifice [Area] by US.continuity.Vmax+Diameter | 
|  18095-0 | Main pulmonary artery Crossection [Area] by US | 
|  18096-8 | Pulmonic valve Orifice [Area] by US.continuity | 
|  18097-6 | Mitral valve Minimum orifice [Area] by US.doppler pressure half time | 
|  18098-4 | Mitral valve Minimum orifice minor axis [Area] by US 2D | 
|  18099-2 | Left ventricular Apical plane 2 chamber diastole [Area] by US 2D | 
|  181-8 | Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1810-1 | Amylase/Creatinine [Mass Ratio] in Serum or Plasma | 
|  18100-8 | Left ventricular Apical plane 2 chamber systole [Area] by US 2D | 
|  18101-6 | Left ventricular Apical plane 4 chamber diastole [Area] by US 2D | 
|  18102-4 | Left ventricular Apical plane 4 chamber systole [Area] by US 2D | 
|  18103-2 | Left ventricular outflow tract Planimetry parasternal short axis [Area] by US 2D | 
|  18104-0 | Aortic valve Pressure half time by US.doppler | 
|  18105-7 | Aortic valve regurgitant jet Pressure half time by US.doppler | 
|  18106-5 | Cardiac Echo Study Procedure | 
|  18107-3 | Cardiac echo study Procedure stress method | 
|  18108-1 | Aortic valve Prosthetic valve type by US | 
|  18109-9 | Mitral valve Prosthetic valve type by US | 
|  1811-9 | Amylase/Creatinine renal clearance [Ratio] in 24 hour Urine and Serum or Plasma | 
|  18110-7 | Pulmonic valve Prosthetic valve type by US | 
|  18111-5 | Tricuspid valve Prosthetic valve type by US | 
|  18112-3 | Aortic valve Regurgitation degree by US.doppler | 
|  18113-1 | Mitral valve Regurgitation degree by US.doppler | 
|  18114-9 | Pulmonic valve Regurgitation degree by US.doppler | 
|  18115-6 | Tricuspid valve Regurgitation degree by US.doppler | 
|  18116-4 | Left ventricular Segmental wall appearance by US | 
|  18117-2 | Left ventricular Segmental wall motion by US score | 
|  18118-0 | Left ventricular Segmental wall motion Narrative by US | 
|  18119-8 | Left ventricular apical anterior Segmental wall motion by US | 
|  1812-7 | Alpha fucosidase [Enzymatic activity/mass] in Tissue | 
|  18120-6 | Left ventricular apical septum Segmental wall motion by US | 
|  18121-4 | Left ventricular basal anterior Segmental wall motion by US | 
|  18122-2 | Left ventricular basal anterior septum Segmental wall motion by US | 
|  18123-0 | Left ventricular basal inferior Segmental wall motion by US | 
|  18124-8 | Left ventricular basal lateral Segmental wall motion by US | 
|  18125-5 | Left ventricular basal posterior Segmental wall motion by US | 
|  18126-3 | Left ventricular basal septum Segmental wall motion by US | 
|  18127-1 | Left ventricular inferior apical Segmental wall motion by US | 
|  18128-9 | Left ventricular lateral apical Segmental wall motion by US | 
|  18129-7 | Left ventricular mid anterior Segmental wall motion by US | 
|  1813-5 | Alpha galactosidase A [Enzymatic activity/volume] in Serum or Plasma | 
|  18130-5 | Left ventricular mid anterior septum Segmental wall motion by US | 
|  18131-3 | Left ventricular mid inferior Segmental wall motion by US | 
|  18132-1 | Left ventricular mid lateral Segmental wall motion by US | 
|  18133-9 | Left ventricular mid posterior Segmental wall motion by US | 
|  18134-7 | Left ventricular mid septum Segmental wall motion by US | 
|  18135-4 | Left ventricular Minor axis.mitral level.diastole [Area] by US 2D | 
|  18136-2 | Left ventricular Minor axis.mitral level.systole [Area] by US 2D | 
|  18137-0 | Left ventricular Minor axis.papillary level.diastole [Area] by US 2D | 
|  18138-8 | Left ventricular Minor axis.papillary level.systole [Area] by US 2D | 
|  18139-6 | Stress study Stage by US | 
|  1814-3 | Acid alpha glucosidase [Enzymatic activity/volume] in Semen | 
|  18140-4 | Central cardiovascular Study observation by US | 
|  18141-2 | Central cardiovascular Study observation Narrative by US | 
|  18142-0 | Heart chambers Study observation by US | 
|  18143-8 | Heart chambers Study observation Narrative by US | 
|  18144-6 | Heart valves Study observation Narrative by US | 
|  18145-3 | Heart valves Study observation by US | 
|  18146-1 | Central cardiovascular Overall Study observation Narrative by US | 
|  18147-9 | Central cardiovascular Overall Study observation by US | 
|  18148-7 | Left ventricular End-systolic volume by US | 
|  18149-5 | Left ventricular End-systolic volume by US.2D+Calculated by single-plane ellipse method | 
|  1815-0 | Acid alpha glucosidase [Enzymatic activity/mass] in Tissue | 
|  18150-3 | Left ventricular End-systolic volume by US.2D+Calculated by biplane ellipse method | 
|  18151-1 | Left ventricular End-systolic volume by US 2D modified | 
|  18152-9 | Left ventricular posterior wall Thickness during diastole by US | 
|  18153-7 | Right ventricular anterior wall Thickness during diastole by US | 
|  18154-5 | Interventricular septum Thickness during diastole by US | 
|  18155-2 | Left ventricular Thickness septal wall/Thickness posterior wall by US | 
|  18156-0 | Left ventricular posterior wall Thickness during systole by US | 
|  18157-8 | Right ventricular anterior wall Thickness during systole by US | 
|  18158-6 | Interventricular septum Thickness during systole by US | 
|  18159-4 | Cardiac Echo Study Transducer site | 
|  1816-8 | Acid alpha glucosidase [Enzymatic activity/volume] in Leukocytes | 
|  18160-2 | Cardiac echo imaging device Class | 
|  18161-0 | Tricuspid valve Maximum blood flow by US.doppler | 
|  18162-8 | Pulmonic valve Maximum blood flow by US.doppler | 
|  18163-6 | Aorta root Peak systolic flow by US.doppler | 
|  18164-4 | Left ventricular outflow tract Peak systolic flow by US.doppler | 
|  18165-1 | Pulmonic valve regurgitant jet Peak diastole flow by US.doppler | 
|  18166-9 | Tricuspid valve regurgitant jet Peak systolic flow by US.doppler | 
|  18167-7 | Aorta root Mean systolic flow by US.doppler | 
|  18168-5 | Aorta root Blood velocity-time integral by US.doppler | 
|  18169-3 | Aortic valve Blood velocity-time integral by US.doppler | 
|  1817-6 | Alpha ketoglutarate [Mass/volume] in Serum or Plasma | 
|  18170-1 | Left ventricular outflow tract Blood velocity-time integral by US.doppler | 
|  18171-9 | Right ventricular outflow tract Blood velocity-time integral by US.doppler | 
|  18172-7 | Mitral valve Blood velocity-time integral by US.doppler | 
|  18173-5 | Pulmonary artery Blood velocity-time integral by US.doppler | 
|  18174-3 | Pulmonic valve Blood velocity-time integral by US.doppler | 
|  18175-0 | Tricuspid valve Velocity-time integral during diastole by US.doppler | 
|  18176-8 | Cardiac echo imaging device Vendor model number | 
|  18177-6 | Cardiac echo imaging device Vendor serial number | 
|  18178-4 | Left ventricular Wall motion index by US | 
|  18179-2 | Left ventricular Wall segment [Identifier] by US | 
|  1818-4 | Alpha mannosidase [Enzymatic activity/volume] in Serum or Plasma | 
|  18180-0 | Deprecated Albumin | 
|  18182-6 | Osmolality of Serum or Plasma by calculation | 
|  18183-4 | Melatonin [Mass/time] in 24 hour Urine | 
|  18184-2 | Erythrocyte sedimentation rate by 2H Westergren method | 
|  18185-9 | Gestational age | 
|  18186-7 | Calcium [Mass/time] in 12 hour Urine | 
|  18187-5 | Lorazepam [Presence] in Urine | 
|  18188-3 | Acebutolol [Mass/volume] in Unspecified specimen | 
|  18189-1 | Acetone [Mass/time] in 24 hour Urine | 
|  1819-2 | Alpha mannosidase [Enzymatic activity/mass] in Tissue | 
|  18190-9 | Acid phosphatase tartrate resistant [Presence] in Unspecified specimen | 
|  18191-7 | Amino acids [Identifier] in 24 hour Urine | 
|  18192-5 | Bacteria [Presence] in Nose by Light microscopy | 
|  18194-1 | Barium [Mass/time] in 24 hour Urine | 
|  18195-8 | Acid beta glucosidase [Presence] in Tissue | 
|  18196-6 | Beta-N-acetylhexosaminidase.A [Presence] in Tissue | 
|  18197-4 | Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid | 
|  18198-2 | Blastomyces dermatitidis IgE Ab [Presence] in Serum | 
|  18199-0 | Blastomyces dermatitidis IgG Ab [Presence] in Serum | 
|  182-6 | Cinoxacin [Susceptibility] by Disk diffusion (KB) | 
|  1820-0 | Alpha melanocyte stimulating hormone [Mass/volume] in Serum or Plasma | 
|  18200-6 | Blastomyces dermatitidis IgM Ab [Presence] in Serum | 
|  18201-4 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoblot (IB) | 
|  18202-2 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) | 
|  18203-0 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoblot (IB) | 
|  18204-8 | Caffeine renal clearance in 24 hour | 
|  18205-5 | Carbon disulfide [Presence] in Urine | 
|  18206-3 | Catecholamines [Mass/volume] in Plasma --7th specimen post XXX challenge | 
|  18208-9 | Cocaine [Mass/volume] in Unspecified specimen | 
|  18209-7 | Coenzyme Q10 [Units/volume] in Serum or Plasma | 
|  1821-8 | Alpha naphthylesterase [Enzymatic activity/volume] in Serum | 
|  18210-5 | Complement C1 esterase inhibitor bound IgG Ab [Mass/volume] in Serum or Plasma | 
|  18211-3 | Complement C1 esterase inhibitor bound IgM Ab [Mass/volume] in Serum or Plasma | 
|  18212-1 | Complement C1 esterase inhibitor free IgG Ab [Mass/volume] in Serum or Plasma | 
|  18213-9 | Complement C1 esterase inhibitor free IgM Ab [Mass/volume] in Serum or Plasma | 
|  18214-7 | Delta 5-Pregnanetriol [Mass/volume] in Urine | 
|  18215-4 | Delta alanine [Mass/volume] in Urine | 
|  18216-2 | Dezocine [Presence] in Urine by Confirmatory method | 
|  18217-0 | Epidermis IgA Ab [Presence] in Tissue | 
|  18218-8 | Epidermis IgM Ab [Presence] in Tissue | 
|  18219-6 | Epinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge | 
|  1822-6 | Alpha thymosin [Mass/volume] in Serum | 
|  18220-4 | Epinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge | 
|  18221-2 | Epinephrine [Mass/volume] in Urine --4th specimen post XXX challenge | 
|  18222-0 | Epinephrine [Mass/volume] in Urine --5th specimen post XXX challenge | 
|  18223-8 | Epinephrine [Mass/volume] in Urine --6th specimen post XXX challenge | 
|  18224-6 | Epinephrine [Mass/volume] in Urine --7th specimen post XXX challenge | 
|  18225-3 | Erythrocyte shape [Morphology] in Blood | 
|  18226-1 | Erythrocyte size [Morphology] in Blood | 
|  18227-9 | Glucose [Mass/time] in 6 hour Urine | 
|  18228-7 | Glucose-6-Phosphate dehydrogenase [Presence] in Tissue | 
|  18229-5 | Heparan sulfate [Presence] in Serum or Plasma | 
|  1823-4 | Alpha tocopherol [Mass/volume] in Serum or Plasma | 
|  18230-3 | Histone H2a+H2b Ab [Units/volume] in Serum | 
|  18231-1 | Histone H2a+H2b Ab [Presence] in Serum by Immunofluorescence | 
|  18232-9 | Hydrocorticosterone [Presence] in Urine | 
|  18233-7 | Influenza virus Ab [Units/volume] in Cerebral spinal fluid | 
|  18234-5 | Insulin [Presence] in Unknown substance | 
|  18235-2 | Ketone solvents [Identifier] in Blood | 
|  18236-0 | Lead [Presence] in Tissue | 
|  18237-8 | Legionella pneumophila atypical IgM Ab [Presence] in Serum | 
|  18238-6 | Lithium [Mass/mass] in Tissue | 
|  18239-4 | Lupus erythematosus factor [Mass/volume] in Blood by Latex agglutination | 
|  1824-2 | Alpha-1-Antichymotrypsin [Mass/volume] in Serum | 
|  18240-2 | 1,3-Dichlorobenzene [Mass/volume] in Blood | 
|  18241-0 | Cefoxitin IgE Ab [Units/volume] in Serum | 
|  18242-8 | Methyprylon [Mass/time] in 24 hour Urine | 
|  18243-6 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  18244-4 | Niacin [Mass/volume] in Serum or Plasma | 
|  18245-1 | Nickel [Mass/volume] in Unspecified specimen | 
|  18246-9 | Nitrogen [Mass/volume] in Stool | 
|  18247-7 | Nitrogen [Mass/volume] in Dialysis fluid | 
|  18248-5 | Nordiazepam [Mass/volume] in Stool | 
|  18249-3 | Para aminobenzoate [Mass/volume] in Serum or Plasma | 
|  1825-9 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma | 
|  18250-1 | Pentacarboxylporphyrins [Mass/volume] in Blood | 
|  18251-9 | Polychlorinated biphenyl (PCB) [Presence] in Tissue | 
|  18252-7 | Prednisone [Mass/time] in 24 hour Urine | 
|  18253-5 | Serotonin [Mass/time] in 24 hour Urine | 
|  18254-3 | Silicate [Mass/volume] in Body fluid | 
|  18255-0 | Sulfonylurea [Mass/volume] in Serum or Plasma | 
|  18256-8 | Sulfonylurea [Mass/volume] in Urine | 
|  18257-6 | Coproporphyrin [Mass/volume] in Blood | 
|  18258-4 | Trimethoprim IgE Ab [Units/volume] in Serum | 
|  18259-2 | Vasoactive intestinal peptide [Mass/time] in 24 hour Urine | 
|  1826-7 | Alpha 1 antitrypsin MM [Mass/volume] in Serum or Plasma | 
|  18260-0 | Zinc [Presence] in Tissue | 
|  18261-8 | Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate | 
|  18262-6 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 
|  18263-4 | Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate | 
|  18264-2 | Deprecated Direct bilirubin [Mass/volume] in Serum or Plasma | 
|  18265-9 | Acetaminophen [Presence] in Body fluid | 
|  18266-7 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Body fluid | 
|  18267-5 | CD16+CD56+ cells/100 cells in Blood | 
|  18268-3 | CD16+CD56+ cells/100 cells in Body fluid | 
|  18269-1 | Immune complex [Units/volume] in Body fluid | 
|  1827-5 | Alpha 1 antitrypsin MS [Mass/volume] in Serum or Plasma | 
|  18270-9 | Carbamazepine 10,11-Epoxide [Moles/volume] in Serum or Plasma | 
|  18271-7 | Alpha 1 antitrypsin fecal clearance in 24 hour | 
|  18272-5 | RNA Ab [Units/volume] in Serum | 
|  18273-3 | Blood group antibody screen [Presence] in Serum or Plasma from Blood product unit | 
|  18274-1 | Blood group antibody screen [Presence] in Serum or Plasma from donor | 
|  18275-8 | Blood group antigens present [Identifier] on Red Blood Cells from donor | 
|  18276-6 | Blood group antigens absent [Identifier] on Red Blood Cells from donor | 
|  18277-4 | Hemoglobin F [Presence] in Gastric fluid by Apt-Downey method | 
|  18278-2 | Hemoglobin F [Presence] in Meconium by Apt-Downey method | 
|  18279-0 | Deprecated Hemoglobin F [Presence] in Stool by Apt-Downey method | 
|  1828-3 | Alpha 1 antitrypsin MZ [Mass/volume] in Serum or Plasma | 
|  18280-8 | Background stain [Presence] in Blood by Light microscopy | 
|  18281-6 | Calcium [Moles/volume] corrected for total protein in Serum or Plasma | 
|  18282-4 | Cannabinoids [Presence] in Urine by Screen method | 
|  18283-2 | CD11 cells/100 cells in Blood | 
|  18284-0 | CD198 cells/100 cells in Blood | 
|  18285-7 | CDA cells/100 cells in Blood | 
|  18286-5 | Donath Landsteiner Ab [Presence] in Blood | 
|  18287-3 | Donath Landsteiner Ab [Presence] in control Serum and RBC | 
|  18288-1 | Donath Landsteiner Ab [Titer] in control Serum and RBC | 
|  18289-9 | Erythrocytes [Morphology] in Cerebral spinal fluid by Light microscopy | 
|  1829-1 | Alpha 1 antitrypsin SS [Mass/volume] in Serum or Plasma | 
|  18290-7 | Erythrocytes [Morphology] in Synovial fluid by Light microscopy | 
|  18291-5 | Hemoglobin F/Hemoglobin.total in Blood from newborn | 
|  18292-3 | Deprecated Hemoglobin.fetal/Hemoglobin.total^post amniocentesis | 
|  18293-1 | Deprecated Hemoglobin.fetal/Hemoglobin.total^post partum | 
|  18294-9 | Deprecated Hemoglobin.fetal/Hemoglobin.total^pre amniocentesis | 
|  18295-6 | Deprecated Hemoglobin.fetal/Hemoglobin.total^pre partum | 
|  18296-4 | Glucose [Interpretation] in Serum or Plasma--post dose glucose | 
|  18297-2 | Acid hemolysis [Mass/volume] of Red Blood Cells | 
|  18298-0 | High titer low avidity Ab [Presence] in Serum or Plasma | 
|  18299-8 | IgA [Presence] in Serum by Immunofixation | 
|  183-4 | Cinoxacin [Susceptibility] by Serum bactericidal titer | 
|  1830-9 | Alpha 1 antitrypsin SZ [Mass/volume] in Serum or Plasma | 
|  18300-4 | IgA [Presence] in Urine by Immunofixation | 
|  18301-2 | IgG [Presence] in Serum by Immunofixation | 
|  18302-0 | IgG [Presence] in Urine by Immunofixation | 
|  18303-8 | IgM [Presence] in Serum by Immunofixation | 
|  18304-6 | IgM [Presence] in Urine by Immunofixation | 
|  18305-3 | Amoeba identified in Aspirate by Iron hematoxylin stain | 
|  18306-1 | Hydatid cyst identified in Aspirate by Iron hematoxylin stain | 
|  18307-9 | Ova and parasites identified in Stool by Iron hematoxylin stain | 
|  18308-7 | Pneumocystis sp identified in Lung tissue by Immunohistochemical | 
|  18309-5 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Manual count | 
|  1831-7 | Alpha 1 antitrypsin ZZ [Mass/volume] in Serum or Plasma | 
|  18310-3 | Deprecated Hemoglobin.other/Hemoglobin.total [interpretation] in Blood | 
|  18311-1 | Pelger Huet cells [Presence] in Blood by Light microscopy | 
|  18312-9 | Platelet satellitism [Presence] in Blood by Light microscopy | 
|  18313-7 | Coagulation of Semen by Visual observation | 
|  18314-5 | Morphology [Interpretation] in Blood Narrative | 
|  18319-4 | Neutrophils.vacuolated [Presence] in Blood by Light microscopy | 
|  1832-5 | Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid | 
|  18320-2 | Globulin [Mass/volume] in Urine by calculation | 
|  18321-0 | Benzidine [Mass/volume] in Serum or Plasma | 
|  18322-8 | Norketamine [Mass/volume] in Urine | 
|  18323-6 | Smith extractable nuclear IgG Ab [Units/volume] in Serum | 
|  18324-4 | Cockatiel serum IgE Ab [Units/volume] in Serum | 
|  18325-1 | Oxymorphone [Presence] in Urine by Confirmatory method | 
|  18326-9 | Microscopic observation [Identifier] in Cervix by Other stain | 
|  18327-7 | Microscopic observation [Identifier] in Duodenal fluid by Other stain | 
|  18328-5 | Microscopic observation [Identifier] in Body fluid by Other stain | 
|  18329-3 | Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum | 
|  1833-3 | Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid | 
|  18330-1 | Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum | 
|  18331-9 | Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum | 
|  18332-7 | Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma | 
|  18333-5 | Echovirus 7 Ab [Units/volume] in Cerebral spinal fluid | 
|  18334-3 | Naltrexone [Presence] in Urine by Confirmatory method | 
|  18335-0 | Antihistamines [Presence] in Urine by Confirmatory method | 
|  18336-8 | Methyl tert-butyl ether [Mass/volume] in Blood | 
|  18337-6 | Hydroxyitraconazole [Mass/volume] in Serum or Plasma | 
|  18338-4 | Nortramadol [Mass/volume] in Urine | 
|  18339-2 | Nortramadol [Presence] in Serum or Plasma by Confirmatory method | 
|  1834-1 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma | 
|  18340-0 | Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  18341-8 | Propylene glycol [Mass/volume] in Urine | 
|  18342-6 | Glucose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | 
|  18343-4 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method | 
|  18344-2 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Platelets | 
|  18345-9 | Protein S Ag/Coagulation factor VII Ag Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay | 
|  18346-7 | Deprecated Streptococcus pneumoniae 56 IgG Ab [Units/volume] in Serum | 
|  18347-5 | Streptococcus pneumoniae 12 Ab [Units/volume] in Serum --2nd specimen | 
|  18348-3 | Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  18349-1 | CD8+CD25+ cells [#/volume] in Blood | 
|  1835-8 | Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma | 
|  18350-9 | CD8+CD57+ cells [#/volume] in Blood | 
|  18351-7 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | 
|  18352-5 | Volume of 4 hour Urine | 
|  18353-3 | Glucose [Mass/volume] in Serum or Plasma --6 hours post 50 g lactose PO | 
|  18354-1 | Glucose [Mass/volume] in Serum or Plasma --12 hours post 50 g lactose PO | 
|  18355-8 | Methylenedioxyamphetamine [Mass/volume] in Urine | 
|  18356-6 | Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma | 
|  18357-4 | Methylenedioxymethamphetamine [Mass/volume] in Blood | 
|  18358-2 | Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method | 
|  18359-0 | Methylenedioxyamphetamine [Mass/volume] in Blood | 
|  1836-6 | Alpha-2-Retinol binding protein [Mass/volume] in Serum or Plasma | 
|  18360-8 | 8-Hydroxyamoxapine [Mass/volume] in Urine | 
|  18361-6 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Urine | 
|  18362-4 | Alpha-2-Retinol binding protein [Mass/time] in 24 hour Urine | 
|  18363-2 | Carnitine free (C0) [Units/mass] in Tissue | 
|  18364-0 | Chondroitin sulfate [Mass/volume] in Serum | 
|  18365-7 | Cortisol Free [Mass/volume] in Saliva (oral fluid) | 
|  18366-5 | Cytochrome C oxidase [Enzymatic activity/mass] in Tissue | 
|  18367-3 | Iodine Free [Mass/volume] in Serum or Plasma | 
|  18368-1 | Magnesium [Moles/time] in 2 hour Urine | 
|  18369-9 | Magnesium [Moles/time] in 4 hour Urine | 
|  1837-4 | Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Serum or Plasma | 
|  18370-7 | Nitrite [Mass/volume] in Blood | 
|  18371-5 | Methyl parathion [Mass/volume] in Urine | 
|  18372-3 | Potassium [Moles/time] in 6 hour Urine | 
|  18373-1 | Protein [Mass/time] in 6 hour Urine | 
|  18374-9 | Riboflavin [Mass/volume] in 24 hour Urine | 
|  18375-6 | Deprecated Serotonin [Mass/volume] in Urine | 
|  18376-4 | Sodium [Moles/time] in 6 hour Urine | 
|  18377-2 | Sodium [Moles/time] in 12 hour Urine | 
|  18378-0 | Transcortin [Mass/volume] in Cerebral spinal fluid | 
|  18379-8 | Urate [Mass/time] in 6 hour Urine | 
|  1838-2 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Tissue | 
|  18380-6 | Uroporphyrinogen decarboxylase [Entitic Catalytic Activity] in Red Blood Cells | 
|  18381-4 | Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Blood | 
|  18382-2 | Dry weight [Mass/time] of 24 hour Stool | 
|  18383-0 | Alfentanil [Presence] in Urine | 
|  18384-8 | Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method | 
|  18385-5 | Butalbital [Presence] in Urine by Confirmatory method | 
|  18386-3 | Chlorothiazide [Presence] in Serum or Plasma | 
|  18387-1 | Diamorphine [Mass/volume] in Serum or Plasma | 
|  18388-9 | Diazepam [Presence] in Urine by Confirmatory method | 
|  18389-7 | Methaqualone [Presence] in Urine by Confirmatory method | 
|  1839-0 | Ammonia [Moles/volume] in Blood | 
|  18390-5 | Opiates [Presence] in Urine by Confirmatory method | 
|  18391-3 | Paraldehyde [Mass/volume] in Urine | 
|  18392-1 | Phencyclidine [Presence] in Urine by Confirmatory method | 
|  18393-9 | Quinidine+Quinine [Presence] in Urine | 
|  18394-7 | HLA-A24(9) [Presence] | 
|  18395-4 | Aspergillus niger Ab [Presence] in Cerebral spinal fluid | 
|  18396-2 | HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay | 
|  18397-0 | Polio virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation | 
|  18398-8 | Polio virus 2 Ab [Titer] in Cerebral spinal fluid by Complement fixation | 
|  18399-6 | Polio virus 3 Ab [Titer] in Cerebral spinal fluid by Complement fixation | 
|  184-2 | Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1840-8 | Ammonia [Moles/volume] in Cerebral spinal fluid | 
|  18400-2 | Spermatozoa IgA Ab [Units/volume] in Cervical mucus | 
|  18401-0 | Spermatozoa IgG Ab [Units/volume] in Cervical mucus | 
|  18402-8 | Spermatozoa IgA Ab [Units/volume] in Semen | 
|  18403-6 | Spermatozoa IgG Ab [Units/volume] in Semen | 
|  18404-4 | Spermatozoa IgM Ab [Units/volume] in Semen | 
|  18405-1 | Arsenate [Mass/volume] in Urine | 
|  18406-9 | Arsenic trioxide [Mass/volume] in Urine | 
|  18407-7 | Leukocytes in 12 hour Urine sediment by Light microscopy | 
|  18408-5 | CD3+HLA-DR+ cells/100 cells in Blood | 
|  18409-3 | Curvularia lunata IgG Ab [Units/volume] in Serum | 
|  1841-6 | Ammonia [Moles/volume] in Serum | 
|  18410-1 | Epicoccum purpurascens IgG Ab [Units/volume] in Serum | 
|  18411-9 | Rhizopus nigricans IgG Ab [Units/volume] in Serum | 
|  18412-7 | Stemphylium botryosum IgG Ab [Units/volume] in Serum | 
|  18413-5 | HLA-DR16 [Presence] | 
|  18414-3 | Psilocin [Presence] in Urine | 
|  18415-0 | Psilocin [Mass/volume] in Urine | 
|  18416-8 | Aspergillus nidulans IgG Ab [Units/volume] in Serum | 
|  18417-6 | Black Bean IgG Ab [Units/volume] in Serum | 
|  18418-4 | Casein IgA Ab [Units/volume] in Serum | 
|  18419-2 | Cephalosporine mold IgG Ab [Units/volume] in Serum | 
|  1842-4 | Ammonia [Moles/volume] in Urine | 
|  18420-0 | Chaetomium globosum IgG Ab [Units/volume] in Serum | 
|  18421-8 | Fusarium oxysporum IgG Ab [Units/volume] in Serum | 
|  18422-6 | Microcytes [Presence] in Urine by Light microscopy | 
|  18423-4 | Phthalic anhydride IgG Ab [Units/volume] in Serum | 
|  18424-2 | Phthalic anhydride IgM Ab [Units/volume] in Serum | 
|  18425-9 | Zucchini IgG Ab [Units/volume] in Serum | 
|  18426-7 | Aspergillus sp Ab [Presence] in Cerebral spinal fluid | 
|  18427-5 | Epstein Barr virus early Ab [Presence] in Body fluid | 
|  18428-3 | Epstein Barr virus nuclear IgG Ab [Presence] in Cerebral spinal fluid | 
|  18429-1 | Rickettsia rickettsii IgG Ab [Units/volume] in Cerebral spinal fluid | 
|  1843-2 | Ammonia nitrogen [Mass/time] in 24 hour Urine | 
|  18430-9 | Rickettsia rickettsii IgM Ab [Units/volume] in Cerebral spinal fluid | 
|  18431-7 | Amphetamines [Presence] in Stool by Screen method | 
|  18432-5 | Tetrahydrocannabinol [Presence] in Stool by Screen method | 
|  18433-3 | Deprecated 1,3-Dichlorobenzene [Mass/volume] in Blood | 
|  18434-1 | 1,2-Dichlorobenzene [Mass/volume] in Blood | 
|  18435-8 | Sufentanil [Presence] in Urine | 
|  18436-6 | Acetylcarnitine (C2) [Mass/volume] in Serum or Plasma | 
|  18437-4 | Acrylylcarnitine (C3:1) [Mass/volume] in Serum or Plasma | 
|  18438-2 | Propionylcarnitine (C3) [Mass/volume] in Serum or Plasma | 
|  18439-0 | Butyrylcarnitine (C4) [Mass/volume] in Serum or Plasma | 
|  1844-0 | Ammonium ion [Moles/volume] in Arterial blood | 
|  18440-8 | Crotonylcarnitine (C4:1) [Mass/volume] in Serum or Plasma | 
|  18441-6 | Isovalerylcarnitine (C5) [Mass/volume] in Serum or Plasma | 
|  18442-4 | 3-Hydroxybutyrylcarnitine (C4-OH) [Mass/volume] in Serum or Plasma | 
|  18443-2 | Hexanoylcarnitine (C6) [Mass/volume] in Serum or Plasma | 
|  18444-0 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Mass/volume] in Serum or Plasma | 
|  18445-7 | Benzoylcarnitine (BzCn) [Mass/volume] in Serum or Plasma | 
|  18446-5 | Methylmalonylcarnitine (C4-DC) [Mass/volume] in Serum or Plasma | 
|  18447-3 | Octenoylcarnitine (C8:1) [Mass/volume] in Serum or Plasma | 
|  18448-1 | Octanoylcarnitine (C8) [Mass/volume] in Serum or Plasma | 
|  18449-9 | Glutarylcarnitine (C5-DC) [Mass/volume] in Serum or Plasma | 
|  1845-7 | Ammonium ion [Moles/volume] in Plasma | 
|  18450-7 | Adipoylcarnitine (C6-DC) [Mass/volume] in Serum or Plasma | 
|  18451-5 | cis-4-Decenoylcarnitine (Cis 4 C10:1) [Mass/volume] in Serum or Plasma | 
|  18452-3 | Decanoylcarnitine (C10) [Mass/volume] in Serum or Plasma | 
|  18453-1 | Suberylcarnitine (C8-DC) [Mass/volume] in Serum or Plasma | 
|  18454-9 | Dodecenoylcarnitine (C12:1) [Mass/volume] in Serum or Plasma | 
|  18455-6 | Dodecanoylcarnitine (C12) [Mass/volume] in Serum or Plasma | 
|  18456-4 | Tetradecadienoylcarnitine (C14:2) [Mass/volume] in Serum or Plasma | 
|  18457-2 | Tetradecenoylcarnitine (C14:1) [Mass/volume] in Serum or Plasma | 
|  18458-0 | 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Mass/volume] in Serum or Plasma | 
|  18459-8 | 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Mass/volume] in Serum or Plasma | 
|  1846-5 | Amylo-alpha-1,6-glucosidase [Enzymatic activity/volume] in Red Blood Cells | 
|  18460-6 | Palmitoylcarnitine (C16) [Mass/volume] in Serum or Plasma | 
|  18461-4 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Mass/volume] in Serum or Plasma | 
|  18462-2 | Linoleoylcarnitine (C18:2) [Mass/volume] in Serum or Plasma | 
|  18463-0 | Oleoylcarnitine (C18:1) [Mass/volume] in Serum or Plasma | 
|  18464-8 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Mass/volume] in Serum or Plasma | 
|  18465-5 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Mass/volume] in Serum or Plasma | 
|  18466-3 | Dicarboxyoleylcarnitine (C18:1-DC) [Mass/volume] in Serum or Plasma | 
|  18467-1 | Venlafaxine [Mass/volume] in Urine | 
|  18468-9 | Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid | 
|  18469-7 | Methyclothiazide [Mass/volume] in Serum or Plasma | 
|  1847-3 | Amyloid associated protein [Mass/volume] in Serum | 
|  18470-5 | Norclomipramine [Mass/volume] in Urine | 
|  18471-3 | Metoclopramide [Mass/volume] in Urine | 
|  18472-1 | Organophosphate pesticides [Identifier] in Urine | 
|  18473-9 | Hydromorphone [Presence] in Urine by Confirmatory method | 
|  18474-7 | HER2 Ag [Presence] in Tissue by Immune stain | 
|  18475-4 | Phenylalanine/Creatinine [Molar ratio] in Urine | 
|  18476-2 | Uroporphyrinogen decarboxylase [Presence] in Red Blood Cells | 
|  18477-0 | Lithium [Moles/time] in 24 hour Urine | 
|  18478-8 | Human papilloma virus 16+18 DNA [Presence] in Tissue by DNA probe | 
|  18479-6 | Human papilloma virus 31+35+51 DNA [Presence] in Tissue by DNA probe | 
|  1848-1 | Androstanolone [Mass/volume] in Serum or Plasma | 
|  18480-4 | Human papilloma virus 6+11 DNA [Presence] in Tissue by DNA probe | 
|  18481-2 | Streptococcus pyogenes Ag [Presence] in Throat | 
|  18482-0 | Yeast [Presence] in Unspecified specimen by Organism specific culture | 
|  18483-8 | Yeast [Presence] in Genital specimen by Organism specific culture | 
|  18484-6 | Ku Ab [Presence] in Serum | 
|  18485-3 | Mi-2 Ab [Presence] in Serum | 
|  18486-1 | Methylenediamine [Presence] in Urine | 
|  18487-9 | Broad casts [#/area] in Urine sediment by Microscopy low power field | 
|  18488-7 | Calcium [Mass/volume] in 24 hour Urine | 
|  18489-5 | Valproate.protein bound [Mass/volume] in Serum or Plasma | 
|  1849-9 | Androstanolone [Mass/volume] in Semen | 
|  18490-3 | Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum by Immunofluorescence | 
|  18491-1 | Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum by Immunofluorescence | 
|  18492-9 | Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum by Immunofluorescence | 
|  18493-7 | Ova and parasites identified in Stool by Concentration--3rd specimen | 
|  18494-5 | Ova and parasites identified in Stool by Concentration--2nd specimen | 
|  18495-2 | Ova and parasites identified in Stool by Trichrome stain--3rd specimen | 
|  18496-0 | Ova and parasites identified in Stool by Trichrome stain--2nd specimen | 
|  18497-8 | Microscopic observation [Identifier] in Thyroid fine needle aspirate by Cyto stain | 
|  18498-6 | Microscopic observation [Identifier] in Breast fine needle aspirate by Cyto stain | 
|  18499-4 | Microscopic observation [Identifier] in Nipple discharge by Cyto stain | 
|  185-9 | Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1850-7 | Androstanediol [Mass/volume] in Urine | 
|  18500-9 | Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep | 
|  18501-7 | Microscopic observation [Identifier] in Buccal smear by Cyto stain | 
|  18502-5 | Microscopic observation [Identifier] in Deep tissue fine needle aspirate by Cyto stain | 
|  18503-3 | Microscopic observation [Identifier] in Superficial tissue fine needle aspirate by Cyto stain | 
|  18504-1 | PP interval mean | 
|  18505-8 | R-R interval (Mean value during study) by EKG | 
|  18506-6 | P wave axis horizontal plane Reference beat | 
|  18507-4 | QRS axis.horizontal plane Reference beat | 
|  18508-2 | R wave axis.horizontal plane | 
|  18509-0 | T wave axis.horizontal plane Reference beat | 
|  1851-5 | Androstenedione [Mass/volume] in Amniotic fluid | 
|  18510-8 | ST segment axis.horizontal plane | 
|  18511-6 | P wave onset [Time] Reference beat | 
|  18512-4 | P wave offset [Time] Reference beat | 
|  18513-2 | QRS onset [Time] Reference beat | 
|  18514-0 | QRS offset [Time] Reference beat | 
|  18515-7 | T wave offset [Time] Reference beat | 
|  18516-5 | P wave axis frontal plane Reference beat | 
|  18517-3 | QRS axis.frontal plane Reference beat | 
|  18518-1 | T wave axis.frontal plane Reference beat | 
|  18519-9 | Reference beat | 
|  1852-3 | Androstenedione [Mass/volume] in Capillary blood | 
|  18520-7 | P-R Interval Lead AVF | 
|  18521-5 | P-R Interval Lead AVL | 
|  18522-3 | P-R Interval Lead AVR | 
|  18523-1 | P-R Interval Lead I | 
|  18524-9 | P-R Interval Lead II | 
|  18525-6 | P-R Interval Lead III | 
|  18526-4 | P-R Interval Lead V1 | 
|  18527-2 | P-R Interval Lead V2 | 
|  18528-0 | P-R Interval Lead V3 | 
|  18529-8 | P-R Interval Lead V4 | 
|  1853-1 | Androstenedione [Mass/volume] in Semen | 
|  18530-6 | P-R Interval Lead V5 | 
|  18531-4 | P-R Interval Lead V6 | 
|  18532-2 | Q-T interval Lead AVF | 
|  18533-0 | Q-T interval Lead AVL | 
|  18534-8 | Q-T interval Lead AVR | 
|  18535-5 | Q-T interval Lead I | 
|  18536-3 | Q-T interval Lead II | 
|  18537-1 | Q-T interval Lead III | 
|  18538-9 | Q-T interval Lead V1 | 
|  18539-7 | Q-T interval Lead V2 | 
|  1854-9 | Androstenedione [Mass/volume] in Serum or Plasma | 
|  18540-5 | Q-T interval Lead V3 | 
|  18541-3 | Q-T interval Lead V4 | 
|  18542-1 | Q-T interval Lead V5 | 
|  18543-9 | Q-T interval Lead V6 | 
|  18544-7 | ST amplitude.J point+20 ms Lead AVF | 
|  18545-4 | ST amplitude.J point+20 ms Lead AVL | 
|  18546-2 | ST amplitude.J point+20 ms Lead AVR | 
|  18547-0 | ST amplitude.J point+20 ms Lead I | 
|  18548-8 | ST amplitude.J point+20 ms Lead II | 
|  18549-6 | ST amplitude.J point+20 ms Lead III | 
|  1855-6 | Androstenedione [Mass/volume] in Urine | 
|  18550-4 | ST amplitude.J point+20 ms Lead V1 | 
|  18551-2 | ST amplitude.J point+20 ms Lead V2 | 
|  18552-0 | ST amplitude.J point+20 ms Lead V3 | 
|  18553-8 | ST amplitude.J point+20 ms Lead V4 | 
|  18554-6 | ST amplitude.J point+20 ms Lead V5 | 
|  18555-3 | ST amplitude.J point+20 ms Lead V6 | 
|  18556-1 | ST amplitude.J point+60 ms Lead AVF | 
|  18557-9 | ST amplitude.J point+60 ms Lead AVL | 
|  18558-7 | ST amplitude.J point+60 ms Lead AVR | 
|  18559-5 | ST amplitude.J point+60 ms Lead I | 
|  1856-4 | Androsterone [Mass/volume] in Serum or Plasma | 
|  18560-3 | ST amplitude.J point+60 ms Lead II | 
|  18561-1 | ST amplitude.J point+60 ms Lead III | 
|  18562-9 | ST amplitude.J point+60 ms Lead V1 | 
|  18563-7 | ST amplitude.J point+60 ms Lead V2 | 
|  18564-5 | ST amplitude.J point+60 ms Lead V3 | 
|  18565-2 | ST amplitude.J point+60 ms Lead V4 | 
|  18566-0 | ST amplitude.J point+60 ms Lead V5 | 
|  18567-8 | ST amplitude.J point+60 ms Lead V6 | 
|  18568-6 | ST amplitude.J point+80 ms Lead AVF | 
|  18569-4 | ST amplitude.J point+80 ms Lead AVL | 
|  1857-2 | Angiotensin converting enzyme [Enzymatic activity/volume] in Blood | 
|  18570-2 | ST amplitude.J point+80 ms Lead AVR | 
|  18571-0 | ST amplitude.J point+80 ms Lead I | 
|  18572-8 | ST amplitude.J point+80 ms Lead II | 
|  18573-6 | ST amplitude.J point+80 ms Lead III | 
|  18574-4 | ST amplitude.J point+80 ms Lead V1 | 
|  18575-1 | ST amplitude.J point+80 ms Lead V2 | 
|  18576-9 | ST amplitude.J point+80 ms Lead V3 | 
|  18577-7 | ST amplitude.J point+80 ms Lead V4 | 
|  18578-5 | ST amplitude.J point+80 ms Lead V5 | 
|  18579-3 | ST amplitude.J point+80 ms Lead V6 | 
|  1858-0 | Angiotensin I [Mass/volume] in Plasma | 
|  18580-1 | Ambulance transport, Origination site | 
|  18581-9 | Ambulance transport, Origination site Address | 
|  18582-7 | Ambulance transport, Destination site Name | 
|  18583-5 | Ambulance transport, Destination site Address | 
|  18584-3 | Body weight at ambulance transport Set | 
|  18588-4 | Ambulance transport, Purpose of stretcher (narrative) | 
|  18589-2 | Ambulance transport, Admitted at destination facility | 
|  1859-8 | Angiotensin II [Mass/volume] in Cerebral spinal fluid | 
|  18591-8 | Confined to bed before ambulance transport | 
|  18592-6 | Confined to bed after ambulance transport | 
|  18593-4 | Ambulance transport, Discharged from origin institution | 
|  18594-2 | Psychiatric service attachment | 
|  18598-3 | Control number identification.claims attachment | 
|  186-7 | Ciprofloxacin [Susceptibility] by Disk diffusion (KB) | 
|  1860-6 | Angiotensin II [Mass/volume] in Plasma | 
|  18600-7 | Primary practitioner identifier | 
|  18601-5 | Primary practitioner profession | 
|  18602-3 | ED practitioner identifier | 
|  18605-6 | Medication current Set | 
|  18606-4 | Current medication, Name and Identifier | 
|  18607-2 | Current medication Dose | 
|  18608-0 | Current medication, Timing + Quantity | 
|  18609-8 | Current medication, Route | 
|  1861-4 | Angiotensinogen [Mass/volume] in Plasma | 
|  18610-6 | Medication administered Set | 
|  18611-4 | Administered medication, Name and Identifier | 
|  18612-2 | Administered medication, Route | 
|  18614-8 | Administered medication, Timing | 
|  18615-5 | Medication administered Dose | 
|  18616-3 | Administered medication, Strength | 
|  18617-1 | Medication discharge Set | 
|  18618-9 | Discharge medication, Name and Identifier | 
|  18619-7 | Discharge medication Dose | 
|  1862-2 | Aniline [Mass/volume] in Serum or Plasma | 
|  18620-5 | Discharge medication, Timing + Quantity | 
|  18621-3 | Discharge medication, Route | 
|  18622-1 | Discharge medication, Amount dispensed | 
|  18623-9 | Discharge medication, Refills | 
|  18624-7 | ED problem (narrative) | 
|  18626-2 | Psychiatric rehabilitation treatment plan, New/revised | 
|  18627-0 | Psychiatric rehabilitation treatment plan, Date onset or exacerbation of primary diagnosis | 
|  18628-8 | Deprecated Psychiatric rehabilitation treatment plan, start date | 
|  18629-6 | Deprecated Clinical discipline - Psychiatric rehabilitation treatment plan | 
|  1863-0 | Anion gap 4 in Serum or Plasma | 
|  18630-4 | Primary diagnosis | 
|  18631-2 | Psychiatric rehabilitation treatment plan, Diagnosis addressed by plan Set | 
|  18632-0 | Psychiatric rehabilitation treatment plan, Author of treatment plan Set | 
|  18633-8 | Psychiatric rehabilitation treatment plan, Author name | 
|  18634-6 | Psychiatric rehabilitation treatment plan, Author profession Identifier | 
|  18635-3 | Psychiatric rehabilitation treatment plan, Signature date Date and time | 
|  18637-9 | Psychiatric rehabilitation treatment plan, Visit frequency TQ2 | 
|  18638-7 | Psychiatric rehabilitation treatment plan, Visit duration Time | 
|  18639-5 | Psychiatric rehabilitation treatment plan, Date range (from/through) described by plan Set | 
|  1864-8 | Anserine [Mass/volume] in Cerebral spinal fluid | 
|  18640-3 | Psychiatric rehabilitation treatment plan, Start date | 
|  18641-1 | Psychiatric rehabilitation treatment plan, End date | 
|  18642-9 | Psychiatric rehabilitation treatment plan, Date range (from/through) Set | 
|  18643-7 | Psychiatric rehabilitation treatment plan, Start date of hospitalization leading to treatment | 
|  18644-5 | Psychiatric rehabilitation treatment plan, End date of hospitalization leading to treatment | 
|  18645-2 | Psychiatric rehabilitation treatment plan, Continuation status | 
|  18646-0 | Psychiatric rehabilitation treatment plan, Date attending MD referred patient for Date | 
|  18647-8 | Psychiatric rehabilitation treatment plan, Date attending MD signed Date and time | 
|  18648-6 | Psychiatric rehabilitation treatment plan, Date rehabilitation professional signed Date and time | 
|  18649-4 | Psychiatric rehabilitation treatment plan, Signature of responsible attending physician on file | 
|  1865-5 | Anserine [Presence] in Serum or Plasma | 
|  18650-2 | Psychiatric rehabilitation treatment plan, Signature of responsible rehabilitation professional on file | 
|  18651-0 | Psychiatric rehabilitation treatment plan, Medication administered Set | 
|  18652-8 | Psychiatric rehabilitation treatment plan, Prognosis for rehabilitation | 
|  18653-6 | Psychiatric rehabilitation treatment plan, Estimated date of completion Date | 
|  18654-4 | Psychiatric rehabilitation treatment plan, Date of last plan of treatment certification | 
|  18655-1 | Psychiatric rehabilitation treatment plan, Past medical history and Level of function (narrative) | 
|  18656-9 | Psychiatric rehabilitation treatment plan Initial evaluation note (narrative) | 
|  18657-7 | Psychiatric rehabilitation treatment plan, Plan of treatment (narrative) | 
|  18658-5 | Psychiatric rehabilitation treatment plan Progress note and attainment of goals (narrative) | 
|  18659-3 | Psychiatric rehabilitation treatment plan, Reason to continue (narrative) | 
|  1866-3 | Anserine [Mass/volume] in Serum or Plasma | 
|  18660-1 | Psychiatric rehabilitation treatment plan, Justification (narrative) | 
|  18661-9 | Psychiatric rehabilitation treatment plan, Psychiatric symptoms (narrative) | 
|  18662-7 | Alcohol-substance abuse rehabilitation treatment plan, Chief complaint+Reason for referral+Reason for relapse if known (narrative) | 
|  18663-5 | Alcohol-substance abuse, rehabilitation plan, History of present alcohol/substance abuse (narrative) | 
|  18664-3 | Rehabilitation treatment plan, Follow-up approach Set | 
|  18665-0 | Alcohol-substance abuse rehabilitation treatment plan, Agency that will follow up Identifier | 
|  18666-8 | Alcohol-substance abuse rehabilitation treatment plan, Person that will follow up after Identifier | 
|  18667-6 | Alcohol-substance abuse rehabilitation treatment plan, Methodology for follow up (narrative) Text | 
|  18668-4 | Alcohol-substance abuse rehabilitation treatment plan, Frequency of assessments for follow up # | 
|  18669-2 | Rehabilitation treatment plan, Level of patient participation Text | 
|  1867-1 | Anserine [Mass/volume] in Urine | 
|  18670-0 | Rehabilitation treatment plan, Date of next planned rehabilitation treatment Set | 
|  18671-8 | Psychiatric rehabilitation treatment plan, Next plan of treatment (narrative) Text | 
|  18672-6 | Alcohol or substance abuse symptoms with physiological dependence indicator | 
|  18673-4 | Alcohol-substance abuse rehabilitation treatment plan, rehabilitation problem remission status | 
|  18674-2 | Alcohol-substance abuse rehabilitation treatment plan, longest period of sobriety for abused substance (composite) | 
|  18675-9 | Alcohol-substance abuse rehabilitation treatment plan, abused substance | 
|  18676-7 | Alcohol-substance abuse rehabilitation treatment plan, longest period of sobriety | 
|  18677-5 | Service claims attachment | 
|  18679-1 | ED claims attachment (composite) | 
|  1868-9 | Antithrombin Ag [Mass/volume] in Platelet poor plasma by Immunologic method | 
|  18682-5 | Ambulance claims attachment | 
|  18684-1 | First Blood pressure Set | 
|  18685-8 | First Blood pressure special circumstances | 
|  18686-6 | First Respiration rate Set | 
|  18687-4 | First Respiration rate special circumstances | 
|  18688-2 | First Body temperature Set | 
|  18689-0 | First Body temperature special circumstances | 
|  1869-7 | Apolipoprotein A-I [Mass/volume] in Serum or Plasma | 
|  18690-8 | First Body weight Set | 
|  18692-4 | First Body weight special circumstances | 
|  18693-2 | ED consultant practitioner Set | 
|  18694-0 | ED consultant practitioner name | 
|  18695-7 | ED clinical finding type | 
|  18696-5 | ED clinical finding (narrative) | 
|  18697-3 | ED clinical finding data source | 
|  18698-1 | ED clinical finding (composite) | 
|  18699-9 | ED practitioner Set | 
|  187-5 | Ciprofloxacin [Susceptibility] by Serum bactericidal titer | 
|  1870-5 | Apolipoprotein A-II [Mass/volume] in Serum or Plasma | 
|  18700-5 | ED practitioner name | 
|  18701-3 | ED practitioner profession | 
|  18702-1 | ED practitioner role | 
|  18703-9 | ED diagnostic procedure results Set | 
|  18704-7 | ED referring practitioner Set | 
|  18705-4 | ED referring practitioner name | 
|  18706-2 | ED referring practitioner identifier | 
|  18707-0 | ED referring practitioner profession | 
|  18708-8 | First Heart rate Set | 
|  18709-6 | First Heart rate special circumstances | 
|  1871-3 | Apolipoprotein B-100 [Mass/volume] in Serum or Plasma | 
|  18710-4 | Primary practitioner Set | 
|  18711-2 | Primary practitioner name | 
|  18716-1 | Allergy studies (set) | 
|  18717-9 | Blood bank studies (set) | 
|  18718-7 | Cell marker studies (set) | 
|  18719-5 | Chemistry studies (set) | 
|  1872-1 | Apolipoprotein B-150 [Mass/volume] in Serum or Plasma | 
|  18720-3 | Coagulation studies (set) | 
|  18721-1 | Therapeutic drug monitoring studies (set) | 
|  18722-9 | Fertility studies (set) | 
|  18723-7 | Hematology studies (set) | 
|  18724-5 | HLA studies (set) | 
|  18725-2 | Microbiology studies (set) | 
|  18726-0 | Radiology studies (set) | 
|  18727-8 | Serology studies (set) | 
|  18728-6 | Toxicology studies (set) | 
|  18729-4 | Urinalysis studies (set) | 
|  1873-9 | Apolipoprotein B-48 [Mass/volume] in Serum or Plasma | 
|  18730-2 | Psychiatric rehabilitation treatment plan, Author ID Identifier | 
|  18733-6 | Physician attending Progress note | 
|  18734-4 | Occupational therapy Initial evaluation note | 
|  18735-1 | Physical therapy Initial evaluation note | 
|  18736-9 | Physician Initial evaluation note | 
|  18737-7 | Podiatry Initial evaluation note | 
|  18738-5 | Psychology Initial evaluation note | 
|  18739-3 | Social work Initial evaluation note | 
|  1874-7 | Apolipoprotein B/Apolipoprotein A-I [Mass Ratio] in Serum or Plasma | 
|  18740-1 | Speech-language pathology Initial evaluation note | 
|  18741-9 | Deprecated Attending physician progress note | 
|  18742-7 | Arthroscopy study | 
|  18743-5 | Autopsy report | 
|  18744-3 | Bronchoscopy study | 
|  18745-0 | Cardiac catheterization study | 
|  18746-8 | Colonoscopy Study | 
|  18747-6 | Deprecated CT Unspecified system Study | 
|  18748-4 | Diagnostic imaging study | 
|  18749-2 | Electromyogram study | 
|  1875-4 | Apolipoprotein C-I [Mass/volume] in Serum or Plasma | 
|  18750-0 | Electrophysiology study | 
|  18751-8 | Endoscopy study | 
|  18752-6 | Exercise stress test study | 
|  18753-4 | Flexible sigmoidoscopy study | 
|  18754-2 | Holter monitor study | 
|  18755-9 | Deprecated MRI Unspecified site study | 
|  18756-7 | MR Spine study | 
|  18757-5 | Deprecated Nuclear medicine study | 
|  18758-3 | Deprecated PET scan Unspecified system Study | 
|  18759-1 | Spirometry study | 
|  1876-2 | Apolipoprotein C-II [Mass/volume] in Serum or Plasma | 
|  18760-9 | Deprecated US Unspecified system Study | 
|  18761-7 | Provider-unspecified Transfer summary | 
|  18762-5 | Deprecated Chiropractor Progress note | 
|  18763-3 | Physician consulting Initial evaluation note | 
|  18764-1 | Deprecated Nurse practitioner Progress note | 
|  18765-8 | Deprecated Podiatry visit note | 
|  18766-6 | Deprecated Psychology visit note | 
|  18767-4 | Blood gas studies (set) | 
|  18768-2 | Cell counts+Differential studies (set) | 
|  18769-0 | Microbial susceptibility tests Set | 
|  1877-0 | Apolipoprotein C-III [Mass/volume] in Serum or Plasma | 
|  18770-8 | Dictating practitioner name | 
|  18771-6 | Provider signing name | 
|  18772-4 | Surgeon.resident name | 
|  18773-2 | Surgeon.staff name | 
|  18774-0 | Staff practitioner name | 
|  18775-7 | Staff practitioner identifier | 
|  18776-5 | Plan of care | 
|  18777-3 | Psychiatric rehabilitation treatment plan, Primary diagnosis (narrative) | 
|  18779-9 | Radiology Comparison study - date and time | 
|  1878-8 | Apolipoprotein A-III [Mass/volume] in Serum or Plasma | 
|  18780-7 | Ordering practitioner identifier | 
|  18781-5 | Ordering practitioner name | 
|  18782-3 | Radiology Study observation (narrative) | 
|  18783-1 | Radiology Study recommendation (narrative) | 
|  18785-6 | Radiology Reason for study (narrative) | 
|  18789-8 | Include all data of the selected type within the date window associated with the service | 
|  1879-6 | Apolipoprotein E2 [Mass/volume] in Serum or Plasma | 
|  18790-6 | Include all data of the selected type on or before the date of service | 
|  18791-4 | Include all data of the selected type within or aligned to an encounter by the same service or encounter | 
|  18792-2 | Include all data of the selected type on or after the date of service | 
|  18793-0 | Use no fixed time limit on data (any of the selected type are relevant no matter when obtained) | 
|  18794-8 | Send all items of the specified type within the time window | 
|  18795-5 | Send all items of the specified type within the time window relevant to the service | 
|  18796-3 | Send all abnormals within the time window | 
|  18797-1 | Send the first abnormals within the time window | 
|  18798-9 | Send the last abnormals within the time window | 
|  18799-7 | Send the first (i.e., oldest) result for each kind of observation in the time window | 
|  188-3 | Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC) | 
|  1880-4 | Beta 2 glycoprotein 1 [Mass/volume] in Serum or Plasma | 
|  18800-3 | Send the worst abnormal result for each kind of observation in the time window | 
|  18802-9 | Send the last (most recent) within the time window | 
|  18803-7 | Include all data of the selected type that represents observations made 30 days or fewer before the starting date of service | 
|  18804-5 | Include all data of the selected type that represents observations made 3 months or fewer before the starting date of service | 
|  18805-2 | Include all data of the selected type that represents observations made six months or fewer before the starting date of service | 
|  18806-0 | Include all data of the selected type that represents observations made nine months or fewer before the starting date of service | 
|  18807-8 | Include all data of the selected type that represents observations made one year or less before the starting date of service | 
|  1881-2 | Apolipoprotein LPA [Mass/volume] in Serum or Plasma | 
|  18810-2 | EKG Study observation overall (narrative) | 
|  18812-8 | Ambulance transport, Ordering practitioner Identifier | 
|  18813-6 | Ambulance transport, Ordering practitioner name | 
|  18814-4 | Ambulance transport, Reason for scheduled trip | 
|  18815-1 | Ambulance transport, Reason for scheduled trip additional service information (narrative) | 
|  18816-9 | Medication name + identifier | 
|  18817-7 | Medication dose | 
|  18818-5 | Medication timing + Quantity | 
|  18819-3 | Psychiatric rehabilitation treatment plan, Medication route Identifier | 
|  1882-0 | Apolipoprotein LPQ [Mass/volume] in Serum or Plasma | 
|  18820-1 | Psychiatric rehabilitation treatment plan, Primary diagnosis Identifier | 
|  18821-9 | Diagnosis addressed by plan | 
|  18822-7 | Diagnosis addressed by plan (narrative) | 
|  18823-5 | Alcohol and/or substance abuse service attachment | 
|  18824-3 | Cardiac service attachment | 
|  18825-0 | Medical social services attachment | 
|  18826-8 | Occupational therapy service attachment | 
|  1883-8 | Apolipoprotein A [Mass/volume] in Serum or Plasma | 
|  18833-4 | First Body weight | 
|  18834-2 | Radiology Comparison study (narrative) | 
|  18835-9 | Aortic valve area method Narrative | 
|  18836-7 | Cardiac stress study Procedure | 
|  18837-5 | Left ventricle Segmental wall appearance by US Narrative | 
|  18838-3 | Cardiac echo study Transducer site Narrative | 
|  18839-1 | Cardiac echo imaging device Class Narrative | 
|  1884-6 | Apolipoprotein B [Mass/volume] in Serum or Plasma | 
|  18840-9 | Left ventricular Wall motion index by US Narrative | 
|  18841-7 | Hospital consultations Document | 
|  18842-5 | Discharge summary | 
|  18843-3 | EKG Comparison study (narrative) | 
|  18844-1 | EKG impression Narrative | 
|  18845-8 | Reference beat type (narrative) by EKG | 
|  18846-6 | Examination level ultrasound (narrative) | 
|  18847-4 | Narrative Fetal position palpation | 
|  18848-2 | Narrative Fetal position US | 
|  18849-0 | Narrative Fetal presentation palpation | 
|  1885-3 | Apolipoprotein C [Mass/volume] in Serum or Plasma | 
|  18850-8 | Narrative Fetal presentation US | 
|  18851-6 | Fetal Placenta Grade US (narrative) | 
|  18852-4 | Deprecated Operative note - surgical drains (narrative) | 
|  18855-7 | 5-Fluorocytosine [Susceptibility] | 
|  18857-3 | Almecillin [Susceptibility] | 
|  18859-9 | Amdinocillin [Susceptibility] | 
|  1886-1 | Apolipoprotein E [Mass/volume] in Serum or Plasma | 
|  18860-7 | Amikacin [Susceptibility] | 
|  18861-5 | Amoxicillin [Susceptibility] | 
|  18862-3 | Amoxicillin+Clavulanate [Susceptibility] | 
|  18863-1 | Amphotericin B [Susceptibility] | 
|  18864-9 | Ampicillin [Susceptibility] | 
|  18865-6 | Ampicillin+Sulbactam [Susceptibility] | 
|  18866-4 | Azithromycin [Susceptibility] | 
|  18867-2 | Azlocillin [Susceptibility] | 
|  18868-0 | Aztreonam [Susceptibility] | 
|  18869-8 | Bacampicillin [Susceptibility] | 
|  1887-9 | Appearance of Amniotic fluid | 
|  18870-6 | Bacitracin [Susceptibility] | 
|  18871-4 | Butirosin [Susceptibility] | 
|  18872-2 | Capreomycin [Susceptibility] | 
|  18873-0 | Carbenicillin [Susceptibility] | 
|  18874-8 | Cefaclor [Susceptibility] | 
|  18875-5 | Cefadroxil [Susceptibility] | 
|  18876-3 | Cefamandole [Susceptibility] | 
|  18877-1 | Cefatrizine [Susceptibility] | 
|  18878-9 | Cefazolin [Susceptibility] | 
|  18879-7 | Cefepime [Susceptibility] | 
|  1888-7 | Aquacobalamin [Mass/volume] in Serum or Plasma | 
|  18880-5 | Cefixime [Susceptibility] | 
|  18881-3 | Cefmetazole [Susceptibility] | 
|  18882-1 | Cefodizime [Susceptibility] | 
|  18883-9 | Cefonicid [Susceptibility] | 
|  18884-7 | Cefoperazone [Susceptibility] | 
|  18885-4 | Ceforanide [Susceptibility] | 
|  18886-2 | Cefotaxime [Susceptibility] | 
|  18887-0 | Cefotetan [Susceptibility] | 
|  18888-8 | Cefoxitin [Susceptibility] | 
|  18889-6 | Cefpirome [Susceptibility] | 
|  1889-5 | Arachidonate (C20:4w6) [Mass/volume] in Serum or Plasma | 
|  18890-4 | Cefpodoxime [Susceptibility] | 
|  18891-2 | Cefprozil [Susceptibility] | 
|  18892-0 | Cefsulodin [Susceptibility] | 
|  18893-8 | Ceftazidime [Susceptibility] | 
|  18894-6 | Ceftizoxime [Susceptibility] | 
|  18895-3 | Ceftriaxone [Susceptibility] | 
|  18896-1 | Cefuroxime Parenteral [Susceptibility] | 
|  18897-9 | Cephalexin [Susceptibility] | 
|  18898-7 | Cephaloglycin [Susceptibility] | 
|  18899-5 | Cephaloridine [Susceptibility] | 
|  189-1 | Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | 
|  1890-3 | Arginase [Enzymatic activity/volume] in Red Blood Cells | 
|  18900-1 | Cephalothin [Susceptibility] | 
|  18901-9 | Cephapirin [Susceptibility] | 
|  18902-7 | Cephradine [Susceptibility] | 
|  18903-5 | Chloramphenicol [Susceptibility] | 
|  18904-3 | Chlortetracycline [Susceptibility] | 
|  18905-0 | Cinoxacin [Susceptibility] | 
|  18906-8 | Ciprofloxacin [Susceptibility] | 
|  18907-6 | Clarithromycin [Susceptibility] | 
|  18908-4 | Clindamycin [Susceptibility] | 
|  18909-2 | Clotrimazole [Susceptibility] | 
|  1891-1 | Arginine [Mass/volume] in Cerebral spinal fluid | 
|  18910-0 | Cloxacillin [Susceptibility] | 
|  18911-8 | Colistimethate | 
|  18912-6 | Colistin [Susceptibility] | 
|  18913-4 | Cyclacillin [Susceptibility] | 
|  18914-2 | Cycloserine [Susceptibility] | 
|  18915-9 | Demeclocycline [Susceptibility] | 
|  18916-7 | Dicloxacillin [Susceptibility] | 
|  18917-5 | Doxycycline [Susceptibility] | 
|  18918-3 | Enoxacin [Susceptibility] | 
|  18919-1 | Erythromycin [Susceptibility] | 
|  1892-9 | Arginine [Presence] in Serum or Plasma | 
|  18920-9 | Erythromycin+Sulfisoxazole [Susceptibility] | 
|  18921-7 | Ethambutol [Susceptibility] | 
|  18922-5 | Ethionamide [Susceptibility] | 
|  18923-3 | Floxacillin [Susceptibility] | 
|  18924-1 | Fluconazole [Susceptibility] | 
|  18925-8 | Deprecated 5-Fluorocytosine [Susceptibility] | 
|  18926-6 | Framycetin [Susceptibility] | 
|  18927-4 | Fusidate [Susceptibility] | 
|  18928-2 | Gentamicin [Susceptibility] | 
|  18929-0 | Gentamicin.high potency [Susceptibility] | 
|  1893-7 | Arginine [Mass/volume] in Serum or Plasma | 
|  18930-8 | Gramicidin D [Susceptibility] | 
|  18931-6 | Hetacillin [Susceptibility] | 
|  18932-4 | Imipenem [Susceptibility] | 
|  18933-2 | Deprecated Imipenem+Cilastatin [Susceptibility] | 
|  18934-0 | Isoniazid [Susceptibility] | 
|  18935-7 | Kanamycin [Susceptibility] | 
|  18936-5 | Kanamycin.high potency [Susceptibility] | 
|  18937-3 | Ketoconazole [Susceptibility] | 
|  18938-1 | Lincomycin [Susceptibility] | 
|  18939-9 | Lomefloxacin [Susceptibility] | 
|  1894-5 | Arginine [Mass/volume] in Urine | 
|  18940-7 | Loracarbef [Susceptibility] | 
|  18941-5 | Lymecycline [Susceptibility] | 
|  18942-3 | Meclocycline [Susceptibility] | 
|  18943-1 | Meropenem [Susceptibility] | 
|  18944-9 | Methacycline [Susceptibility] | 
|  18945-6 | Methicillin [Susceptibility] | 
|  18946-4 | Metronidazole [Susceptibility] | 
|  18947-2 | Mezlocillin [Susceptibility] | 
|  18948-0 | Minocycline [Susceptibility] | 
|  18949-8 | Miocamycin [Susceptibility] | 
|  1895-2 | Arginine [Mass/time] in 24 hour Urine | 
|  18950-6 | Moxalactam [Susceptibility] | 
|  18951-4 | Nafcillin [Susceptibility] | 
|  18952-2 | Nalidixate [Susceptibility] | 
|  18953-0 | Neomycin [Susceptibility] | 
|  18954-8 | Netilmicin [Susceptibility] | 
|  18955-5 | Nitrofurantoin [Susceptibility] | 
|  18956-3 | Norfloxacin [Susceptibility] | 
|  18957-1 | Novobiocin [Susceptibility] | 
|  18958-9 | Nystatin [Susceptibility] | 
|  18959-7 | Ofloxacin [Susceptibility] | 
|  1896-0 | Argininosuccinate [Mass/volume] in Serum or Plasma | 
|  18960-5 | Oleandomycin [Susceptibility] | 
|  18961-3 | Oxacillin [Susceptibility] | 
|  18962-1 | Oxytetracycline [Susceptibility] | 
|  18963-9 | Pefloxacin [Susceptibility] | 
|  18964-7 | Penicillin [Susceptibility] | 
|  18965-4 | Penicillin G [Susceptibility] | 
|  18966-2 | Penicillin V [Susceptibility] | 
|  18967-0 | Phenethicillin [Susceptibility] | 
|  18968-8 | Pipemidate [Susceptibility] | 
|  18969-6 | Piperacillin [Susceptibility] | 
|  1897-8 | Argininosuccinate [Mass/volume] in Urine | 
|  18970-4 | Piperacillin+Tazobactam [Susceptibility] | 
|  18971-2 | Pivampicillin [Susceptibility] | 
|  18972-0 | Polymyxin B [Susceptibility] | 
|  18973-8 | Pyrazinamide [Susceptibility] | 
|  18974-6 | Rifampin [Susceptibility] | 
|  18975-3 | Ristocetin [Susceptibility] | 
|  18976-1 | Rolitetracycline [Susceptibility] | 
|  18977-9 | Rosoxacin [Susceptibility] | 
|  18978-7 | Roxithromycin [Susceptibility] | 
|  18979-5 | Sisomicin [Susceptibility] | 
|  1898-6 | Argininosuccinate lyase [Enzymatic activity/volume] in Serum | 
|  18980-3 | Spectinomycin [Susceptibility] | 
|  18981-1 | Spiramycin [Susceptibility] | 
|  18982-9 | Streptomycin [Susceptibility] | 
|  18983-7 | Streptomycin.high potency [Susceptibility] | 
|  18984-5 | Sulfadiazine [Susceptibility] | 
|  18985-2 | Sulfamethoxazole [Susceptibility] | 
|  18986-0 | Sulfisoxazole [Susceptibility] | 
|  18987-8 | Sulfonamide [Susceptibility] | 
|  18988-6 | Talampicillin [Susceptibility] | 
|  18989-4 | Teicoplanin [Susceptibility] | 
|  1899-4 | Argininosuccinate synthase [Enzymatic activity/mass] in Tissue | 
|  18990-2 | Temafloxacin [Susceptibility] | 
|  18991-0 | Temocillin [Susceptibility] | 
|  18992-8 | Terbinafine [Susceptibility] | 
|  18993-6 | Tetracycline [Susceptibility] | 
|  18994-4 | Ticarcillin [Susceptibility] | 
|  18995-1 | Ticarcillin+Clavulanate [Susceptibility] | 
|  18996-9 | Tobramycin [Susceptibility] | 
|  18997-7 | Trimethoprim [Susceptibility] | 
|  18998-5 | Trimethoprim+Sulfamethoxazole [Susceptibility] | 
|  18999-3 | Troleandomycin [Susceptibility] | 
|  19-0 | Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) | 
|  190-9 | Clarithromycin [Susceptibility] by Disk diffusion (KB) | 
|  1900-0 | Arylamidase [Enzymatic activity/volume] in Serum | 
|  19000-9 | Vancomycin [Susceptibility] | 
|  19001-7 | Viomycin [Susceptibility] | 
|  19002-5 | Physical therapy service attachment | 
|  19003-3 | Respiratory therapy service attachment | 
|  19004-1 | Skilled nursing service attachment | 
|  19005-8 | Radiology Imaging study [Impression] (narrative) | 
|  19006-6 | Cardiac echo imaging device Image quality Narrative by US | 
|  19007-4 | Psychiatric rehabilitation treatment plan, Primary diagnosis Set | 
|  19008-2 | Transducer site Narrative | 
|  19009-0 | Medication current (narrative) | 
|  1901-8 | Arylsulfatase [Enzymatic activity/volume] in Serum or Plasma | 
|  19010-8 | Medication discharge (narrative) | 
|  19011-6 | Medication administered (narrative) | 
|  19012-4 | Discharge medication, Substitution instruction | 
|  19013-2 | Medications current report request | 
|  19014-0 | Medications discharge report request | 
|  19015-7 | Medications administered report request | 
|  19016-5 | X12 277, all requests for information that are included in this transaction are stated for individual services | 
|  1902-6 | Ascorbate [Mass/volume] in Blood | 
|  19021-5 | Palpitation Cervix Study observation (narrative) | 
|  19022-3 | Neisseria meningitidis C+w135 Ag [Presence] in Cerebral spinal fluid | 
|  19023-1 | Granulocytes/100 leukocytes in Blood by Automated count | 
|  1903-4 | Ascorbate [Mass/volume] in Serum or Plasma | 
|  1904-2 | Ascorbate [Presence] in Urine | 
|  19044-7 | Fish Feed IgE Ab RAST class [Presence] in Serum | 
|  19045-4 | Salmon IgG Ab RAST class [Presence] in Serum | 
|  19046-2 | Deprecated Bovine serum albumin (BSA) IgE Ab RAST class in Serum | 
|  19047-0 | Tuna IgG Ab RAST class [Presence] in Serum | 
|  19048-8 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood | 
|  19049-6 | Metanephrine [Mass/time] in 24 hour Urine | 
|  1905-9 | Ascorbate [Mass/time] in 24 hour Urine | 
|  19050-4 | Metanephrines [Mass/volume] in 24 hour Urine | 
|  19051-2 | Saquinavir [Mass/volume] in Serum or Plasma | 
|  19052-0 | Borrelia burgdorferi DNA [Presence] in Urine by Probe with amplification | 
|  19053-8 | Brucella sp Ab [Titer] in Serum by Agglutination | 
|  19054-6 | Mycoplasma pneumoniae [Presence] in Unspecified specimen by Organism specific culture | 
|  19055-3 | Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine | 
|  19056-1 | Mercury [Presence] in Urine | 
|  19057-9 | ABO and Rh group [Type] in Blood from newborn | 
|  19058-7 | Allergens identified in Serum | 
|  19059-5 | Amphetamines cutoff [Mass/volume] in Urine | 
|  1906-7 | Asparagine [Mass/volume] in Cerebral spinal fluid | 
|  19060-3 | Deprecated Blood group antibodies identified in Serum or Plasma | 
|  19064-5 | Benzodiazepines cutoff [Mass/volume] in Urine | 
|  19065-2 | Benzoylecgonine cutoff [Mass/volume] in Urine | 
|  19066-0 | Blood bank comment | 
|  1907-5 | Asparagine [Presence] in Serum or Plasma | 
|  19071-0 | Blood removed from patient [Volume] | 
|  19072-8 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma | 
|  19073-6 | Cannabinoids cutoff [Mass/volume] in Urine | 
|  19074-4 | Carnitine esters [Moles/volume] in Serum or Plasma | 
|  19075-1 | Cells Counted Total [#] in Cerebral spinal fluid | 
|  19076-9 | Cells Counted Total [#] in Unspecified specimen | 
|  19077-7 | Cells identified in Body fluid | 
|  19078-5 | CD23 cells/100 cells in Unspecified specimen | 
|  19079-3 | CD43 cells/100 cells in Unspecified specimen | 
|  1908-3 | Asparagine [Mass/volume] in Serum or Plasma | 
|  19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma | 
|  19085-0 | Deprecated Collection duration of Urine - time unspecified | 
|  19086-8 | Collection of urine specimen end date | 
|  19087-6 | Collection of urine specimen end time | 
|  19088-4 | Collection of urine specimen start date | 
|  19089-2 | Collection of urine specimen start time | 
|  1909-1 | Asparagine [Mass/volume] in Urine | 
|  19090-0 | Colony count [#/volume] in Urine | 
|  19091-8 | Colony count [#] in Urine by Visual count | 
|  19092-6 | Cotinine cutoff [Mass/volume] in Urine | 
|  19096-7 | Electrolytes - single valence [Interpretation] in 24 hour Urine Narrative | 
|  19098-3 | Erythrocytes [Presence] in Amniotic fluid | 
|  19099-1 | Events counted [#] in Unspecified specimen | 
|  191-7 | Clarithromycin [Susceptibility] by Serum bactericidal titer | 
|  1910-9 | Asparagine [Mass/time] in 24 hour Urine | 
|  19101-5 | Fungus colony count [#/volume] in Unspecified specimen by Culture | 
|  19102-3 | Genetic screen in Unspecified specimen by Molecular genetics method Narrative | 
|  19104-9 | Glucose [Interpretation] in Serum or Plasma--1 hour post dose glucose | 
|  19105-6 | Glucose [Interpretation] in Serum or Plasma--3 hours post dose glucose | 
|  19106-4 | Herpes simplex virus IgG Ab [Presence] in Serum | 
|  19107-2 | Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA) | 
|  19108-0 | Histoplasma capsulatum Ag [Presence] in Serum | 
|  19109-8 | Histoplasma capsulatum Ag [Presence] in Unspecified specimen | 
|  1911-7 | Aspartate [Mass/volume] in Cerebral spinal fluid | 
|  19110-6 | HIV 1 gp41+gp43 Ab [Presence] in Serum by Immunoblot (IB) | 
|  19111-4 | Mother's hospital number | 
|  19113-0 | IgE [Units/volume] in Serum or Plasma | 
|  19114-8 | Lamellar bodies [#/volume] in Amniotic fluid | 
|  1912-5 | Aspartate [Presence] in Serum or Plasma | 
|  19122-1 | CD42 cells/100 cells in Blood | 
|  19123-9 | Magnesium [Mass/volume] in Serum or Plasma | 
|  19124-7 | Magnesium [Mass/volume] in Urine | 
|  19125-4 | Meconium [Presence] in Amniotic fluid | 
|  19126-2 | Bacteria identified in Bone marrow by Aerobe culture | 
|  19127-0 | Bacteria identified in Sputum by Acute Respiratoy Distress (ARDS) culture | 
|  19128-8 | Bacteria identified in Catheter tip by Culture | 
|  19129-6 | Microscopic observation [Identifier] in Tissue by Biopsy culture | 
|  1913-3 | Aspartate [Mass/volume] in Serum or Plasma | 
|  19132-0 | Mother's name | 
|  19133-8 | Neisseria meningitidis A+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination | 
|  19134-6 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination | 
|  19137-9 | Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot (IB) | 
|  19138-7 | Opiates cutoff [Mass/volume] in Urine | 
|  19139-5 | Pathologist name | 
|  1914-1 | Aspartate [Mass/volume] in Urine | 
|  19140-3 | Phospholipid Ab [Presence] in Serum | 
|  19141-1 | Propoxyphene [Presence] in Urine | 
|  19144-5 | Reason for drug test [Interpretation] | 
|  19145-2 | Reference lab test name | 
|  19146-0 | Reference lab test results | 
|  19147-8 | Reference lab test reference range | 
|  19148-6 | RhoGam candidate (yes/no) | 
|  19149-4 | Rifabutin [Susceptibility] | 
|  1915-8 | Aspartate [Mass/time] in 24 hour Urine | 
|  19150-2 | Specimen creatinine acceptable [Presence] in Urine | 
|  19151-0 | Specimen drawn [Date and time] of Serum or Plasma | 
|  19152-8 | Specimen specific gravity acceptable [Presence] in Urine | 
|  19153-6 | Volume in Urine collected for unspecified duration | 
|  19156-9 | Susceptibility method - Unspecified specimen | 
|  19157-7 | Tube number of Cerebral spinal fluid |